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Studies towards C-C bond activation-based methodologies involving strained ring systems 
are presented. The work aims to develop further directing group-assisted cyclisations developed 
in Bristol. Specifically, aminocyclopropane-based and related ring systems were examined to 
identify suitable substrates for directed transition metal-catalysed ring cleavage and subsequent 
transformations. 
Rare examples of carbonylative rearrangements of aminocyclopropanes using a temporary 
directing group have been discovered. The process involves an unusual ring contraction and can 
be used to provide a range of γ-lactams. The method is conceptually unique compared to other 
temporary directing group strategies used in C-C bond activation. 
Investigations into substrates for intramolecular nucleophilic addition to C-C bond 
activation derived metallacycles identified aminocyclopropanes equipped with anilines as suitable 
substrates. These cyclopropanes undergo carbonylative cyclisation to form 8-membered N-
heterocycles. Studies were also undertaken to evaluate a range of alternative substrates with 
tethered nucleophiles under carbonylative conditions. 
A novel (3+1+2) cycloaddition between aminocyclopropanes, CO and tethered 
π-unsaturates has been developed. An extensive study of the reaction scope was undertaken, and 
conditions for asymmetric cycloadditions were identified. This methodology provides the first 
examples of highly enantioselective C-C bond activations of aminocyclopropanes. 
Additionally, the reactivity of various homologated aminocyclopropanes was investigated. 
A previously developed carbonylative rearrangement of aminomethylcyclopropanes to 
α-aminocyclopentanones was re-evaluated. Second-generation conditions were optimised and 
these offered enhanced efficiencies for certain substrates. The carbonylative rearrangement was 
integrated into cascade and tandem processes to access various polycyclic products (e.g. 
spirocycles and indoles). 
Efforts to achieve challenging C-C bond activation-triggered transformations of 
aminocyclobutanes are described. Several representative aminocyclobutane-based substrates were 
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Aspects of this Chapter have been adapted from a review article. 
(Sokolova, O. O.; Bower, J. F. Chem. Rev. 2021, In press) 
1.1 Transition metal-assisted C-C single-bond cleavage 
Catalytic processes involving oxidative addition of a transition metal into a C-C bond 
(“C-C bond activation”) allow the atom economical assembly of complex scaffolds.1-4 Examples 
of stoichiometric C-C bond cleavage by transition metals have been known since 1955,5,6 but the 
catalytic application of this process has gained traction only in the last few decades. This can be 
attributed to the challenging nature of C-C bond activation.7 Competing C-H bond activation is 
usually favoured due to greater orbital availability, the statistical abundance of C-H bonds (vs. 
C-C bonds), and the lower activation energy barrier (0-9 kcal/mol for C-H insertion vs. 13-27 
kcal/mol for C-C insertion of second row late transition metals).8,9 These considerations mean that 
C-C bond activation is usually a kinetically unfavoured process. Moreover, oxidative insertion of 
transition metals into relatively stable C-C bonds (approximate bond energy of 90 kcal/mol) is 
thermodynamically unfavoured because two weak metal-carbon bonds (approximate bond 
energies of 20–30 kcal/mol) are formed instead.10 Nonetheless, C-C bond activation 
methodologies remain highly attractive from a synthetic viewpoint as they offer a direct and 
unconventional approach towards target molecules that might otherwise require multistep 
synthesis.  
The focus of the work presented in this dissertation is on C-C bond activation-based 
methodologies involving strained ring systems. This introduction aims to cover key early 
investigations into carbonylative processes involving C-C bond cleavage of cyclopropanes via 
oxidative addition of transition metals (Scheme 1A). Recent developments in C-C bond activation 
of cyclopropylamines are of particular interest to the research contained within this dissertation 
and are reviewed in depth here. An overview of asymmetric methodologies involving C-C bond 
activation is provided in Chapter 4. Processes involving C-C bond activation of cyclobutane-based 
systems are discussed in Chapter 6. It should be noted that transition metal-catalysed C(sp3)-C(sp3) 
bond cleavage can also be achieved via -carbon elimination (Scheme 1B)11,12 or the activation of 
specialised unstrained compounds (e.g. pincer ligands, Scheme 1C);13,14 these kinds of processes 
are not discussed in detail here because they are not directly relevant to studies described later. 
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Scheme 1: Strategies for transition metal-catalysed C(sp3)-C(sp3) bond cleavage. 
 
1.2 Carbonylative C-C bond activation of cyclopropanes 
Small ring systems, in particular cyclopropanes, play an important role in C-C bond 
activation as the release of ring strain, in addition to high orbital availability, facilitates metal 
insertion.7,15 The desirable bond angle for sp3 hybridised carbons is 109.5°, but the strained 
structure of cyclopropane forces internal bond angles to be 60°. This difference means the C-C 
bonds bend outward, leading to partial rehybridisation and increased p character. Indeed, 
calculations show that the natural hybrid orbitals of cyclopropane C-C bonds are sp3.46 hybridised 
(vs. sp2.56 for ethane). 16,17 To some extent, this makes the HOMO and LUMO of cyclopropane 
similar to π and π* orbitals of alkenes and, as a result, bonding with transition metals is highly 
favoured for cyclopropane-based systems compared to linear alkanes (Figure 1). 
 
Figure 1: Walsh model for metal-cyclopropane orbital interaction. 
Early reports on C-C bond activation focused on the use of activated cyclopropane-based 
rings, such as cyclopropenes, alkylidene cyclopropanes, vinylidene cyclopropanes and vinyl 
cyclopropanes (Scheme 2A).2,18-23 More recent methodologies have enabled the routine 
exploitation of less activated cyclopropane-based substrates in reaction design. As discussed 
above, the intrinsic ring strain of cyclopropanes facilitates metal insertion into their C-C bond. 
However, the instability of the resulting metallacyclobutanes, which are prone to β-elimination, 
limits their use in reaction design (Scheme 2B). A viable strategy for making productive use of 
cyclopropane derived metallacyclobutanes is to trap them with CO, as the CO insertion process is 
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fast compared to β-hydride elimination. The resulting metallacyclopentanones are less strained 
and much more stable. In 1968, Wilkinson and co-workers24 showed, through stoichiometric 
studies, that rhodacyclopentanone 1 (which is dimeric via chloride bridging) can be generated by 
exposure of cyclopropane to [Rh(CO)2Cl]2. For substituted cyclopropanes 2, the regioselectivity 
of transition metal oxidative addition and CO migratory insertion is uncertain, and can, in 
principle, lead to multiple regioisomers of the rhodacyclopentanone (Scheme 2B, top). 
Rhodacyclopentanones can also be accessed by C-C bond activation of cyclobutanones 3 (Scheme 
2C). Usually oxidative insertion of a transition metal to cyclobutanones occurs at bond a, adjacent 
to the carbonyl, allowing more precise regiocontrol. This process has underpinned many 
methodologies, with significant contributions from the groups of Murakami25-28 and, later, 
Cramer29-31 and Dong32-35 (for details of some processes involving C-C activation of 
cyclobutanones, see Chapter 4, Schemes 60-62). Despite the improved regioselectivity, the 
shortcoming of cyclobutanone-based processes is that synthetic routes to the starting material are 
less flexible compared to cyclopropanes. 
 
Scheme 2: (A) Three-membered ring systems used in C-C oxidative addition processes; (B) and (C) Cleavage of 
cyclopropanes and cyclobutanones by C−C bond activation. 
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McQuillin and Powell36,37 have examined the regioselectivity of carbonylative C-C bond 
activation of substituted cyclopropanes through stoichiometric studies, which revealed that this 
aspect is substrate dependent (Scheme 3A). For benzylcyclopropane 4, oxidative insertion into the 
more sterically accessible bond b gave 5, whereas phenylcyclopropane 6 delivered 7 via cleavage 
of more hindered but also more activated bond a. The issue of enforcing the regioselectivity of 
transition metal oxidative addition of substituted cyclopropanes was addressed by Chirik and co-
workers.38 They studied the C-C bond cleavage of cyclopropanes 8 and 11, which contain 
coordinating and non-coordinating substituents, respectively (Scheme 3B). It was found that 
branched olefin 10 formed when cyclopropane 8 was used. Mechanistically, oxidative addition of 
Rh into less sterically hindered distal bond a provides rhodacyclobutane 9, which undergoes β-
hydride elimination and C-H reductive elimination to give branched alkene 10. When the O-
substituent was switched to a coordinating phosphinite, the reaction efficiency dramatically 
increased and complete conversion of starting cyclopropane 11 was observed in 6 h (as opposed 
to 55 h for 8). The reaction regioselectivity also switched, and this was attributed to the phosphinite 
directing metal insertion into the more hindered proximal bond b, thereby favouring the formation 
of rhodacyclobutane 12. From this intermediate, β-hydride elimination and C-H reductive 
elimination affords linear alkene 13. Accordingly, directing groups can have a strong influence on 
reaction rate and regioselectivity in transition metal-catalysed C-C bond activations of 
cyclopropanes. 
 
Scheme 3: (A) C-C bond activation regioselectivity studies with substituted cyclopropanes. (B) Non-directed and 
directed C-C bond activation of a cyclopropane. 
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Other types of directing group strategy have been employed for accessing 
rhodacyclopentanones by carbonylative C-C bond activation. Narasaka and Koga used 
cyclopropane 14 to obtain bicyclic products via an intramolecular (3+1+2) cycloaddition39 that is 
superficially similar to the Pauson-Khand reaction (Scheme 4A).40-42 The selective formation of 
rhodacyclopentanone 15 is governed by the tethered alkyne, which directs oxidative addition of 
the pre-coordinated Rh catalyst into the less sterically accessible cyclopropane bond a. This is 
followed by CO insertion (to 15), alkyne insertion and C-C reductive elimination to generate 
cycloadduct 16 along with a small amount of oxidised product 17. The reactivity of trans-
disubstituted cyclopropane 18 was studied as well: C-C bond activation-triggered cycloaddition of 
18 delivered regioisomers 19a and 19b, resulting from insertion into bond a and b, respectively 
(Scheme 4B). The products were formed in a 3:1 ratio favouring 19a, which indicates a preference 
for cleavage of the less sterically hindered bond a. In these studies, products arising from cleavage 
of bond c were not observed, emphasizing the role of the alkyne in directing oxidative addition. 
Scheme 4: Alkyne-directed carbonylative (3+1+2) cycloadditions of cyclopropanes. 
1.3 Directed C-C bond activation of cyclopropylamines  
An alternative strategy for achieving regiocontrol during the formation of 
metallacyclopentanones is to use a nitrogen-based directing group. Rhodium-catalysed 
carbonylation of simple cyclopropylamine to give γ-lactams was reported by Iqbal in 1971 
(Scheme 5A).43 Here, major lactam product 20 was formed alongside other lactams 21-23. A 
mechanism was not advanced for these processes, but product 20 could conceivably form via the 
directed formation of a rhodacyclopentanone.  
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Further developments in this area occurred much later when directing-group promoted C-C 
bond activations of cyclopropylamines were developed in Bristol.2,44,45 Early work focused on a 
prototype (3+1+2) cycloaddition process for the preparation of bicyclic products, such as 26 and 
27 (Scheme 5B).46 These studies were inspired by the seminal work from Narasaka and Koga (see 
Scheme 4),39 where a tethered alkyne unit was used to direct insertion of Rh into the cyclopropane 
C-C bond. In contrast, the process in Scheme 5 uses the urea directing group of 24 to enhance the 
rate and control the regioselectivity of rhodacyclopentanone (25) formation. Directing group 
dissociation, alkyne insertion and C-C reductive elimination then leads to the targets. Subsequent 
studies showed that, under specific conditions and for certain substrates, replacement of 
[Rh(cod)Cl]2 with [Rh(cod)2]OTf leads to higher yields and shorter reaction times.
47 
 
Scheme 5: (A) First examples of the carbonylation of aminocyclopropane; (B) Rh-catalysed carbonylative (3+1+2) 
cycloadditions of aminocyclopropanes and alkynes. 
The process in Scheme 5B was underpinned by detailed studies on the directed C-C bond 
activation step. Under non-carbonylative conditions, different directing groups (e.g. sulfonamides, 
amides and carbamates) were evaluated for their ability to direct formation of the key 
rhodacyclobutane (28). In the event, sufonamides, amides and carbamates were all effective, as 
evidenced by the formation (via β-hydride elimination and C-H reductive elimination) of linear N-
alkenyl products 29 (Scheme 6A). Model rhodacyclopentanones 30a-c could also be isolated and 
analysis of their CO stretching frequencies revealed that urea directing groups are stronger donors 
than carbamates or amides (Scheme 6B). For the process in Scheme 5B, a urea is required to 
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outcompete the alkyne for coordination to Rh(I) prior to C-C oxidative addition of the 
cyclopropane. 
 
Scheme 6: Mechanistic studies on the directed C-C bond activation of protected aminocyclopropanes. 
Alkenes coordinate less strongly to Rh(I) than alkynes, and so for alkene-based (3+1+2) 
cycloadditions, less strongly coordinating carbamate directing groups can be used.48 This enables 
efficient Cbz-directed cycloadditions of 31 to provide interesting trans-fused heterocycles 32 
(Scheme 7A). High yields required the addition of i-Pr(CO)NH2 and dimethyl fumarate; the Lewis 
basicity of i-Pr(CO)NH2 may assist with stabilisation of the Rh-catalyst and dimethyl fumarate is 
a labile electron-deficient ligand that may accelerate alkene insertion and/or reductive 
elimination.49 An interesting feature of these processes is the high diastereoselectivity that is 
achieved with respect to the new stereocentre adjacent to nitrogen. Stoichiometric studies support 
a mechanism wherein non-selective and reversible generation of diastereomeric 
rhodacyclopentanones 33a and 33b precedes diastereo-determining alkene insertion (Scheme 7B). 
Geometry dependent regioselectivity was observed for 1,2-disubstituted aminocyclopropanes: 
cycloaddition of trans-34 provided 35, whereas cycloaddition of cis-34 generated 36 (Scheme 7C). 
As confirmed by stoichiometric studies, these product regioselectivies reflect the inherent 
regiochemical preference of directed rhodacyclopentanone formation. 
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Scheme 7: Rh-catalysed carbonylative (3 + 1 + 2) cycloadditions of aminocyclopropanes and alkenes. 
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Acrylamide-based systems 37 undergo a distinct reaction pathway leading to synthetically 
challenging 8-membered rings 39 (Scheme 8A).50 Here, insertion of the alkene into the 
rhodacyclopentanone generates metallabicycle 38, which undergoes β-hydride elimination (via 
C7) and C-H reductive elimination to provide the targets. This pathway is supported by deuterium 
labelling studies. An unusual aspect is that both trans- and cis-1,2-disubstituted cyclopropanes 
(e.g. trans-40 and cis-40) delivered the same regioisomer of the product (39c) as a result of Rh(I) 
oxidative addition into the more hindered cyclopropane bond b (Scheme 8B). While previous 
studies from Bristol demonstrated that this regioselectivity is typical for cis-1,2-disubstituted 
cyclopropanes, the outcome for trans-1,2-disubstituted cyclopropanes was rationalised by 
invoking β-hydride elimination from 41 as the first irreversible step in the reaction pathway. 
Regioisomer 41a arising from insertion into sterically accessible bond a possesses a cis-Me 
substituent at C7 and C7-H is not available for syn-β-hydride elimination. However, insertion into 
less favoured bond b gives rise to intermediate 41b, in which syn-β-hydride elimination is possible 
and, following C-H reductive elimination, provides 39c. 
 
Scheme 8: Rh-catalysed carbonylative (7 + 1) cycloadditions of aminocyclopropanes and alkenes. a 10 mol% 
[Rh(cod)2]BARF and 10 mol% P(4-(CN)C6H4)3 were employed. 
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Rhodacyclopentanones generated by directed carbonylative C-C bond activation of 
aminocyclopropanes are sufficiently electrophilic at the Rh-centre to engage conventional tethered 
protic nucleophiles (Scheme 9A). This “capture” event generates intermediate 42 which undergoes 
C-N or C-C bond forming reductive elimination and protodemetallation (“collapse”) to provide 
challenging ring sizes (7- or 8-membered). Here, the relief of cyclopropane ring strain and the 
templating effect of the metallabicyclic intermediate (42) address the thermodynamic and entropic 
barriers that are typical of medium ring closures.51,52 In a prototype study, this approach was used 
to access 1,3-diazepanes from NH ureas 43 (Scheme 9B).53 C4-C5 unsaturated systems 44 were 
generated selectively for systems with substituents at R1. Conversely, saturated products 45 formed 
preferentially when R1=H, presumably due to the increased stability of protonated Rh(III)-hydride 
46, such that β-hydride elimination to C4-C5 unsaturated product occurs slower and C-H reductive 
elimination to 45 is preferred. 
 
 
Scheme 9: Rh-catalysed carbonylative formation of 7-membered heterocycles from aminocyclopropanes. 
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The “capture-collapse” strategy extends to carbon-based nucleophiles. N-Aryl 
aminocyclopropanes 47 undergo efficient carbonylative ring expansion to provide 
pharmaceutically relevant benzazepines 48 (Scheme 10A).54 Here the key rhodacyclopentanone 
intermediate (49) is used to effect ortho-metallation of the aryl unit in advance of the “collapse” 
sequence. Mechanistic studies suggest that all steps up to C-C reductive elimination are reversible. 
A relatively nucleophilic arene is required for metallation at the stage of 49, suggesting that this 
process proceeds via an electrophilic aromatic substitution type mechanism. Based on this, 
investigations into other C-based nucleophiles were undertaken, and these studies showed that N-
vinyl units (50) are also competent nucleophiles (Scheme 10B). This then allows access to non-
benzofused azepines 51 in a direct manner. 
 
Scheme 10: Rh-catalysed carbonylative formation of azepines from (A) N-aryl cyclopropylamines; (B) N-vinyl 
cyclopropylamines. 
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The process described above is limited to the synthesis of 7-membered rings; however, if 
the substrate is redesigned so as the directing group and nucleophile are part of the same unit, then 
access to more challenging 8-membered rings is possible (Scheme 11).55 Using this strategy, a 
variety of electron rich heteroarenes 52 underwent carbonylative heterocyclization via either C3 
or C2 to provide challenging 8-membered heterocycles (e.g. 53-57) (Scheme 12A). Extensive 
studies were undertaken to establish conditions that gave high selectivity for the C7-C8 saturated 
products over the corresponding unsaturated variants. Cyclization via C4 of pyrrole 58 was also 
demonstrated and this provided 59 and 60 in a 3:4 ratio (Scheme 12B). The low selectivity was 
resolved by using a separate hydrogenation step, which converted 59 to 60. Processes involving 
substituted aminocyclopropanes provided access to adducts 62 (98.5:1.5 e.r.) and 63; the former is 
derived from enantioenriched starting material and demonstrates that the process is enantiospecific 
(Scheme 12C). It should be noted, that for substituted aminocyclopropanes, N-H heterocyclic 
systems such as 52a,b were inefficient and so N-Me heterocycles 61 were used instead. 
 
Scheme 11: Strategy to generate 8-membered N-heterocycles by C-C bond activation of aminocyclopropanes. 
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Scheme 12: Carbonylative C-C bond activation of aminocyclopropanes to generate 8-membered N-heterocycles. 
The “capture-collapse” strategy can be extended to the formation of multiple ring systems 
by delaying the final protodemetallation step (see Scheme 9A). In this approach, C-Nu bond 
forming reductive elimination is followed by carbometallation of a formally electrophilic 
component prior to protodemetallation (Scheme 13A).56 This approach offers high flexibility and 
uses the rhodacyclopentanone 64 as a synthetic equivalent to ambiphilic synthon 65, thereby 
allowing the assembly of two rings instead of one. In one example of this methodology, it was 
shown that indoles 66 are competent nucleophiles leading to intermediates 67. From here, 
carbometallation of the indole C2-C3 π-system is followed by protodemetallation to give complex 
polycycles 68 (Scheme 13B). The mechanism of this process was probed experimentally and by 
DFT studies. 
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Scheme 13: Polycyclisations via rhodacyclopentanone intermediates. 
Exo-selective polycyclizations can also be achieved (Scheme 14). For systems 69, C-C 
reductive elimination generates 70 and this is followed by syn-stereospecific carbometallation of 
the alkyne prior to protodemetallation. A wide variety of electron-rich arenes participate 
efficiently, providing access to polycycles 71 (Scheme 14A). A related process gives access to 
bicyclic 1,3-diazepane 73 - here the first ring forms by C-N reductive elimination from 72 (Scheme 
14B). Further studies on systems similar to 73 are discussed in Chapter 2. Other classes of 
electrophile can be used to initiate the second cyclization event (Scheme 14C). For the conversion 
of dienyl system 74 to polycycle 75, a distinct mechanism was proposed involving protonation to 
Rh(III)-hydride 76 in advance of diene hydrometalation and C-C reductive elimination. The 
formation of Rh-π-allyl 77 prior to C-C reductive elimination accounts for the geometry switch 
observed at C3-C4.57,58 
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Scheme 14: Rh-catalysed exo-polycyclizations. a15 mol% 4-NMe2C6H4CO2H; b100 mol% 2-NO2C6H4CO2H 
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The methodologies developed in Bristol (Schemes 5-14) are intramolecular 
transformations. Under certain conditions Rh-catalysed directed C-C bond activation of 
aminocyclopropanes can be used for intermolecular processes. For example, the Yamaguchi 
group59 reported regiodivergent Rh-catalysed hydrosilylations of protected aminocyclopropanes 
under non-carbonylative conditions (Scheme 15A). Branched products (e.g. 78 and 79) were 
favoured when tri-1-naphthylphosphine (P(1-nap)3) was used as ligand. Conversely, by using 
tricyclohexylphosphine, a more electron-rich and bulky ligand, the regioselectivity switched to 
give linear products such as 80. Wang and co-workers60 have shown that aminocyclopropane 
derived rhodacyclopentanones can be trapped by α-hydroxy carbonyl compounds or 1,2-diols to 
give esters, such as 81 and 82 (Scheme 15B); mechanistically, these processes are similar to the 
“capture-collapse” sequence shown in the Scheme 9A. It should be noted, that unsymmetrical diols 
gave poor regioselectivity and that the methodology is limited by the requirement for a non-labile 
urea directing group. 
 
 
Scheme 15: Rh-catalysed transformations of aminocyclopropanes to linear products. 
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The processes described above employ Rh-based complexes as catalysts, but for certain 
systems Pd-catalysed processes have also been demonstrated. For example, uncommon 
regioselectivity for Pd-catalysed aminocyclopropane C-C bond cleavage was observed by Rene 
and co-workers61 in the context of spiro-fused cyclopropanes 83 (Scheme 16). In this case, 
experimental and DFT studies supported Pd-insertion into the less hindered distal bond of the 
cyclopropylamine unit to give palladacyclobutane 84. Collapse of this by β-nitrogen elimination 
generates π-allyl intermediate 85, which undergoes C-N bond forming reductive elimination to 
provide the targets. The methodology provides access to interesting 7-membered N-heterocycles 
86, including examples containing multiple heteroatoms. 
 
 
Scheme 16: Pd-catalysed cleavage of the distal bond of cyclopropylamine-based systems. 
 
An isolated example of Pd-catalyzed C-C bond cleavage of a difluorocyclopropylamine 
derivative was reported by the Fu group (Scheme 17).62 The proposed mechanism starts with 
insertion of palladium into the lengthened C1-C3 bond of the cyclopropane.63 Then, β-fluorine 
elimination from the palladacyclobutane gives π-allyl complex 87, which is susceptible to attack 
by an external nucleophile. In this case, the preferred site of nucleophilic attack was at C1, 
generating branched product 88. Interestingly, for other classes of difluorinated cyclopropane, the 
process led to alternate regioselectivity, where the nucleophile attacked at C3. 
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Scheme 17: Pd-catalysed cleavage of the C-C bond of a difluorocyclopropylamine. 
 
The processes discussed in Section 1.3 involve cleavage of strained cyclopropylamine C-C 
bonds by oxidative addition of transition metal complexes. It is important to note that a range of 
alternate mechanistic options exist for promoting ring cleavage (Scheme 18). The N-lone pair of 
cyclopropylamines provides a “push”, which means that cyclopropane rings are often relatively 
electron rich and can behave as competent nucleophiles in certain cases. This behaviour is present 
in donor−acceptor (DA) based systems 89, which possess a highly labile cyclopropane C−C bond 
and have found wide use in reaction design.64,65 The drawback of this approach is the prerequisite 
for an electron-withdrawing substituent on the cyclopropane ring. In addition to polar reaction 
pathways, oxidation to N-centred radicals can be used to trigger β-scission en route to reactive 
carbon-centred radicals.66 This strategy has recently been employed to great effect in the 
development of cycloaddition reactions.67-74. For a detailed discussion of these and other 
processes, the reader is directed to the comprehensive review article cited at the beginning of this 
chapter. 
 
Scheme 18: Ring cleavage modes available to aminocyclopropane derivatives.  
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1.4 Project aims and thesis overview 
Section 1.3 outlines a summary of previous work at Bristol on the use of 
aminocyclopropanes to form rhodacyclopentanone-based intermediates. The research contained 
within this dissertation explores further the carbonylative C-C bond activation of 
aminocyclopropanes and homologated structures (aminomethylcyclopropanes and 
aminocyclobutanes). The general aim of the studies was to exemplify Rh(I)-catalysed C-C 
activation with a variety of strained ring systems. The majority of reported methodologies 
involving C-C bond cleavage use activated substrates, which are often challenging to synthesise. 
Accordingly, the evaluation of readily available systems (e.g. aminocyclopropane derivatives) was 
prioritised. Specific research projects are described over five Chapters, and each Chapter is 
contextualised with a specific introductory section. 
Known C-C bond activation processes involving aminocyclopropanes typically rely on a 
directing group to direct oxidative addition. As a result, the directing group becomes integrated 
into the reaction product. The work described in Chapter 2 details studies on the development of 
carbonylative transformation that employs a temporary directing group to generate the 
rhodacyclopentanone intermediate (Scheme 19A). Here, the temporary directing group is not 
incorporated into the final product, and the aim was to use such a process in a variety of cascade 
protocols. 
The goal of Chapter 3 was to demonstrate that rhodacyclopentanones can be trapped by 
various heteroatom-based nucleophiles (Scheme 19B). This work was inspired by seminal work 
from Bristol on the “capture” of rhodacyclopentanones with tethered urea-based nucleophiles.53 
Attempts were undertaken to develop a general set of conditions for the synthesis of 8-membered 
ring systems from cyclopropylamines bearing tethered anilines. Additionally, studies aimed at 
identifying alternate substrates bearing tethered nucleophiles are presented. 
Chapter 4 describes studies aimed at developing a new class of substrate for intramolecular 
(3+1+2) cycloadditions between cyclopropylamines, CO and tethered π-unsaturates (Scheme 
19C).46,48 A key objective was to develop an asymmetric (3+1+2) cycloaddition, as such processes 
had not previously been realised. The studies described in this chapter represent the first highly 
enantioselective C-C bond activations of cyclopropylamines. 
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Scheme 19: Overview of the research described in Chapters 2-4. 
The research described in Chapters 5 and 6 was conducted prior to Chapters 2-4, and 
focuses on generating and exploiting rhodacyclohexanones as key intermediates. Chapter 5 
describes the use of these in a cyclopentanone forming reaction. The process is enabled by C-C 
bond activation of aminomethylcyclopropanes and builds upon previous studies at Bristol (Scheme 
20A).75 Finally, Chapter 6 details the synthesis of a range of cyclobutanes in pursuit of the first 
cyclobutane-based C-C bond activation process (Scheme 20B). 
 






Temporary directing group-enabled 
C-C bond activation of aminocyclopropanes 
Aspects of this Chapter have been adapted from a communication. 
(Wang, G.-W.†; Sokolova, O. O.†; Young, T. A.; Christodoulou, E. M. S.; Butts, C. P.; Bower, J. F. 
J. Am. Chem. Soc. 2020, 142, 19006. †G.-W. Wang and O. O. Sokolova contributed equally) 
2.1 Introduction 
Methods based on catalytic C-C bond activation commonly require directing groups to 
accelerate the rate and control the regioselectivity of metal insertion.1-4,12,76-78 “Permanent” 
directing groups have been used to facilitate the activation of a relatively broad range of C-C 
bonds.38,79-92 Section 1.3 outlines the directing group (DG) strategy developed in Bristol for the 
Rh-catalysed C-C bond activation of aminocyclopropanes. A key feature of such processes is the 
use of an N-carbonyl-based directing group, which either becomes part of the new ring system or, 
in some cases (e.g. N-Cbz), can be removed after the C-C bond activation process. On the other 
hand, “temporary” directing groups (TDGs) are potentially more powerful because they can avoid 
the need for discrete DG installation and removal steps. Jun’s seminal works93-95 achieved 
activations of ketone-based substrates such as 90 via condensation with 2-amino-3-picoline 91 to 
generate the corresponding imines (Scheme 21A). Pyridine-directed C-C bond activation of these 
delivers intermediate 92 which, after β-hydride elimination, alkene hydrometallation and C-C 
reductive elimination affords linear ketones 93. More recently, this strategy has been developed 
significantly by Dong and co-workers,96-99 who used the 2-amino-3-picoline-derived TDG for the 
activation of small cyclic ketones. Of particular relevance to the research discussed in this chapter 
are examples involving 4-membered ring systems 94, based on cyclobutanones (Scheme 21B).32 
By contrast, the use of TDGs for the activation of 3-membered carbocycles (e.g. cyclopropanes) 
is virtually unknown. Perhaps the closest precedent is Montgomery’s use of cyclopropanal-derived 
imines 95 in Ni-catalysed (3+2) cycloadditions (Scheme 21C).100,101 Here, discrete steps were 
required for DG installation and removal, although there is evident potential for refinement to a 
“full” TDG-based protocol. An impediment in this area is that, until recently, most C-C bond 
activation methodologies involving 3-membered carbocycles required highly activated or 
specialized variants (e.g. spirocyclopropanes, cyclopropenes, alkylidene cyclopropanes).2 These 
systems are usually unstable and not easily adapted to TDG-based settings. Thus, the identification 
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of a suitable system for TDG-assisted C-C bond activation of unactivated cyclopropanes is highly 
desirable. 
 
Scheme 21: Known temporary directing groups used in C-C bond activation. 
Initial studies on this research topic were undertaken by Dr Gang-Wei Wang, a postdoctoral 
researcher in the Bower group. Upon prolonged heating of urea-protected substrate 96 under Rh-
catalysed carbonylative conditions, he observed the formation of trace amounts of γ-lactam 97 in 
addition to expected product 73 (Scheme 22A); the formation of 73 is described in detail in section 
1.3 (Scheme 14B).56 When the N-benzyl substituent of 96 was changed to a cyclohexyl unit, 5,5-
fused ring system 97 was generated as the major product and its yield increased when the 
temperature was raised (Scheme 22B); for example, at 120 °C 97 was obtained in 21% yield, 
whereas at 140 °C the yield increased to 52%. 
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Scheme 22: Preliminary results for the formation of the 5,7-fused ring systems obtained by Wang. 
A control experiment was performed in which diazepane 99 was isolated and heated to  
140 °C in 1,2-dichlorobenzene. This provided γ-lactam 97 in excellent yield along with urea 100. 
It was reasoned that the formation of 100 may be due to cyclohexyl isocyanate 101 being generated 
in the course of the reaction. Hydrolysis of 101 would form amine 102, which could react with a 
second equivalent of isocyanate to provide urea 100 (Scheme 23A). The starting material 98 can 
be prepared in high yield by heating amine 103 in the presence of cyclohexyl isocyanate 101. This 
allowed Dr Wang to develop a streamlined two-step one-pot procedure, where urea 98 is formed 
in situ prior to the C-C bond activation induced cascade (Scheme 23B). To prove further that 
isocyanate is released under these conditions, benzyl alcohol was used as an additive. In this 
experiment, carbamate 104 was obtained in high yield, which is consistent with the attack of benzyl 
alcohol onto isocyanate 101 (Scheme 23C). 
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Scheme 23: Mechanistic investigations of the ring contraction cascade and a one-pot procedure developed by Wang. 
 
Based on the observations outlined above, a plausible mechanism for the formation of 97 
is presented on Scheme 24. The process commences with the formation of urea 98, and this allows 
directed Rh(I) oxidative insertion into the cyclopropane prior to migratory insertion of CO, which 
delivers rhodacyclopentanone 105. After directing group dissociation, the pendent nucleophilic 
N-H group coordinates to the cationic Rh(III) complex and, following deprotonation, C-N 
reductive elimination generates alkyl-Rh(I) species 106. Carbometallation of the tethered alkyne 
forms the second 5-membered ring, and protodemetallation affords 99. From here, intramolecular 
nucleophilic attack of nitrogen induces the ring contraction with concomitant expulsion of 
isocyanate 101 to deliver the target 97. Thus, the directing group is appended and then “disappears” 
over the course of the reaction. 
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Scheme 24: Plausible mechanism for the ring contraction cascade. 
Ring contractions related to 99 to 97 are unusual, and only a few examples have been 
reported (Scheme 25). In 1968, Felix and Fryer attempted the synthesis of 2,4-benzodiazepane-
1,3-dione 108 by oxidation of compound 107.102 The desired product could not be isolated and, 
after evaluating various oxidation conditions, only compound 109 was obtained (Scheme 25A). 
Later, Ferraccioli and co-workers described Pd(0)-catalysed carbonylative cyclisation of urea 110 
(Scheme 25B).103 This provided significant quantities of ring contraction product 111 in addition 
to expected product 112. The formation of 109 and 112 can both be rationalised by expulsion of 
an isocyanate. A related deconstructive lactamisation with carbon dioxide as a leaving group has 
been reported recently by the Sartillo‐Piscil group (Scheme 25C).104 In this two-step methodology, 
sequential oxidation of piperidine derivatives, such as 113, delivers piperidine-2,3-dione 114 and 
then seven-membered cycle 116 via intermediate 115. From here, decarboxylative cyclisation 
gives lactam 117. 
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Scheme 25: Known ring contractions leading to γ-lactam-containing products. 
As demonstrated above, the state-of-art of TDGs in C-C bond activation is limited to 
carbonyl-containing starting materials (Scheme 21). Additionally, none of the ring contractions in 
Scheme 25 use a transient directing group or C-C bond activation to access γ-lactam scaffolds. 
The process discovered in Bristol (Scheme 23) demonstrates the unprecedented use of TDG-
assisted C-C bond activation of aminocyclopropanes for the formation of γ-lactams. With a 
suitable system for the ring contraction cascade identified, further developments were directed at 
showcasing the strategy. 
2.2 Further developments of the temporary directing group enabled C-C 
bond activation of aminocyclopropanes 
2.2.1 Further mechanistic considerations 
The effect of different isocyanates on the ring contraction was investigated further to 
identify an optimal N-substituent (Table 1). The R substituent was evaluated using ureas 96 and 
118a,b under Rh-catalysed carbonylative conditions (7.5 mol% [Rh(cod)2]OTf, 15 mol% PPh3, 
1,2-DCB, 130 °C, “conditions B”). Alternatively, the urea unit was installed on amine 103 in situ 
by reaction with the isocyanate at 80 °C in 1,2-DCB (“conditions A”), followed by addition of the 
components required for the carbonylative heterocyclisation/ring contraction sequence 
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(“conditions B”). It was found that reaction of N-benzyl-substituted 96 gave a moderate yield of 
the desired γ-lactam 97 at elevated temperature, while N-phenyl-substituted urea 118a caused a 
significant decrease of yield (Table 1, Entries 1 and 2). Installing tertiary N-substituents on the 
urea, e.g. tert-butyl and 1-adamantyl proved to be completely inefficient, indicating that there is a 
fine balance in the overall reaction with respect to the R substituent’s steric bulk (Table 1, Entries 
3 and 4). Secondary isocyanates, such as isopropyl isocyanate, worked well for the ring contraction 
in general. However, isocyanates with cyclic substituents, such as cyclopentyl or cyclohexyl 
isocyanate performed better than those possessing acyclic groups (Table 1, Entries 5-7). Although 
both cyclopentyl and cyclohexyl isocyanate gave comparable yields of 97 (78-80%), the reaction 
conditions in Entry 7 were identified as “optimal” because cyclohexyl isocyanate is much cheaper 





R Yield of 97a (%) 
1 Bb,c 96 Bn 57 
2 Bc 118a Ph <20 
3 Bc 118b t-Bu 0 
4 A, then B 103 1-Adamantyl 0 
5 A, then B 103 i-Pr 65 
6 A, then B 103 c-Pent 80 
7 A, then Bc 103 c-Hex 78 (77) 
Table 1: Directing group substituent studies for the ring contraction cascade. a Yields were determined by 1H NMR 
spectroscopy using 1,4-dinitrobenzene as a standard. Isolated yields are given in parentheses. b Reaction performed at 
140 °C. c Result obtained by Wang. 
2.2.2 Scope of the alkyne in the cascade reaction 
As discussed earlier (Section 2.1), Wang had discovered an efficient diazepane formation-
ring contraction cascade for substrate 103 (cf. Scheme 23B). To evaluate scope, a range of 
cyclopropylamines 119a-d containing tethered alkynes with different aromatic substituents at the 
terminal position was synthesised. This was achieved from alkyne 120 via sequential Sonogashira 
reaction, alcohol tosylation and nucleophilic substitution with cyclopropylamine (Scheme 26A). 
Pleasingly, these substrates all performed well under the standard reaction conditions regardless 
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of the substituent’s electronics, delivering γ-lactams 121a-d in high to moderate yields  
(Scheme 26B). 
Next, the effect of α-substitution on the alkyne was evaluated. The key question was 
whether the reaction would exhibit innate control over the stereorelationship between C1 and C7 
(Scheme 27A). To this end, the synthesis of α-phenyl-substituted starting material 124 was 
attempted. Tosylate 123 was generated via regioselective alkynylation of styrene oxide with 
triisopropoxy titanium acetylide,106 followed by treatment of the resulting alcohol 122 with TsCl. 
Unfortunately, the subsequent alkylation of cyclopropylamine with 123 was problematic and target 
124 was not observed (Scheme 27B). Instead, elimination predominated to provide alkene 125; 
the facility of this competing process can be rationalised by the steric hinderance around the 
electrophilic centre, as well as the favourable formation of a new conjugated π-bond. 
 
 
Scheme 26: Synthesis and reactivity of cyclopropylamines 119a-d. Reagents and conditions: (i) PdCl2(PPh3)2, CuI, 
Ar-I or Ar-Br, Et3N, r.t. or 60 °C; (ii) TsCl, Et3N, DMAP, DCM, 0 °C to r.t.; (iii) cyclopropylamine, MeCN, reflux. 
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Scheme 27: Attempted synthesis of 122. Reagents and conditions: (i) (a) Ti(Oi-Pr)4, TiCl4, hexane, r.t.; (b) n-BuLi, 
phenylacetylene, THF, 0 °C to r.t., then ClTi(Oi-Pr)3, styrene oxide, -41 °C to r.t.; (ii) TsCl, Et3N, DMAP, DCM, 0 
°C to r.t.; (iii) cyclopropylamine, MeCN, reflux;  
 
Subsequently, substrate 130 containing an α-methyl substituent was targeted  
(Scheme 28A). The synthesis commenced with Darzens reaction of phenylacetylene 126 with 
chloroacetone to give 127. Regioselective reductive oxirane opening107 using DIBAL-H gave 
alcohol 128, which was converted to tosylate 129. This product was used for the alkylation of 
cyclopropylamine to give target amine 130 in moderate yield. 
When amine 130 was subjected to optimised carbonylative conditions, γ-lactam 131 was 
formed as a 1:0.65 mixture of diastereomers, thereby demonstrating poor diastereocontrol 
(Scheme 28B). The lack of diastereocontrol is not surprising if oxidative addition of the Rh(I)-
catalyst into cyclopropane is the stereodetermining step; in this scenario, high diastereocontrol 
requires the substituent at C1 to bias Rh-insertion into one of the two diastereotopic cyclopropane 
C-C bonds. Based on earlier diastereoselective C-С bond activation protocols developed in 
Bristol,48,108 it may be assumed that the d.r. of 131 depends on the stereochemistry of alkyl Rh(I)-
intermediate 132. It is possible that equilibration of 132 and 132' can occur via reversible β-hydride 
elimination, this would provide a mechanism for achieving diastereocontrol. The low 
diastereoselectivity observed for 130 to 131 therefore indicates that either (a) the rates of 
carbometallation from 132 and 132' are comparable or (b) reversible β-hydride elimination does 
not occur and diastereoselectivity is solely governed by the carbonyl-directed C-C oxidative 
addition step, which generates 132 and 132' in nearly equal amounts. 
To circumvent the issue of poor diastereoselectivity, spiro-cyclopentyl-containing amine 
135 was synthesised. This was achieved by a sequence of electrophilic alkynylation of methyl 
cyclopentanecarboxylate, a two-step conversion of ester 133 to aldehyde 134, and reductive 
amination with cyclopropylamine (Scheme 28C). Pleasingly, spiro-substituted amine 135 gave 
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tricyclic product 136 in high yield, indicating that the reaction is relatively insensitive to the steric 
effects of substitution at C1. 
 
 
Scheme 28: Synthesis and reactivity of cyclopropylamines 130 and 135. aYield was determined by 1H NMR 
spectroscopy using 1,4-dinitrobenzene as a standard. Reagents and conditions: (i) n-BuLi, chloroacetone, THF, -41 
°C to -78 °C to r.t.; (ii) DIBAL-H; THF, -20 °C to r.t.; (iii) TsCl, Et3N, DMAP, DCM, 0 °C to r.t.; (iv) 
cyclopropylamine, MeCN, reflux; (v) n-BuLi, NCS, THF, -78 °C to r.t.; (vi) methyl cyclopentanecarboxylate, LDA, 
THF, -78 °C to r.t.; (vii) DIBAL-H, THF, -78 °C to 0 °C; (viii) PCC, silica gel, DCM, r.t.; (ix) cyclopropylamine, 
MgSO4, DCM, r.t., then NaBH4, MeOH, 0 °C to r.t. 
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2.2.3 Hydrogenation - ring contraction cascade of diazepanes and computational 
studies 
The possibility of ring contractions of unsaturated 7-membered rings was also examined. 
Wang attempted the thermal ring contraction of unsaturated diazepane 137, which can easily be 
synthesised by the group’s previously developed catalytic methodology,53 but did not obtain 
dihydropyrrol-2-one 138 (Scheme 29). The failure of this process may be due to the increased 
strain of 138 vs. 140 and/or the lower nucleophilicity of the nitrogen centre of 137 vs. 139 (as a 
result of cross-conjugation with the adjacent C4-C5 π-bond). To circumvent this issue, after 
carbonylative cyclisation, the C4-C5 double bond of 137 was hydrogenated to give 139, which, 
under the high reaction temperature, contracted to give lactam 140. The carbonylative cyclisation 
and hydrogenation steps were achieved using the same Rh(I)-source; after completion of the first 
step, Xantphos ligand and H2 were added to facilitate the reduction process. 
 
 
Scheme 29: Hydrogenation - ring contraction sequence developed by Wang. 
The ring contraction of diazepanes to γ-lactams is unusual and has not previously been 
interrogated mechanistically. Accordingly, DFT studies were performed by Tom A. Young, a 
collaborator from the University of Oxford. Using simplified system 141a, an energetically 
feasible concerted pathway was found for expulsion of methyl isocyanate. In this process, the 
C2-N1 bond cleaves as attack of N6 onto C2 occurs (Figure 2). The energy barrier of 33.5 kcal/mol 
for TS1a is consistent with the reaction conditions (150 ºC, ~1 day). A more conventional stepwise 
addition-elimination mechanism was discounted because tetrahedral TS2 could not be located on 
the potential energy surface and is > 100 kcal/mol less stable than 141a. The concerted nature of 
the ring contraction process is similar to recently reported ring contractions of cyclic N-
carboxyanhydrides (cf. Scheme 25C).104 In the process outlined in Figure 2, the nucleophilicity of 
the N6 center is key: ring contraction of unsaturated system 141b, where cross-conjugation with 
the alkene likely diminishes the nucleophilicity of the nitrogen lone pair, has a higher energy 
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barrier (TS1b, ΔG‡ = 39.7 kcal mol-1). This result is consistent with the observation that 
unsaturated 141b does not undergo ring contraction to dehydro-142. 
 
 
Figure 2: Free energy profiles computed at SMD(DCB)-DLPNO-CCSD(T)/def2-TZVPP//PBE0-D3BJ/def2-TZVP, 
423.15 K. 3D geometries with key distances are quoted in Å. 
Unfortunately, the Rh-mediated hydrogenation conditions used for 137 to 139 were not 
compatible with the more hindered methyl-substituted diazepane 144, which was accessed from 
urea 143 (>99:1 e.r.) using previously established methodology;53 here, only trace amounts of 
hydrogenated product were formed (Scheme 30A). Consequently, a modified two-step procedure 
was developed: hydrogenation using Pd/C reduced the C4-C5 unsaturation, and this product (not 
depicted) was isolated prior to thermally promoted ring contraction, which provided 145 in 95% 
yield. It is important to note that the ring contraction step did not result in significant epimerization 
of the C3 stereocentre. The hydrogenation-ring contraction cascade offers an alternative approach 
to challenging enantioenriched α-substituted γ-lactams, which typically require multistep 
synthesis.109 
To evaluate the scope of the hydrogenation-ring contraction sequence further, butyl-
analogue 147 was targeted (Scheme 30B). Following the developed at Bristol methodology,53 
carbonylative cyclisation of urea 146 provided 147 in 64% yield. The more hindered alkene of 147 
rendered the hydrogenation step more sluggish and necessitated a prolonged reaction time. 
Nonetheless, the subsequent ring contraction proceeded smoothly, giving butyl-substituted lactam 
148 in 63% yield. 
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Scheme 30: Hydrogenation - ring contraction sequence of more complex substrates. 
 
To examine a secondary nitrogen as the potential nucleophile, diazepane 14953 was trialled. 
Interestingly, 149 did not undergo thermally promoted ring contraction (Scheme 31); a possible 
explanation for this is the lowered nucleophilicity of the nitrogen centre due to the poorly electron-
donating hydrogen substituent. On the other hand, conversion to target lactam 150 was feasible 
when a slight excess of base (t-BuOK) was used. Here, computational studies performed by Young 
suggest that the model substrate may be deprotonated to generate 151 with a sufficiently 
nucleophilic nitrogen to form a tetrahedral intermediate 152 (Figure 3). This intermediate then 
collapses to give the ring contracted product 150' upon loss of isocyanate. This is in contrast to 
the concerted reaction mechanism for N-alkyl substituted variant 141a, where a tetrahedral 
intermediate is energetically unfeasible (Figure 2 vs. Figure 3). 
 
 
Scheme 31: Base-promoted ring contraction of diazepane 149. aYield was determined by 1H NMR spectroscopy using 
1,4-dinitrobenzene as a standard. 
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Figure 3: Free energy profile computed at SMD(DCB)-DLPNO-CCSD(T)/def2-TZVPP//PBE0-D3BJ/def2-TZVP. 
2.2.4 Pictet-Spengler cyclisation - ring contraction cascade of diazepanes 
This part of the project was conducted with the assistance of Ektor Christodoulou, a 
summer student in the Bower group, and studies conducted by Christodoulou are highlighted in 
the text. 
The DFT studies outlined in Section 2.2.3 show that ring contraction only occurs for 
diazepanes that possess C4-C5 saturation. It was envisaged that processes that exploit removal of 
the easily installed C4-C5 unsaturation in further bond formations could be used as a method to 
“activate” unsaturated 7-membered rings. Previous studies in the Bower group53 showed that 
carbonylative C-C bond activation product 153 can undergo Pictet-Spengler cyclisation at 60 °C 
via iminium ion 154 to give tricyclic products 155 (Scheme 32). Dr Wang found that when the 
TFA-promoted cyclisation step was carried out at higher temperature (150 vs. 60 °C), the 
corresponding ring contraction products 156a,b were obtained instead. 
 
Scheme 32: Initial studies on Pictet-Spengler cyclisation - ring contraction sequence. 
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To extend further the scope of this cascade to more challenging substrates, benzyl-
substituted substrate 158 bearing a tethered dimethoxyphenyl moiety was made from 157 by Boc 
deprotection, alkylation and urea formation (Scheme 33). Christodoulou used the same approach 
to convert 159 to racemic methyl-substituted substrate 160, which bears a tethered thienyl 
substituent (Scheme 34). Enantioenriched (S,S)-159 was prepared from (R)-propylene oxide by a 
known two-step sequence53,110 and transformed to enantioenriched (S,S)-160 (>97:3 e.r.) in a 
similar manner to racemic 160. 
 
Pleasingly, by applying conditions previously developed for trans-disubstituted urea-
protected cyclopropylamines,53 both substrates delivered seven-membered products 161a,b 
(Scheme 35). When the conditions for the one-pot Pictet-Spengler cyclisation - ring contraction 
process were applied to diazepane 161a, the desired tricyclic product 162a was obtained in poor 
diastereoselectivity (2:1 d.r.) (Scheme 35B). Lowering the temperature to 60 °C for the TFA-
promoted ring formation and then heating up to 150 °C in the absence of TFA for the subsequent 
ring contraction improved the d.r. to 5:1. The improvement in d.r. at lower temperatures suggests 
that this is the kinetic outcome of the Pictet-Spengler-like reaction. Cyclopropanes 158 and 160 
both gave good yields of γ-lactams 162a,b with the established conditions (Scheme 35A). 
Selective nOe studies confirmed the relative stereochemistry of the major diastereomer (depicted). 
It is also worth pointing out that the absolute stereochemistry of enantioenriched thiophene-
substituted cyclopropane (S,S)-160 was retained through the C-C activation, cyclisation and ring 
contraction steps, which makes this methodology potentially attractive for total syntheses. 
 
 
Scheme 33: Synthesis of 158. Reagents and conditions: (i) TFA, DCM, r.t.; (ii) K2CO3, MeCN, 90 °C; (iii) benzyl 
isocyanate, NEt3, DCM, 0 °C to r.t. 
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Scheme 34: Synthesis of 160 and (S,S)-160. Reagents and conditions: (i) TFA, DCM, r.t.; (ii) K2CO3, MeCN, 90 °C; 
(iii) benzyl isocyanate, DCM, 0 °C to r.t.; (iv) DPPA, NEt3, t-BuOH, 80 °C. 
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2.2.5 Diels-Alder cyclisation - ring contraction cascade of diazepanes 
Having established the Pictet-Spengler cyclisation - ring contraction cascade to access 
tricyclic scaffolds, other cascades forming complex products were sought. It was found that 
aminocyclopropanes 163 equipped with tethered dienes offer the possibility of effecting Diels-
Alder-based cascades (Scheme 36B). Wang’s original idea was to trigger an additional cyclisation 
via diene carbometallation from intermediate 164; a similar sequence had been demonstrated in 
the group’s earlier work (Scheme 36A).56 Unexpectedly, trace amounts of tricyclic compound 165 
were isolated; it was suggested that this may form via inverse electron-demand Diels-Alder 
reaction of enamide 166 with an isomerised diene unit. The isomerisation process may be 
facilitated by hydrometallation of the diene111,112 either before (Scheme 36B, “path a”) or after 
(Scheme 36B, “path b”) formation of the 7-membered ring. The Diels-Alder process removes the 
C4-C5 unsaturation from cyclic enamide 166, thereby triggering ring contraction to 165. This 
serendipitous discovery suffered from a poor yield, and so further reaction optimisation was 
required. 
 
Scheme 36: Previously known reaction, developed in the group and reactivity study of 163, performed by Wang. 
Based on the preliminary results from Scheme 36B, diene-bearing substrates 167a and 
167b were suggested as suitable starting materials (Scheme 37). These compounds have the 
previously optimised cyclohexyl group on the urea moiety and the diene is correctly positioned 
for the Diels-Alder cycloaddition. The synthesis of 167a started with commercially available 
trans-crotylaldehyde, whereas 167b was derived from known113 aldehyde 168 (Scheme 37A). 
Wittig olefination delivered a mixture of cis/trans-dienes 169a,b. The alcohols were then tosylated 
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and tosylates 170a,b were used to alkylate cyclopropylamine. Finally, urea formation with 
cyclohexyl isocyanate gave the desired starting materials 167a,b. 
With 167a,b in hand, the Diels-Alder cyclisation - ring contraction cascade was attempted. 
The substrates performed poorly under the conditions outlined in Scheme 36, giving 171a and 
171b in low yield (<30%, as determined by 1H NMR analysis of the reaction mixture). 
Nonetheless, this was deemed a promising result that seemed to validate the mechanistic 
hypothesis for transformation of diene 163 into 165. It was thought that using BHT as an additive 
may help to suppress radical polymerization of the diene substrate during the reaction.28,114 A 
weakly coordinating electron-deficient dimethyl fumarate ligand was used as well because it was 
found to be beneficial in previously reported C-C bond activation methodologies.48,49 Under the 
reaction conditions from Scheme 36, modified with the aforementioned additives, tricyclic lactams 
171a and 171b were obtained in 51% and 47% yield, respectively (Scheme 37B). The relative 
stereochemistry of tricyclic lactam 171a was determined by nOe-distance analysis115 in 
collaboration with Prof. Craig Butts (see the Experimental for further details). Overall, this 
multistep process involves C-C activation, carbonylation, C-N bond formation, Diels-Alder 
reaction and ring contraction in the course of just one transformation. Even mid-range yields are 
impressive when accounting for the complexity of the resulting tricyclic products. 
 
Scheme 37: Synthesis and reactivity of 167a,b. Reagents and conditions: (i) triethyl phosphonoacetate, DME, 0 °C 
to r.t.; (ii) DIBAL-H, THF, -78 °C or 0 °C; (iii) PCC, silica gel, DCM, r.t.; (iv) n-BuLi, THF, 0 °C; (v) TsCl, Et3N, 
DMAP, DCM, 0 °C to r.t.; (vi) cyclopropylamine, K2CO3, MeCN, 90 °C; (vii) cyclohexyl isocyanate, DCM, 0 °C to 
r.t.; a E/Z = 4:1; b E/Z = 10:1; c E/Z > 15:1. 
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Systems equipped with other types of tethered dienes were also tested: the less sterically 
hindered diene 172 and the methyl-substituted diene 173, where the methyl substituent may help 
the diene to adopt the s-cis conformation required for the Diels-Alder cycloaddition (Scheme 38A). 
Unfortunately, diene 172 did not undergo the carbonylative cyclisation cascade, which may be due 
to its susceptibility to competitive hydrometallation under the reaction conditions. Electron-rich 
diene 173 was also not suitable; this is in line with the notion that inverse electron demand Diels-
Alder reactions prefer more electron-poor dienes. Therefore intermolecular inverse electron 
demand Diels-Alder reactions between enamide 174 and tetrazines, which are typical partners for 
related [4+2] cycloadditions,116 were also investigated, but no cycloaddition was observed. 
Attempts to use ketenes in a [2+2] cycloaddition with 174 were also not fruitful. 
 
Scheme 38: Failed diene substrates and other attempted cycloadditions. 
2.3 Conclusions 
The studies outlined in this chapter have demonstrated that a range of different cascades can 
be employed to trigger a ring contraction in diazepane systems; these are obtained from urea-
protected cyclopropylamines by Rh(I)-catalysed carbonylative cyclisation. Substrates with 
tethered alkynes and dienes engage in subsequent cyclisations or cycloadditions in the course of 
the C-C bond activation reaction. C-C bond activation products bearing appropriately positioned 
electron-rich aromatics were used to perform Pictet-Spengler-like cyclisations and this enabled 
ring contraction to give γ-lactams. Similarly, hydrogenation of unsaturated diazepanes can be used 
to trigger ring contractions. The processes are stereospecific, which allows the absolute 
stereochemistry of the cyclopropylamine precursors to be transferred to the products. In broader 
terms, these studies validate a conceptually unique TDG-based strategy for C-C bond activation. 
Specifically, the processes are the first in this area that do not harness carbonyl condensation and 





New substrates for intramolecular nucleophilic addition to 
rhodacyclopentanones 
Aspects of this Chapter have been adapted from a paper. 
(Boyd, O.†; Wang, G.-W.†; Sokolova, O. O.; Calow, A. D. J.; Bertrand, S. M.; Bower, J. F. 
Angew. Chem. Int. Ed. 2019, 58, 18844. †O. Boyd and G.-W. Wang contributed equally) 
3.1 Introduction 
As outlined in section 1.3, early investigations into nucleophilic addition to 
rhodacyclopentanones via intermediate 42 demonstrated that urea-protected aminocyclopropanes 
can undergo a (6+1) carbonylative cyclisation to give a range of diazepanes (Scheme 39). The 
scope of nucleophiles that can trap out the rhodacyclopentanone intermediate was then extended 
to carbon-based systems. Aromatic, vinylic and heterocyclic units, such as indoles, pyrroles and 
furans were demonstrated to provide challenging 7- and 8-membered rings. 
 
Scheme 39: Successful nucleophilic additions to rhodacyclopentanones. 
3.1.1 Prior studies carried out in Bristol 
In pursuit of new protected aminocyclopropane-based systems that can “capture” 
rhodacyclopentanones, Dr. McCreanor and Dr. Stanton tested various systems containing oxygen, 
carbon and nitrogen-based nucleophiles.75,117 Oxygen-based nucleophiles were efficient in 
intermolecular transformations. Subjection of cyclopropylamine 175 to carbonylative conditions 
in the presence of PhOH or BnOH gave linear adducts 176 and 177 in 47 and 50% yield, 
respectively (Scheme 40A). However, when an oxygen-based nucleophile was incorporated into 
aminocyclopropane-bearing substrates 178a-d, none of the desired cycloadducts 179a-d were 
Chapter 3 – New substrates for intramolecular nucleophilic addition to rhodacyclopentanones 
41 
observed (Scheme 40B). With respect to carbon-based nucleophiles, it was envisaged that 
substrates 180a-c may be nucleophilic due to the presence of enolisable C1-H protons  
(Scheme 40C). It was proposed that these substrates may form an O-bound Rh(III)-enolate 181 
which isomerises to C-bound Rh(III)-enolate 182. Subsequent C-C bond forming reductive 
elimination would then give 7-membered products 183a-c. However, the desired products were 
not observed under various catalytic conditions. 
 
Scheme 40: Other systems trialled in nucleophilic additions to rhodacyclopentanones. 
Although the studies in Scheme 40 were largely unsuccessful, linear side products 185 
were observed in some cases (Scheme 41A). Side products 185 likely arise via directed formation 
of rhodacyclobutane 184, which then undergoes β-hydride elimination and C-H reductive 
elimination. For example, substrate 189 gave enamide 185a in 41% yield, and this presumably 
arises via rhodacyclobutane 184a (Scheme 41B). Cyclic structures 186, formed by intramolecular 
nucleophilic addition to enamide 185, were also observed. When aminocyclopropane 190, which 
bears a nitrogen-based nucleophile, was used, enamides 185b or 188b were not observed but 5-
membered cyclic product 186b was isolated instead in 37% yield. This result can be rationalized 
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via a directed C-C bond activation pathway, involving conversion of 185b to 186b (Scheme 41C). 
The formation of side products 185a and 186b indicates that directed C-C bond activation had 
occurred, but, presumably, either the formation of intermediate 187 or the reductive elimination 
process are problematic, such that the target products 188 do not form. 
 
Scheme 41: Typical side products resulting from failed nucleophilic additions to rhodacyclopentanones. 
Further studies on nucleophilic addition to rhodacyclopentanones were carried out by Dr 
Adam Calow. As there are several examples known in the literature118-121 where nitrogen 
incorporated in the starting material directs Rh(I)-catalysed transformations, Dr Calow 
investigated various substrates containing tethered nitrogen-based nucleophiles (Scheme 42A). 
With protected aminocyclopropane 191, no target 9-membered product 192 could be obtained. On 
the other hand, the transformation of similar substrate 193 delivered trace amounts of 8-membered 
product 194. Encouraged by this result, similar substrates were made. When substrate 195a, 
containing an unprotected aniline was used, diazonine 196a was obtained in 39% yield; side 
products 197 and 198a were also formed (Scheme 42B). Unfortunately, attempts to suppress the 
formation of 6-membered adducts 197 and 198a and improve the yield of 196a were unsuccessful. 
Finally, substrate 199a, containing a monosubstituted aniline, underwent Rh(I)-catalysed 
transformation to 200a in 17% yield; here, only traces of adduct 201 were observed (Scheme 42C). 
This promising result prompted further investigation of parent substrate 199a. 
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Scheme 42: Investigations by Dr. Calow on nucleophilic addition to rhodacyclopentanones. 
3.2 Further work on nucleophilic addition to rhodacyclopentanones 
The initial aims of the work described in this section were to screen different substitution 
patterns on general substrate 195 in order to suppress the formation of undesired side products 
(e.g. 198a) (Scheme 43A) and improve the yield of 8-membered product 200a (Scheme 43B). 
Related substrates for the carbonylative rearrangement were also proposed (Scheme 43C). For the 
screening studies described below, several parameters were evaluated: Rh(I) precatalyst (cationic 
– [Rh(cod)2]BARF, [Rh(cod)2]BF4 or [Rh(cod)2]OTf; neutral – [Rh(cod)Cl]2 or [Rh(cod)OMe]2), 
phosphine ligand (PPh3 and its derivatives with various electronics), reaction solvent (coordinating 
PhCN or non-coordinating 1,2-DCB) and reaction temperature (100-160 °C). 
Scheme 43: Further work on the “capture-collapse” strategy - project aims.  
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3.2.1 Substrate evaluation for the formation of 9-membered cycloadducts 
To assess the effect of sterics on the formation of 9-membered product 196 and 6-
membered adduct 198, substrates 195b-e, with different R-substituents, were made via a two-step 
sequence. Amide coupling of amines 202b,c,e with 2-nitrobenzoic acid provided amides 203b,c,e. 
Subsequent reduction of the nitro group with iron in acetic acid delivered aniline derivatives 
195b,c,e. Methyl-substituted compound 195d was synthesised by the methylation of 203e under 
basic conditions (methyl iodide, base) to give 203d followed by nitro group reduction to 195d. 
When substrates 195b-e were exposed to carbonylative reaction conditions, at most, only 
traces of target material 196b-e were observed in the 1H NMR spectrum of the crude reaction 
mixture. Instead, C1-N2 unsaturated adducts 198b-e were obtained; in particular, 198e was 
isolated in 30% yield. The yields of 198b-d were determined by 1H NMR analysis of the crude 
reaction mixture and were not isolated. These results indicate that the reaction outcome is highly 
dependent on the R-substituent, such that only benzyl substituted 195a is suitable for efficient 
carbonylative cyclisation (to 196a). 
 
Scheme 44: Synthesis and reactivity of substrates with different substituents on nitrogen. Reagents and conditions: 
(i) EDCI, DMAP, DCM, 0 °C to r.t., 18 h; (ii) Fe, AcOH, EtOH, 85-90 °C, 2-18 h; a This compound was made by Dr 
Calow. Yields in (B) were determined by 1H NMR spectroscopy using 1,4-dinitrobenzene as a standard. An isolated 
yield for 198e is given in parentheses. 
3.2.2 Optimisation of the carbonylative heterocyclisation process 
To improve the yield of the carbonylative heterocyclisation of 199a, an extensive 
evaluation of reaction conditions was carried out (>250 sets of conditions), and selected results are 
shown in Table 2. Raising the reaction temperature to 150 or 160 °C did not give a substantial 
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increase in yield and mass recovery was poor (Table 2, Entries 1-3). Using a combination of 
dimethyl fumarate as a π-acidic ligand and 20 mol% of a Na2SO4 as a desiccant improved the yield 
to 43% (Table 2, Entry 4). Both dimethyl fumarate and Na2SO4 proved necessary to achieve this 
moderate yield, and using only Na2SO4 gave 200a in 21% yield (Table 2, Entry 5). Increasing the 
reaction time led to greater consumption of starting material, but gave 200a in 35% yield (Table 
2, Entry 6). This result may indicate that the product is unstable under the reaction conditions and 
longer reaction times facilitate decomposition. A possible pathway involves protonation of 
enamide 200a to give iminium 204 which can then hydrolyse to aldehyde 205; this behaviour is 
consistent with related 7- and 8-membered structures in the literature (Scheme 45).122,123  
To avoid the formation of presumed iminium ion 204, different basic additives were 
screened. However, the reaction demonstrated high sensitivity towards these, and 30 mol% of the 
base (e.g. NaOAc) was enough to completely prevent formation of target 200a (Table 2, Entry 7). 
Nevertheless, an improved yield was obtained by using the same molar concentration of base as 
Rh-catalyst (5 mol% NaOAc) (Table 2, Entry 8). By switching to a stronger base (NaOt-Bu) and 
increasing the reaction temperature to 160 °C, 200a was formed in 46% yield (Table 2, Entries 9, 
10). Further screening of reaction conditions did not improve the yield of 200a and efforts turned 
to an evaluation of the reaction’s scope. As the results with 20 mol% Na2SO4 (Table 2, Entry 4) 
and 5 mol% NaOt-Bu (Table 2, Entry 10) were comparable, both sets of conditions were used for 
this endeavour. 
 
Entry Additives (mol %) T (°C) Time (h) 199a (%) 200a (%) 201 (%) 
1 DF (100) 140 24 82 17 trace 
2 DF (100) 150 72 25 25 8 
3 DF (100) 160 72 trace 37-38 8 
4 DF (100), Na2SO4 (20) 150 72 20 47 (43) 6 
5 Na2SO4 (20) 150 72 33 21 9 
6 DF (100), Na2SO4 (20) 150 96 9 35 6 
7 DF (100), NaOAc (30) 150 72 86 0 0 
8 DF (100), NaOAc (5) 150 72 25 39 trace 
9 DF (100), NaOt-Bu (5) 150 72 31 44 4 
10 DF (100), NaOt-Bu (5) 160 72 11 51 (46) 6 
Table 2: Optimization studies for the formation of 200a. Yields were determined by 1H NMR spectroscopy using 1,4-
dinitrobenzene as a standard. Isolated yields are given in parentheses. DF = dimethyl fumarate. 




Scheme 45: Proposed pathway for the decomposition of 200a. 
In order to explore the effect of different electronics on the aniline unit, substrates 199a-f 
were targeted (Scheme 46A). The syntheses commenced with condensation of bromoacetyl 
bromide 206 and N-benzylcyclopropanamine to give 2-bromoacetamide 207 in quantitative yield. 
207 was then used to alkylate a range of anilines, delivering 199a-e in 41-75% yield. The formation 
of 199f did not occur under these alkylation conditions, presumably due to the low nucleophilicity 
of pentafluoroaniline. An alternative approach, where C6F6 underwent SNAr reaction with primary 
amine 193 provided 199f in 83% yield (Scheme 46B). 
 
Scheme 46: Synthesis of substrates 199a-f. Reagents and conditions: (i) bromoacetyl bromide, K2CO3, DCM, 0 °C 
to r.t., 18 h; (ii) corresponding aniline, K2CO3, toluene, 90 °C, 2-18 h; (iii) DMSO, C6F6, KF, 100 °C, 18 h. 
Substrates 199a-f were then exposed to the optimised carbonylative reaction conditions 
(Table 3). It was observed that aminocyclopropanes 199b-d, possessing electron-rich substituents 
on the aniline, cyclized to provide 1,4-diazocanes 200b-d in moderate and similar yields (30-42%). 
The structure of o-methoxy-substituted 1,4-diazocane 200c was confirmed by single-crystal X-ray 
diffraction. It was proposed that substrates equipped with electron-poor anilines (4-CF3 and F5) 
might enhance the reaction rate by reducing coordinative saturation of Rh by N-coordination124,125 
and also by electronically facilitating C-N reductive elimination at the stage of 187 (see  
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Scheme 41).126-128 However, substrates 199e,f were less efficient at delivering the desired adducts 
200e,f (12-17% yield). Overall, these results suggest that efficient generation of metallabicyclic 
intermediate 187 is the key factor, and more nucleophilic anilines facilitate this. 
 
Table 3: Scope of the aniline component. a 5% NaOtBu instead of 20% Na2SO4, 160°C. b Yield was determined by 
1H NMR spectroscopy using 1,4-dinitrobenzene as a standard. 
 
Moving away from aniline nucleophiles, other N-based nucleophiles were trialled with 
limited success. More nucleophilic amines were expected to perform better in the transformation 
because electron-poor anilines 199e and 199f gave 200e,f in only 12-17% yield. To address this, 
methylamine and benzylamine were alkylated with 2-bromoacetamide 207 to provide 208 and 209, 
respectively (Scheme 47A). Subjection of these substrates to the Rh(I)-catalysed carbonylative 
conditions led predominantly to decomposition, although trace quantities of target products 210 
and 211 were observed in the 1H NMR spectrum of the crude reaction mixture. Pyrrolidine-derived 
substrate 213 was accessed via 212 by amide coupling of N-Boc-proline and N-
benzylcyclopropanamine followed by Boc deprotection (Scheme 47B). Subjection of 213 to a 
range of catalytic conditions led to starting material degradation and the formation of bicyclic 
structure 214 did not occur. The poor performance of these cyclisations indicates that aniline-
substituted substrates are uniquely suitable for the transformation. For the substrates depicted in 
Scheme 47, the strongly Lewis basic amine moieties may outcompete the weakly coordinating 
amide directing group and prevent directed C-C bond activation.129 
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Scheme 47: Synthesis and reactivity of substrates 208, 209 and 213. Reagents and conditions: (i) 40% aq. MeNH2, 
EtOH, 65 °C, 18 h; (ii) benzylamine, K2CO3, toluene, 80 °C, 18 h; (iii) N-Boc-proline, EDCI, DMAP, DCM, 0 °C to 
r.t., 18 h; (iv) TFA, DCM, 1 h. a Yield was determined by 1H NMR spectroscopy using 1,4-dinitrobenzene as a 
standard. 
3.2.3 Further product derivatisation via Pictet-Spengler cyclisation 
To demonstrate the use of the Rh(I)-catalysed cyclisation products in further 
transformations, enamide 220 was made (Scheme 48). It was envisaged that the tethered electron-
rich aromatic ring might be amenable to Pictet-Spengler-like cyclisation.130,131 First, alcohol 215 
was converted to tosylate 216, and this was used to provide 217 via alkylation of 
aminocyclopropane. Amine 217 was alkylated with bromoacetyl bromide to give 218 in 84% 
yield. Next, reaction of 218 with aniline provided heterocyclisation substrate 219. Exposure of 219 
to the optimised carbonylative conditions delivered 8-membered product 220 in 40% yield. 
Finally, 220 was treated with TFA to deliver complex tricycle 221 in 75% yield. This result 
showcases the reactivity of the enamide moiety of the carbonylative heterocyclization product. 
 
Scheme 48: Synthesis of Pictet-Spengler product 221. Reagents and conditions: (i) TsCl, Et3N, DMAP, DCM, r.t., 4 
h; (ii) cyclopropylamine, MeCN, 90 °C, 18 h; (iii) bromoacetyl bromide, K2CO3, DCM, 0 °C to r.t., 18 h; (iv) aniline, 
K2CO3, toluene, 90 °C, 4 h; (v) [Rh(cod)Cl]2 (5 mol%), dimethyl fumarate (100 mol%), Na2SO4 (20 mol%), PhCN 
(0.1 M), CO (1 atm), 150 °C, 72 h; (vi) TFA, DCM, 60 °C, 24 h.  
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3.2.4 Evaluation of alternative systems with tethered nucleophiles 
Having established that 8-membered rings can be accessed using aniline nucleophiles, 
efforts were undertaken to identify other suitable substrate classes. N-Alkyl amines 208 and 209 
were inefficient for the cyclisation (Scheme 47A), so substrates containing less basic sulfonamide 
and urea units were targeted next. Protection of primary amine 193 with either tosyl chloride or 
dimethylcarbamoyl chloride delivered 222 and 223, respectively (Scheme 49). Both of these 
substrates, which contain N-based nucleophiles to “capture” the rhodacyclopentanone 
intermediate, did not undergo the desired carbonylative rearrangement and adducts 224, 225 were 
not observed upon exposure to various Rh(I) catalysed conditions. In the case of sulfonamide 222, 
only starting material was recovered, while urea 223 decomposed under the reaction conditions. It 
may be that the nucleophilicity of the N1-unit is insufficient to promote the heterocyclisation of 
224 and 225. 
 
 
Scheme 49: Synthesis and reactivity of N-substituted substrates 222 and 223. Reagents and conditions: (i) TsCl, 
pyridine, DMAP, DCM, 0 °C to r.t., 18 h; (ii) dimethylcarbamyl chloride, TEA, DCM, 0 °C to r.t., 18 h. 
In concurrent studies, urea-derived substrate 226 was designed in an attempt to access 
larger 10-membered products like 227 (Scheme 50). The first approach to 226, starting with the 
condensation of carbamoyl chloride 228 with the 2-nitroaniline, did not deliver any of intermediate 
urea 229 (Scheme 50A). An alternative approach, where 2-nitroaniline was transformed into its 
corresponding carbamoyl chloride 230 and then reacted with N-benzylcyclopropanamine, gave 
229 in 80% yield. Finally, the reduction of the nitro group of 229 with stannous chloride provided 
urea 226. Unfortunately, under various Rh-catalysed reaction conditions, the formation of 227 did 
not occur (Scheme 50B). Depending on the reaction conditions, β-hydride elimination product 231 
or cyclisation to 232 could be observed in the 1H NMR spectrum of the crude reaction mixture. 
This implies that the C-C bond activation step takes place, but that degradation of the intermediate 
occurs prior to either nucleophilic trapping of the rhodacyclopentanone or C-N reductive 
elimination (cf. Scheme 41A). 
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Scheme 50: Synthesis and reactivity of 226. Reagents and conditions: (i) triphosgene, pyridine, DCM, 0 °C to r.t., 4 
h; (ii) 2-nitroaniline, DMAP, DCM, 0 °C to r.t., 18 h; (iii) 2-nitroaniline, NaH, THF, 0 °C to r.t. to 60 °C, 18 h; (iv) 
N-benzylcyclopropanamine, DMAP, DCM, 0 °C to r.t., 18 h; (v) SnCl2•2H2O, EtOAc, 50 °C, 6 h. a [Rh(cod)Cl]2 (5 
mol%), dimethyl fumarate (100 mol%), PhCN (0.1 M), CO (1 atm), 140 °C, 48 h. b [Rh(cod)2]BARF (5 mol%), PPh3 
(10 mol%), PhCO2H (30 mol%), 1,2-DCB (0.1 M), CO (1 atm), 100 °C, 48 h. 
Substrates 233a and 233b were also made to explore the possibility of carbonylative 
heterocyclisations with tethered O-based nucleophiles. The synthesis of 233a involved HOBt-
assisted amide coupling with glycolic acid 235 (Scheme 51A). Upon exposure of 233a to various 
Rh-catalysed carbonylative conditions, decomposition of the starting material occurred, and 
oxazocane 234a did not form. Similar reactivity was observed with alcohol 233b, which was 
obtained by the nucleophilic ring opening of β-propiolactone 236 with N-benzylcyclopropanamine 
(Scheme 51B). The target 9-membered product 234b was not formed, and, instead, starting 
material 233b degraded under the reaction conditions. The inability of substrates 233a and 233b 
to deliver cyclisation products 234a and 234b may be due to the lower nucleophilicity of tethered 
alcohols compared to tethered anilines. The intrinsically challenging nature of C-O reductive 
elimination may also contribute to the failure of these reactions.132 
 
Scheme 51: Synthesis and reactivity of 233a,b. Reagents and conditions: (i) EDCI, HOBt, N-methylmorpholine, 
DMF, r.t., 18 h; (ii) β-propiolactone, toluene, 105 °C, 15 min. 
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3.3 Conclusions 
The studies in this chapter have demonstrated that 8-membered rings can be accessed in 
moderate yield when anilines are used as the nucleophilic component in capture-collapse 
heterocyclisations (Scheme 52A). A range of other substrates with tethered N- and O-based 
nucleophiles was examined, but no suitable systems were identified (Scheme 52B). The success 
of the carbonylative cyclisation is highly dependent on the electronics of the incoming nucleophile 
and, so far, only anilines have proved suitable for the transformation. The key challenge is to 
ensure that formation of the nucleophile-bound rhodacyclic intermediate 42 and subsequent C-Nu 
reductive elimination step are efficient enough to prevent competitive degradation pathways.  
Future work in this area could focus on further evaluation of various substrates with tethered 
nucleophiles. For example, the studies outlined in Chapter 2 demonstrated that nucleophilic 
addition of ureas to rhodacyclopentanones may be followed by intramolecular carbometalation of 







Asymmetric C-C bond activation of cyclopropylamines 
4.1 Introduction 
Achieving high levels of enantioselectivity under C-C bond activation conditions is 
challenging because such reactions often require high temperatures. However, enantioselective 
methodologies involving the C-C bond activation of activated cyclopropanes, such as 
alkylidenecyclopropanes, vinylidenecyclopropanes, vinylcyclopropanes, and 4-ring systems, such 
as benzocyclobutenones and cyclobutanones, have been developed. To date, enantioselective 
transformations involving non-activated aminocyclopropane systems have not been reported. 
(Scheme 53). 
 
Scheme 53: Different systems for enantioselective transformations via C-C bond activation. 
Alkylidenecyclopropanes (approximate strain energy of 40 kcal/mol) are highly reactive 
towards transition-metal-catalysed C-C oxidative addition due to the strain release during 
formation of the metallacycle.133 As a result, many cycloaddition methodologies use 
alkylidenecyclopropane motifs.2 Although this area has been explored for over 50 years,134 only 
two reports demonstrate asymmetric induction in the course of the C-C bond activation process. 
In 2007, Mascareñas and co-workers reported135 the first example of a Pd-catalysed 
enantioselective intramolecular cycloaddition involving an alkylidenecyclopropane 237. Exposure 
of alkylidenecyclopropane 237 to a catalyst system derived from Pd(0) and phosphoramidite 
ligand L1 afforded carbocycle 239 in 73% yield and 43% e.e. (Scheme 54A). In this process, the 
Pd(0)-catalyst was proposed to insert into  the distal bond “b”, and the resulting palladacyclobutane 
subsequently undergoes allylic rearrangement to give palladacycle 238. This is followed by ring-
forming diastereoselective carbopalladation, allylic isomerisation and C-C reductive elimination 
to afford the target cycloadduct 239. A more efficient set of conditions has been developed 
subsequently by the same group.136 
Building upon the work of Mascareñas, Evans and co-workers137 reported a Rh(I)-catalysed 
enantioselective transformation involving alkylidenecyclopropane 240 (Scheme 54B). In this 
process, high enantioselectivity was achieved through the use of bidentate P,N-ligand L2. Here, a 
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strong preference for rhodium insertion into the distal bond “b” over proximal bond “a” was 
observed, leading to rhodacyclobutane 241. Computational studies revealed that an unusual six-
coordinate 18-electron Rh(III)-trimethylenemethane complex 242 is formed upon isomerisation of 
241. Subsequent alkene insertion affords η3-allyl complex 243, which, after CO migratory 
insertion, C-C reductive elimination and alkene isomerisation, provided the target structure 244 in 
high enantiopurity. To date, this is the only example of an enantioselective carbonylative C-C 




Scheme 54: Enantioselective transformations involving alkylidenecyclopropane derivatives. 
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Aside from alkylidenecyclopropanes, vinylidenecyclopropanes have also been employed 
in asymmetric transformations.139-141 For example Wei, Shi and co-workers demonstrated that 
regiochemical cycloadducts 245a and 245b can be obtained from vinylidenecyclopropane 246 
through judicious choice of BINAP-derived ligands L3,4 (Scheme 55).141 Control experiments 
suggested that 245a and 245b do not interconvert, indicating that different mechanistic pathways 
occur for their formation, and that the distinct outcomes are not down to alkene isomerisation at 
the stage of the cycloadduct. 
 
Scheme 55: Enantioselective transformations of vinylidenecyclopropane derivatives. 
 
Another reactive strained system that has been successfully used in enantioselective C-C 
bond cleavage is based on the vinylcyclopropane (VCP) core. Although less strained than 
alkylidenecyclopropanes (approximate strain energies of 28 vs 40 kcal/mol),133 
vinylcyclopropanes are nonetheless highly reactive towards transition metal-catalysed ring 
cleavage. Here, the vinyl unit brings the Rh(I)-catalyst into close proximity of the cyclopropane 
and promotes the formation of π-allyl rhodacycle 247 (Scheme 56A). Utilising this type of C-C 
bond activation process, the Yu group has reported an enantioselective intramolecular (3+2) 
cycloaddition involving vinylcyclopropane 248, where the metallacycle is trapped by tethered 
alkynes (Scheme 56B).142 High enantioselectivity was achieved with a cationic rhodium catalyst, 
which was formed in situ from [Rh(CO)2Cl]2, AgSbF6 and (R)-H8-BINAP. Computational 
calculations suggested that reversible formation of rhodacycle 249 from 248 is followed by 
irreversible rate determining and stereodetermining alkyne insertion. Asymmetric (5+2) 
annulations have also been studied. The first example, published by Wender and co-workers, 
demonstrated moderate enantioselectivity with (S,S)-Chiralphos as the ligand (Scheme 56C).143 
Later, the enantioselectivity of this cycloaddition was improved by using different chiral 
ligands.144,145 
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Scheme 56: Enantioselective transformations involving vinylcyclopropane derivatives. 
Usually, C-C bond cleavage in VCPs occurs prior to C-C bond formation (Scheme 56A).146 
Mechanistically distinct transformations, involving oxidative coupling (to 250) prior to β-carbon 
elimination and C-C reductive elimination were reported by the Anderson group (Scheme 57).147 
Exposure of ynamide substrates, such as 251, to a cationic Rh(I)-catalyst and phosphoramidite 
ligand L5 provided [5.3.0]-azabicyclic structures, such as 252, in excellent yield and with high 
enantioselectivity. The reaction conditions are notably mild, with room temperature being 
sufficient for high turnover. This may reflect that cleavage of the cyclopropane unit occurs via -
carbon elimination instead of C-C oxidative addition. 
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Scheme 57: Enantioselective (5+2) cycloaddition of ynamide substrates. 
 
 
Scheme 58: Dynamic kinetic asymmetric (3 + 2) cycloadditions of vinylcyclopropanes. 
Vinylcyclopropanes bearing electron withdrawing groups can form electrophilic 
zwitterionic η3-allyl complexes, such as 253, in the presence of a chiral transition metal catalyst 
(Scheme 58A). This complex adds in an enantioselective manner across electron-poor olefins to 
give various (3+2) cycloadducts, a reactivity mode first demonstrated by Trost and co-
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workers.148,149 Using the classic Trost ligand L6, the group was able to use alkylidene azlactones 
as two-carbon components yielding highly substituted five-membered cyclic systems 254 in high 
e.e. (Scheme 58B). Following this, many other π-unsaturates have been used in Pd(0)-catalysed 
asymmetric (3+2) cycloadditions, e.g. β,γ-unsaturated α-keto esters,150 α-heterocycle-substituted 
acrylates,151 nitroolefins,152-154 p-quinone methides,155 electron-deficient alkynes,156 imines,157-159 
and isatins (Scheme 58C).160 
Linear products with well-defined stereochemistry are also accessible using VCPs. For 
example, Pd-catalysed asymmetric alkylations of 3-substituted indoles was disclosed by the Trost 
group using modified Trost ligand L7 (Scheme 59A).161 Here, unlike with electron-deficient 
olefins (cf. Scheme 58), the initially formed 1,3-dipole first acts as an electrophile. This allows 
quaternary centres to be installed (e.g. 255) by alkylation of 3-substituted indoles. In these 
processes, the -nucleophilicity of the indole is enhanced by using triethylborane as additive.162 
Recently, Krische and co-workers reported163 an umpolung process, where a donor-
acceptor VCP and the cyclometalated Krische Ir-catalyst was used to generate an unusual 
nucleophilic π-allyl intermediate (Scheme 59B). This was able to engage in efficient asymmetric 
carbonyl allylation. The coupling partner in the process is either an aldehyde with a sacrificial 
equivalent of isopropanol as reductant, or an alcohol, which is converted to an aldehyde in situ. 
 
Scheme 59: Asymmetric transformations of vinylcyclopropanes giving linear products. 
Four-membered systems, namely cyclobutanone derivatives, have also been employed in 
asymmetric transformations. Dong and co-workers have published several methodologies in which 
benzocyclobutenones undergo Rh-catalysed C-C bond activation. Following C-C oxidative 
Chapter 4 – Asymmetric C-C bond activation of cyclopropylamines 
58 
addition of the cyclobutanone (e.g. 256), the rhodabenzocyclopentenone intermediate is trapped 
by a tethered -unsaturate (Scheme 60). First, it was shown that rhodacycle 257, formed upon 
regioselective insertion of rhodium into cyclobutenone 256, can undergo enantiodetermining 
migratory insertion of the tethered alkene to give tricyclic products like 258 by using a bulky and 
electron-rich SEGPHOS-based ligand (Scheme 60A).164 Subsequently, the group showcased the 
methodology in the total synthesis of (−)-cycloclavine.165 Later, it was shown that oximes 259 can 
function as the inserting -unsaturate to provide lactams 260 (Scheme 60B).166 Interestingly, a 
mixed-ligand catalyst system was necessary: while (R)-Xylyl-SDP gave higher enantiomeric 
excess than (S)-Xylyl-BINAP (98 vs. 92% e.e.), the yield was higher for the latter (53 vs 79%). 
Combining both ligands resulted in prolonged catalytic activity and high enantioselectivity. 
 
Scheme 60: Asymmetric transformations of benzocyclobutenones. 
Aside from benzocyclobutenones, less strained cyclobutanone derivatives have also been 
used in asymmetric C-C bond activations and related processes. In particular, there are several 
publications that demonstrate the use of an aromatic tether between the cyclobutanone unit and the 
inserting -unsaturate. Building upon research from Murakami and co-workers,167 the Cramer 
group have demonstrated Rh(I)-catalysed C-C bond activation of cyclobutanone derivatives 261 
(Scheme 61A).29 Highly enantioselective C-C bond activation occurs when (R)-DTBM-
SEGPHOS (cf. Scheme 60A) is used. The researchers propose that the initial coordination of the 
inserting alkene and the cyclobutanone carbonyl to Rh provides a highly ordered transition state, 
which makes the C-C cleavage step more enantioselective. As a result, different complex bicyclic 
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ketones such as 262a and 262b are formed efficiently after migratory insertion and reductive 
elimination. An analogous process, using ketones and aldehydes in place of the alkene component, 
has also been published (Scheme 61B).31 
 
 
Scheme 61: Asymmetric transformations of cyclobutanones, tethered to an aromatic ring. 
 
Finally, recent publications from Dong and co-workers have explored the possibility of 
asymmetric transformations of cyclobutanones using -unsaturates that are attached by an 
aliphatic (rather than aromatic) linker. For allene-derived substrate 263, regiochemically distinct 
cycloadducts 264 and 265 can be obtained using either Rh- or Ni-based catalyst systems (Scheme 
62A vs. Scheme 62B).33,35 Cyclobutanones 266 with tethered alkynes or terminal alkenes have 
been shown to participate in Rh(I)-catalysed kinetic resolutions at room temperature, giving fused 
bicyclic products 267 (Scheme 62C).168 
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Scheme 62: Asymmetric transformations and kinetic resolutions of cyclobutanones. 
A single report of enantioselective C-C bond activations using less activated 3-ring systems 
has been disclosed by Ye and co-workers. Here, a ligand-enabled bimetallic strategy was employed 
to allow enantioselective intermolecular (3+2) cycloadditions between cyclopropyl carboxamides 
268 and alkynes (Scheme 63).169 In this process, ligand L9 is ligated to both a Ni-catalyst and an 
aluminium-based Lewis acid; the latter, coordinates to the carbonyl unit of 268, which facilitates 
the formation and stabilisation of nickelacycle 269. An additional achiral phosphine ligand (P(o-
Tol)3) further stabilises the nickelacycle and is proposed to assist with the initial oxidative addition 
event. 
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Scheme 63: Asymmetric transformation of cyclopropyl carboxamides. 
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4.2 Reaction design 
The processes described above encompass enantioselective transformations that are possible 
via C-C bond cleavage of small ring systems. However, achieving high levels of enantioselectivity 
in C-C bond activation processes involving simple, non-activated cyclopropane-based systems is 
highly challenging due to the lower reactivity of such motifs. To date, there are no reported highly 
asymmetric processes involving aminocyclopropanes. Early investigations conducted at Bristol by 
Dr. Shaw sought to address this issue, and the urea-directed C-C activation protocol involving 
protected aminocyclopropane 270 was screened with various chiral ligands (see also Section 1.3, 
Scheme 5B).123 An encouraging level of enantioselectivity was achieved using phosphoramidite 
ligand L10, which afforded 271 in 35% e.e., albeit in low yield (Scheme 64). 
 
Scheme 64: Early study towards enantioselective (3+1+2) cycloadditions in the Bower group. 
As a result of this preliminary study, efforts were directed towards finding other substrate 
classes suitable for an enantioselective C-C bond activation-based methodology. Extensive efforts 
were made to render the (3+1+2) cycloaddition process involving substrate 270 highly 
enantioselective, but no further improvements were forthcoming. Accordingly, substrate 
modification was deemed an attractive direction of research (Scheme 65A). Initial studies on urea-
based substrates highlighted the importance of a strong directing group (urea) to outcompete the 
alkyne for coordination to Rh(I) prior to C-C oxidative addition of the cyclopropane. However, 
system 272 was considered as an alternative to 24 (Scheme 65B). It was proposed that the 
requirement for the strong directing group might be alleviated by tethering the alkyne moiety to 
the directing group unit; here, inductive effects should decrease the alkyne’s donor ability. 
Additionally, in this design, the R1 substituent on nitrogen can be varied, which offers more 
diversity versus the approach in Scheme 65A. 
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Scheme 65: Relevant work from the Bower group and starting material design. 
With the design in Scheme 65B in hand, amide 273 was synthesised (Scheme 66A). This 
was achieved by Sonogashira cross-coupling of 3-butyn-1-ol with phenyl iodide to form 274, Jones 
oxidation (to 275) and amide formation via the corresponding acid chloride. Subjection of 273 to 
>10 sets of Rh(I)-catalysed conditions resulted only in degradation of starting material and 
cycloadduct 276 was not observed (Scheme 66B). It was reasoned that this might be due to the 
acidic and enolisable propargylic CH2 group of substrate 273. 
 
Scheme 66: Synthesis and reactivity of cyclopropylamide 273. Reagents and conditions: (i) PdCl2(PPh3)2, CuI, PhI, 
Et3N, r.t.; (ii) CrO3, H2SO4, H2O, acetone, 0 °C; (iii) oxalyl chloride, DCM, r.t., then N-benzylcyclopropanamine, 
DCM, 0 °C to r.t. 
An easy way to prevent enolisation at the -position of 273 is to change the C-H bonds to 
two identical substituents. Synthesis of substrates 277a-c was achieved by electrophilic 
alkynylation of various gem-disubstituted methyl esters with alkynyl chloride 278 to form esters 
279a-c (Scheme 67A).170-172 Subsequent ester hydrolysis and amide coupling of the resulting 
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carboxylic acids delivered target substrates 277a-c. Substrates 277a-c may also benefit from the 
Thorpe-Ingold effect: bulky substituents at the tetrahedral centre can compress the angle between 
the other two reacting substituents (θ1>θ2) (and/or more strongly favour the reactive conformer, 
vide infra), and this effect can accelerate alkyne insertion (Scheme 67B).173,174 
 
Scheme 67: Synthesis of cyclopropylamides 277a-c and a rationalisation of the Thorpe-Ingold effect. Reagents and 
conditions: (i) n-BuLi, NCS, THF, -78 °C to r.t.; (ii) corresponding methyl ester, LDA, THF, -78 °C to r.t.; (iii) 4.0 
M aq. NaOH, MeOH, r.t.; (iv) N-benzylcyclopropanamine, EDCI, DMAP, DCM, 0 °C to r.t. 
Initial studies to test the feasibility of the proposed transformation were undertaken with 
cyclopentyl derivative 277a (Table 4). First, cationic and neutral Rh(I) sources modified with PPh3 
were screened in either coordinating or non-coordinating solvents (Table 4, Entries 1-4). 
Pleasingly, cyclohexenone 280a was isolated in 71% yield utilising a cationic precatalyst 
([Rh(cod)2]OTf) and non-coordinating solvent (1,2-DCB) (Table 4, Entry 4). The use of other 
cationic Rh(I) sources and electron-rich or electron-poor triphenylphosphine derivatives was 
detrimental to the reaction yield (not shown in Table 4). With the first-generation conditions in 
hand, other disubstituted derivatives were evaluated. Cyclohexyl derivative 277b performed much 
worse than its cyclopentyl homologue 277a and a significant amount of phenol side product 281b 
was obtained (Table 4, Entry 5). This side product may be the result of further oxidation of 
cyclohexenone 280b, suggesting that under these conditions cycloaddition of substrate 277b is 
faster. Lowering the temperature or reaction time gave comparable yields and suppressed 
formation of the phenol side product 281b (Table 4, Entries 6 and 7); for convenience, further 
optimisation was pursued using a reaction time of 48 h. Pleasingly, reducing the loading of 
[Rh(cod)2]OTf from 10 to 5 mol% did not appreciably change yields of 280a-c (Table 4, Entries 
8-10). 













Yield of 280a 
(%) 
Yield of 281a 
(%) 
1 [Rh(cod)Cl]2 (5) -(CH2)4- 1,2-DCB (0.1) 130 72 0 0 
2 [Rh(cod)Cl]2 (5) -(CH2)4- PhCN (0.1) 130 72 12 0 
3 [Rh(cod)2]OTf (10) -(CH2)4- PhCN (0.1) 130 72 37 0 
4 [Rh(cod)2]OTf (10) -(CH2)4- 1,2-DCB (0.1) 130 72 73 (71) trace 
5 [Rh(cod)2]OTf (10) -(CH2)5- 1,2-DCB (0.1) 130 72 31 (26) 35 (20) 
6 [Rh(cod)2]OTf (10) -(CH2)5- 1,2-DCB (0.1) 120 72 80 trace 
7 [Rh(cod)2]OTf (10) -(CH2)5- 1,2-DCB (0.1) 130 48 82 trace 
8 [Rh(cod)2]OTf (5) -(CH2)5- 1,2-DCB (0.1) 130 48 81 (78) trace 
9 [Rh(cod)2]OTf (5) -(CH2)4- 1,2-DCB (0.1) 130 48 79 (75) 0 
10 [Rh(cod)2]OTf (5) Me 1,2-DCB (0.1) 130 48 80 (77) trace 
Table 4: Optimisation studies for the new (3+1+2) cycloaddition. aYields were determined by 1H NMR spectroscopy 
using 1,4-dinitrobenzene as a standard. Isolated yields are given in parentheses. 
4.3 Reaction scope 
4.3.1 Scope of the substitution on the alkyne component 
With the optimised reaction conditions established, efforts focused on defining the scope of 
the transformation. To vary the alkyne component, a different approach to the synthesis of the 
substrates was employed (Scheme 68, cf. Scheme 67A). The synthesis of 277d-h commenced with 
alkynylation of acetone to give tertiary alcohol 282 in good yield, which was treated with HCl to 
form alkyl chloride 283 in excellent yield. Grignard formation followed by a quench with dry ice 
afforded carboxylic acid 284, and subsequent amide coupling gave amide 285. TMS deprotection 
led to terminal alkyne 286, which was cross-coupled with various aromatic halides giving 277d-g 
in excellent yield (85-98%). Alternatively, deprotonation of alkyne 286 with n-BuLi and alkylation 
of the resulting anion with methyl iodide afforded 277h. 
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Scheme 68: Synthesis of cyclopropylamides 277d-h. Reagents and conditions: (i) n-BuLi, acetone, THF, -78 °C to 
r.t.; (ii) conc. HCl, 0 °C to r.t.; (iii) Mg, THF, 0 °C to r.t., then CO2 (dry ice); (iv) N-benzylcyclopropanamine, EDCI, 
DMAP, DCM, 0 °C to r.t.; (v) K2CO3, MeOH, 0 °C to r.t.; (vi) PdCl2(PPh3)2, CuI, Ar-Hal, Et3N, r.t. or 60 °C; (vii) 
n-BuLi, MeI, -78 °C to r.t. 
Cyclopropanes 277a-h were used under the optimised Rh(I)-catalysed conditions and good 
yields were obtained regardless of the electronics of the alkyne component (52-88% yield) (Table 
5). Both electron-poor (280d) and electron-rich (280e) aromatic substituents were tolerated, as 
well as heteroaromatic functionality (280g) and alkyl substituents (280h). The structure of para-
methoxyphenyl-substituted cyclohexenone 280e was confirmed by X-ray crystallography (see 
Table 5). 
Table 5: Scope of the (3+1+2) cycloaddition with respect to the alkyne containing unit. 
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Substrate 286, bearing a terminal alkyne, and TMS-protected alkyne 285 were also 
evaluated under the reaction conditions (Scheme 69). Substrate 286 gave 287 in poor yield, which 
may be rationalised by the competing formation of inactive Rh-vinylidene species.175,176 
Interestingly, when silyl-protected alkyne 285 was used in the reaction instead, the product (287) 
that had been expected from the cycloaddition of 286 was obtained and silylated analogue 288 was 
not observed. It is unclear at which stage desilylation occurs. In one scenario, slow release of the 
unprotected terminal alkyne 286 prevents catalyst poisoning, or, alternatively, desilylation occurs 
to deliver 287 after formation of TMS-bearing cyclohexenone 288. If the latter is operative, the 
process must be relatively facile as 288 was not observed in the 1H NMR spectrum of the crude 
reaction mixture.  
 
Scheme 69: Reactivity of cyclopropylamides 285 and 286. aYield was determined by 1H NMR spectroscopy using 
1,4-dinitrobenzene as a standard. 
The design of the gem-disubstituted substrates used so far was, in part, driven by the idea 
that angle compression might facilitate cycloaddition (see Scheme 67B). To probe this further, 
substrate 289, which has a cyclopropane as the gem-disubstituting unit, was synthesised. Exposure 
of this to optimised conditions provided cycloaddition product 290 in 54% yield (Scheme 70). The 
fact that the yield of 290 is comparable to parent system 285 helps distinguish the two commonly 
invoked explanations for the gem-disubstituent effect: “angle compression upon substitution” and 
the “reactive rotamer effect”.173,177 If the former is operative, then switching the dimethyl 
substituents of e.g. 285 to a cyclopropyl moiety (289) would increase the angle between the alkyne 
and cyclopropane-bearing units of the molecule and this would be expected to significantly 
decrease reaction efficiency. Related bond angle changes have been confirmed by X-ray analysis 
of substituted malonic acids (Scheme 70, right);178 note how the angle is increased to 118.4° in the 
case of the cyclopropyl system. Hence, the commonly invoked explanation for the “Thorpe-Ingold 
effect” does not account for the high efficiency of the conversion of 289 to 290; instead, the 
“reactive rotamer effect” provides a more compelling explanation. The successful conversion of 
289 to 290 is notable also because it shows that there is a strong preference for oxidative insertion 
of Rh(I) into the cyclopropylamine C-C bond over the more electron poor α-cyclopropyl unit. 
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Scheme 70: Cycloaddition involving cyclopropylamide 289. aAmide 289 was synthesised by Curley. 
A plausible mechanism for the (3+1+2) cycloaddition is outlined in Scheme 71. First, 
amide-directed formation of rhodacyclopentanone 292 occurs from substrate 277c via 
rhodacyclobutane 291. Then, after directing group dissociation, access to π-complex 294 is 
facilitated by the greater conformational population of the “reactive” rotamer: steric clashes 
between the gem-disubstituents and the Rh(III)-centre in 293 shifts the equilibrium more towards 
294. This facilitates alkyne coordination and leads to migratory insertion and reductive elimination 
to give the target cyclohexenone 280c. The migratory insertion step could involve either the Rh-
acyl bond or the Rh-C(sp3) bond – these options have not been distinguished experimentally. 
 
 
Scheme 71: Proposed reaction mechanism. 
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4.3.2 Scope of the nitrogen substituent 
To evaluate further the scope of the carbonylative cycloaddition, cyclopropylamides 277i and 
296, containing two different substituents on the nitrogen were made by amide coupling with acid 
295 (Scheme 72). Substrate 277i, containing an n-butyl group, performed well in the reaction, 
giving 280i in 70% yield. When secondary amide 296 was tested, only degradation of the starting 
material occurred with no target material 297 observed in the 1H NMR spectrum of the crude 
mixture or by TLC analysis. The lack of productive reactivity can be attributed to side reactions, 
possibly involving inter- or intramolecular addition of the amide across the alkyne.179 
Unfortunately, the process resulted in a complex mixture of products, and so a precise 
rationalisation for its failure cannot be advanced. 
 
 
Scheme 72: Evaluation of substrates with different substituents on the nitrogen. Reagents and conditions: (i) 
corresponding cyclopropanamine, EDCI, DMAP, DCM, 0 °C to r.t. 
4.3.3 Synthesis and evaluation of substrates with different alkyne tether lengths 
With the successful cycloaddition of one class of substrates demonstrated (cf. Table 5), 
attention turned to finding other amenable systems. Ultimately, a wide pool of suitable substrates 
would increase the chances of finding a suitable system for a subsequent asymmetric protocol. 
Substrates similar to the working system, but with different linker lengths between the alkyne 
and the directing group were tested under various Rh(I)-catalysed carbonylative conditions. To 
test whether another CH2 group could be inserted into the linker, amide 301 was synthesised via a 
four-step protocol (Scheme 73A). First, Appel reaction with propargylic alcohol 298 afforded 
bromide 299, which was used as an alkylating reagent with the enolate of methyl isobutyrate. The 
resulting ester was saponified to carboxylic acid 300 in good overall yield. Finally, amide coupling 
between carboxylic acid 300 and N-benzylcyclopropanamine provided the desired amide 301. 
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Unfortunately, exposure of amide 301 to the optimised cycloaddition protocol did not result in the 
formation of expected bicyclic product 302. Instead, lactone 303 was isolated as a mixture of 
geometric isomers (Scheme 73B). This outcome may be rationalised by attack of the amide 
carbonyl onto the alkyne to give intermediate 304. Subsequent hydrolysis would afford 303. In 
this case, Rh(I) may act as a Lewis acid, promoting the intramolecular cyclisation. 
 
Scheme 73: Synthesis and reactivity of cyclopropylamide 301. Reagents and conditions: (i) PPh3, Br2, DCM, 0 °C, 
then n-pentane, r.t.; (ii) DIPA, n-BuLi, methyl isobutyrate, THF, -78 °C to r.t.; (iii) 4.0 M aq. NaOH, MeOH, r.t.; (iv) 
N-benzylcyclopropanamine, EDCI, DMAP, DCM, 0 °C to r.t. 
Moving forward, analogue 307, which possesses a shorter alkyne tether, was also 
synthesised (Scheme 74A). To do this, amide coupling of 305 with N-benzylcyclopropanamine 
provided 306, which was subjected to a Sonogashira cross-coupling with iodobenzene to provide 
307. Studies were undertaken to examine the feasibility of the carbonylative cycloaddition of 307. 
The standard conditions from Table 5 were not suitable, but an interesting result was observed 
using a neutral Rh(I) precatalyst; under these conditions, cycloadduct 308 containing a β-lactam 
was isolated in 15% yield. This demonstrates that the methodology can even access highly strained 
four membered rings. Attempts to improve the yield of the reaction by varying the reaction time, 
temperature, solvent, Rh(I)-precatalyst and ligand were not successful. 
To see if other classes of cyclopropane might be suitable, aminomethylcyclopropane 
system 310 was made from 305 by a method similar to that used for 307 (Scheme 74B). Under a 
range of conditions, no significant formation of cycloaddition product 312 was observed and only 
decomposition occurred. The cyclopropane unit of substrate 310 is considerably less nucleophilic 
compared to the one in 307, making Rh(I) C−C oxidative addition more challenging. Additionally, 
upon formation of rhodacyclopentanone 311 and DG dissociation, facile exocyclic β-hydride 
elimination can occur, which, in turn, leads to decomposition. 
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Scheme 74: Synthesis and reactivity of cyclopropanes 307 and 310. Reagents and conditions: (i) corresponding amine, 
DCC, DCM, 0 °C to r.t.; (ii) PdCl2(PPh3)2, CuI, PhI, Et3N, 80 °C. 
Further attempts to achieve 6-ring cycloadditions focused on substrates that possess a high 
degree of conformational bias. Accordingly, system 315 was targeted, as it was anticipated that 
the aromatic linker would facilitate the formation of benzofused system 316 (Scheme 75). 
Carboxylic acid 314, which was prepared from ester 313 using a literature procedure,180 was 
coupled with N-benzylcyclopropanamine to provide 315 in 89% yield. Subsequently, 
cycloaddition of 315 was evaluated under Rh(I)-catalysed carbonylative conditions, but target 316 
was not observed and 315 was recovered. In this case, it may be that competing amide direct aryl 
C-H activation prevents C-C bond activation.181  
 
Scheme 75: Synthesis and reactivity of cyclopropylamide 315. Reagents and conditions: (i) PdCl2(PPh3)2, CuI, 
phenylacetylene, Et3N, THF, reflux; (ii) 4.0 M aq. NaOH, MeOH, r.t.; (iii) N-benzylcyclopropanamine, EDCI, DMAP, 
DCM, 0 °C to r.t. 
At this stage, it had been determined that the new cycloaddition protocol is suitable for 5-
ring cyclisations involving systems where R2 is carbon-based (cf. Table 5). To explore scope 
further and to assess the effects of electronic factors, substrates 323 and 325, containing 
heteroatoms at R2 were evaluated. For this purpose, a divergent synthetic approach was used, 
starting from common intermediate 318 (Scheme 76A). This was accessed by copper-catalysed 
addition of phenylacetylene to acyl chloride 317. The yield of this process varied depending on 
scale (18% at 20 mmol vs. 40% at 5 mmol); diminished yields at higher scale are attributed to 
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poorer control of reaction exotherms. 318 was converted to 320 and 322 by two distinct sequences. 
For the former, 318 was protected as 1,3-dioxolane derivative 319, which, upon saponification, 
provided acid 320. The synthesis of 322 required the conversion of the C1 carbonyl unit to a gem-
difluoride, and this was readily achieved using diethylaminosulfur trifluoride (DAST). As before, 
saponification of the ester provided target acid 322. Acids 320 and 322 were converted to amides 
323 and 325 using EDCI-promoted coupling with N-benzylcyclopropanamine (Scheme 76B). 
With difluoro acid 322, the EDCI mediated amide coupling did not give useful amounts of product 
325, so an alternative approach, proceeding via the corresponding acid chloride, was used. Amides 
323 and 325 were evaluated under the standard Rh(I)-catalysed carbonylative conditions, and both 
delivered the desired cycloaddition product (324 and 326, respectively), but in low yields. Brief 
attempts were made to optimise these reactions by varying the ligand and the Rh(I) source, but 
improvements in yield were not achieved. Accordingly, the process does not tolerate inductively 
withdrawing substituents at C1. These would be expected to decrease the coordinating ability of 
both the amide DG and the alkyne, and both aspects may be detrimental to cycloaddition 
efficiency. 
 
Scheme 76: Synthesis and reactivity of cyclopropylamides 323 and 325. Reagents and conditions: (i) CuI, 
phenylacetylene, TMEDA, Et3N, r.t.; (ii) ethane-1,2-diol, BF3•Et2O, MeCN, r.t.; (iii) 4.0 M aq. NaOH, MeOH, r.t.; 
(iv) DAST, DCM, 0 °C to r.t.; (v) N-benzylcyclopropanamine, EDCI, DMAP, DCM, 0 °C to r.t.; (vi) oxalyl chloride, 
DCM, r.t., then N-benzylcyclopropanamine, DCM, 0 °C to r.t. 
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4.3.4 Synthesis and evaluation of other substrates 
As outlined above, the (3+1+2) cycloaddition allows the synthesis of fused lactams from 
protected aminocyclopropanes. Further, distinct systems were evaluated to assess the possibility 
of accessing alternative cyclic products. Substrate 330, containing a ynamide unit, was synthesised 
based on modified methodology from the Anderson group (Scheme 77A).182 First, vinylation of 
urea 327 with trichloroethylene afforded 328. Treatment of 328 with LiHMDS resulted in 
elimination of HCl to afford chloroynamide 329. This underwent copper(I)-catalysed coupling 
with freshly formed diphenylzinc to give 330. 
 
Scheme 77: Synthesis of ynamide 330. Reagents and conditions: (i) PhNCO, Et3N, DCM, 0 °C to r.t.; (ii) 
(n-Bu)4N(HSO4), KOH, toluene, H2O, 60 °C, then trichloroethylene, 60 °C to r.t.; (iii) LiHMDS, Et2O, 0 °C; (iv) 
PhMgBr, ZnCl2, TMEDA, toluene, r.t., then CuCN•2LiCl. 
Exposure of 330 to Rh(I)-catalysed cycloaddition conditions at 130 °C only led to the 
decomposition of starting material; no desired cycloaddition product 331 was formed. When the 
reaction temperature was lowered to 120 °C, the formation of ketourea 332, a formal hydration 
product of 330, was observed (Scheme 78A). The observed regioselectivity for hydration is not 
typical for ynamides - usually amides of type 333 are formed because ynamide protonation leads 
preferentially to a keteniminium ion (Scheme 78B).183,184 It is likely that the Rh-catalyst promotes 
hydration of 330 by adventitious water. A related gold-catalysed process has been reported – here, 
Au(I) coordinates to the triple bond of 334, which promotes attack of the Boc-carbonyl group to 
form 335 after loss of the tert-butyl group (Scheme 78C).185 In a similar manner, Rh(I) may 
coordinate to the alkyne of 330 and assist the formation of oxazolium ion 336 (Scheme 78D). 
Attack of water and protodemetalation gives 337, which opens to  
ketourea 332. 
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Scheme 78: (A) Reactivity of ynamide 330; (B) General regioselectivity in ynamide hydrolysis. (C, D) Related gold-
catalysed process and the mechanism for the formation of 332.  
To test whether a carbamate may act as a suitable directing group in a similar (3+1+2) 
cycloaddition process, substrate 339 was made (Scheme 79). Commercially available 3-phenyl-2-
propyn-1-ol was converted to chloroformate 338, and this was exposed to N-
benzylcyclopropanamine to provide 339. Exposure of the resulting carbamate to the Rh-catalysed 
cycloaddition conditions failed to deliver any of the target product 340 and decomposition of 
starting material occurred. It is possible that the C1-O bond ionises to give a Rh-propargyl species 
and this prevents the desired reaction pathway.186 
 
Scheme 79: Synthesis and reactivity of carbamate 339. Reagents and conditions: (i) triphosgene, activated charcoal, 
Et2O, 0 °C; (ii) N-benzylcyclopropanamine, Et3N, DCM, 0 °C to r.t. 
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4.4 Extension of the methodology to alkenes 
4.4.1 Reaction discovery and optimisation 
Section 4.3 outlines intramolecular (3+1+2) cycloadditions where alkynes are used as π-
unsaturated component. Based upon previously reported48 methodologies from Bristol, whereby 
substrates bearing alkenes have been used as a “2”-component (cf. Section 1.3, Scheme 7), system 
341 was proposed (Scheme 80A). The resulting bicyclic product would contain one extra 
stereocenter and is more “sp3-rich” than the alkyne-derived products obtained so far. To evaluate 
the possibility of using alkenes, amide 341 was synthesised in two steps from 342 (Scheme 80B). 
In the first step, 342 was converted to the corresponding allyl Grignard reagent and this was 
exposed to CO2 to give acid 344b. The regiochemical outcome of this process can be rationalised 
via 6-membered transition state 343b, wherein allylic inversion of the sterically favoured, primary 
σ-allyl Grignard reagent leads to γ-addition product 344b.187 Subsequent amide coupling provided 
target amide 341 in 53% yield.  
 
Scheme 80: Reaction design and synthesis of model cyclopropylamide 341. Reagents and conditions: (i) Mg, THF, 
r.t. to 0 °C, then CO2 (dry ice); (ii) N-benzylcyclopropanamine, EDCI, DMAP, DCM, 0 °C to r.t. 
Amide 341 was evaluated under different Rh-catalysed carbonylative cycloaddition 
conditions. Pleasingly, the conditions optimised for alkyne 277 provided 345 in 33% yield (Table 
6, Entry 1). 345 was formed as a single diastereomer, and the relative stereochemistry of the ring 
junction was determined as trans by nOe studies. Efforts to optimise this process focussed on 
solvent and Rh-source, and selected results are presented in Table 6. By changing the solvent from 
1,2-DCB to PhCN, the yield of 345 could be improved to 58% (Table 6, Entry 2). Interestingly, 
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[Rh(cod)Cl]2, a neutral Rh(I) precatalyst, gave a much higher yield when PhCN was used instead 
of 1,2-DCB (80% vs. 29%, Table 6, Entries 3 and 4). These conditions were carried forward to 







Yield of 345a (%) 
1 [Rh(cod)2]OTf (10) 1,2-DCB (0.1) 33 
2 [Rh(cod)2]OTf (10) PhCN (0.1) 58 
3 [Rh(cod)Cl]2 (5) 1,2-DCB (0.1) 29 
4 [Rh(cod)Cl]2 (5) PhCN (0.1) 80 (73) 
Table 6: Optimisation studies for the new (3+1+2) cycloaddition with an alkene. aYields were determined by 1H NMR 
spectroscopy using 1,4-dinitrobenzene as a standard. Isolated yields are given in parentheses. 
4.4.2 Scope of the alkene component 
This part of the project was conducted with the assistance of Matthew Curley, an MSci 
student in the Bower group, and studies conducted by Curley are highlighted in the text. 
To find out whether gem-disubstitution at C1 of 341 is necessary for cycloaddition to occur, 
amide 346 was made from the corresponding carboxylic acid 347 in 14% yield (Scheme 81). The 
low yield reflects purification difficulties rather than inefficient reaction. Employing substrate 346 
in the Rh(I)-catalysed cycloaddition protocol failed to afford 348, and only decomposition was 
observed. This result emphasises that substitution α to the carbonyl is crucial for the 
transformation. 
 
Scheme 81: Synthesis and reactivity of cyclopropylamide 348. Reagents and conditions: (i) N-
benzylcyclopropanamine, EDCI, DMAP, DCM, 0 °C to r.t. 
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To investigate further the scope of the alkene component, Curley synthesised amides 349-
351 and evaluated them under the optimised cycloaddition conditions (Scheme 82).188 For 
substrate 349, which bears only one methyl substituent at C1, it was found that the transformation 
is feasible at 160 °C, and 352 was formed in 23% yield (major diastereomer). The process was 
highly diastereoselective (>10:1 d.r.) and the relative stereochemistry of the major diastereomer 
was supported by nOe studies. Other diastereomers were observed in the 1H NMR of the crude 
reaction mixture, but these could not be isolated cleanly for full characterisation. A high reaction 
temperature was required to afford cyclohexanone 352; at 130 °C only traces were observed 
(Scheme 82A). The use of dimethyl fumarate as an electron deficient ligand was also important; 
its role may be to accelerate alkene insertion and/or reductive elimination.49 A similar effect has 
been observed for previous alkene-based cycloadditions developed in the Bower group.48 
Substrates 350 and 351, bearing 1,2- and 1,1-disubstituted alkenes, did not deliver cycloaddition 
products 353 and 354; the failure of these systems can be attributed to the increased steric bulk of 
the alkene, which presumably hinders coordination to the Rh(III)-centre of the 
rhodacyclopentanone intermediate (Scheme 82B). 
 
Scheme 82: Evaluation of a range of alkene tether substitution conducted by Curley. Yields were determined by 1H 
NMR spectroscopy using 1,4-dinitrobenzene as a standard. Isolated yields are given in parentheses. 
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4.5 (3+1+2) Cycloadditions of polysubstituted cyclopropanes 
The newly discovered system enables the transformation of simple racemic starting 
materials into complex cyclic products. The enantiospecificity of the (3+1+2) cycloaddition was 
studied next, focussing specifically on the use of more highly substituted and enantioenriched 
cyclopropanes. To test this, and to explore the tolerance of the reaction towards increased steric 
bulk on the cyclopropane ring, several substrates with di/trisubstituted cyclopropanes were 
synthesised. 
4.5.1 Cycloadditions of polysubstituted cyclopropanes with alkynes 
Substrates 357a-e, with an alkyne as the π-unsaturated moiety, were made from N-Boc-
protected cyclopropylamines 355a-e, which were synthesised according to well-established 
synthetic routes.48 TFA-promoted Boc deprotection followed by reductive amination gave amines 
356a-e, which underwent subsequent amide coupling to 357a-e (Scheme 83).  
 
Scheme 83: Synthesis of polysubstituted cyclopropylamides 357a-e. Reagents and conditions: (i) (a) TFA, DCM, r.t.; 
(b) benzaldehyde, MgSO4, toluene, r.t., then NaBH4, MeOH, 0 °C to r.t.; (ii) for 355a only (a) TFA, DCM, r.t.; (b) 
benzaldehyde, NaHCO3, MeOH, reflux, then NaBH4, 0 °C to r.t.; (iii) 2,2-dimethyl-4-phenylbut-3-ynoic acid 295, 
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When cyclopropylamide 357a was submitted to the optimised reaction conditions 
([Rh(cod)2]OTf/PPh3, 1,2-DCB, 130 °C), only trace amounts of a complex mixture of regio- and 
diastereoisomers was obtained (Table 7, Entry 1). The exact amount of remaining starting material 
357a was hard to quantify due to its highly rotameric nature. To improve efficiency, combinations 
of neutral ([Rh(cod)Cl]2) or cationic ([Rh(cod)2]OTf) sources of rhodium(I) and coordinating or 
non-coordinating (PhCN or 1,2-DCB) solvents were evaluated (Table 7, Entries 1-4). Based upon 
these results, the conditions from Entry 3 ([Rh(cod)Cl]2/PPh3, PhCN) were brought forward as 
they gave the highest yield of 358a and 359a (30% combined yield). Upon prolonged heating at 
150 °C, a significant improvement in the yield of 358a was observed (63% yield), alongside 
smaller amounts of 359a (22% yield, 1.2:1 d.r.). 
The factors governing the poor diastereoselectivity of cyclohexenone 359a are unclear. It 
may be that cycloadduct 359a epimerises under the reaction conditions, or, alternatively, 
epimerisation may occur at an earlier stage. For example, a reversible β-hydride elimination-
hydrometallation sequence at the stage of rhodacyclobutane 360 could also result in epimerisation 
(Scheme 84A). It should be noted that the effect of trans-substitution on the cyclopropane ring has 
been evaluated in Bristol on other related systems and similar results were obtained. For example, 
(3+1+2) cycloaddition of 361 occurred in low yield and regioselectivity, with minor product 362b 
formed as a 1:1 mixture of diastereomers (Scheme 84B).123 In this case, control experiments 
indicate that epimerisation of C1 occurs by epimerisation of 362b. 
Further optimisation was still required as it was challenging to separate one of the 
diastereomers of 359a from the main product 358a. Accordingly, a range of triphenylphosphine-
based ligands was screened (several examples are shown in Table 7, Entries 6-8). The use of more 
electron-rich P(4-OMeC6H4)3 did not significantly affect the reaction outcome (Table 7, Entry 6), 
but electron-poor ligands suppressed the formation of 358a (Table 7, Entries 7 and 8). P(C6F5)3 
was especially selective, and full conversion of 357a into cyclohexenone 358a was possible. This 
highly electron-deficient ligand may enforce kinetic C-C bond activation selectivity (via bond a) 
by enhancing coordination or accelerating migratory insertion of the alkene at the stage of 
rhodacyclopentanone 363 (Scheme 84C). If either of these processes are slow, then reversible 
rhodacyclopentanone formation can erode regiochemical fidelity by competitive activation of 
bond b. 
 


















1 [Rh(cod)2]OTf (5) PPh3, 10 1,2-DCB, 0.1 48 130 5 10 (1:1 d.r.) 
2 [Rh(cod)Cl]2 (5) PPh3, 20 1,2-DCB, 0.1 48 130 11 trace 
3 [Rh(cod)Cl]2 (5) PPh3, 20 PhCN, 0.1 48 130 6 24 (1:1 d.r.) 
4 [Rh(cod)2]OTf (5) PPh3, 10 PhCN, 0.1 48 130 15 5 (1:1 d.r.) 
5 [Rh(cod)Cl]2 (5) PPh3, 20 PhCN, 0.1 72 150 63  22 (1.2:1 d.r.) 
6 [Rh(cod)Cl]2 (5) P(4-OMeC6H4)3, 20 PhCN, 0.1 72 150 62 4 (2:1 d.r.) 
7 [Rh(cod)Cl]2 (5) P(3,4,5-F3C6H4)3, 20 PhCN, 0.1 72 150 57 trace 
8 [Rh(cod)Cl]2 (5) P(C6F5)3, 20 PhCN, 0.1 72 150 86 (84) trace 
Table 7: Optimisation studies for the (3+1+2) cycloaddition with a trans-disubstituted cyclopropanamide. aYields 
were determined by 1H NMR spectroscopy using 1,4-dinitrobenzene as a standard. Isolated yields are given in 
parentheses. 
 
Scheme 84: Mechanistic considerations for systems with trans-disubstituted cyclopropanes. 
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The conditions from Table 7, Entry 8 were employed with benzyl-substituted 
cyclopropylamide 357b and delivered desired product 358b in 67% yield (Scheme 85A). As with 
357a, only traces of product 359b resulting from C-C bond activation of bond b were observed. 
Accordingly, the optimised protocol appears to be generally applicable to trans-1,2-disubstituted 
cyclopropanes. Next, an enantioenriched sample of methyl-substituted cyclopropylamide (S,S)-
357a was made from commercially available (R)-propylene oxide (Scheme 85B). The synthesis 
commenced with the known enantioretentive Horner−Wadsworth−Emmons cyclopropanation 
reaction, which gave acid (S,S)-364 in 99% e.e. after saponification of the crude ester.110 
(S,S)-364a was then transformed to N-Boc-protected cyclopropylamine (S,S)-355a by Curtius 
rearrangement.189 Boc deprotection followed by reductive amination provided secondary amine 
(S,S)-356a, which was used in an amide coupling reaction to give the enantioenriched 
cyclopropylamide (S,S)-357a (>98% e.e.). Carbonylative rearrangement of (S,S)-357a proceeded 
with complete retention of both stereocenters, forming the target cycloadduct (S,R)-358a in >99% 
e.e. This result confirms that the process is enantiospecific, such that no epimerisation occurs 
during the course of the reaction. 
 
Scheme 85: Synthesis and reactivity of other trans-disubstituted cyclopropanes with tethered alkyne. Reagents and 
conditions: (i) (a) triethylphosphonoacetate, n-BuLi, 2-MeTHF; (b) NaOH, H2O, 100 °C; (ii) diphenylphosphoryl 
azide, Et3N, t-BuOH, 80 °C; (iii) (a) TFA, DCM, r.t.; (b) benzaldehyde, MgSO4, toluene, r.t., then NaBH4, MeOH, 0 
°C to r.t. (iv) 2,2-dimethyl-4-phenylbut-3-ynoic acid, EDCI, DMAP, DCM, 0 °C to r.t.  
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To determine whether the catalytic conditions for trans-disubstituted cyclopropylamides 
could also be used for the cis-disubstituted cyclopropylamides, methyl-substituted substrate 357c 
was exposed to the conditions outlined in Scheme 85A. Under these conditions, regioisomer 359c, 
which is derived from C-C bond activation of more hindered bond b, was formed in 9% yield and 
as a single diastereomer; the mass balance consisted of unidentified degradation products (Table 
8, Entry 1). The regiochemical outcome of this process reflects earlier work from Bristol.48 Bond 
b is more electron rich than bond a, and the cis-configuration of 357c alleviates steric hindrance 
compared to trans-system 357a. Accordingly, the Rh-catalyst can preferentially coordinate to 
bond b and this leads the observed C-C bond activation selectivity.190 Further exploration of the 
electronics of the triarylphosphine ligand (Table 8, Entries 2-5) revealed that electron-rich  
P(4-OMeC6H5)3 is most suitable and this modification provided 359c in 50% yield as a single 
diastereomer.  
 
Entry R Ligand 359 (%) 
1 Me P(C6F5)3 9 
2 Me PPh3 22 
3 Me P(3,5-Me2C6H3)3 28 
4 Me P(4-OMeC6H4)3 51 (50) 
5 Me P((2,4,6-OMe)3C6H2)3 <10 
6 n-Bu P(4-OMeC6H4)3 45 (48) 
7 n-Bu P(3,5-Me2-4-OMeC6H2)3 35 
Table 8: Optimisation studies for (3+1+2) cycloaddition with cis-disubstituted cyclopropanamides. aYields were 
determined by 1H NMR spectroscopy using 1,4-dinitrobenzene as a standard. Isolated yields are given in parentheses. 
 
The conditions optimised for 357c also transferred to n-butyl analogue 357d, which was 
formed in 48% yield (Table 8, Entry 6). In this case, dienyl side product 365 also formed in 6% 
yield. Several pathways can account for the formation of 365 (Scheme 86). One possibility 
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involves β-hydride elimination from rhodacyclobutane 366 to generate Rh-allyl 367. This can then 
engage in alkyne carbometallation and C-H reductive elimination. An alternative mechanism 
involves alkyne migratory insertion into rhodacyclobutane 366, followed by β-hydride elimination 
from the resulting metallacycle and C-H reductive elimination. 
 
Scheme 86: Cycloaddition of a cis-disubstituted cyclopropylamide with a tethered alkyne and a plausible 
mechanism. 
Finally, when trans-trisubstituted cyclopropylamide 357e was evaluated in the 
cycloaddition protocol, unexpected product 368 was isolated (Scheme 87). This α-
hydroxycyclohexenone was not observed in the 1H NMR of the crude reaction material and is 
presumably a result of aerobic oxidation of expected cycloadduct 359e during purification. 
Although the exact mechanism and rationale for this transformation is unclear, precedence for 
metal-free aerobic C-H oxidation of cyclic enones exists in the literature.191 
 
Scheme 87: Cycloaddition of a trisubstituted cyclopropylamide with a tethered alkyne. 
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4.5.2 Cycloadditions of polysubstituted cyclopropanes with alkenes 
With cycloaddition conditions optimised for polysubstituted systems bearing alkynes, the 
effect of substitution on the cyclopropane moiety in processes involving alkenes was studied next. 
In these cases, the cycloaddition products contain an extra stereocentre, offering a facile entry to 
more complex, sp3-rich scaffolds. Accordingly, methyl-substituted substrate 369 and n-butyl 
substituted substrate 371 were made from amines 356a and 356d by amide coupling reactions 
(Scheme 88, cf. Scheme 83). 
 
Scheme 88: Synthesis and reactivity of disubstituted cyclopropylamides 369 and 371. Reagents and conditions: (i) 
2,2-dimethylbut-3-enoic acid, EDCI, DMAP, DCM, 0 °C to r.t. 
 
The catalytic conditions established for cycloadditions of trans-disubstituted cyclopropanes 
with alkynes transferred efficiently to system 369, and gave target 370 as a single diastereomer 
and regioisomer (68% yield, >20:1 d.r.) (Scheme 86A). However, when the conditions optimised 
for cycloadditions of cis-disubstituted cyclopropanes (vide supra, Scheme 86) alkynes were 
applied to substrate 371, a complex mixture of 372 and 373 was isolated. Similarly to alkynes 357c 
and 357d, product 372, derived from C-C bond activation of bond b, predominated and 
epimerisation of the C1 stereocentre occurred (Scheme 88B, cf. Table 8). Attempts to improve the 
yield by lowering the temperature, or changing the ligand or Rh(I) source were not fruitful. 
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4.6 Asymmetric (3+1+2) cycloadditions 
The focus then shifted to finding suitable conditions to render the new (3+1+2) 
cycloaddition asymmetric. It should be noted that, because rhodacyclopentanone formation can be 
highly reversible, there are several stages in the cycloaddition that might be enantiodetermining.  
One of these involves oxidative addition of the rhodium into one of the two enantiotopic proximal 
cyclopropylamine bonds. The studies described in this section provide circumstantial evidence 
that this is indeed the enantiodetermining step. 
4.6.1 Ligand screen for alkyne-based cycloadditions 
In collaboration with Curley, a representative range of commercially available chiral 
ligands was screened by adapting the non-enantioselective conditions optimised for alkyne system 
277c (Table 9). Generally, bidentate ligands, including P,P-, N,N- and P,N-variants, were 
detrimental for this reaction in terms of yield and e.e. (Table 9, Row 1). Given that the Rh(I) 
catalyst requires a vacant coordination site for oxidative addition and alkyne insertion, it is 
important that active intermediates are not coordinatively saturated. Indeed, chiral monodentate 
ligands gave higher yields, but low to minimal enantioinduction was observed in most cases (21-
38% Yield, 0-14% e.e.) (Table 9, Row 2). A derivative of (R)-SEGPHOS has been shown to be 
very efficient for the kinetic resolution of cyclobutanones via rhodacyclopentanone formation (cf. 
Scheme 62), but, in this case, (R)-SEGPHOS gave only 4% e.e.. Nonetheless, as higher yields 
were observed with monodentate ligands, screening of these continued, focussing particularly on 
variation of the ligand backbone. 
To date, most Rh(I)-based enantioselective catalytic systems employ chiral bidentate 
ligands.192-194 In recent years, more attention has been drawn to monodentate systems, in particular 
ligands bearing spirocyclic backbones.195 (R)-SIPHOS-PE, a phosphoramidite ligand with a 
SPINOL-derived structure, had previously been identified as the most promising for urea-directed 
(3+1+2) cycloadditions (cf. Scheme 64).123 When applied to 277c, this ligand gave a moderate 
yield and lower enantioselectivity (12% vs. 35% e.e.). Zhou and co-workers have demonstrated 
the use of two other SPINOL-based monodentate ligands, ShiP and FuP-tBu, for Rh(I)-catalysed 
asymmetric arylation196 and hydrogenation,197 respectively. Although none of these ligands gave 
a significant enantiomeric excess, the 17% e.e. with (S)-ShiP was the best result achieved so far 
(Table 9, Row 3). This result highlighted that the ligand needs a backbone with a large dihedral 
angle. Pleasingly, the geometrically similar, but more electron rich (S)-SITCP, gave 280c in 
excellent yield and enantioselectivity (86% e.e.). This result constitutes the first highly 
enantioselective carbonylative higher order cycloaddition of a “simple” cyclopropane. 
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Table 9: Survey of chiral ligands for asymmetric (3+1+2) cycloaddition of cyclopropylamide 277c. Yields were 
determined by 1H NMR spectroscopy using 1,4-dinitrobenzene as a standard. a Bidentate ligands: 5 mol%, monodentate 
ligands: 10 mol%. b Reaction carried out by Curley. c 48% Yield, 78% e.e. if reaction is heated for 72 h.188 
 
4.6.2 Enantioselective reaction optimisation 
The result with (S)-SITCP was optimised further for enantioselectivity by screening Rh(I) 
sources, reaction time, temperature, and concentration - an abridged summary is represented in 
Table 10. Neutral Rh(I) precatalysts, such as [Rh(cod)Cl]2, did not generate cyclohexenone 280c, 
whilst [Rh(cod)2]BF4 performed considerably worse than [Rh(cod)2]OTf (Table 10, Entries 1-3). 
Increasing the dilution provided 280c in excellent yield but decreased the enantioselectivity of the 
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process (Table 10, Entry 4). Pleasingly, when the reaction was run for 72 h at a lower temperature 
of 115 °C, 280c was formed in 66% yield and 90% enantiomeric excess (Table 10, Entry 5). 
Further studies focused on improving the yield while maintaining the high 
enantioselectivity. Increasing the loading of the rhodium catalyst lowered the e.e., but full 
conversion as observed at 115 °C (Table 10, Entry 6). Finally, when the reaction was heated to 
110 °C for 96 h using 7.5 mol% [Rh] and 15 mol% (S)-SITCP, a combination of good yield and 
(76%) excellent enantioselectivity (90% e.e.) was achieved (Table 10, Entry 7). It should be noted, 
that one equivalent of the chiral ligand relative to Rh is sufficient to achieve high enantioselectivity 
(Table 10, Entries 8-10). This suggests that the second equivalent is sacrificial, and may only be 



















1 [Rh(cod)2]OTf (5) 10 0.1 48 130 73 0 (+21% 281c) 86 
2 [Rh(cod)Cl]2 (5) 20 0.1 48 130 0 >99 - 
3 [Rh(cod)2]BF4 (5) 10 0.1 48 130 47 0 40 
4 [Rh(cod)2]OTf (5) 10 0.05 48 130 92 0 (+7% 281c) 84 
5 [Rh(cod)2]OTf (5) 10 0.1 72 115 66 32 90 
6 [Rh(cod)2]OTf (7.5) 15 0.1 72 115 83 trace 80 
7 [Rh(cod)2]OTf (7.5) 15 0.1 96 110 78 (76) 7 90 
8 [Rh(cod)2]OTf (7.5) 11.25 0.1 96 110 66 - 89 
9 [Rh(cod)2]OTf (7.5) 7.5 0.1 96 110 68 - 82 
10 [Rh(cod)2]OTf (7.5) 18.75 0.1 96 110 63 - 90 
Table 10: Optimisation studies for the asymmetric (3+1+2) cycloaddition. aYields were determined by 1H NMR 
spectroscopy using 1,4-dinitrobenzene as a standard. Isolated yields are given in parentheses. 
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The conditions from Table 10, Entry 7 were carried forward and applied to a wide range of 
substrates and Table 11 summarises the results obtained. In general, good yields and enantiomeric 
ratios were observed regardless of the substrate’s electronics. For example, para-chlorophenyl and 
3-thienyl analogues 280d and 280g were both formed in 93:7 e.r. Similarly, variation of 
substitution α to the amide had only a minor effect (cf. 280a vs. 280c). For compound 280f, 
rotation around the C1-C2 bond is sufficiently restricted that atropisomers are formed; chiral SFC 
analysis revealed that both of these diastereomers were generated with similar levels of 
enantioselectivity. The absolute stereochemistry of 280d was determined by single crystal X-ray 
diffraction, and the absolute stereochemistries of the other cyclohexenones were assigned by 
analogy. 
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Substrates with TMS-protected alkynes 285 and 289 also engaged in the asymmetric 
cycloaddition. As observed previously (see Scheme 69), the silyl unit “disappeared” over the 
course of the reaction and products 287 and 290 were formed in a highly asymmetric manner 
(Scheme 89). The optimised conditions using the (S)-SITCP ligand were also examined on 
cyclopropylamine 270 (Scheme 90). Compared to previously established conditions (see Scheme 
64), a higher yield was obtained and the enantioselectivity was similar. Thus, the conditions appear 
to be specific for the substrate class developed here. 
 
Scheme 89: (3+1+2) Cycloadditions of TMS-protected alkynes 287 and 290. a The reaction was run at 120 °C. 
 
 
Scheme 90: (3+1+2) cycloaddition of the urea-based system 270 under optimised conditions.  
4.6.3 Enantioselective alkene-based cycloadditions 
It was also of interest to assess whether the newly identified chiral ligand system would 
perform well with alkene-bearing substrates, as this would allow the formation of two contiguous 
stereocentres in an enantioselective and diastereoselective manner. Further, in these processes, (a) 
trapping of the rhodacyclopentanone is expected to be slower because the alkene is a less good 
ligand than the alkynes used previously, and (b) the sterics of the alkene unit are distinct from 
alkyne substrates. Thus, if high enantioselectivities are still achieved, then it would offer 
circumstantial evidence that the primary enantiodetermining step in these cycloadditions is the C-
C bond activation process. 
Cycloaddition of system 341 to 345 was explored using (S)-SITCP under the conditions 
previously optimised for the non-asymmetric transformation ([Rh(cod)Cl]2 in PhCN). This 
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experiment led only to the recovery of starting material (Table 12, Entry 1). Pleasingly, conditions 
optimised for the alkyne-bearing substrates ([Rh(cod)2]OTf in 1,2-DCB) transferred efficiently to 
cyclopropylamine 341, and cyclohexanone 345 was isolated as a single diastereomer in 63% yield 
and 78% e.e. (Table 12, Entry 2). The enantioselectivity observed here is similar to that obtained 


















1 [Rh(cod)Cl]2 (5) 20 PhCN, 0.1 72 130 0 >99 - 
2 [Rh(cod)2]OTf (7.5) 15 1,2-DCB, 0.1 96 110 70 (63) 0 89:11 
Table 12: Optimisation studies on an alkene-based asymmetric (3+1+2) cycloaddition. aYields were determined by 
1H NMR spectroscopy using 1,4-dinitrobenzene as a standard. Isolated yields are given in parentheses. The absolute 
configuration of 345 at C1 was tentatively assigned as (S) by analogy with 280d. 
The (S)-SITCP ligand was also evaluated on the previously established Cbz-directed 
cycloaddition of substrate 31' to 32' (Scheme 91, cf. Section 1.3, Scheme 7).48 The expected 
product 32' was not observed, and only some starting material 31' was recovered. The poor mass 
balance is attributed to decomposition of the starting material and no further studies were 
undertaken on this reaction. 
 
Scheme 91: Attempted enantioselective cycloaddition of 31'. 
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4.7 Conclusions and future directions 
To summarise, novel carbonylative (3+1+2) cycloadditions of aminocyclopropanes 
bearing tethered alkynes or alkenes have been developed. An extensive study of the scope and 
limitations of the reaction has been undertaken. The first asymmetric C-C bond activation of 
aminocyclopropanes has been realised and exemplified. The complementary transformation giving 
racemic products was studied with respect to polysubstituted cyclopropanes. For enantioenriched 
cyclopropane units, the enantiospecific nature of the Rh(I)-catalysed C-C bond activation process 
has been established. The studies described here add to a growing body of enantioselective C-C 
bond activations,2,138 and provide rare examples of enantioselective carbonylative C-C bond 
activations.137 Within this context, these are the first examples of highly enantioselective higher 
order (multicomponent) cycloadditions that use “simple” non-activated cyclopropanes. 
Future studies should focus on ligand design to improve the enantioselectivity of the 
process. Other tethered π-unsaturates, such as bicyclic alkenes198, N-oximes166 and allenes33 could 
also be tested under C-C bond activation conditions and the possibility of making these 
cycloadditions asymmetric can be explored (Scheme 92A). Additionally, C-C bond activation 
methodologies previously established in the Bower group should be re-examined using the newly 
developed enantioselective conditions (e.g. Scheme 92B).108 
 




C-C Bond activation of aminomethylcyclopropanes 
5.1 Introduction 
5.1.1 Directed C-C bond activation in aminocyclopropane homologues 
In general, C-C bond activation processes employing cyclopropane derivatives either 
require activated variants137,199-201 or rely on the incoming π-unsaturate to direct C-C activation,202 
thereby limiting further application of the initiation mode. The studies at Bristol are therefore 
significant because relatively unactivated cyclopropanes can be used in a range or processes. Aside 
from aminocyclopropanes, several related classes of cyclopropane can also undergo amide-
directed C-C bond activation. Previous research has demonstrated that electronically distinct 
aminomethylcyclopropanes 374 undergo directed carbonylative C-C bond activation to form a 
wide range of (3+1+2) cycloaddition products 375 (Scheme 93A).108 This transformation proceeds 
through a relatively unstable 6-ring chelate 376, which adds an additional challenge as facile 
exocyclic β-hydride elimination can occur upon dissociation of the directing group. The process 
also employs an electron neutral nonactivated cyclopropane instead of the more electron-rich 
aminocyclopropane. The less nucleophilic cyclopropane of 374 makes C-C oxidative addition to 
form intermediate 376 more difficult. Systems containing an electron-poor cyclopropylamide unit 
(377) are even more challenging and required the design of a specific hemilabile arsine ligand 
(As(2-OMeC6H4)3, Scheme 93B).
203 Here, control experiments showed that directed C-C 
activation of 377 to 378 is less favourable than for 374 to 375; this is likely due to a combination 
of the electronics of the cyclopropane and the generation of a relatively strained 4-membered 
chelate 379 (vs. 6-membered chelate 376). The studies outlined in Scheme 93 demonstrate that 
directed C-C bond activation can occur regardless of the cyclopropane electronics; however, the 
more electron-poor the cyclopropane unit, the more challenging the process is. 
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Scheme 93: Rhodium-catalysed (3 + 1 + 2) cycloadditions of aminocyclopropane homologues. 
5.1.2 Preliminary investigations into aminomethylcyclopropane ring expansions 
During further studies on the reactivity of aminomethylcyclopropane derivatives, Dr. Niall 
McCreanor discovered that α-aminocyclopentanone 381a can be obtained from 380a under 
carbonylative conditions (Scheme 94).75 A plausible mechanism for the formation of 381a 
commences with amide directed formation of rhodacyclopentanone 382. Subsequent directing 
group dissociation and β-hydride elimination from 382 forms Rh(III)-acyl hydride species 383. 
Hydrometallation of the resultant enamide generates rhodacyclohexanone 384, a metallacycle 
which is scarcely presented in the literature. Finally, C(sp3)-C(sp2) reductive elimination affords 
cyclopentanone adduct 381a. The process represents an unusual example of a C-C bond activation 
triggered alkene hydroacylation and also offers the option of exploring further the chemistry of 
unusual metallacycle 384. 
 
Scheme 94: Proposed mechanism for carbonylative ring expansion of aminomethylcyclopropane 380a. 
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Optimisation studies carried out by McCreanor on aminomethylcyclopropane 380a 
revealed that neutral Rh-precatalysts (e.g. [Rh(cod)Cl]2) are less active than cationic 
[Rh(cod)2]OTf, and that strongly coordinating solvents (benzonitrile, N,N-dimethylformamide) 
suppress cyclisation, whilst weakly coordinating variants (anisole, 1,2-DCB) are more effective. 
For example, 381a was obtained in 9% yield using PhCN as a solvent, whereas in 1,2-DCB the 
yield increased to 71%. Electron-deficient monodentate ligands increased the yield, and P(3,4,5-
(F)3C6H2)3 was found to be the optimum ligand for this transformation. Electron-deficient 
bidentate P-ligands such as dfppe and dfppb were also examined; however, they proved ineffective 
at promoting the carbonylative cyclisation. Later, it was found by Dr. Gabriele Fumagalli that the 
addition of 20 mol% PhCO2H has a positive effect on the yield of the reaction. Under the optimised 
conditions shown in Table 13, a range of substituted aminomethylcyclopropanes 380a-i with 
varying directing groups were evaluated. Amide based systems 380a-e cyclised in moderate to 
excellent yield, whereas sulfonamide (380f), carbamate (380g) and urea-based systems (380h) 
were ineffective. In these cases, only starting material was recovered. 
 
Table 13: Selected examples of carbonylative cyclisation of aminomethylcyclopropanes to α-aminocyclopentanones. 
For 381a, 20 mol% of PhCO2H was used as an additive; for 381d, 15 mol% P(3,5-(CF3)2C6H3)3 was used as a ligand 
and the reaction was stirred for 48 h. aCompound 381a was obtained in 81% yield at 110 °C. 
5.1.3 Known systems proceeding via rhodacyclohexanone intermediates 
Section 5.1.2 demonstrates rare examples of a transformation proceeding via the formation 
of a rhodacyclohexanone (384). In principle, rhodacyclohexanones can be formed by C-C bond 
activation of cyclopentanones; however, this is a challenging process. In contrast to three-
membered rings, cyclopentanones lack sufficient thermodynamic driving force to favour oxidative 
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addition of a transition metal, with the reverse process being energetically preferred.204 Thus, the 
catalytic C-C activation of non-strained rings, such as cyclopentanones, is underdeveloped. 
In 1994, rhodium-mediated decarbonylation of cyclopentanone 385 was described by 
Murakami and co-workers (Scheme 95A).205 However, this process requires stoichiometric 
amounts of a Rh(I)-complex and showed low overall efficiency, primarily because the released 
rhodium carbonyl complex 386 does not turnover.206 Dong has shown that the problem of low 
reactivity can be solved by merging an unfavourable C-C bond activation with a tandem sp2 C-H 
functionalisation - this enables an overall thermodynamically favoured transformation (Scheme 
95B).96 Installation an aryl group at the C3 position of the cyclopentanone allows the transient C-C 
bond activation intermediate to undergo intramolecular ortho-C-H activation. Several 3-
arylcyclopentanones 387 were employed and gave rise to two products, α-tetralones 388a, which 
were formed as a result of the cleavage of the more hindered C1-C2 bond, and α-indanones 388b, 
generated from the cleavage of the less hindered C1-C5 bond. This reaction is further enhanced 
by using a transient pyridyl imine as a directing group for the formation of 389; consequently, the 
reaction does not proceed via rhodacyclohexanone. Overall, cyclopentanones show low reactivity 
and undergo highly reversible C-C bond insertion by rhodium species, which makes it hard to 
exploit rhodacyclohexanone intermediates in catalysis. 
 
Scheme 95: (A) Rhodium-mediated decarbonylation of a cyclopentanone; (B) C-C activation of 
3-arylcyclopentanones via tandem sp2 C-H functionalisation. 
Interestingly, less commonly exploited substrates can also lead to the formation of 
rhodacyclohexanones. For example, diene-enes 390 undergo a Rh(I)-catalysed (2+2+1) reaction 
to provide hexahydropentalen-2-ones 391 (Scheme 96A).207 Computational studies revealed that 
this process proceeds through a rhodacyclohexanone intermediate 392.208 The study found that the 
presence of the additional C1-C2 π-based fragment in the diene moiety is crucial, and this allows 
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the metal to be coordinatively saturated during the critical oxidative coupling step. Furthermore, 
cyclobutanone 393, which contains a phenoxymethyl side chain, can also undergo C-C bond 
activation leading to the formation of the olefin-coordinated acylrhodium intermediate 394. This 
intermediate forms through successive cleavage of C-C and C-O bonds (Scheme 96B).27 
Subsequent recyclisation of 394 leads to rhodacyclohexanone 395 by 6-endo aryloxymetallation. 
C-C reductive elimination of 395 then gives cyclopentanone 396. 
 
Scheme 96: (A) Diene-ene (2+2+1) carbocyclisation; (B) Successive cleavage of C-C and C-O bonds of a 
cyclobutanone system; E = CO2Me; Rh cat. = [Rh(nbd)(dppp)]PF6; nbd - norborna-2,5-diene; dppp - 1,3-
bis(diphenylphosphino)propane. 
The processes above are rare examples of the intermediacy of rhodacyclohexanones (or 
related species) in catalysis. The newly discovered transformation of aminomethylcyclopropanes 
380 shown in Scheme 94 offers a simple entry to the rhodacyclohexanone intermediates. 
Furthermore, the process provides an unconventional approach to the synthesis of protected 
α-aminocyclopentanones 381. As such, further studies into this and related transformations were 
warranted.  
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5.2 C-C Bond activation-triggered hydroacylation of 
aminomethylcyclopropanes 
5.2.1 Synthesis and reactivity of N-benzyl-N-(cyclopropylmethyl)acetamide 
Previously developed conditions75 allowed the successful cyclisation of benzoyl protected 
substrate 380a in good yield, but the yields decreased when tertiary amides (e.g. 380d) were used 
(i.e. R ≠ H, see Table 13). Although cyclopropane 380d bearing a benzyl group on the nitrogen 
did form the desired cyclopentanone 381d in 62% yield, all further attempts to increase the yield 
were not fruitful. It was envisaged desirable to optimise this process, because appendage of 
additional units to the N-centre may allow the design of processes that divert the 
rhodacyclohexanone intermediate into other pathways. 
Acyl-protected amide 398 was readily synthesised by reductive amination of 
cyclopropylmethanamine with benzaldehyde to give amine 397, which was acetylated using acetic 
anhydride to give 398 in 80% overall yield (Scheme 97). When amide 398 was exposed to the 
developed catalytic system at 85 °C, starting material 398 and target material 399 were observed 
in a 1:1 ratio, and no other significant products were formed. Pleasingly, cyclopentanone 399 could 
be delivered in excellent yield (98%) simply by raising the temperature to 110 °C (Scheme 97). 
 
Scheme 97: Synthesis and Rh-catalysed carbonylative cyclisation of N-benzyl-N-(cyclopropylmethyl)acetamide. 
Reagents and conditions: (i) (a) benzaldehyde, NaHCO3, MeOH, reflux, 3 h; (b) NaBH4, 0 °C to r.t., 4 h; (ii) acetic 
anhydride, TEA, DCM, 0 °C to r.t., 16 h. a Yields were determined by 1H NMR spectroscopy using 1,4-dinitrobenzene 
as an internal standard. 
5.2.2 Carbonylative rearrangement of substituted aminomethylcyclopropanes 
With high yielding conditions in hand, further studies with respect to substitution on the 
cyclopropane unit were conducted. For this purpose, 2,2-dimethylcyclopropyl derivative 402 was 
synthesised. The amide unit of commercially available 400 was reduced with LiAlH4 to generate 
amine 401, and this was protected with benzoyl chloride to deliver cyclopropane 402 (Scheme 
98A). Dimethylcyclopropane 402 was subjected to the optimised reaction conditions (7.5 mol% 
[Rh(cod)2]OTf, 15 mol% P(3,4,5-F3C6H2)3, 20 mol% benzoic acid, 0.15 M 1,2-DCB, 1 atm CO, 
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85 °C) but target product 403 was not observed. To address this, temperature (85 to 160 °C), 
catalyst loading (7.5 to 15 mol%) and reaction time (24 to 48 h) were all varied. It was found that 
cyclopropane 402 generally remained unreacted at low temperatures, but, at 120 °C, some 
reactivity was observed, and cyclopentanone 403 was isolated in 5% yield (Scheme 98B). Alkene 
404 was observed as the major product of the reaction, and this likely forms via β-hydride 
elimination from the initially generated rhodacyclobutane 405. It is worth noting that 
cyclopentanone 403 results from metal insertion into the less hindered C-C bond a of cyclopropane 
402, whereas 404 arises from insertion into the more hindered bond b. Raising the reaction 
temperature further to 140 or 160 °C led to a complex mixture of cyclopropane 402, alkenyl 
product 404 and its isomers, and cyclopentanone 403 was not observed. 
 
Scheme 98: Synthesis and reactivity of (dimethylcyclopropyl)methylbenzamide 402. Reagents and conditions: (i) 
LiAlH4, THF, 0 °C to reflux, 16 h; (ii) BzCl, TEA, DCM, 0 °C to r.t., 16 h. 
In an attempt to avoid the β-hydride elimination pathway, diphenyl-substituted 
cyclopropane 406 was synthesised (Scheme 99A). It was anticipated that this system might 
undergo C-C bond activation at lower temperature as a result of benzylic activation of the C-C 
bond. Initial Rh-catalysed cyclopropanation of 1,1-diphenylethylene produced cyclopropane ester 
407. Subsequent saponification to acid 408 was followed by reaction of the corresponding acyl 
chloride with ammonia to produce amide 409. Reduction of amide 409 with LiAlH4 generated 
amine 410, which was protected with benzoyl chloride to deliver cyclopropane 406. 
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When diphenylcyclopropane 406 was subjected to the conditions that proved optimal for 
398 (see Scheme 97), only starting material was recovered. At elevated temperatures, the reaction 
led to degradation of the rhodacyclic intermediate by β-hydride elimination, as evidenced by the 
formation of 412. Indeed, increasing the temperature to 160 °C resulted in formation of alkene 412 
in 68% yield and product 411 was not observed (Scheme 99B). This result indicates that insertion 
into sterically bulky aminomethylcyclopropane 406 is extremely slow and, upon formation of the 
rhodacyclic intermediate, degradation occurs in preference to either (reversible) CO insertion or 
acyl-C reductive elimination. 
 
Scheme 99: Synthesis and reactivity of (diphenylcyclopropyl)methylbenzamide 406. Reagents and conditions: (i) 
Rh2(OAc)4, ethyl diazoacetate, Et2O, 8 h; (ii) KOH, 1,4-dioxane:H2O 1:1, reflux, 80 °C, 4 h; (iii) oxalyl chloride, 
DCM, r.t., then NH3, THF, 0 °C, 1.5 h; (iv) LiAlH4, THF, 0 °C to reflux, 16 h; (v) BzCl, TEA, DCM, 0 °C to r.t., 16 
h. 
The results with 2,2-disubstituted cyclopropanes 402 and 406 suggested that switching to 
a less hindered system might suppress undesired β-hydride elimination. Benzyl-substituted 
cyclopropane 413, which is equipped with a directing group analogous to efficient system 398 (cf. 
Section 5.2.1), was synthesised in 7 steps via the synthetic route depicted in Scheme 100. 
Allylbenzene was treated with m-CPBA to deliver the corresponding epoxide. Subsequent Horner–
Wadsworth–Emmons cyclopropanation generated ester 414 as a single trans-diastereomer.209,210 
Hydrolysis of ester 414 and treatment of the corresponding acid chloride with ammonia delivered 
amide 415, which was reduced to amine 416 in the presence of LiAlH4. Finally, reductive 
amination followed by acylation afforded trans-1,2-disubstituted methylcyclopropane 413. 
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Scheme 100: Synthesis of trans-1,2-disubstituted aminomethylcyclopropane 413. Reagents and conditions: (i) 
m-CPBA, DCM, 0 °C to r.t., 18 h; (ii) triethylphosphonoacetate, n-BuLi, DME, 130 °C, 16 h; (iii) 4.0 M aq. NaOH, 
MeOH, r.t., 3 h; (iv) oxalyl chloride, DCM, r.t., then NH3, THF, 0 °C, 1.5 h; (v) LiAlH4, THF, 0 °C to reflux, 16 h; 
(vi) (a) benzaldehyde, NaHCO3, MeOH, reflux, 3 h; (b) NaBH4, 0 °C to r.t., 4 h; (vii) acetic anhydride, TEA, DCM, 
0 °C to r.t., 16 h. 
Carbonylative rearrangement of cyclopropane 413 under standard conditions yielded 417b 
as a mixture of diastereomers (~2:1) in less than 5% yield (Table 14, Entry 1). Cyclopentanone 
417b is a result of oxidative addition of the Rh(I)-catalyst into the less hindered proximal C-C 
bond b leading to rhodacyclopentanone 418. Mechanistically, the lack of diastereocontrol is 
unsurprising. If hydrometallation is the stereodetermining step for this process, enamide 
isomerisation may occur upon the formation of Rh(III)-acyl hydride species 419, thus delivering 
a mixture of diastereomeric rhodacyclohexenones 420 (Table 14, top). Even if a geometrically 
defined enamide is formed, hydroacylation can occur via either face of intermediate 419, which 
would also lead to a mixture of diastereomers. Finally, the C1 stereocenter of 417b is potentially 
labile and may epimerise under the reaction conditions. 
Although poor diastereisomeric ratios (approx. 2:1) were observed for 417b, studies were 
undertaken to improve the yield. It was found that increasing the reaction time and temperature 
led to the formation of 417b in approximately 30% yield (Table 14, Entries 2-3). Although no 
starting material was observed in the reaction mixture, acetamide 413 was converted into a 
complex mixture of undesired products (Table 14, Entry 3). As a result, a range of cationic Rh(I)-
sources, with various counterions (OTf, BF4, SbF6 and BARF), was evaluated (Table 14, Entries 
3-6). A Rh(I)-precatalyst with a highly dissociating counteranion, [Rh(cod)2]BARF, suppressed 
the formation of by-products and cyclopentanone 417b was isolated in 52% yield (Table 14, Entry 
6). Increasing the reaction temperature in this case did not increase the yield (Table 14, Entry 7). 
Interestingly, longer reaction times resulted in the formation of trace quantities of alternate 
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regioisomer 417a, which arises from Rh insertion into the more hindered C-C bond a (Table 14, 
Entry 8). Electron-rich or -neutral P-ligands, as well as sterically bulky and bidentate P-ligands, 
were all detrimental to the yield of the reaction. None of the ligands assessed displayed a 
significant advantage over P(3,4,5-(F)3C6H2)3. Although the overall yield of transformation was 
significantly improved, further investigations failed to enhance the levels of diastereoselectivity.  
 




1 [Rh(cod)2]OTf 100 24 68 <5 - 
2 [Rh(cod)2]OTf 120 24 24 32 (27)b 1:1.5 
3 [Rh(cod)2]OTf 130 48 0 34 1:1.3 
4 [Rh(cod)2]BF4 120 72 82 <10 - 
5 [Rh(cod)2]SbF6 120 72 28 52 (38)b 1.5:1 
6 [Rh(cod)2]BARF 120 24 22 56 (52)b 2.2:1 
7 [Rh(cod)2]BARF 140 24 15 48 1.6:1 
8 [Rh(cod)2]BARF 120 48 15 65 (68)b,c 2.0:1 
Table 14: Proposed mechanism and selected conditions for Rh-catalysed carbonylative ring expansion of trans-1,2-
disubstituted aminomethylcyclopropane 413. aYields were determined by 1H NMR analysis of the crude reaction 
mixture against an internal standard (1,4-dinitrobenzene). Isolated yields are given in parentheses. b Isolated as a 
mixture of diastereomers. c Isolated as an approx. 3:1 mixture of regioisomers. 
5.2.3 α-Substituted N-(cyclopropylmethyl)benzamides 
The generality of the carbonylative cyclopentanone 422 synthesis was next examined by 
evaluating α-substituted N-(cyclopropylmethyl)benzamides 421 (Scheme 101A). To this end, 
phenyl and vinyl substituted cyclopropanes 421a and 421b were synthesised. Compound 421a 
was obtained through a two-step sequence (Scheme 101B). Firstly, PhCN was treated with freshly 
formed cyclopropylmagnesium bromide to give the corresponding imine, which was immediately 
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reduced with NaBH4 to provide amine 423 in quantitative yield. This was subsequently reacted 
with benzoyl chloride to give the target starting material 421a. The synthesis of α-vinyl substituted 
substrate 421b was achieved using an alternative route (Scheme 101C). Condensation of 
cyclopropanecarboxaldehyde with tert-butyl carbamate and sodium p-toluenesulfinate afforded 
sulfone 424. This was then treated with an excess of Grignard reagent to convert 424 into the 
corresponding imine which then reacted with another equivalent of vinylmagnesium bromide to 
give addition product 425 in 62% yield.211 Boc-deprotection using trifluoroacetic acid, and amide 
formation with benzoyl chloride provided cyclopropane 421b. 
Cyclopropanes 421a and 421b were exposed to a range of catalytic conditions, employing 
neutral (PPh3), electron-deficient (P(3,5-CF3C6H3)3, P(3,4,5-F3C6H2)3) and electron-rich 
(P(4-OMeC6H4)3) monodentate ligands, and neutral ([Rh(cod)Cl]2) and cationic ([Rh(cod)2]OTf) 
Rh-precatalysts. Non-coordinating (1,2-DCB and mesitylene) and strongly coordinating solvents 
(benzonitrile), different temperatures (85-180 °C) and reaction times of up to 3 days were 
investigated. However, for 421a only starting material was recovered, whereas for 421b 
consumption of starting material was observed, but target product 422 could not be isolated. The 
failure of these systems might suggest that additional substitution at C1 suppresses β-hydride 
elimination (cf. Scheme 92, 383 to 383) and/or enamide hydrometallation (383 to 384). 
Alternatively, C-C bond activation of these sterically demanding substrates may be inefficient. 
 
Scheme 101: (A) Proposed Rh-catalysed cyclisation of α-substituted N-(cyclopropylmethyl)benzamides. (B) 
Synthesis of N-[cyclopropyl(phenyl)methyl]benzamide 421a. (C) Synthesis of N-(1-cyclopropylallyl)benzamide 
421b. Reagents and conditions: (i) (a) Mg, benzonitrile, THF, 0 °C, 6 h; (b) NaBH4, MeOH, 0 °C to r.t., 16 h; (ii) 
BzCl, TEA, DCM, 0 °C to r.t., 16 h; (iii) tert-butyl carbamate, sodium p-toluenesulfinate, HCO2H, H2O:MeOH 2:1, 
r.t., 2 d; (iv) vinylmagnesium bromide, THF, -78 °C to r.t., 2 h; (v) (a) TFA, DCM, r.t., then (b) BzCl, TEA, DCM, 0 
°C to r.t., 16 h. 
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5.2.4 ortho-Halogenated N-(cyclopropylmethyl)benzamides 
In 1997, Muratake and Natsume reported the synthesis of spirobicycles 427 via the Pd-
catalysed intramolecular α-arylation of cyclic ketones 426 (Scheme 102A).212 A catalytic cycle for 
cyclopentanone α-arylation is shown in Scheme 102B.213 Initially, oxidative addition of aryl halide 
426a to the Pd(0) complex forms arylpalladium(II) complex 428. Substitution of the coordinated 
halide by an enolate nucleophile and reductive elimination from the resulting C-bound palladium 
enolate σ-complex 429, which is preferred over O-bound palladium enolate σ-complex 430,214-216 
gives aryl ketone 427a and regenerates the Pd(0) complex. 
 
Scheme 102: Pd-catalysed intramolecular α-arylation of α-substituted cyclic ketones as demonstrated by Muratake 
and Natsume and a generic α-arylation mechanism. 
Subsequently, intramolecular α-arylations of this type have proved to be a powerful 
synthetic method for constructing α-arylated compounds.217 In theory, this approach could be 
applied in the further functionalisation of α-aminocyclopentanones 431a-c (Scheme 103A). In 
order to test the intramolecular cyclisation, a range of ortho-halogenated 
cyclopropylmethylbenzamides 432a-c were synthesised from the corresponding substituted 
benzoyl chlorides. Unfortunately, the desired cyclopentanones 431a-c were not observed when 
432a-c were exposed to a variety of Rh-catalysed carbonylation conditions. Even with increased 
reaction times, catalyst loading and elevated temperature, only starting material remained in the 
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reaction mixture. To test if the ortho-halide causes catalyst deactivation, a 1:1 mixture of 
unsubstituted cyclopropylmethylbenzamide 380a and ortho-chloro-substituted 
cyclopropylmethylbenzamide 432a was subjected to catalytic reaction conditions using 7.5 mol% 
of [Rh] at 100 °C (Scheme 103B). After 24 h, only the starting cyclopropanes were observed. A 
plausible explanation for the low reactivity of ortho-halogenated derivatives is that Rh insertion 
into the C-Hal bond of 432a-c occurs, which then inhibits C-C bond activation. 
 
Scheme 103: Synthesis of ortho-halogenated cyclopropylmethylbenzamides and attempted Rh-catalysed ring 
expansion. Reagents and conditions: (i) ArCOCl, TEA, DCM, 0 °C to r.t., 16 h. aThis compound was prepared by Dr. 
Fumagalli 
It was proposed that increasing the distance between the amide directing group and ortho-
halogenated aromatic ring would lower the chance of catalyst deactivation. To test this hypothesis, 
secondary amide 433 and tertiary amide 434 were synthesised (Scheme 104); however, both 
substrates were unreactive under the standard catalytic conditions. Similarly, when exposed to 
harsher reactions conditions no product was observed in an analogous manner to systems 432a-c. 
 
Scheme 104: Synthesis of amides 433 and 434. Reagents and conditions: (i) 2-bromophenylacetic acid, EDCI, 
DMAP, DCM, 0 °C to r.t.; (ii) (a) benzaldehyde, NaHCO3, MeOH, reflux, 18 h; (b) NaBH4, 0 °C to r.t., 18 h; (iii) 2-
(2-bromophenyl)acetyl chloride, TEA, DCM, 0 °C to r.t., 16 h. 
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The efficiency of the N-benzyl-N-(cyclopropylmethyl)acetamide system 398 (Section 
5.2.1, Scheme 97) prompted evaluation of systems where ortho-halogenation is incorporated into 
the N-benzyl group instead of the benzamide unit (cf. 432a-c). Acetamide 435 was readily 
synthesised in two steps in an analogous manner to 398 (vide supra) and exposed to the standard 
catalytic system (Scheme 105). At 85 °C, no conversion of the starting material was observed. 
However, in contrast to other systems, where the ortho-substituted aromatic ring was within the 
amide directing moiety (see Schemes 103 and 104), amide 435 does not deactivate the catalyst and 
the carbonylative rearrangement is feasible at elevated temperatures. At 140 °C, cyclopentanone 
436 was formed in 82% yield, which then makes further functionalisation of C1 possible. 
 
Scheme 105: Synthesis and Rh-catalysed carbonylative rearrangement of 435. Reagents and conditions: (i) (a) 2-
bromobenzaldehyde, NaHCO3, MeOH, reflux, 3 h; (b) NaBH4, 0 °C to r.t., 4 h; (ii) acetic anhydride, TEA, DCM, 0 
°C to r.t., 16 h. 
A typical procedure for the cross-coupling of a nucleophilic enolate and electrophilic aryl 
halide employs a Pd catalyst and a base (Table 15). Products of this reaction contain a new carbon-
carbon bond at the α-carbon of the carbonyl compound. Buchwald and co-workers have 
demonstrated a general approach for the α-arylation of a wide variety of substrates using sodium 
or lithium tert-butoxide as the base.218,219 Unfortunately, this strategy was inefficient for the 
proposed intramolecular arylation (Table 15, Entries 1-3) and led predominantly to dehalogenated 
species 399, along with the target spirobicycle 437. Conditions from the pioneering study by 
Muratake and Natsume212 employ caesium carbonate as the base and THF or 1,4-dioxane as the 
solvent. These conditions were more promising (Table 15, Entries 4, 5), and, by switching to 
toluene as the solvent, 437 was formed in 47% yield and with good selectivity over dehalogenated 
product 399 (Table 15, Entry 6). A number of different bases were screened (Table 15, Entries 7, 
8), but none of them were as effective as caesium carbonate. Finally, an 81% yield of target 437 
was obtained by using PdCl2(PPh3)2 as the precatalyst with 200mol% Cs2CO3 (Table 15, Entry 9 
vs Entry 6); under these conditions, minimal amounts of dehalogenated side product 399 were 
observed. The structure of novel spirobicyle 437 was unambiguously determined by single crystal 
X-ray diffraction. 











100 1 : 0.00 <5 
2 
Pd2(dba)3/ 
2 × PPh3 
LiOt-Bu, 200 toluene, 0.1 110 1 : 0.20 15 
3 
Pd2(dba)3/ 
2 × PPh3 
KOt-Bu, 200 toluene,0.1 110 1 : 0.33 53 
4 
PdCl2∙(CH3CN)2/ 
2 × PPh3 
Cs2CO3, 300 THF, 0.1 100 1 : 0.25 31b,c 
5 PdCl2(PPh3)2 Cs2CO3, 300 1,4-dioxane, 0.1 100 1 : 0.31 55 
6 PdCl2(PPh3)2 Cs2CO3, 300 toluene, 0.1 110 1 : 0.17 47b 
7 PdCl2(PPh3)2 LiOt-Bu, 200 toluene, 0.1 110 1 : 0.15 25 
8 PdCl2(PPh3)2 KOt-Bu, 200 toluene, 0.1 110 1 : 0.32 78 
9 PdCl2(PPh3)2 Cs2CO3, 200 toluene, 0.1 110 1 : 0.09 81b 
Table 15: Selected conditions for Pd-catalysed intramolecular α-arylation of cyclopentanone 436. aYields were 
determined by 1H NMR analysis of the crude reaction mixture against an internal standard (1,4-dinitrobenzene). 
bIsolated yield. c10 mol% of PdCl2∙(CH3CN)2 were used. 
To test whether larger spirobicycles can be accessed with this methodology, homologated 
substrate 439 was made (Scheme 106A). The requisite N-substituents of 439 were easily installed 
by a reductive amination-acetylation sequence. Conditions optimised for the carbonylative 
cyclisation of benzylacetamide 398 were efficient for this system and cyclopentanone 440 was 
generated in 79% yield. Ortho-halogenated cyclopropane 441 was prepared from amide 433 by a 
sequence of borane reduction and acetylation. When the optimised conditions for the carbonylative 
rearrangement were applied to 441 desired product 442 was formed in 88% yield (Scheme 106B). 
Finally, the optimised protocol for Pd-catalysed intramolecular α-arylation delivered acetamide 
443, bearing spiro-fused five and six-membered rings. 
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Scheme 106: Synthesis of N-(cyclopropylmethyl)-N-phenethylacetamide 439, its ortho-halogenated derivative 441 
and the subsequent carbonylative rearrangement and α-arylation. Reagents and conditions: (i) (a) phenylacetaldehyde, 
MeOH, -78°C, 3 min; (b) NaBH4, -78 to 0 °C, 2 h; (ii) acetic anhydride, TEA, DCM, 0 °C to r.t., 16 h; (iii) 7.5 mol% 
[Rh(cod)2]OTf, 15 mol% P(3,4,5-(F)3C6H2)3, 20 mol% PhCO2H, 0.15 M 1,2-DCB, 1 atm CO, 110 °C, 24 h; (iv) (a) 
BH3•THF, THF, 0 °C to reflux, 20 h; (b) 2.0 M aq. HCl, 85 °C, 1 h; (v) 6 mol% PdCl2(PPh3)2, 200 mol% Cs2CO3, 
toluene, 110 °C, 18 h. 
To test whether a more elaborate sp3-rich spirobicyclic system could be accessed via the 
same synthetic pathway, benzyl-substituted cyclopropane 446 was synthesised. Acid 444 was 
converted to the corresponding acid chloride and this was reacted with 2-bromobenzylamine to 
produce amide 445. Subsequent reduction and acylation gave trans-1,2-disubstituted 
aminomethylcyclopropane 446 in an overall yield of 30% (Scheme 107). Under the best conditions 
found for 413 to 417b (see Table 14), 446 provided only trace amounts of target 447. The low 
yield could be due to competitive oxidative insertion into the C-Br bond, which would lead to 
catalyst deactivation. A variety of harsher reaction conditions were evaluated (e.g. heating to 180 
°C, running the reaction at 1.0 M concentration or using 15 mol% [Rh(cod)2]BARF), but they did 
not facilitate the carbonylative rearrangement of 447. This result indicates that the relative facility 
of C-C versus C-Br bond activation is finely balanced. 
 
Scheme 107: Synthesis and reactivity of trans-1,2-disubstituted methylcyclopropane 446. Reagents and conditions: 
(i) oxalyl chloride, DCM, r.t., then 2-bromobenzylamine hydrochloride, TEA, DCM, 0 °C to r.t., 16 h; (ii) (a) 
benzaldehyde, NaHCO3, MeOH, reflux, 3 h; (b) NaBH4, 0 °C to r.t., 4 h; (iii) acetic anhydride, TEA, DCM, 0 °C to 
r.t., 16 h. Rh-catalysed conditions: 7.5 mol% [Rh(cod)2]OTf or [Rh(cod)2]BARF, 15 mol% P(3,4,5-(F)3C6H2)3, 20 
mol% PhCO2H, 0.15 M 1,2-DCB, 1 atm CO, 110-160 °C, 24-72 h. 
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5.2.5 Evaluation of other enolate-based spirocyclisation processes. 
The possibility of employing the cyclopentanone ketone product as a nucleophile in other 
spirocyclisations was investigated next. Specifically, a carbonylative rearrangement-conjugate 
addition cascade was envisaged using 450a or 450b. The synthesis of these substrates commenced 
with the known two-step alkylation-protection procedure (Scheme 108A).48 Alkylation of 
aminomethylcyclopropane with tosylate 448 delivered secondary amine, which was protected with 
acetic anhydride to afford 449 in 55% yield. Amide 449 was converted to 450a or 450b by alkene 
metathesis between 449 and the corresponding enone or acrylate. 450a was exposed to 
carbonylative cyclisation conditions (Scheme 108B); pleasingly, at 130 °C 5-exo-trig ring closure 
of in situ generated cyclopentanone 452 occurred directly to provide spirobicycle 451a in 41% 
yield and as an approximately 1:1 mixture of diastereomers. A Lewis acid additive screen 
(Zn(OTf)2, La(OTf)3, Eu(OTf)3, Mg(OTf)2, MoO3, ZnCl2) was undertaken in the hope of 
promoting diastereoselective conjugate addition via coordination to both oxygens of intermediate 
452, but improvements in d.r. were not forthcoming. However, the yield of 451a was improved to 
65% when the reaction temperature was lowered from 130 °C to 110 °C and 10 mol% Mg(OTf)2 
was used as an additive. When methyl acrylate 450b was examined under these conditions, 
compound 451b was isolated in 30% yield and in a 2:1 diastereomeric ratio. This initial result was 
irreproducible, with diminished yields and large amounts of intermediate 452 often observed in 
the crude reaction mixture on repeated runs. The variances in the yield were attributed to trace 
amounts of base present in the reaction tube. Subsequently, the crude reaction mixture was treated 
with an excess of K2CO3 at room temperature prior to the purification by silica gel column 
chromatography. This gave 451b in a reproducible 53% yield and 3.6:1 d.r. 
 
Scheme 108: (A) Synthesis of 451a,b. Reagents and conditions: (i) TsCl, Et3N, DCM, r.t., 18 h; (ii) 
aminomethylcyclopropane, MeCN, reflux, 18 h; (iii) acetic anhydride, TEA, DCM, 0 °C to r.t., 16 h; (iv) DCM, 
Hoveyda-Grubbs Catalyst 2nd Gen., r.t., 18 h. (B) Carbonylative rearrangement-conjugate addition cascade of 451a,b. 
a 2 equiv. of K2CO3 were used. 
Chapter 5 – C-C Bond activation of aminomethylcyclopropanes 
109 
Ynone 455 was proposed as a more reactive conjugate acceptor compared to 450a,b. 
Amide 453 was synthesised in 46% yield by the two-step alkylation-protection procedure. 
Deprotonation of the alkyne 453 with n-BuLi and addition of the resulting Li-acetylide to 
benzaldehyde provided alcohol 454. This was subjected to PDC oxidation to furnish ynone 455 in 
78% yield (Scheme 109). Unfortunately, carbonylative rearrangement of 455 under standard 
catalytic conditions and at elevated temperatures was unsuccessful. In most cases, degradation of 
starting material was observed and the formation of 456 did not occur. It is possible that strong 




Scheme 109: Synthesis and attempted Rh-catalysed ring expansion of ynone 455. Reagents and conditions: (i) TsCl, 
Et3N, DCM, r.t., 18 h; (ii) methyaminocyclopropane, MeCN, reflux, 18 h; (iii) acetic anhydride, TEA, DCM, 0 °C to 
r.t., 16 h; (iv) (a) n-BuLi, THF, 0 °C, 30 min; (b) benzaldehyde, 0 °C to r.t., 2 h; (v) pyridinium dichromate, DCM, 
r.t., 2 h. 
 
Analogous 6-endo-trig ring closures of enones 459a-c were investigated next (Scheme 
110). Ethyl ester 457 was synthesised by the two-step alkylation-protection procedure and then 
transformed into a Weinreb amide 458. This was treated with the appropriate Grignard reagent to 
provide enones 459a-c in low yields. These were exposed to conditions optimised for 450a,b to 
451a,b (see Scheme 108), but, unfortunately, neither bicycle 461a-c or cyclopentanone 450 were 
observed. Only trace amounts of starting material were present in the crude reaction mixtures of 
the carbonylative reaction after 24 h when heated to 85 °C, which may indicate that enones 459a-
c are unstable under the reaction conditions. 




Scheme 110: Synthesis and attempted carbonylative rearrangement-conjugate addition cascade of 459a-c. Reagents 
and conditions: (i) ethyl bromoacetate, MeCN, 0 °C to r.t., 1 h; (ii) acetic anhydride, TEA, DCM, 0 °C to r.t., 16 h; 
(iii) Me2AlCl, MeNHOMe·HCl, 16 h; (iv) Grignard reagent, THF, -78 °C, 2.5 h. 
5.2.6 One-pot synthesis of indoles and dihydroisoquinolines 
The studies outlined above demonstrated that the amide-directed carbonylative 
rearrangement process can be used with a wide variety of substrates, including systems that allow 
subsequent α-functionalisation of the ketone product. In this section, subsequent transformations 
involving direct reaction at the carbonyl unit of the product cyclopentanone are explored. The 
development of a carbonylative rearrangement of N-aryl aminomethylcyclopropanes 462 into 
cyclopentanones 463 could, in principle, enable a subsequent Lewis acid-catalysed pathway to 
novel indole scaffolds 464 (Scheme 111). 
 
Scheme 111: Proposed transformation of derivatised N-aryl α-aminocyclopentanones 463 to N-acetylindoles 464. 
To investigate the proposal in Scheme 111, N-phenylated system 462a and more electron-
rich analogues 462b-d were synthesised. This was achieved either by alkylation of the respective 
acetanilides with cyclopropylmethyl bromide (462a-c) or by Buchwald–Hartwig amination and 
subsequent acetylation (462d) (Scheme 112A). 
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Aminomethylcyclopropanes 462a-d were exposed to the standard catalytic conditions to 
assess the scope of the reaction with respect to the aryl component. Pleasingly, all systems were 
tolerated and cyclopentanones 463a-d were isolated in good yields (Scheme 112B). The resulting 
cyclopentanones 463a-d were exposed to a variety of Brønsted and Lewis acids to promote the 
envisaged intramolecular cyclisation. Conditions included refluxing in TFA for 3 days, heating to 
130 °C in neat polyphosphoric acid, heating in 1,2-dichlorobenzene with AlCl3 or FeCl3, heating 
in dimethoxyethane with MgCl2, ZnCl2, or BF3∙Et2O. The target material 464, bearing an indole 
scaffold, was not observed under these reaction conditions and starting material (or a complex 
mixture in the case of polyphosphoric acid) was recovered. 
 
Scheme 112: (A) Synthesis and (B) carbonylative rearrangements of arylacetamides 463a-d. Reagents and conditions: 
(i) corresponding substituted aniline and Ac2O or AcCl, a prepared according to the literature procedures; (ii) (a) NaH, 
THF, 0 °C to r.t., 1 h; (b) cyclopropylmethyl bromide, r.t. to 50 °C, 18 h; (iii) 2-bromonaphthalene, 
aminomethylcyclopropane, sodium tert-amoxide, Pd2(dba)3, BrettPhos, toluene, 80 °C, 16 h; (iv) 7.5 mol% 
[Rh(cod)2]OTf, 15 mol% P(3,4,5-(F)3C6H2)3, 20 mol% PhCO2H, 0.15 M 1,2-DCB, 1 atm CO, 110 °C, 18 h. 
To promote the cyclisation, attempts were made to remove the acetyl group of acetanilides 
463a-d and give the more electron rich NH anilines 466a-d. Under forcing basic conditions (40 
eq. NaOH, water:1,4-dioxane:MeOH 1:1:1, 135 °C, 72 h) starting material decomposed, whereas 
acidic conditions (conc. HCl:EtOH 1:1, 120 °C, 72 h) yielded the corresponding unsubstituted 
anilines 465a-d, where the cyclopentanone unit has been lost (Scheme 113A). A possible 
mechanistic pathway involves acid-catalysed deacetylation to give the desired amine 466a-d. At 
this stage, iminium ion formation (467) and hydrolysis leads to the corresponding aniline and an 
α-hydroxy ketone, which is unstable in the presence of a strong acid. 
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Next, to evaluate alternative amine protecting groups, pivalamide 468 was prepared in 80% 
yield from amide 469 by the reduction-protection strategy (Scheme 113B). Unfortunately, under 
the carbonylative conditions from Scheme 112, only starting material 468 was observed in the 1H 
NMR spectrum of the crude reaction mixture. Overall, the results in Scheme 113 suggested that a 




Scheme 113: (A) Studies evaluating the deacetylation of 463a-d. Proposed mechanism for the formation of anilines. 
(B) Synthesis and reactivity of pivalamide 468. Reagents and conditions: (i) LiAlH4, THF, 0 °C to reflux, 16 h; (ii) 
pivaloyl chloride, TEA, DCM, 0 °C to r.t., 16 h; (iii) 7.5 mol% [Rh(cod)2]OTf, 15 mol% P(3,4,5-(F)3C6H2)3, 20 mol% 
PhCO2H, 0.15 M 1,2-DCB, 1 atm CO, 110 °C, 18 h. 
 
To address this, trifluoroacetamide 470 was targeted (Scheme 114). Alkylation of 
trifluoroacetyl-protected anilide 471 with cyclopropylmethyl bromide provided secondary aniline 
472, where the trifluoroacetyl group has been removed. This was reinstalled by treatment with 
trifluoroacetic anhydride. Trifluoroacetamide 470 was subjected to the standard catalytic 
conditions, but the desired cyclopentanone 473 was not formed, and only starting material was 
observed. This result indicates that the N-trifluoroacetyl directing group is not sufficiently Lewis 
basic to promote the carbonylative transformation. 
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Scheme 114: Synthesis and evaluation of trifluoroacetamide 470. Reagents and conditions: (iii) (a) NaH, THF, 0 °C 
to r.t., 1 h; (b) cyclopropylmethyl bromide, r.t. to 50 °C, 18 h; (iv) trifluoroacetic anhydride, TEA, DCM, 0 °C to r.t., 
16 h. Catalytic conditions: 7.5 mol% [Rh(cod)2]OTf, 15 mol% P(3,4,5-(F)3C6H2)3, 20 mol% PhCO2H, 0.15 M 1,2-
DCB, 1 atm CO, 85°C or 110 °C, 18 h 
A literature search of condensation reactions related to the idea proposed in Scheme 111 
revealed that 3,5-dimethoxy-substituted anilides might be suitable.220,221 To enable the 
investigation of this electron-rich system, cyclopropane 474a was synthesised by alkylation with 
cyclopropylmethyl bromide in a manner analogous to acetanilides 462a-c (Scheme 115). To assess 
the possible benefits of a stronger N-directing group in the Rh-catalysed carbonylative 
rearrangement, cyclopropane 474b, bearing a dimethylurea directing group, was also synthesised. 
Cyclopropanes 474a,b were exposed to the optimised cationic catalytic conditions and, 
pleasingly, carbonylative rearrangement and one-pot condensation delivered the desired indoles 
476a,b in excellent yield (Scheme 115). This result demonstrates that acid activation is not 
required for intramolecular condensations involving 3,5-dimethoxy-substituted systems. 
Interestingly, cyclopentanones 475a,b were not observed in the 1H NMR spectrum of the crude 
reaction mixture, indicating that cyclocondensation occurs spontaneously. 
 
Scheme 115: Synthesis of cyclopropanes 474a,b and a one-pot indole synthesis. Reagents and conditions: (i) acetic 
anhydride or dimethylcarbamyl chloride; (ii) (a) NaH, THF, 0 °C to r.t., 1 h; (b) cyclopropylmethyl bromide, r.t. to 50 
°C, 18 h; Catalysis conditions: 7.5 mol% [Rh(cod)2]OTf, 15 mol% P(3,4,5-F3C6H2)3, 20 mol% PhCO2H, 0.15M 1,2-
DCB, 1 atm CO, 110 °C, 18 h. 
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With an optimised system in hand, further studies focused on evaluating the scope of the 
reaction. To do this, homologated amide 477a was prepared from the corresponding acid chloride, 
whereas aminomethylcyclopropane 477b was prepared by reductive amination and subsequent 
acetylation (Scheme 116). Substrate 477a failed to provide the desired heterocycle 478a under the 
carbonylative C-C bond activation conditions and instead cyclopentanone 479 was isolated in 48% 
yield. When acetamide 477b was used, the desired 1,2-dihydroisoquinoline 478b was delivered in 
94% yield. Subsequent acid-promoted deacetylation of substrate 478b provided isoquinoline 480 
after spontaneous aerobic oxidation. 480 is a pharmacologically significant heterocyclic scaffold, 
as isoquinoline-based drugs find many applications, including as anaesthetics and vasodilators.222 
 
Scheme 116: Synthesis and evaluation of systems containing a 3,5-dimethoxyphenyl unit. Reagents and conditions: 
(i) 2-(3,5-dimethoxyphenyl)acetyl chloride, TEA, DCM, 0 °C to r.t., 16 h; (ii) (a) 3,5-dimethoxybenzaldehyde, 
NaHCO3, MeOH, reflux, 3 h; (b) NaBH4, 0 °C to r.t., 4 h; (iii) acetic anhydride, TEA, DCM, 0 °C to r.t., 16 h; (iv) 
1,4-dioxane:H2O:conc.HCl 1:1:1, reflux, 2 h; Catalysis conditions: 7.5 mol% [Rh(cod)2]OTf, 15 mol% P(3,4,5-
(F)3C6H2)3, 20 mol% PhCO2H, 0.15M 1,2-DCB, 1 atm CO, 110 °C, 18 h. 
The success of the process in Scheme 116B is finely balanced, and is critically dependent 
on the substitution pattern of the arene. When 3,4-methylenedioxy-substituted substrate 481 was 
employed, target dihydroisoquinoline 482 was not observed and cyclopentanone 483 was isolated 
in 76% yield (Scheme 117). In an effort to promote cyclocondensation, 483 was heated at reflux 
in TFA for 3 days, but this did not lead to the formation of the desired heterocycle. 
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Scheme 117: Synthesis and carbonylative rearrangement of a system containing a 3,4-methylenedioxyphenyl unit. 
Reagents and conditions: (i) (a) piperonal, NaHCO3, MeOH, reflux, 3 h; (b) NaBH4, 0 °C to r.t., 4 h; (ii) acetic 
anhydride, TEA, DCM, 0 °C to r.t., 16 h; Catalysis conditions: 7.5 mol% [Rh(cod)2]OTf, 15 mol% P(3,4,5-(F)3C6H2)3, 
20 mol% PhCO2H, 0.15M 1,2-DCB, 1 atm CO, 110 °C, 18 h. 
5.2.7 Evaluation of substrates for cascade cyclisations 
In addition to the systems described in Section 5.2.6, alternative substrates were examined 
where the carbonyl group of the resulting cyclopentanone can act as an electrophile and induce 
further cyclisations. Amide 484 was prepared from aminomethylcyclopropane and phenylacetyl 
chloride, which was then exposed to the optimised conditions for the Rh-catalysed carbonylative 
rearrangement to provide cyclopentanone 485 in 67% yield (Scheme 118). Upon treatment with 
base (NaOH or KOt-Bu), no formation of the desired pyrrol-2-one 486 was observed. More forcing 
conditions to deprotonate C3 (e.g. LiHMDS)223 were not screened due to the presence of 
competitive sites for deprotonation at C1 and C2 of cyclopentanone 485. 
 
Scheme 118: Synthesis and carbonylative rearrangement of amide 484. Reagents and conditions: (i) phenylacetyl 
chloride, TEA, DCM, 0 °C to r.t., 16 h; Catalysis conditions: 7.5 mol% [Rh(cod)2]OTf, 15 mol% P(3,4,5-F3C6H2)3, 
20 mol% PhCO2H, 0.15M 1,2-DCB, 1 atm CO, 110 °C, 18 h. 
Cyclopropanes 487a,b bearing β-ketoamide directing groups were also investigated 
(Scheme 119). Carbonylative rearrangements of 487a,b under standard catalytic conditions and at 
elevated temperatures were unsuccessful, presumably due to strong coordination of the Rh(I)-
catalyst to the acac-like 1,3-diketone moiety. No traces of cyclopentanone 488a,b or fused bicycle 
489a,b were observed by 1H NMR analysis of the crude reaction mixtures. 
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Scheme 119: Synthesis and attempted carbonylative rearrangement of β-ketoamides 487a,b. Reagents and conditions: 
(i) N-benzyl-1-cyclopropylmethylamine, toluene, reflux, 4 h; (ii) aminomethylcyclopropane, pyridine, xylenes, 120 
°C, 2.5 h; Catalysis conditions: 7.5 mol% [Rh(cod)2]OTf, 15 mol% P(3,4,5-F3C6H2)3, 20 mol% PhCO2H, 0.15M 1,2-
DCB, 1 atm CO, 110 -160 °C, 18 h. 
It was envisaged that 1,2-addition of the C1 enolate of 488 to the ketone may be reversible. 
To circumvent this, less stabilised enolates were also explored. Acetamide 490 was readily 
prepared in two steps, and exposure of this to carbonylative rearrangement conditions resulted in 
spontaneous nucleophilic addition to the ketone to give fused bicyclic structure 491 in 73% yield 
and as a 2:1 mixture of diastereoisomers (Scheme 120). Attempts to promote dehydration of β-
hydroxyketone 491 by screening over 10 sets of conditions (e.g. TFAA/DBU, Burgess reagent,224 
POCl3/pyridine, conc. H2SO4, MsCl/Et3N, MsCl/DMAP/H2O
225) were unsuccessful; this result is 
surprising but can be rationalised by the unfavourable increase in strain of the resulting unsaturated 
product 492. 
 
Scheme 120: Synthesis and carbonylative rearrangement of acetamide 490. Reagents and conditions: (i) 3-
chloropropiophenone, TEA, DCM, 0 °C to r.t., 6 h; (ii) acetic anhydride, TEA, DCM, 0 °C to r.t., 16 h; Catalysis 
conditions: 7.5 mol% [Rh(cod)2]OTf, 15 mol% P(3,4,5-F3C6H2)3, 20 mol% PhCO2H, 0.15M 1,2-DCB, 1 atm CO, 110 
°C, 18 h. 
Finally, substrates equipped with latent nucleophilic functionality were evaluated, as 
outlined in Scheme 121. Aromatic nucleophilic substitution of 1-fluoro-2-nitrobenzene with 
aminomethylcyclopropane, followed by acylation of the resulting amine gave 493 in 74% yield. 
Acetamide 493 underwent carbonylative rearrangement to give cyclopentanone 494. Upon 
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reduction of the nitro group of 494, cyclisation of the intermediate aniline onto the cyclopentanone 
and subsequent imine hydrogenation occurred, affording 495 as a single diastereomer in 55% 
yield. This result encouraged the synthesis of acetamide 496, which was formed in 80% yield via 
a reductive amination-acylation sequence. C-C bond activation-triggered rearrangement provided 
497 in 75% yield, but its conversion to 7-membered target 498 was not observed under a range of 
reductive conditions (Pd/C, H2; Fe/AcOH; SnCl2). This result shows that the formation of larger 
fused ring systems is more challenging and that, in such cases, alternative decomposition pathways 
predominate. The corresponding uncyclised aniline was not observed, although conversion of 
starting material 497 to a complex mixture of products occurred under several of the evaluated 
conditions.  
 
Scheme 121: Synthesis, carbonylative rearrangement and reductive cyclisation of cyclopropanes 493 and 496. 
Reagents and conditions: (i) (a) 1-fluoro-2-nitrobenzene, K2CO3, DMF, r.t., 4 h; (b) Ac2O, conc. H2SO4, 50 to 80 °C, 
3 h, then MeOH, 0 °C, 2 h; (ii) 7.5 mol% [Rh(cod)2]OTf, 15 mol% P(3,4,5-(F)3C6H2)3, 20 mol% PhCO2H, 0.15 M 
1,2-DCB, 1 atm CO, 110 °C, 24 h; (iii) Pd/C, 1 atm H2, MeOH, r.t., 8 h; (iv) (a) 2-nitrobenzaldehyde, MeOH, reflux, 
3 h; (b) NaBH4, 0 °C to r.t., 4 h; (c) acetic anhydride, TEA, DCM, 0 °C to r.t., 16 h. 
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5.3 Synthesis and reactivity of aminomethylcyclopropanes with tethered 
alkenes 
Previous research at Bristol demonstrated that rhodacyclopentanones, formed under 
carbonylative conditions, can be trapped by tethered π-unsaturates to provide a multitude of 
(3+1+2) cycloaddition products (see Chapter 1, Schemes 5,7 and Chapter 4). It was envisaged that 
it might be feasible to integrate the carbonylative rearrangement process into multicomponent 
cycloadditions of this type, thereby delivering analogous stereochemically complex N-
heterobicyclic scaffolds (Scheme 122). Here, trapping of rhodacyclohexanone 499 with tethered 
π-unsaturates (e.g. alkene or alkyne) would lead to fused bicyclic systems 500 via a formal (4+1+2) 
cycloaddition. An alternative (3+1+2) pathway would involve direct trapping of 
rhodacyclopentanone 501 to provide saturated isoquinolinone-type structures 502.  
 
Scheme 122: Proposed cycloadditions between aminomethylcyclopropanes, CO and tethered alkene. 
To investigate the proposed multicomponent cycloaddition, amide 449 (see Scheme 108A) 
was subjected to the standard Rh-catalysed carbonylative conditions. Cycloaddition products 503 
and 504 did not form and only cyclopentanone 505 was isolated in 62% yield (Scheme 123). Along 
with the main C1-C2 unsaturated product 505a, traces of C2-C3 unsaturated system 505b were 
also observed; this presumably arises from isomerisation of the alkene under the reaction 
conditions. This result shows that rearrangement of the rhodacyclopentanone into rhodacyclohexa-
none occurs, but reductive elimination is preferred over coordination and insertion of the alkene. 
 
Scheme 123: Carbonylative rearrangement of 449. Catalysis conditions: 7.5 mol% [Rh(cod)2]OTf, 15 mol% P(3,4,5-
F3C6H2)3, 20 mol% PhCO2H, 0.15M 1,2-DCB, 1 atm CO, 110 °C, 18 h.  
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5.4 Conclusions 
Directing group optimisation and second-generation conditions have been developed for 
the C-C bond activation triggered hydroacylation of aminomethylcyclopropanes. This process 
provides an unusual and direct entry to α-amino cyclopentanones. The scope of the protocol was 
investigated with a range of substituted aminocyclopropanes. The Rh-catalysed carbonylative 
rearrangement can be followed by intramolecular Pd-catalysed α-arylation to create spiro 
compounds (Scheme 124A). Furthermore, one-pot indole and dihydroisoquinoline syntheses were 
discovered. Other cascade processes, leading to (a) spiro compounds and (b) tricyclic products 
have also been investigated. Attempts to adapt previously developed (3+1+2) cycloadditions to 
aminomethylcyclopropane system 449 were unsuccessful and cycloadducts 503 or 504 were not 
be obtained (Scheme 124B). Further studies could focus on trapping intermediates of type 506 
with other reactive units that have been shown to engage rhodacyclopentanones. For example, the 
possibility of accessing 9-membered ring systems could be explored by using systems containing 
heterocycles or anilines as a nucleophile (Scheme 124C).55 
 





Studies towards the C-C bond activation of cyclobutanes 
6.1 Introduction 
The studies in Chapter 5 outline the carbonylative rearrangement of 
aminomethylcyclopropanes 507 to cyclopentanones 508 via rhodacyclohexanone intermediate 
509. In theory, C-C bond activation of cyclobutane 510 could lead to the formation of the same 
rhodacyclic intermediate (Scheme 125). However, there is no precedent for forming 
rhodacyclohexanone 509 intermediates via the C-C bond activation of cyclobutanes. 
 
Scheme 125: Proposed formation of rhodacyclohexanones from cyclobutane 510. 
Compared to three-membered rings, there are far fewer examples of catalytic ring 
expansions for four-membered rings. The primary reason for this difference may simply be that 
there are not many reliable methods to synthesize four-membered rings, whereas there are 
numerous ways to access three-membered rings. Cyclobutane is only slightly less strained than 
cyclopropane (approximate strain energies of 26 vs 29 kcal/mol),226 but it is much less reactive 
under C-C bond activation conditions. Such a difference in reactivity is likely reflective of different 
orbital availability, which is lower for cyclobutanes in comparison to cyclopropanes (Figure 4). 
 
Figure 4: Orbital models for metal-cyclopropane and metal-cyclobutane interactions. 
C-C bond activations of cyclobutanones, i.e. four-membered cyclic ketones, is a well-
known process (see also Section 1.2, Scheme 2C).29-35,168,227,228 On the other hand, examples of 
direct C-C bond activation of simpler cyclobutanes (i.e. those not bearing an endocyclic carbonyl 
group) are scarce in the literature. Aside from cyclobutanones, biphenylene 511 is the most 
Chapter 6 – Studies towards the C-C bond activation of cyclobutanes 
121 
common four-membered cycle that readily allows insertion of Rh into its C-C bond. In 1994, 
Perthuisot and Jones demonstrated229 the formation of rhodacycle 512 upon treatment of 
biphenylene with complex 513 (Scheme 126A). The reaction proceeds through the formation of 
kinetic C-H activated product 514 (as observed by NMR spectroscopy), which then rearranges to 
give thermodynamic product 512. This kind of oxidative addition process has given rise to diverse 
reactivity. It has been long known230 that exposure of biphenylene to Rh-carbonyl complexes gives 
trace amounts of 515. More recently, a high-yielding Rh-catalysed carbonylation of biphenylene 
to give fluorenone 515 has been reported,231 although the reaction takes 6 days to proceed to 
completion (Scheme 126B). Following this, intermolecular cycloadditions of biphenylene with 
alkynes,232,233 alkenes232,234 and nitriles233,235 have been demonstrated (Scheme 126B). 
 
Scheme 126: (A) Formation of rhodacycle 512 from biphenylene; (B) Carbonylation and cycloadditions of 
biphenylene with alkynes, alkenes and nitriles; dtbpm = bis(di-tert-butylphosphino)methane), dppe = 1,2-
bis(diphenylphosphino)ethane. 
Other four-membered carbocycles show limited reactivity in C-C bond activation 
processes. Stoichiometric carbonylations using [Rh(CO)2Cl]2 have been demonstrated for several 
strained saturated systems. Bicyclo-[2.2.0]hexane 516 and syn-tricyclo[4.2.0.0]octane 519 give 
bridged dimers 517 and 520 (Scheme 127A).236 Treatment of complex 517 with excess PPh3 results 
in aldehyde 518, which forms via a sequence of β-hydride elimination, rearrangement and C-H 
reductive elimination. In contrast, reaction of complex 520 with PPh3 results in C-C reductive 
elimination, which gives ketone 521 in a low yield of 19%. Cubane 522 demonstrates similar 
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behaviour when exposed to [Rh(CO)2Cl]2 (Scheme 127B);
237 tetramer 523 is formed first (with 
chloride as a triply bridging ligand), and then phosphine-induced reductive elimination leads to 
524.  
 
Scheme 127: Carbonylation of (A) bicyclo-[2.2.0]hexane, syn-tricyclo[4.2.0.0]octane and (B) cubane. 
 
To date, efficient C-C bond activations of simple cyclobutanes, where all carbons are sp3-
hybridised, have not been developed. This limitation stimulated investigations at Bristol. The 
research presented in the following sections is focused on the synthesis and reactivity of substituted 
aminocyclobutanes, which might, in principle, form rhodacyclohexanones 509 upon carbonylative 
C-C bond activation. Subsequent C-C reductive elimination would then deliver cyclopentanones 
508 (see Scheme 125). Alternatively, rhodacyclohexanone 509 might be amenable to diversion via 
other reaction pathways, leading to other types of scaffold. 
6.2  Synthesis and reactivity of aminocyclobutanes 
The low reactivity of cyclobutanes towards C-C bond activation calls for careful design of 
a suitable system. The possibility of C-C bond activation of cyclobutanes containing different 
nitrogen-based directing groups was investigated first. Aminocyclobutanes 524 and 525 were 
synthesised via Buchwald-Hartwig cross-coupling (Scheme 128A), and exposed to a range of Rh-
catalysed carbonylation conditions. Cyclobutane 524 failed to deliver any of desired product 526, 
and only starting material was recovered. When cyclobutane 525 was used, the formation of amide 
527 occurred in 75% yield (Scheme 128B). This product presumably results from 
aminocarbonylation of the 1,2-dichlorobenzene solvent, via a sequence involving oxidative 
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addition of Rh into the C-Cl bond and CO insertion. The resulting acylmetal species 528 is 
intercepted by the nucleophilic N-center of 525 prior to C-N reductive elimination. 
 
Scheme 128: (A) Synthesis of N-substituted aminocyclobutanes. Reagents and conditions: (i) 2-Bromopyridine or 
iodobenzene, sodium tert-amoxide, Pd2(dba)3, BrettPhos, 80 °C, 16 h; (B) Proposed mechanism for the formation of 
amide 527 from amine 525. 
Having established that aminocyclobutanes 524 and 525 are not suitable for the envisaged 
C-C bond activation process, modified substrates were considered. It was envisaged that addition 
of a methyl group to the pyridine ring in 529 would facilitate nitrogen-directed insertion of Rh into 
the C-C bond. This idea was based on the notion that the methyl group should bias the preferred 
conformation towards 529', in which the pyridine nitrogen is appropriately positioned to direct Rh 
insertion into the C-C bond (for the use of the 2-picoline-based directing group in C-C bond 
activation methodologies, see Chapter 2, Scheme 21).238 529 was accessed in 79% yield by 
Buchwald-Hartwig cross-coupling of 2-bromo-3-methylpyridine and cyclobutylamine (Scheme 
129A). Surprisingly, when 529 was exposed to [Rh(cod)2]OTf/PPh3 at 160 °C in 1,2-DCB under 
1 atm of CO, vinylogous amide 530 was isolated in low yield (Scheme 129B). It should be noted, 
that in all other cases only starting material was recovered under different Rh-catalysed 
carbonylation conditions. 
The mechanism for the formation of 530 may proceed via insertion of Rh into the N-H 
bond of 529 to give intermediate 531 after -carbon elimination (Scheme 129B). At this stage, 
migratory insertion of CO would give 532, which can undergo 1,2 acyl-metallation of the enamine 
to give 533. β-Hydride elimination would then release product 530. To avoid insertion of Rh into 
the N-H bond, tertiary amine 534 was synthesised by reductive amination of amine 529 with 
acetaldehyde. Unfortunately, despite an extensive screening of carbonylative conditions (>20 sets 
of conditions), only starting material was recovered using substrate 534 and cyclopentanone 535 
did not form (Scheme 129C).  
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Scheme 129: (A) Synthesis of aminocyclobutanes 529 and 534. Reagents and conditions: (i) sodium tert-amoxide, 
Pd2(dba)3, BrettPhos, 80 °C, 16 h; (ii) acetaldehyde, NaBH(OAc)3, 1,2-dichloroethane, r.t., 4 h; (B) Proposed 
mechanism for the formation of vinylogous amide 530 from amine 529. (C) Attempted C-C bond activation of 534. 
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6.3  Synthesis and reactivity of donor-acceptor cyclobutanes 
One way to enhance aminocyclobutane reactivity is to add an electron-withdrawing 
substituent to the ring.239 The nitrogen of aminocyclobutane in 536 acts as an electron-donating 
group, such that the vicinal C-C bond is strongly polarized and prone to cleavage under a range of 
conditions to give a 1,4-dipole 537 (Scheme 130A). In this context, donor-acceptor cyclobutane 
538 was synthesised in 88% yield by iron-catalysed [2+2] cycloaddition between 539 and 540 
(Scheme 130B).240 
 
Scheme 130: (A) Cleavage of the C-C bond in donor-acceptor aminocyclobutane derivatives. (B) Synthesis of β-
succinimide dicarboxylic ester 538. Reagents and conditions: (i) i-Pr2NH·TFA, TFA, paraformaldehyde, THF, reflux, 
7 h; (ii) Na2[PdCl4], vinyl acetate, reflux, 3 d; (iii) FeCl3, DCM, r.t., 18 h. 
 
Cyclobutane 538 was subjected to a range of catalytic conditions, encompassing various 
phosphine ligands, neutral ([Rh(cod)Cl]2) and cationic ([Rh(cod)2]OTf) Rh-precatalysts, non-
coordinating (1,2-DCB and decalin) and strongly coordinating solvents (benzonitrile), different 
temperatures (100-190 °C), carbon monoxide pressures (1, 5 atm) and reaction times of up to 2 
days. Under these conditions, cyclobutane 538 remained mainly unreacted and target 
cyclopentanone 541 was not formed (Table 16, Entries 1-5). The only observable product was 
alkene 542 (Table 16, Entries 2-4). 
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Entry Solvent T, °C Conditions Yield of 542, %a 
1 1,2-DCB 100 CO, 1 atm 0 
2 1,2-DCB 140 CO, 1 atm 19 
3 1,2-DCB 180 CO, 1 atm 89 
4 PhCN 180 CO, 1 atm trace 
5 Decalin 190 CO, 1 atm 0 
Table 16: Selected conditions for cyclobutane 538 ring opening. a Yields were determined by 1H NMR analysis of the 
crude reaction mixture against an internal standard (1,4-dinitrobenzene). 
The formation of alkene 542 merited further investigation. It was found that cyclobutane 
538 remained unreacted over the course of 2 days when heated at 180 °C in 1,2-DCB in the absence 
of catalyst (Table 17, Entry 1). This implies that the formation of alkene 542 is facilitated by Rh, 
and this may occur via a sequence of C-C bond activation, β-hydride elimination and C-H 
reductive elimination. Alternatively, the Rh catalyst may act as a Lewis acid and coordinate to 
ester groups of cyclobutane 538, thereby facilitating ring cleavage. Alkene 542 also formed under 
non-carbonylative conditions using a Rh-based catalytic system (Table 17, Entry 2). On the 
presumption that a rhodacyclohexanone intermediate may be forming, the possibility of alkyne 
insertion (Table 17, Entries 3, 4) was investigated, but the envisaged cycloadducts 543 were not 
observed. 
 
Entry Solvent T, °C Conditions Yield of 542, %a 
1 1,2-DCB 180 no CO, no [Rh]/PPh3 0 (+96% 538) 
2 1,2-DCB 180 no CO 33 a 
3 1,2-DCB 180 , 1,5 eq. 0 
4 1,2-DCB 180 , 1.5 eq. 0 
Table 17: Selected conditions for ring opening of cyclobutane 538. aYields were determined by 1H NMR analysis of 
the crude reaction mixture against an internal standard (1,4-dinitrobenzene). a Isolated yield.  
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6.4  Synthesis and reactivity of para-methoxyphenyl cyclobutane 
In efforts to facilitate the C-C bond activation of cyclobutanes, more highly activated 
variants were sought. It was proposed that π-donation from an aromatic ring to the σ*-antibonding 
orbital of the C-C bond of the cyclobutane could weaken the C-C bond and facilitate Rh insertion. 
Substrate 544 was identified as a suitable starting material to probe the formation of 
cyclopentanone 545 under Rh-catalysed carbonylative conditions (Scheme 131). C-C bond 
insertion into 544 should be facilitated by a relatively electron-rich aromatic ring and the amide-
based directing group. 
 
Scheme 131: Proposed transformation of cyclobutane 544 to cyclopentanone 545. 
The first synthetic pathway to 544 was via acid intermediate 550 and is depicted in Scheme 
132A. 1,3-Dihalogenated alkane 548, which was synthesised from 3-chloropropiophenone 546 via 
alcohol 547 according to a literature procedure,241 was used for sequential alkylation of dimethyl 
malonate. This delivered diester 549 in 52% yield, which is equivalent to a 39% yield for 549 over 
three steps. This was followed by Krapcho decarboxylation to afford ester 550 as a 1.6:1 mixture 
of diastereomers. The poor diastereoselectivity and lower overall yield made the approach outlined 
in Scheme 132A unfavourable. An alternative synthetic pathway was then used; here, 
dicarboxylate precursor 549 was accessed in 61% yield by employing a [2+2] cycloaddition 
protocol (Scheme 132B, cf. 39% yield of 549 over three steps, Scheme 132A).242 Saponification 
of ester 549 and thermally promoted decarboxylation of the corresponding diacid 551 gave 
trans-552. Subsequent Curtius rearrangement of acid 552 delivered N-Boc aminocyclobutane 553. 
Finally, Boc-deprotection and acylation with benzoyl chloride provided target cyclobutane 544 in 
47% yield. Unfortunately, despite trialling a number of Rh-catalysed carbonylation conditions, 
cyclobutane 544 did not deliver C-C bond activation derived products such as 545 and only starting 
material was observed (Scheme 132C). 
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Scheme 132: (A) Initial approach towards 550. Reagents and conditions: (i) NaBH4, MeOH, 0 °C, 30 min; (ii) HBr, 
H2O, r.t., 3 h; (iii) dimethyl malonate, NaH, 1,4-dioxane, reflux, 18 h; (iv) LiCl, H2O, DMSO, 180 °C, 2 h. (B) An 
alternative synthesis of cyclobutane benzamide 544. Reagents and conditions: (v) dry ZnBr2, DCM, -130 to -78 °C, 3 
h; (vi) KOH, 1,4-dioxane: H2O 1:1, reflux, 80 °C, 4 h; (vii) DMF, reflux, 3 h; (viii) diphenylphosphoryl azide, NEt3, 
t-BuOH, 80 °C, 17 h; (ix) (a) TFA, DCM, r.t., then (b) BzCl, TEA, DCM, 0 °C to r.t., 16 h. (C) Attempted C-C bond 
activation of 544.  
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6.5  Combining the C-C bond activation of cyclopropanes with ring-opening 
of larger carbocycles 
 
6.5.1 Known methods for β-carbon elimination in cyclobutanes 
As described in Sections 6.2-6.4, little to no reactivity was observed when direct C-C bond 
activations of cyclobutanes were attempted. However, β-carbon elimination is a well-known 
process for ring-opening cyclobutanes, with cyclobutanol being the most common unit employed 
in such reactions.243-250 The commonly accepted mechanism of this ring opening involves ligand 
exchange between cyclobutanol 554 and the catalyst to give 555 (Scheme 133A). Alkoxide 555 
then undergoes C-C bond cleavage by β-carbon elimination to generate intermediate 556, which 
is able to engage in subsequent processes. In certain cases, defined quaternary stereocentres can 
be generated if a chiral ligand is used. For example, Cramer and Seiser showed that the 
enantioselective generation of ketones 557 is possible using a [Rh(OH)(cod)]2/DTBM-SEGPHOS 
system (Scheme 133B).244 Deuterium labelling studies demonstrated that methyl substituted 
ketones 557 are obtained via protonation of Rh-enolate 558 rather than via direct 
protodemetallation of alkyl-metal intermediate 556. Another example is depicted in Scheme 133C. 
Based on earlier works on the synthesis of indanols,245,246 Cramer and co-workers developed247 an 
asymmetric synthesis of indanones, such as 559. This process uses two consecutive β-carbon 
eliminations. First, cyclobutanol ring-opening gives 560, which undergoes a [1,4]-Rh shift and 
intramolecular 1,2-addition to yield alkoxide 561. A second β-carbon elimination forms 559 and 
Rh-thienyl species 562, which likely undergoes protodemetallation to regenerate the active 
catalyst. 
  




Scheme 133: (A) β-Carbon elimination triggered ring opening of cyclobutanols; (B) Enantioselective synthesis of 
linear compounds with methyl substituted quaternary centres; (C) Enantioselective synthesis of indanones.  
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6.5.2 Studies on C-C bond activation-triggered β-carbon elimination 
Taking the previous developments in the area into account, a novel method was proposed 
which combines C-C bond activation and β-carbon elimination. Cyclopropyl cyclobutane 563 was 
considered a suitable starting material to form rhodacyclobutane 564 or rhodacyclopentanone 565 
(Scheme 134A). It was thought that either of these intermediates might undergo β-carbon 
elimination of the strained 4-membered ring in advance of C-C reductive elimination to enamide 
566 or 567. 
The synthesis of 563 started with the formation of racemic Ellman's sulfinamide 568 from 
cyclobutanone (Scheme 134B).251,252 Vinyl Grignard addition to 568 gave vinyl cyclobutane 569, 
which underwent quantitative deprotection (HCl, MeOH) to give amine 570 as its HCl salt. 
Following this, a reductive amination-acylation sequence furnished N-benzyl acetamide 571 in 
87% yield. Various methods for Simmons-Smith cyclopropanation253-255 of 571 were trialled. 
Under certain conditions 563 was observed, but the reaction was extremely sensitive to scale, 
difficult to purify and full conversion of 571 to cyclopropane 563 could not be achieved. 
Concurrently, cyclopropyl cyclopentane 572 was made to see whether the C-C bond 
activation/β-carbon elimination strategy is feasible for five-membered rings (Scheme 134C). The 
route commenced with the addition of lithiated cyclopropane to cyclopentanone to give tertiary 
alcohol 573 in 61% yield. Nucleophilic substitution of the alcohol with sodium azide afforded 573, 
which was immediately reduced using LiAlH4.
256 The resulting crude amine 574 was then reacted 
with benzoyl chloride to provide amide 575 in 23% yield over the three steps. When cyclopropane 
575 was subjected to Rh-catalysed carbonylative conditions ([Rh(cod)2]OTf/P(3,4,5-(F)3C6H2)3, 
1,2-DCB, 1 atm. CO, 110 °C), no evidence for the C-C bond activation triggered ring-opening 
cascade could be obtained. Instead, benzamide 576 formed in quantitative yield. It is unclear at 
which stage of the catalytic cycle the reaction fails. One of the possibilities is that the C1-N2 bond 
undergoes facile cleavage under the reaction conditions due to the formation of a relatively stable 
tertiary cyclopentyl carbocation. This explanation is supported by the successful SN1-type 
transformation of alcohol 572 to azide 573, which presumably proceeds via acid-promoted 
formation of a cyclopropane-stabilised tertiary carbocation. 
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Scheme 134: (A) Proposed reactivity mode for cyclobutane 563; (B) Attempted synthesis of aminocyclobutane 563; 
(C) Synthesis and reactivity of cyclopentane 575. Reagents and conditions: (i) t-Butanesulfinamide, Ti(OEt)4, THF, 
r.t., 18 h; (ii) vinylmagnesium bromide, THF, -78 °C to r.t., 18 h; (iii) HCl, MeOH, Et2O, 0 °C to r.t., 1 h; (iv) (a) 
benzaldehyde, NaHCO3, MeOH, reflux, 3 h; (b) NaBH4, 0 °C to r.t., 4 h; (c) acetic anhydride, TEA, DCM, 0 °C to 
r.t., 16 h; (v) Et2Zn, CH2I2, DCE or Et2Zn, CH2I2, TFA, DCM; (vi) cyclopropyl bromide, t-BuLi, Et2O, -78 °C, 4 h 
then r.t., 18 h; (vii) NaN3, TFA, PhMe, 0 °C, 4 h; (viii) LiAlH4, THF, 0 °C to rt, 16 h then 50 °C, 1 h; (ix) benzoyl 
chloride, TEA, DCM, 0 °C to r.t., 16 h. 
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6.6 Conclusions 
4-Membered rings are considerably more challenging systems for C-C bond activation than 
cyclopropanes. In particular, such process have not previously been demonstrated for relatively 
unstrained all sp3-hybridised cyclobutanes. Inspired by this deficiency, studies have been 
undertaken to assess whether cyclopentanones can be accessed by carbonylative C-C bond 
activation of cyclobutanes. A donor-acceptor cyclobutane, aminocyclobutanes bearing N-based 
directing groups, and an arene activated cyclobutane were synthesised (Scheme 135). These were 
subjected to a range of carbonylative C-C bond activation conditions, but, in most cases, the 
cyclobutanes remained unreacted and the target cyclopentanones were not observed. An 
alternative β-carbon elimination approach to the ring-opening of small carbocycles was also 
unsuccessful. 
 




Overall summary and conclusions 
The work presented in this thesis has established several C-C bond activation 
methodologies. Chapter 2 summarises the development of a ring contraction cascade to access 
diverse γ-lactams from aminocyclopropanes (Scheme 136A). Unlike the previously known 
methods for directed oxidative addition of transition metals to aminocyclopropanes, this 
transformation uses an isocyanate-based temporary directing group which can easily be installed 
in a one-pot manner. Chapter 3 investigates new systems for nucleophilic additions to 
rhodacyclopentanones (Scheme 136B). Substrates with aniline-based nucleophiles were identified 
as promising precursors to 8-membered heterocycles; several alternative substrates with pendent 
nucleophiles were trialled with limited success. Studies in Chapter 4 resulted in the discovery of a 
novel asymmetric (3+1+2) cycloaddition between aminocyclopropanes, CO and tethered π-
unsaturates (Scheme 136C). This transformation constitutes the first highly enantioselective 
aminocyclopropane-based C-C bond activation methodology. The identified catalytic system is 
expected to encourage further development of asymmetric C-C bond activations in Bristol. 
 
Scheme 136 
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Chapter 5 demonstrates unique examples of processes where aminomethylcyclopropane 
C-C bond activation leads to rhodacyclohexanone intermediates (Scheme 137A). These undergo 
reductive elimination to provide α-aminocyclopentanones, which were employed in tandem and 
cascade processes to obtain distinct polycyclic products. Finally, the possibility of 
aminocyclobutane C-C bond activation was investigated in Chapter 6 with a variety of systems 
(Scheme 137B). Unfortunately, the desired reactivity was not observed and the cyclobutanes 
remained mainly unreacted. Nonetheless, these studies demonstrated that several cyclobutane-
based systems are not suitable, and the results will guide further efforts in this area. 
 
Scheme 137 
To summarise, this thesis has advanced the field of C‑C bond activation through studies on 
the chemistry of aminocyclopropanes and related strained ring systems. The developed 
methodologies offer efficient and atom-economical entries to complex heterocyclic scaffolds, and 
highlight the power of using C-C bond activation of cyclopropanes as a by-product free reaction 
initiation mode. The new methods provide compounds that are challenging to synthesise using 
conventional approaches. A particular highlight of the work described here is the realisation of 
enantioselective carbonylative C-C bond activations of aminocyclopropane-based substrates. This 
will set the stage for future studies that harness cyclopropanes as readily available C3 units for 






8.1 General experimental details 
All materials for which a synthetic route is not described or referenced were purchased 
from commercial sources (Sigma-Aldrich, Alfa Aesar, Fluorochem and Strem) and used as 
received unless otherwise stated. Anhydrous solvents were obtained by distillation using standard 
procedures or by passage through drying columns supplied by Anhydrous Engineering Ltd. The 
removal of solvents in vacuo was achieved using both a Büchi rotary evaporator (bath temperatures 
up to 40 °C) at a pressure of either 15 mmHg (diaphragm pump) or 0.1 mmHg (oil pump), as 
appropriate, and a high vacuum line at room temperature. Catalytic reactions were carried out 
inside oven/flame dried glass reaction tubes equipped with a Suba-Seal® and a balloon of inert gas 
(or carbon monoxide in the case of carbonylation reactions). Petrol refers to petroleum ether 
consisting of aliphatic hydrocarbons boiling in the range 40–60 °C. Flash column chromatography 
(FCC) was performed using silica gel (Aldrich 40-63 µm, 230-400 mesh). Thin layer 
chromatography was performed using aluminium backed 60 F254 silica plates. Visualisation was 
achieved by UV fluorescence or a basic KMnO4 solution and heat. Proton nuclear magnetic 
resonance spectra (NMR) were recorded on the following spectrometers: JEOL ECS400, JEOL 
ECZ400, Varian 400-MR, Bruker Nano400, Varian VNMR 500, and Bruker Avance III HD 500 
Cryoprobe. 1H NMR spectra were recorded at 400 MHz or 500 MHz as stated. 13C NMR spectra 
were recorded at 101 MHz or 126 MHz as stated. Chemical shifts (δ) are given in parts per million 
(ppm). Peaks are described as singlets (s), doublets (d), triplets (t), quartets (q), septets (sept), 
multiplets (m) and broad (br.). Coupling constants (J) are quoted to the nearest 0.5 Hz. All 
assignments of NMR spectra were based on 2D NMR data (COSY, HSQC, HMBC, TOCSY, and 
nOe experiments where appropriate). Where compounds were isolated as a mixture of isomers 
(e.g. rotamers), they are referred as A and B. NMR yields were determined by employing 1,4-
dinitrobenzene as an internal standard. Mass spectra were recorded using the following 
instruments: Bruker Daltonics FT-ICR-MS Apex 4e 7.0T FT-MS or Bruker Daltonics micrOTOF 
II (ESI), Shimadzu GCMS QP2010+ or Thermo Scientific Orbitrap Elite (EI), Bruker 
ultrafleXtreme 2 (MALDI), Thermo Scientific Orbitrap Elite (APCI) and Waters Synapt G2S 
(Nanospray). Infrared spectra were recorded on a Perkin Elmer Spectrum Two FT-IR spectrometer 
as thin films or solids compressed on a diamond plate. Melting points were determined using 
Reichert melting point apparatus. Optical rotations were measured using an ADP440+ polarimeter 
at the concentration and temperature stated. Enantiomeric excess was determined using an Agilent 
1290 Infinity chiral SFC under the conditions noted for each compound.  
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8.2 General procedures 
 
General procedure A for the N-alkylation of primary amines 
To a reaction tube containing the appropriate tosylate (1.00 eq) in MeCN (0.4 M) was added 
cyclopropylamine (4.00 eq). The tube was sealed and heated to reflux for 16 h. The reaction 
mixture was cooled to r.t. and concentrated in vacuo. Sat. aq. NaHCO3 (10 mL/mmol) and DCM 
(5 mL/mmol) were added, the layers were separated and the aqueous portion was further extracted 
with DCM (2 × 5 mL/mmol). The organic extracts were combined, dried over MgSO4 and 
concentrated in vacuo. The residue was purified by flash column chromatography, under the 
conditions noted, to afford the desired N-substituted amine. 
General procedure B for tosylation of alcohols 
To a solution of alcohol (1.00 eq) in DCM (0.5 M) was added Et3N (1.20 eq), DMAP (0.20 eq) 
and TsCl (1.20 eq) at 0 °C. The reaction was warmed to r.t. and stirred for 16 h. Water (5 
mL/mmol) was added and the solution was extracted with DCM (3 × 5 mL/mmol). The organic 
extracts were combined, washed with brine (5 mL/mmol), dried over MgSO4 and concentrated in 
vacuo. The residue was purified by flash column chromatography, under the conditions noted, to 
provide the desired tosylate. 
General Procedure C for the traceless directing group enabled C-C activation of 
aminocyclopropanes 
To an oven dried reaction tube, fitted with a magnetic stirrer, was added amine substrate (100 
mol%), cyclohexyl isocyanate (100 mol%) and anhydrous 1,2-DCB (0.10 M) under argon. The 
mixture was then heated at 80 °C for 3 hours. The reaction was cooled to room temperature, 
[Rh(cod)2]OTf (7.5 mol%), PPh3 (15 mol%), 4-(dimethylamino)benzoic acid (15 mol%) and 
anhydrous 1,2-DCB (0.05 M) were added to the tube under argon. The reaction vessel was purged 
with CO for 10 minutes and then the solution was sparged with CO for approx. 20 seconds. The 
mixture was heated at 130 °C for 72 hours, under a CO atmosphere (1 atm). The mixture was 
cooled to room temperature, concentrated in vacuo and the residue was purified by flash column 
chromatography, under the conditions noted, to afford the desired product. 
General Procedure D for preparation of protected amines 
To a stirring solution of cyclopropylamine (1.00 eq) and NEt3 (1.20 eq) in DCM (0.20 M) was 
added the corresponding acid chloride/sulfonyl chloride/anhydride (1.20 eq) dropwise at 0 °C over 
a period of 10 minutes under an atmosphere of nitrogen. The mixture was warmed to r.t. and for 
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18 h. The mixture was diluted with water (10 mL/mmol) and extracted with DCM (3 × 10 
mL/mmol). The organic extracts were combined, washed with brine (10 mL/mmol), dried over 
MgSO4 and concentrated in vacuo. Purification of the residue by flash column chromatography, 
under the conditions noted, afforded the corresponding substituted amine. 
General procedure E for the alkylation of anilines with 2-bromoacetamide-substituted 
substrates 
A solution of the specified 2-bromoacetamide (1.00 eq), specified aniline (5.00 eq) and K2CO3 
(1.20 eq) in toluene (1.0 M) was heated at 90 °C for 5 h. The reaction mixture was concentrated in 
vacuo and then sat. aq. NaHCO3 (10 mL/mmol) was added. The solution was extracted with EtOAc 
(3 × 5 mL/mmol) and then the organic extracts were combined, washed with brine (5 mL/mmol), 
dried over MgSO4 and concentrated in vacuo. The residue was purified by recrystallisation or by 
flash column chromatography, under the conditions noted, to afford the title compound. 
 
General procedure F for carbonylative ring expansions of aniline tethered 
aminocyclopropane substrate 
An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate (100 mol%), [Rh(cod)Cl]2 (5 mol%) and dimethyl fumarate (100 mol%). The tube was 
fitted with a rubber septum and purged with argon. Anhydrous PhCN (0.1 M) was added via 
syringe. The reaction mixture was sparged with CO for approx. 10 seconds, then heated at 150 °C 
under a CO atmosphere (1 atm) for 72 h. The mixture was cooled to r.t., concentrated in vacuo and 
purified by flash column chromatography, under the conditions noted, to afford the title compound. 
 
General procedure G for the amide coupling with EDCI 
To a solution of acid (1.00 eq) in DCM (0.3 M), EDCI (1.10 eq) was added at 0 °C and the reaction 
was stirred for 10 min. Then, the specified amine (1.00 eq) and DMAP (10 mol%) were added at 
0 °C and the reaction was slowly warmed to r.t., stirred for 18 h and then concentrated in vacuo. 
1.0 M aq. NaOH (5 mL/mmol) was added and the solution was extracted with EtOAc (3 × 3 
mL/mmol). The organic extracts were combined, washed with 1.0 M aq. HCl (5 mL/mmol) and 
brine (5 mL/mmol), dried over MgSO4 and concentrated in vacuo. The product was purified by 
flash column chromatography, under the conditions noted, to afford the target amide. 
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General procedure H for the preparation of aryl-substituted alkyne substrates via 
Sonogashira reaction 
An oven-dried reaction tube, fitted with a magnetic stirrer, was charged with terminal alkyne (1.00 
eq) and aryl halide (1.10-1.20 eq as noted). The tube was fitted with a rubber septum and purged 
with argon. Anhydrous Et3N (1.0 M) was added and the solution was sparged with argon for 
approx. 5 min. Pd(PPh3)4 (2 mol%) and CuI (2 mol%) were added, the tube was sealed and stirred 
(at r.t., 60 or 80 °C as noted) for 2-16 h. The mixture was concentrated in vacuo. The residue was 
purified by flash column chromatography, under the conditions noted, to afford the desired aryl-
substituted alkyne. 
 
General procedure I for carbonylative ring expansion of protected alkynyl 
aminocyclopropanes to cyclohexenones 
An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate (100 mol%), PPh3 (10 mol%) and [Rh(cod)2]OTf (5 mol%). The tube was fitted with a 
rubber septum, evacuated and backfilled with nitrogen three times and anhydrous 1,2-DCB (0.1 
M) was added via syringe. The reaction mixture was sparged with CO for approx. 10 seconds, then 
heated at 130 °C under a CO atmosphere (1 atm, balloon) for 48 h. The mixture was cooled to r.t., 
concentrated in vacuo and purified by flash column chromatography, under the conditions noted, 
to afford the target cyclohexenone. 
 
General procedure J for asymmetric carbonylative ring expansion of protected alkynyl 
aminocyclopropanes to cyclohexenones 
An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate (100 mol%) and [Rh(cod)2]OTf (7.5 mol%). In the glovebox, (S)-SITCP (15 mol%) was 
added. The tube was fitted with a rubber septum, taken out of the glovebox and anhydrous 1,2-
DCB (0.1 M) was added via syringe. The reaction mixture was sparged with CO for ca. 10 seconds, 
then heated at 110 °C under a CO atmosphere (1 atm, balloon) for 96 h. The mixture was cooled 
to r.t., concentrated in vacuo and purified by flash column chromatography, under the conditions 
noted, to afford the target cyclohexenone. 
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General procedure K for the reduction of amides by LiAlH4 
A solution of LiAlH4 in THF (1.0 M, 1.50 eq) was added dropwise to a solution of amide (1.00 
eq) in dry THF (0.50 M) over a period of 5 mins at 0 °C. The mixture was warmed to r.t. and then 
heated to reflux for 16 h. The reaction was diluted with Et2O, cooled to 0 °C and subsequently 
quenched with H2O (0.04 mL per mmol of LiAlH4), 15% NaOH (0.04 mL per mmol of LiAlH4) 
and H2O (3 × 0.04 mL per mmol of LiAlH4). The crude mixture was warmed to r.t. and stirred for 
10 min. Anhydrous magnesium sulphate was added and the solution was stirred for 5 min. The 
precipitate was filtered off and the resulting solution was concentrated in vacuo to yield title 
compound. 
 
General procedure L for the synthesis of primary amides from carboxylic acids 
To a solution of carboxylic acid (1.00 eq) in DCM (0.5 mL/mmol), stirring under a nitrogen 
atmosphere at room temperature, oxalyl chloride (2.00 eq) was added dropwise. Evolution of gas 
was immediately observed and the reaction was stirred until gas effervescence stopped. DCM and 
an excess of oxalyl chloride were removed in vacuo and the corresponding acyl chlorides were 
used in the next step without purification. Ammonia was bubbled through the solution of the acyl 
chloride (1.00 eq) in dry THF (0.3 mL/mmol) at 0 °C stirring under a nitrogen atmosphere for 15 
minutes. The solvent was removed in vacuo and the resulting precipitate was washed abundantly 
with water. 
 
General procedure M for the synthesis of N, N-disubstituted amides via a two-step reductive 
amination-protection method 
A solution of primary amine (1.00 eq), aldehyde (1.05 eq) and NaHCO3 (1.5 eq) in MeOH (0.5 
M) was heated at 40 °C for 3 h. The reaction mixture was cooled to 0 °C and NaBH4 (1.50 eq. or 
2.00 eq) was added portionwise. The solution was warmed to r.t. and stirred for 4 h. The reaction 
mixture was concentrated in vacuo and then sat. aq. NaHCO3 (10 mL/mmol) was added. The 
solution was extracted with DCM (3 × 5 mL/mmol) and then the organic extracts were combined, 
washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo to afford the secondary 
amine intermediate. To a stirring solution of secondary cyclopropylmethylamine (1.00 eq) in dry 
DCM (3 mL/mmol), TEA (1.20 eq) and a corresponding acid chloride/anhydride (1.20 eq) were 
added at 0 °C under nitrogen. The solution was warmed to r.t. and stirred for 16 h. Sat. aq. NaHCO3 
(10 mL/mmol) was added and the aqueous layer was extracted with DCM (3 × 5 mL/mmol). The 
combined organic extracts were washed with brine (10 mL/mmol), dried over MgSO4 and 
concentrated in vacuo. The product was purified by flash column chromatography, under the 
conditions noted, to afford the title compound. 
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General Procedure N for Rh-catalysed carbonylative rearrangement of amide protected 
methylaminocyclopropanes to cyclopentanones 
An oven dried reaction tube, fitted with a magnetic stirrer, was charged with the starting material 
(1.00 eq), benzoic acid (20 mol%), Rh catalyst (7.5 mol%) and ligand (15 mol%). The tube was 
fitted with a rubber septum and purged with argon. Dry and degassed 1,2-DCB (1.5 M) was added 
via syringe. The reaction mixture was sparged with CO for approximately 10 seconds, then heated 
to the specified temperature under a CO atmosphere (1 atm) for the specified reaction time (18 – 
48 h as noted). The mixture was cooled to r.t., concentrated in vacuo and purified by silica gel 
column chromatography, under the conditions noted. 
 
General procedure O for Buchwald–Hartwig amination 
A flame dried reaction tube, fitted with a magnetic stirrer, was charged with sodium tert-amoxide 
(1.50 eq), Pd2(dba)3 (0.01 eq) and BrettPhos (0.03 eq). The tube was fitted with a rubber septum 
and purged with argon. Anhydrous toluene (2 mL/mmol) followed by aromatic halide (1.00 eq) 
and amine of choice (1.20 eq) were then added to the reaction mixture. The tube was sealed and 
heated at 80 °C for 16 h. The reaction mixture was cooled to r.t., diluted with diethyl ether, filtered 
through a pad of silica and concentrated in vacuo. The residue was purified by flash column 
chromatography, under the conditions noted, to afford the title compound. 
 
General procedure P for the N-alkylation of secondary amides 
To a solution of NaH (2.00 eq, 60 % dispersion in mineral oil) in THF (1.0 M) was added a solution 
of protected aminomethylcyclopropane (1.00 eq) of choice in THF (2.0 M) at 0 °C and the reaction 
was stirred at r.t. for 1 h. Cyclopropylmethyl bromide (2.00 eq ) was added dropwise over 5 
minutes and the reaction was heated to 50 °C for 18 h. Water (5 mL/mmol) was added and the 
mixture was extracted with Et2O (3 × 2 mL/mmol). The organic extracts were combined, washed 
with brine (5 mL/mmol), dried over MgSO4 and concentrated in vacuo. The residue was purified 
by column chromatography under the conditions noted to yield the desired product. 
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General procedure A: 4-(4-Methoxyphenyl)but-3-yn-1-yl 4-methylbenzenesulfonate (1.98 g, 
6.00 mmol, prepared according to the literature procedure257 from 4-iodoanisole and 3-butyn-1-ol) 
was employed. Flash column chromatography (50% EtOAc/hexane) afforded the title compound 
119a (0.83 g, 64%) as a pale yellow oil; νmax / cm
-1: 2932 (w), 2836 (w), 1606 (m), 1508 (s), 1288 
(m), 1243 (s), 1172 (m), 1032 (m), 830 (s); 1H NMR (CDCl3, 400 MHz): δ 7.36 – 7.32 (m, 2H, 2 
× C4-H), 6.84 – 6.79 (m, 2H, 2 × C3-H), 3.80 (s, 3H, C1-H3), 2.92 (t, J = 6.6 Hz, 2H, C9-H2), 2.60 
(t, J = 6.6 Hz, 2H, C8-H2), 2.19 (tt, J = 6.6, 3.6 Hz, 1H, C11-H), 1.88 (br. s, 1H, N10-H), 0.48 – 
0.41 (m, 2H, C12-H2), 0.40 – 0.34 (m, 2H, C12-H2); 
13C NMR (CDCl3, 101 MHz): δ 159.3 (C2), 
133.1 (C4), 115.9 (C5), 113.9 (C3), 86.5 (C7), 81.6 (C6), 55.4 (C1), 48.1 (C9), 29.9 (C11), 20.6 





General procedure A: 4-(4-Fluorophenyl)but-3-yn-1-yl 4-methylbenzenesulfonate (1.91 g, 6.00 
mmol, prepared according to the literature procedure257 from 4-fluoroiodobenzene and 3-butyn-1-
ol) was employed. Flash column chromatography (40% EtOAc/hexane) afforded the title 
compound 119b (0.82 g, 67%) as a pale yellow oil; νmax / cm
-1: 2928 (m), 1506 (s), 1220 (s), 1156 
(m), 1093 (m), 1014 (m), 834 (s); 1H NMR (CDCl3, 400 MHz): δ 7.40 – 7.34 (m, 2H, 2 × C4-H), 
7.02 – 6.94 (m, 2H, 2 × C3-H), 2.92 (t, J = 6.7 Hz, 2H, C9-H2), 2.60 (t, J = 6.6 Hz, 2H, C8-H2), 
2.19 (tt, J = 6.6, 3.6 Hz, 1H, C11-H), 1.87 (br. s, 1H, N10-H), 0.49 – 0.43 (m, 2H, C12-H2), 0.40 
– 0.34 (m, 2H, C12-H2); 
13C NMR (CDCl3, 101 MHz): δ 162.3 (d, J = 248.2 Hz, C2), 133.5 (d, J 
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= 8.2 Hz, C4), 119.9 (d, J = 3.4 Hz, C5), 115.6 (d, J = 22.1 Hz, C3), 87.9 (d, J = 1.4 Hz, C7), 80.8 
(C6), 48.0 (C9), 29.8 (C11), 20.6 (C8), 6.5 (C12); 19F NMR (CDCl3, 376 MHz): -111.87 (tt, J = 





General procedure A: 4-(naphthalen-1-yl)but-3-yn-1-yl 4-methylbenzenesulfonate (2.10 g, 6.00 
mmol, prepared according to the literature procedure257 from 1-iodonaphthalene and 3-butyn-1-ol) 
was employed. Flash column chromatography (30-40% EtOAc/hexane) afforded the title 
compound 119c (0.70 g, 50%) as a pale yellow oil; νmax / cm
-1: 3006 (m), 2926 (m), 2830 (m), 
2222 (w), 1586 (m), 1396 (m), 1015 (m), 799 (s), 773 (s); 1H NMR (CDCl3, 400 MHz): δ 8.33 (d, 
J = 8.2 Hz, 1H, C2-H), 7.84 (d, J = 7.9 Hz, 1H, C5-H), 7.79 (d, J = 8.3 Hz, 1H, C7-H), 7.64 (d, J 
= 7.1 Hz, 1H, C9-H), 7.58 – 7.48 (m, 2H, C3-H and C4-H), 7.40 (t, J = 7.7 Hz, 1H, C8-H), 3.05 
(t, J = 6.6 Hz, 2H, C14-H2), 2.79 (t, J = 6.6 Hz, 2H, C13-H2), 2.26 (tt, J = 6.6, 3.6 Hz, 1H, C16-
H), 1.85 (br. s, 1H, N15-H), 0.52 – 0.45 (m, 2H, C17-H2), 0.44 – 0.38 (m, 2H, C17-H2); 
13C NMR 
(CDCl3, 101 MHz): δ 133.6, 133.3 (C1 and C6), 130.3 (C9), 128.4 (C5), 128.3 (C7), 126.7, 126.4 
(C3 and C4), 126.4 (C2), 125.3 (C8), 121.5 (C10), 93.3 (C12), 79.9 (C11), 48.2 (C14), 29.9 (C16), 





A solution containing but-3-yn-1-ol 120 (1.51 mL, 20 mmol) and 3-bromothiophene (2.06 mL, 22 
mmol) in dry triethylamine (25 mL) was purged with argon. Pd(PPh3)2Cl2 (280.8 mg, 0.4 mmol) 
and CuI (76.2 mg, 0.4 mmol) were added and the solution was heated to 60 °C for 16 h. The 
reaction mixture was cooled to r.t., filtered through Celite® and silica gel with DCM and 
concentrated in vacuo. The residue was purified by flash column chromatography (10-20% 
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EtOAc/hexane) to afford the alcohol (2.44 g, 80%) as a yellow oil; νmax / cm
-1: 3362 (m), 3106 
(m), 2885 (m), 1668 (m), 1413 (m), 1046 (s), 782 (s); 1H NMR (CDCl3, 400 MHz): δ 7.39 (dd, J 
= 3.0, 1.2 Hz, 1H, C1-H), 7.24 (dd, J = 5.0, 3.0 Hz, 1H, C2-H), 7.08 (dd, J = 5.0, 1.2 Hz, 1H, C3-
H), 3.80 (t, J = 6.2 Hz, 2H, C8-H2), 2.67 (t, J = 6.2 Hz, 2H, C7-H2), 1.84 (br. s, 1H, O9-H); 
13C 
NMR (CDCl3, 101 MHz): δ 130.1 (C3), 128.4 (C1), 125.3 (C2), 122.4 (C4), 86.0 (C6), 77.7 (C5), 
61.3 (C8), 23.9 (C7). The spectroscopic properties of this compound were consistent with the data 
available in the literature.258 
 
4-(Thiophen-3-yl)but-3-yn-1-yl 4-methylbenzenesulfonate (119d') 
 
General procedure B: 4-(Thiophen-3-yl)but-3-yn-1-ol (2.44 g, 16.03 mmol) was employed. 
Flash column chromatography (100% toluene) afforded the tosylate (3.12 g, 99%) as an off-white 
solid; m.p. 51-53 °C (DCM); νmax / cm
-1: 2959 (w), 1356 (s), 1189 (s), 1172 (s), 973 (s), 897 (s), 
782 (s), 763 (s); 1H NMR (CDCl3, 400 MHz): δ 7.84 – 7.79 (m, 2H, 2 × C10-H), 7.35 – 7.29 (m, 
3H, 2 × C11-H and C1-H), 7.23 (dd, J = 5.0, 3.0 Hz, 1H, C2-H), 7.01 (dd, J = 5.0, 1.2 Hz, 1H, C3-
H), 4.17 (t, J = 7.1 Hz, 2H, C8-H2), 2.76 (t, J = 7.1 Hz, 2H, C7-H2), 2.43 (s, 3H, C13-H3); 
13C 
NMR (CDCl3, 101 MHz): δ 145.1 (C9), 133.0 (C12), 130.0, 130.0 (C3 and C11), 128.7 (C1), 
128.1 (C10), 125.3 (C2), 122.1 (C4), 83.5 (C6), 77.9 (C5), 67.8 (C8), 21.8 (C13), 20.5 (C7); 





General procedure A: 4-(Thiophen-3-yl)but-3-yn-1-yl 4-methylbenzenesulfonate 119d' (1.53 g, 
5.00 mmol) was employed. Flash column chromatography (30-40% EtOAc/ hexane) afforded the 
title compound 119d (0.56 g, 58%) as a pale yellow oil; νmax / cm
-1: 2926 (m), 1435 (m), 1346 (s), 
1013 (s), 778 (s); 1H NMR (CDCl3, 500 MHz): δ 7.36 (dd, J = 3.0, 1.2 Hz, 1H, C1-H), 7.23 (dd, J 
= 5.0, 3.0 Hz, 1H, C2-H), 7.08 (dd, J = 5.0, 1.2 Hz, 1H, C3-H), 2.92 (t, J = 6.7 Hz, 2H, C8-H2), 
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2.60 (t, J = 6.7 Hz, 2H, C7-H2), 2.19 (tt, J = 6.6, 3.6 Hz, 1H, C10-H), 1.87 (br. s, 1H, N9-H), 0.48 
– 0.42 (m, 2H, C11-H2), 0.38 – 0.34 (m, 2H, C11-H2); 
13C NMR (CDCl3, 126 MHz): δ 130.1 (C3), 
128.0 (C1), 125.2 (C2), 122.8 (C4), 87.8 (C6), 76.8 (C5), 48.0 (C8), 29.8 (C10), 20.6 (C7), 6.5 





General procedure C: N-(4-(4-Methoxyphenyl)but-3-yn-1-yl)cyclopropanamine 119a (32.3 mg, 
0.15 mmol) and cyclohexyl isocyanate (19 µL, 0.15 mmol) were employed. Flash column 
chromatography (10% MeCN/DCM) afforded the title compound 121a (27.3 mg, 75%) as a pale 
brown oil; νmax / cm
-1: 2938 (w), 1699 (s), 1606 (m), 1512 (s), 1406 (m), 1249 (s), 1177 (m); 1H 
NMR (CDCl3, 500 MHz): δ 7.22 (d, J = 8.8 Hz, 2H, 2 × C10-H), 6.88 (d, J = 8.8 Hz, 2H, 2 × C11-
H), 6.27 (dd, J = 2.5, 2.5 Hz, 1H, C8-H), 4.55 (td, J = 7.6, 1.9 Hz, 1H, C7-H), 4.03 (ddd, J = 11.8, 
7.4, 4.6 Hz, 1H, C3-HaHb), 3.81 (s, 3H, C13-H3), 3.15 – 3.03 (m, 1H, C3-HaHb), 2.93 – 2.85 (m, 
2H, C2-H2), 2.73 (dddd, J = 16.5, 10.9, 8.9, 1.4 Hz, 1H, C5-HaHb), 2.52 (dddd, J = 12.5, 9.2, 7.3, 
1.9 Hz, 1H, C6-HaHb), 2.42 (ddd, J = 16.5, 9.2, 2.0 Hz, 1H, C5-HaHb), 1.93 (dddd, J = 12.5, 10.9 
9.5, 7.6 Hz, 1H, C6-HaHb); 
13C NMR (CDCl3, 126 MHz): δ 175.6 (C4), 158.6 (C12), 140.5 (C1), 
129.9 (C9), 129.6 (C10), 121.7 (C8), 114.0 (C11), 65.0 (C7), 55.4 (C13), 41.7 (C3), 34.1 (C5), 
31.7 (C2), 28.1 (C6); HRMS: (ESI+) calculated for C15H18NO2: 244.1332, found [M+H]
+: 
244.1333. This compound is unstable and was stored as a frozen matrix in benzene. 
  




General procedure C: N-(4-(4-Fluorophenyl)but-3-yn-1-yl)cyclopropanamine 119b (30.5 mg, 
0.15 mmol) and cyclohexyl isocyanate (19 µL, 0.15 mmol) were employed. Flash column 
chromatography (10% MeCN/DCM) afforded the title compound 119b (23.3 mg, 67%) as a pale 
brown oil; νmax / cm
-1: 2932 (w), 1691 (s), 1601 (m), 1508 (s), 1407 (m), 1224 (s), 1159 (m), 832 
(m); 1H NMR (CDCl3, 400 MHz): δ 7.23 (dd, J = 8.5, 5.0 Hz, 3H, 2 × C10-H), 7.07 – 6.99 (m, 
2H, 2 × C11-H), 6.29 (d, J = 2.7 Hz, 1H, C8-H), 4.55 (t, J = 7.6 Hz, 1H, C7-H), 4.04 (ddd, J = 
11.8, 7.0, 4.8 Hz, 1H, C3-HaHb), 3.15 – 3.03 (m, 1H, C3-HaHb), 2.91 – 2.83 (m, 2H, C2-H2), 2.73 
(ddd, J = 16.5, 9.9, 9.5 Hz, 1H, C5-HaHb), 2.58 – 2.47 (m, 1H, C6-HaHb), 2.42 (ddd, J = 16.5, 9.4, 
1.9 Hz, 1H, C5-HaHb), 1.99 – 1.86 (m, 1H, C6-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 175.6 (C4), 
161.70 (d, J = 247.3 Hz, C12), 142.6 (C1), 133.2 (d, J = 3.2 Hz, C9), 129.9 (d, J = 8.0 Hz, C10), 
121.2 (C8), 115.5 (d, J = 21.5 Hz, C11), 64.9 (C7), 41.7 (C3), 34.0 (C5), 31.7 (C2), 28.0 (C6); 19F 
NMR (CDCl3, 376 MHz): -114.54 (tt, J = 8.6, 5.5 Hz, F13); HRMS: (ESI
+) calculated for 





General procedure C: N-(4-(Naphthalen-1-yl)but-3-yn-1-yl)cyclopropanamine 119c (35.3 mg, 
0.15 mmol) and cyclohexyl isocyanate (19 µL, 0.15 mmol) were employed. Flash column 
chromatography (10% MeCN/DCM) afforded the title compound 121c (21.3 mg, 54%) as a pale 
brown oil; νmax / cm
-1: 2928 (w), 1692 (s), 1412 (m), 1395 (m), 1280 (m), 783 (s); 1H NMR (CDCl3, 
500 MHz): δ 7.97 – 7.94 (m, 1H, C12-H), 7.89 – 7.85 (m, 1H, Ar-H), 7.78 (d, J = 8.4 Hz, 1H, Ar-
H), 7.55 – 7.43 (m, 3H, Ar-H), 7.39 – 7.35 (m, 1H, Ar-H), 6.93 (d, J = 2.5 Hz, 1H, C8-H), 4.69 
(td, J = 7.6, 1.9 Hz, 1H, C7-H), 3.94 (dt, J = 12.1, 6.2, 6.0 Hz, 1H, C3-H2), 3.13 – 3.05 (m, 1H, 
C3-H2), 2.86 – 2.75 (m, 3H, C2-H2 and C5-HaHb), 2.65 (dddd, J = 12.5, 9.0, 7.3, 1.8 Hz, 1H, C6-
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H2), 2.51 (ddd, J = 16.5, 9.4, 1.8 Hz, 1H, C5-HaHb), 2.11 (dddd, J = 12.5, 11.3, 9.4, 7.9 Hz, 1H, 
C6-H2); 
13C NMR (CDCl3, 126 MHz): δ 175.7 (C4), 145.1, 134.1, 133.7, 131.7, 128.8, 127.9, 
126.2, 126.1, 126.0, 126.0, 125.4 (3 × Ar-C, 7 × Ar-CH and C1), 124.3 (C8), 64.6 (C7), 41.6 (C3), 
34.3 (C5), 31.5 (C2), 28.3 (C6); HRMS: (ESI+) calculated for C18H18NO: 264.1383, found 




General procedure C: N-(4-(thiophen-3-yl)but-3-yn-1-yl)cyclopropanamine 119d (28.7 mg, 
0.15 mmol) and cyclohexyl isocyanate (19 µL, 0.15 mmol) were employed. Flash column 
chromatography (10% MeCN/DCM) afforded the title compound 121d (21.7 mg, 66%) as a 
colourless oil; νmax / cm
-1: 2931 (w), 1684 (s), 1415 (m), 1279 (m), 777 (m), 637 (m); 1H NMR 
(CDCl3, 400 MHz): δ 7.31 (dd, J = 5.0, 2.9 Hz, 1H, C11-H), 7.15 – 7.12 (m, 1H, C12-H), 7.10 
(dd, J = 5.0, 1.3 Hz, 1H, C10-H), 6.39 – 6.35 (m, 1H, C8-H), 4.55 (td, J = 7.6, 2.1 Hz, 1H, C7-H), 
4.08 (ddd, J = 11.9, 7.1, 4.9 Hz, 1H, C3-HaHb), 3.17 – 3.08 (m, 1H, C3-HaHb), 2.93 – 2.85 (ddt, J 
= 8.3, 4.7, 2.3 Hz, 2H, C2-H2), 2.74 (dddd, J = 16.4, 10.7, 9.0, 1.5 Hz, 1H, C5-HaHb), 2.53 (dddd, 
J = 12.4, 9.0, 7.4, 2.1 Hz, 1H, C6-HaHb), 2.42 (ddd, J = 16.4, 9.4, 2.1 Hz, 1H, C5-HaHb), 1.93 
(dddd, J = 12.4, 10.8, 9.4, 7.6 Hz, 1H, C6-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 175.5 (C4), 
141.9 (C1), 138.7 (C9), 127.9 (C10), 125.7 (C11), 122.7 (C12), 116.4 (C8), 64.7 (C7), 41.6 (C3), 
34.0 (C5), 32.1 (C2), 27.9 (C6); HRMS: (ESI+) calculated for C12H14NOS: 220.0791, found 
[M+H]+: 220.0780. 
  




This compound was prepared according to the modified literature procedure.106 To a solution of 
Ti(OiPr)4 (7.76 mL, 30.0 mmol) in dry hexane (40 mL) under a nitrogen atmosphere, TiCl4 (1.10 
mL, 10.0 mmol) was added dropwise at room temperature and the solution was stirred for 1 h, 
allowing the exothermic formation of ClTi(OiPr)3. In a separate flame-dried flask, n-BuLi (25.16 
mL, 40.0 mmol, 1.59 M in hexanes) was added dropwise to a solution of phenylacetylene (4.39 
mL, 40.0 mmol) in dry THF (20 mL) at 0 °C and the solution was stirred for 30 min. The solution 
was concentrated in vacuo at 0 °C, redissolved in dry THF (40 mL), and cooled down to -41 °C 
(acetonitrile/dry ice bath). A solution of triisopropyloxytitanium chloride (40.0 mmol in 40 mL of 
hexanes) was added via syringe. After 30 min, styrene oxide (2.28 mL, 20.0 mmol) was slowly 
added dropwise at -41 °C. The solution was warmed to room temperature and stirred for 15 h. 2.0 
M aq. HCl (150 mL) was added and the solution was extracted with Et2O (3 × 75 mL). The organic 
extracts were combined, washed with brine (100 mL), dried over MgSO4 and concentrated in 
vacuo. The residue was purified by flash column chromatography (10% EtOAc/hexane) to afford 
the title compound 122 (3.07 g, 69%) as a brown oil; νmax / cm
-1: 3371 (br. m), 1598 (m), 1490 (s), 
1453 (m), 1058 (s), 755 (s), 692 (s); 1H NMR (CDCl3, 400 MHz): δ 7.50 – 7.45 (m, 4H, 4 × Ar-
H), 7.41 – 7.35 (m, 2H, 2 × Ar-H), 7.34 – 7.30 (m, 4H, 4 × Ar-H), 4.10 (t, J = 6.8 Hz, 1H, C3-H), 
3.86 (t, J = 6.9 Hz, 2H, C4-H2), 1.92 (t, J = 7.0 Hz, 1H, O5-H); 
13C NMR (CDCl3,101 MHz): δ 
138.1 (C7), 131.9 (Ar-CH), 128.9 (Ar-CH), 128.4 (Ar-CH), 128.3 (Ar-CH), 128.1 (Ar-CH), 127.6 
(Ar-CH), 123.2 (C6), 88.3 (C2), 85.0 (C1), 67.9 (C4), 42.2 (C3). The spectroscopic properties of 
this compound were consistent with the data available in the literature.259 
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2,4-Diphenylbut-3-yn-1-yl 4-methylbenzenesulfonate (123) 
 
General procedure B: 2,4-Diphenylbut-3-yn-1-ol 122 (3.00 g, 13.50 mmol) was employed. Flash 
column chromatography (100% toluene) afforded the title compound 123 (3.33 g, 66%) as an 
orange oil; νmax / cm
-1: 1491 (m), 1361 (s), 1189 (s), 1175 (s), 971 (s), 757 (s); 1H NMR (CDCl3, 
400 MHz): δ 7.70 (d, J = 8.1 Hz, 2H, 2 × C14-H), 7.44 – 7.22 (m, 12H, 2 × C2-H, 2 × C3-H, 2 × 
C9-H, 2 × C10-H, 2 × C15-H, C1-H and C11-H), 4.34 – 4.15 (m, 3H, C7-H and C12-H2), 2.42 (s, 
3H, C17-H3); 
13C NMR (CDCl3, 101 MHz): δ 144.8 (C13), 136.6, 133.0 (C8 and C16), 131.9, 
129.9, 128.9, 128.4, 128.4, 128.2, 128.0, 128.0 (14 × Ar-CH), 122.9 (C4), 86.5 (C6), 85.0 (C5), 
72.9 (C12), 38.6 (C7), 21.8 (C17); HRMS: (MALDI) calculated for C23H20NaO3S: 399.1025, 




General procedure A: 2,4-Diphenylbut-3-yn-1-yl 4-methylbenzenesulfonate 123 (1.00 g, 2.66 
mmol) was employed. Flash column chromatography (0-20% EtOAc/hexane) afforded the side 
product 125 (0.13 g, 24%) as a yellow oil; νmax / cm
-1: 3056 (w), 2198 (w), 1597 (m), 1490 (s), 
1443 (m), 908 (m), 754 (s), 690 (s); 1H NMR (CDCl3, 400 MHz): δ 7.78 – 7.73 (m, 2 × Ar-CH), 
7.59 – 7.54 (m, 2 × Ar-CH), 7.44 – 7.33 (m, 6 × Ar-CH), 6.01 (d, J = 1.2 Hz, C8-HaHb), 5.79 (d, 
J = 1.2 Hz, C8-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 137.4 (C7), 131.8 (C3), 130.7 (C9), 128.6, 
128.5, 126.2 (C2, C10 and C11), 128.1, 128.0 (C1 and C12), 123.2 (C4), 120.8 (C8), 90.9 (C5), 
88.7 (C6). The spectroscopic properties of this compound were consistent with the data available 
in the literature.260 
  




General procedure A: 2-Methyl-4-phenylbut-3-yn-1-yl 4-methylbenzenesulfonate 129 (0.50 g, 
1.59 mmol, prepared according to the General procedure B from the corresponding alcohol, 
prepared according to the literature procedure261 from phenyl acetylene) was employed. Flash 
column chromatography (40% EtOAc/hexane) afforded the title compound 130 (102.4 mg, 32%) 
as a pale yellow oil; νmax / cm
-1: 2968 (m), 2932 (m), 2226 (w), 1490 (m), 1442 (m), 1371 (m), 
1343 (m), 1014 (m), 755 (s); 1H NMR (CDCl3, 400 MHz): δ 7.43 – 7.39 (m, 2H, 2 × C3-H), 7.31 
– 7.25 (m, 3H, C1-H and 2 × C2-H), 2.92 (q, J = 6.9 Hz, 1H, C7-H), 2.78 (d, J = 6.9 Hz, 2H, C9-
H2), 2.23 – 2.17 (m, 1H, C11-H), 1.88 (br. s, 1H, N10-H), 1.25 (d, J = 6 .9 Hz, 3H, C8-H3), 0.48 
– 0.42 (m, 2H, C12-H2), 0.40 – 0.35 (m, 2H, C12-H2); 
13C NMR (CDCl3, 101 MHz): δ 131.8 (C3), 
128.3 (C2), 127.8 (C1), 123.8 (C4), 93.0 (C6), 81.8 (C5), 55.2 (C7), 29.9 (C11), 27.2 (C9), 18.9 






General procedure C: N-(2-methyl-4-phenylbut-3-yn-1-yl)cyclopropanamine 130 (29.9 mg, 
0.15 mmol) and cyclohexyl isocyanate (19 µL, 0.15 mmol) were employed. An in situ yield (79%) 
was obtained by using 1,4-dinitrobenzene as an internal standard for 1H NMR spectroscopy. 
1H NMR (CDCl3, 400 MHz, characteristic signals only, mixture of diastereomers A:B = 1:0.65): 
δ 6.28 (s, 1H, C2-H, B), 6.21 (s, 1H, C2-H, A), 4.58 (t, J = 7.3 Hz, 1H, C3-H, A), 4.53 (td, J = 8.0, 
1.7 Hz, 1H, C3-H, B), 1.16 (d, J = 7.0 Hz, 3H, C1-H3, A), 1.09 (d, J = 7.1 Hz, 3H, C1-H3, B). 
 
 




A solution of 1-(phenylethynyl)cyclopentane-1-carbaldehyde 134 (0.26 g, 1.31 mmol, prepared 
according to the literature procedure262), cyclopropylamine (0.18 mL, 2.63 mmol) and MgSO4 
(0.63 g, 5.26 mmol) in DCM (5 mL) was stirred at r.t. for 16 h. The resulting slurry was filtered, 
rinsed with DCM (2 × 5 mL) and concentrated in vacuo. The imine was redissolved in MeOH (10 
mL), cooled to 0°C and then NaBH4 (74.3 mg, 1.97 mmol) was added at once. The reaction was 
warmed up to r.t., concentrated in vacuo, water (20 mL) was added and the solution was extracted 
with DCM (3 × 10 mL). The organic extracts were combined, washed with brine (20 mL), dried 
over MgSO4 and concentrated in vacuo. Flash column chromatography (0-10% EtOAc/hexane) 
afforded the title compound 135 (206.7 mg, 66% over two steps) as a colourless oil; νmax / cm
-1: 
2954 (m), 1491 (m), 1442 (m), 1014 (m), 754 (s), 691 (s); 1H NMR (CDCl3, 400 MHz): δ 7.41 – 
7.36 (m, 2H, 2 × C3-H), 7.31 – 7.24 (m, 3H, 2 × C2-H and C1-H), 2.76 (s, 2H, C10-H2), 2.23 (tt, 
J = 6.6, 3.6 Hz, 1H, C11-H), 2.01 – 1.63 (m, 8H, 2 × C8-H2 and 2 × C9-H2), 0.47 – 0.32 (m, 4H, 
2 × C12-H2); 
13C NMR (CDCl3, 101 MHz): δ 131.7 (C3), 128.3 (C2), 127.6 (C1), 124.1 (C4), 96.4 
(C6), 81.5 (C5), 58.5 (C10), 44.1 (C7), 38.9 (C8), 31.0 (C11), 24.8 (C9), 6.7 (C12); HRMS: (ESI+) 





General procedure C: Amine 135 (35.9 mg, 0.15 mmol) was employed and the residue was 
purified by flash column chromatography (10-20% MeCN/DCM) to yield the title compound 136 
(29.8 mg, 74%) as a colourless oil; νmax / cm
-1: 2939 (m), 2870 (m), 1690 (s), 1448 (m), 1401 (s), 
1281 (m), 1247 (m); 1H NMR (CDCl3, 400 MHz): δ 7.34 – 7.27 (m, 2H, 2 × C12-H), 7.26 – 7.16 
(m, 3H, C14-H and 2 × C13-H), 6.44 (s, 1H, C10-H), 4.59 (td, J = 7.9, 2.0 Hz, 1H, C9-H), 3.80 
(d, J = 11.2 Hz, 1H, C5-HaHb), 2.72 (d, J = 11.2 Hz, 1H, C5-HaHb), 2.78 – 2.65 (m, 1H, C7-HaHb), 
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2.57 – 2.48 (m, 1H, C8-HaHb), 2.44 (ddd, J = 16.2, 9.1, 1.4 Hz, 1H, C7-HaHb), 1.98 – 1.81  (m, 
2H, C8-HaHb and C3-HaHb), 1.76 – 1.65 (m, 3H, C3'-H2 and C4-HaHb), 1.63 – 1.35 (m, 3H, C4'-
H2 and C4-HaHb), 1.32 – 1.21 (m, 1H, C3-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 176.2 (C6), 
151.5 (C1), 137.1 (C11), 129.0 (C13), 128.1 (C12), 127.0 (C14), 122.6 (C10), 66.4 (C9), 57.2 
(C5), 55.8 (C2), 40.8 (C3'), 34.0 (C3), 33.6 (C7), 30.1 (C8), 25.5 (C4'), 25.4 (C4); HRMS: (ESI+) 





A solution of (S)-1,3-dibenzyl-6-methyl-3,6-dihydro-1H-1,3-diazepine-2,7-dione 144 (10 mg, 
0.03 mmol, prepared according to the literature procedure53) in MeOH (2 mL) was added to Pd on 
carbon (10 mg, 10% w/w) under nitrogen. The reaction was stirred at r.t. under 1 atm of H2 for 3 
h and then filtered through Celite® and concentrated in vacuo. The crude was redissolved in 1,2-
DCB (0.5 mL), stirred at 160 °C for 65 h and concentrated in vacuo. The residue was purified by 
flash column chromatography (50% EtOAc/hexane) to afford lactam 145 (5.6 mg, 95%) as a 
colourless oil; νmax / cm
-1: 2929 (m), 2871 (m), 1683 (s), 1454 (m), 1358 (s), 740 (s), 713 (s); 1H 
NMR (CDCl3, 400 MHz): δ 7.34 – 7.20 (m, 5H, 2 × C2-H, 2 × C3-H and C1-H), 4.45 (d, J = 14.7 
Hz, 1H, C5-HaHb), 4.40 (d, J = 14.7 Hz, 1H, C5-HaHb), 3.19 – 3.12 (m, 2H, C10-H2), 2.55 – 2.44 
(m, 1H, C7-H), 2.19 (dddd, J = 12.9, 8.7, 6.2, 4.7 Hz, 1H, C9-HaHb), 1.64 – 1.51 (m, 1H, C9-
HaHb), 1.22 (d, J = 7.1 Hz, 3H, C8-H3); 
13C NMR (CDCl3, 101 MHz): δ 177.5 (C6), 136.8 (C4), 
128.8, 128.2, 127.6 (C1, C2 and C3), 46.9 (C5), 44.8 (C10), 36.9 (C7), 27.2 (C9), 16.6 (C8). The 
spectroscopic properties of this compound were consistent with the data available in the 
literature.263 
The enantiopurity of this compound was determined by chiral SFC against a racemic standard 
(prepared as described above from 1,3-dibenzyl-6-methyl-3,6-dihydro-1H-1,3-diazepine-2,7-
dione, prepared according to the literature procedure53). 
Chiral SFC: (DAICEL CHIRALPAK-IA column (25 cm), CO2:MeOH 92:8, 2 mL/min, 140 bars, 
40 °C). Retention times: major diastereomer – 3.6 minutes (major), 4.0 minutes (minor), e.r. = 
98:2. 




A solution of 1,3-dibenzyl-5-butyl-3,6-dihydro-1H-1,3-diazepine-2,7-dione 147 (10 mg, 0.03 
mmol, prepared according to the literature procedure53) in MeOH (2 mL) was added to Pd on 
carbon (10 mg, 10% w/w) under nitrogen. The reaction was stirred at r.t. under 1 atm of H2 for 24 
h and then filtered through Celite® and concentrated in vacuo. This was repeated two more times 
and then the crude was redissolved in 1,2-DCB (0.5 mL), stirred at 160 °C for 65 h and 
concentrated in vacuo. The residue was purified by flash column chromatography (50% 
EtOAc/hexane) to afford lactam 148 (4.0 mg, 63%) as a pale yellow oil; νmax / cm
-1: 2925 (m), 
1690 (s), 1425 (m), 1268 (m), 701 (m); 1H NMR (CDCl3, 500 MHz): δ 7.35 – 7.21 (m, 5H, 2 × 
C2-H, 2 × C3-H and C1-H), 4.47 (d, J = 14.7 Hz, 1H, C5-HaHb), 4.41 (d, J = 14.7 Hz, 1H, C5-
HaHb), 3.33 (dd, J = 9.7, 8.0 Hz, 1H, C9-HaHb), 2.87 (dd, J = 9.7, 6.7 Hz, 1H, C9-HaHb), 2.57 (dd, 
J = 16.6, 8.7 Hz, 1H, C7-HaHb), 2.32 – 2.2 (m, 1H, C8-H), 2.12 (dd, J = 16.6, 7.9 Hz, 1H, C7-
HaHb), 1.44 – 1.34 (m, 2H, C10-H2), 1.31 – 1.17 (m, 4H, C11-H2 and C12-H2), 0.87 (t, J = 7.1 Hz, 
3H, C13-H3); 
13C NMR (CDCl3, 126 MHz): δ 174.7 (C6), 136.8 (C4), 128.8, 128.3 (C2 and C3), 
127.7 (C1), 52.6 (C9), 46.6 (C5), 37.9 (C7), 34.6 (C10), 31.9 (C8), 29.7 (C11), 22.8 (C12), 14.1 





To a solution of the Boc-protected cyclopropylamine 157 (1.20 g, 4.85 mmol, prepared according 
to the literature procedure46) in DCM (5 mL) was added trifluoroacetic acid (3.72 mL, 48.52 mmol) 
and the reaction was stirred at r.t. for 3 h. The reaction mixture was concentrated in vacuo, water 
(15 mL) was added and the solution was extracted with DCM (15 mL). The aqueous portion was 
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adjusted to pH 12 by addition of 2.0 M aq. NaOH and then extracted with DCM (3 × 10 mL). The 
organic extracts were combined, dried over MgSO4 and concentrated in vacuo. The residue was 
dissolved in MeCN (10 mL) and transferred to a sealed tube. K2CO3 (1.01 g, 7.28 mmol) and a 
solution of 3,4-dimethoxyphenethyl 4-methylbenzenesulfonate (1.63 g, 4.85 mmol, prepared 
according to the literature procedure50) in MeCN (2 mL) were added. The tube was sealed and the 
reaction was heated to 90 °C for 18 h. The reaction was cooled to r.t. and concentrated in vacuo. 
The residue was dissolved in DCM (20 mL), washed with water (30 mL) and the aqueous portion 
was further extracted with DCM (2 × 20 mL). The organic extracts were combined, dried over 
MgSO4 and concentrated in vacuo. The residue was dissolved in dry DCM (10 mL) and cooled 
down to 0 °C. Triethylamine (0.60 mL, 4.85 mmol) and benzyl isocyanate (0.68 mL, 4.85 mmol) 
were added at 0 °C, the reaction mixture was warmed to r.t. and stirred for 18 h. The solution was 
diluted with DCM (10 mL) and washed with water (20 mL), aq. 1.0 M HCl (20 mL), sat. aq. 
NaHCO3 (20 mL) and brine (20 mL). The organic layer was dried over MgSO4 and concentrated 
in vacuo. The residue was purified by flash column chromatography (30% EtOAc/hexane) to 
afford the title compound 158 (0.43 g, 20% over 3 steps) as a colourless oil; νmax / cm
-1: 3441 (w), 
2933 (w), 1651 (m), 1511 (s), 1453 (m), 1261 (s), 1235 (s), 1028 (s), 699 (s); 1H NMR (CDCl3, 
400 MHz): δ 7.32 – 7.10 (m, 10H, 2 × C2-H, 2 × C3-H, 2 × C13-H, 2 × C14-H, C1-H and C15-
H), 6.77 (d, J = 8.1 Hz, 1H, C20-H), 6.69 (d, J = 1.9 Hz, 1H, C23-H), 6.64 (dd, J = 8.1, 2.0 Hz, 
1H, C19-H), 5.07 (br. t, J = 5.9 Hz, 1H, N10-H), 4.14 (dd, J = 15.1, 6.0 Hz, 1H, C11-HaHb), 4.07 
(dd, J = 15.1, 6.0 Hz, 1H, C11-HaHb), 3.86 (s, 3H, C24-H3 or C25-H3), 3.82 (s, 3H, C24-H3 or 
C25-H3), 3.54 (ddd, J = 13.6, 9.0, 6.2 Hz, 1H, C16-HaHb), 3.35 (ddd, J = 13.6, 9.0, 6.2 Hz, 1H, 
C16-HaHb), 2.93 – 2.85 (m, 1H, C17-HaHb), 2.80 – 2.65 (m, 2H, C5-H2), 2.27 – 2.23 (m, 1H, C6-
H), 2.16 (dd, J = 14.3, 9.0 Hz, 1H, C17-HaHb), 1.37 – 1.27 (m, 1H, C8-H), 0.88 (ddd, J = 9.2, 5.1, 
3.7 Hz, 1H, C7-HaHb), 0.77 – 0.70 (m, 1H, C7-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 158.5 (C9), 
148.9 (C22), 147.5 (C21), 140.1, 140.0 (C4 and C12), 132.5 (C18), 129.1, 128.6, 128.5, 127.3 
(C2, C3, C13 and C14), 127.0, 126.9 (C1 and C15), 120.9 (C19), 112.3 (C23), 111.2 (C20), 56.0, 
56.0 (C24 and C25), 49.2 (C16), 44.3 (C11), 38.7 (C17), 34.4, 34.4 (C5 and C6), 24.4 (C8), 15.7 
(C7); HRMS: (ESI+) calculated for C28H33N2O3: 445.2486, found [M+H]
+: 445.2478. 
  




Starting cyclopropylamine 159 and 2-(thiophen-3-yl)ethyl 4-methylbenzenesulfonate were 
synthesised by Christodoulou. To a solution of the Boc-protected cyclopropylamine 159 (0.34 g, 
2.00 mmol, prepared according to the literature procedure53) in DCM (2 mL) was added 
trifluoroacetic acid (1.53 mL, 20.00 mmol) and the reaction was stirred at r.t. for 3 h. The reaction 
mixture was concentrated in vacuo, water (15 mL) was added and the solution was extracted with 
DCM (15 mL). The aqueous portion was adjusted to pH 12 by addition of 2.0 M aq. NaOH and 
then extracted with DCM (3 × 10 mL). The organic extracts were combined, dried over MgSO4 
and concentrated in vacuo. The residue was dissolved in MeCN (7 mL) and transferred to a sealed 
tube. K2CO3 (0.41 g, 3.00 mmol) and a solution of 2-(thiophen-3-yl)ethyl 4-
methylbenzenesulfonate (0.56 g, 2.00 mmol, prepared according to the literature procedure53) in 
MeCN (2 mL) were added. The tube was sealed and the reaction was heated to 90 °C for 18 h. The 
reaction was cooled to r.t. and concentrated in vacuo. The residue was dissolved in DCM (20 mL), 
washed with water (30 mL) and the aqueous portion was further extracted with DCM (2 × 20 mL). 
The organic extracts were combined, dried over MgSO4 and concentrated in vacuo. The residue 
was dissolved in dry DCM (5 mL) and cooled down to 0 °C. Triethylamine (0.28 mL, 2.00 mmol) 
and benzyl isocyanate (0.25 mL, 2.00 mmol) were added at 0 °C, the reaction mixture was warmed 
to r.t. and stirred for 18 h. The solution was diluted with DCM (10 mL) and washed with water 
(10 mL), aq. 1.0 M HCl (10 mL), sat. aq. NaHCO3 (10 mL) and brine (10 mL). The organic layer 
was dried over MgSO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography (30-40% EtOAc/hexane) to afford the title compound 160 (0.29 g, 43% over 3 
steps, d.r. = 5:1) as a colourless oil. 
Data for the mixture of compounds: νmax / cm
-1: 2952 (w), 1643 (s), 1509 (s), 1452 (m), 1285 (s), 
728 (s), 698 (s); HRMS: (ESI+) calculated for C18H23N2OS: 315.1526, found [M+H]
+: 315.1518. 
Data for the major trans-diastereomer: 1H NMR (CDCl3, 400 MHz): δ 7.35 – 7.20 (m, 6H, 2 × 
C15-H, 2 × C16-H, C17-H and C9-H), 7.01 – 6.96 (m, 2H, C8-H and C10-H), 5.37 (t, J = 5.8 Hz, 
1H, N12-H), 4.48 – 4.43 (m, 2H, C13-H2), 3.62 (ddd, J = 14.4, 8.0, 6.6 Hz, 1H, C5-HaHb), 3.52 
(ddd, J = 14.4, 8.0, 6.6 Hz, 1H, C5-HaHb), 2.94 – 2.88 (m, 2H, C6-H2), 2.01 – 1.94 (m, 1H, C4-
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H), 1.02 – 0.93 (m, 4H, C2-H and C1-H3), 0.80 – 0.73 (m, 1H, C3-HaHb), 0.55 – 0.48 (m, 1H, C3-
HaHb); 
13C NMR (CDCl3, 101 MHz): δ 158.5 (C11), 140.0 (C7), 139.7 (C14), 128.6 (C10), 128.5, 
127.3, 127.1, 125.3 (C9, C15, C16 and C17), 121.1 (C8), 47.7 (C5), 44.6 (C13), 35.4 (C4), 29.0 
(C6), 16.9, 16.8, 16.4 (C1, C2 and C3). 
Data for the minor cis-diastereomer: Characteristic signals only: 1H NMR (CDCl3, 400 MHz): δ 
5.46 (t, J = 6.0 Hz, 1H, N12-H), 3.87 (ddd, J = 14.0, 9.1, 6.6 Hz, 1H, C5-HaHb), 3.35 (ddd, J = 
14.0, 8.9, 5.7 Hz, 1H, C5-HaHb), 2.38 – 2.32 (m, 1H, C4-H); 





Cyclopropylamine (S,S)-160 was synthesised by Christodoulou. Enantioenriched substrate (S,S)-
160 (97:3 e.r.) was synthesised starting from commercially available (R)-propylene oxide 
according to the literature procedure in a similar to 160 way.53,110 
[𝛼]D
23.7 = +39.4 (c = 0.22, CHCl3). 
The enantiopurity of this compound was determined by chiral SFC analysis against a racemic 
standard. Chiral SFC: DAICEL CHIRALPAK-IA column (25 cm), CO2:MeOH 88:12, 2 mL/min, 
140 bars, 40 °C. Retention times: 7.4 minutes (minor), 8.0 minutes (major), e.r. = 97:3. 
  





An oven dried reaction tube, fitted with a magnetic stirrer, was charged with cyclopropylamine 
(S,S)-160 (47.2 mg, 0.15 mmol), PPh3 (5.9 mg, 0.02 mmol) and PhCO2H (2.7 mg, 0.02 mmol). 
The tube was fitted with a rubber septum and purged with argon. Anhydrous 1,2-DCB (0.75 mL) 
was added via syringe. The reaction vessel was purged with CO for 10 minutes and then the 
solution was sparged with CO for approx. 20 seconds. The mixture was heated at 100 °C for 72 
hours, under a CO atmosphere (1 atm). The mixture was cooled to room temperature, concentrated 
in vacuo and the residue was purified by flash column chromatography (30% EtOAc/hexane) to 
afford the title compound (S)-161a (34.3 mg, 67%) as a pale brown oil; νmax / cm
-1: 2936 (w), 1698 
(m), 1645 (s), 1405 (m), 1289 (m), 1189 (m), 723 (m), 697 (m); 1H NMR (CDCl3, 400 MHz): δ 
7.31 – 7.20 (m, 6H, 2 × C15-H, 2 × C16-H, C17-H and C2-H), 6.86 (dd, J = 5.0, 1.3 Hz, 1H, C1-
H), 6.79 – 6.77 (m, 1H, C3-H), 5.72 (dd, J = 6.9, 2.0 Hz, 1H, C7-H), 5.17 (dd, J = 14.7 Hz, 1H, 
C13-HaHb), 5.08 (dd, J = 6.9, 6.0 Hz, 1H, C8-H), 4.89 (d, J = 14.7 Hz, 1H, C13-HaHb), 4.00 (ddd, 
J = 13.5, 7.4, 7.4 Hz, 1H, C6-HaHb), 3.60 (ddd, J = 13.5, 7.1, 6.0 Hz, 1H, C6-HaHb), 3.00 – 2.75 
(m, 3H, C5-H2 and C9-H), 1.28 (d, J = 6.8 Hz, 3H, C10-H3); 
13C NMR (CDCl3, 101 MHz): δ 172.6 
(C11), 153.8 (C12), 138.4, 138.0 (C4 and C14), 129.1, 128.5, 128.1, 128.1, 127.3, 126.0 (C1, C2, 
C7, C15, C16 and C17), 122.0 (C3), 120.2 (C8), 50.8 (C6), 48.2 (C13), 37.9 (C9), 28.8 (C5), 13.7 
(C10); HRMS: (ESI+) calculated for C19H21N2O2S: 341.1318, found [M+H]
+: 342.1316. 
[𝛼]D
23.2 = +192 (c = 0.21, CHCl3). 
The enantiopurity of this compound was determined by chiral SFC analysis against a racemic 
standard (prepared from racemic starting material 160 by using the same method as above). Chiral 
SFC: DAICEL CHIRALPAK-IB column (25 cm), CO2:MeOH 96:4, 2 mL/min, 140 bars, 40 °C. 
Retention times: 18.3 minutes (minor), 18.9 minutes (major), e.r. > 99:1. 
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(8S,9aS)-8-Methyl-4,8,9,9a-tetrahydrothieno[3,2-g]indolizin-7(5H)-one ((S,S)-162a) and 
(8S,9aR)-8-methyl-4,8,9,9a-tetrahydrothieno[3,2-g]indolizin-7(5H)-one ((S,R)-162a) 
 
A reaction tube with a solution of diazepane (S)-161a (50.0 mg, 0.15 mmol) and TFA (0.11 mL, 
1.47 mmol) in DCM (1.5 mL) was fitted with a rubber septum and heated to 60 °C for 9 h. The 
reaction was cooled to r.t., concentrated in vacuo, redissolved in 1,2-DCB (1.5 mL) and heated to 
150 °C for 24 h. The mixture was cooled to room temperature, concentrated in vacuo and the 
residue was purified by flash column chromatography (66% EtOAc/hexane) to afford the title 
compound 162a (27.5 mg, 90%, 5:1 d.r.) as a pale brown oil. 
Data for the mixture of compounds: νmax / cm
-1: 2928 (w), 1628 (s), 1452 (m), 1419 (s), 1360 (m), 
1299 (m), 865 (m), 723 (m); HRMS: (ESI+) calculated for C11H14NOS: 208.0791, found [M+H]
+: 
208.0789. 
Data for the major compound (S,S)-162a: 1H NMR (CDCl3, 400 MHz): δ 7.18 (d, J = 5.0 Hz, 1H, 
C5-H), 6.79 (d, J = 5.0 Hz, 1H, C4-H), 4.75 (dd, J = 9.1, 6.6 Hz, 1H, C7-H), 4.46 – 4.35 (m, 1H, 
C1-HaHb), 3.02 – 2.91 (m, 1H, C1-HaHb), 2.82 – 2.54 (m, 4H, C2-H2, C8-HaHb and C9-H), 1.50 
(ddd, J = 11.4, 9.4, 9.4 Hz, 1H, C8-HaHb), 1.21 (d, J = 6.9 Hz, 3H, C10-H3); 
13C NMR (CDCl3, 
101 MHz): δ 175.3 (C11), 136.2 (C6), 133.3 (C3), 127.3 (C4), 123.5 (C5), 53.9 (C7), 37.8, 37.7 
(C8 and C9), 37.0 (C1), 25.6 (C2), 15.8 (C10). The relative stereochemistry of this compound was 
corroborated by nOe experiments (as indicated on the compound structure). No nOe was observed 
between C7-H and C10-H3. 
Data for the minor compound (S,R)-162a: Characteristic signals only: 1H NMR (CDCl3, 400 
MHz): δ 4.88 (t, J = 7.3 Hz, 1H, C7-H), 2.24 – 2.11 (m, 1H, C8-HaHb), 1.28 (d, J = 7.3 Hz, 1H, 
C10-H3). The relative stereochemistry of this compound was corroborated by nOe experiments (as 
indicated on the compound structure). A strong nOe was observed between C7-H and C10-H3. 
The enantiopurity of this compound was determined by chiral SFC against a racemic standard 
(prepared from racemic 161a by the same method as above). 
Chiral SFC: DAICEL CHIRALPAK-IC column (25 cm), CO2:MeOH 92:8, 2 mL/min, 140 bars, 
40 °C. Retention times: major diastereomer – 13.1 minutes (minor), 14.2 minutes (major), e.r. 
>99:1; minor diastereomer – 12.2 minutes (major), 13.7 minutes (minor), e.r. >99:1. 
 




An oven dried reaction tube, fitted with a magnetic stirrer, was charged with cyclopropylamine 
158 (66.7 mg, 0.15 mmol), PPh3 (5.9 mg, 0.02 mmol) and PhCO2H (2.7 mg, 0.02 mmol). The tube 
was fitted with a rubber septum and purged with argon. Anhydrous 1,2-DCB (0.75 mL) was added 
via syringe. The reaction vessel was purged with CO for 10 minutes and then the solution was 
sparged with CO for approx. 20 seconds. The mixture was heated at 100 °C for 72 hours, under a 
CO atmosphere (1 atm). The mixture was cooled to room temperature, concentrated in vacuo and 
the residue was purified by flash column chromatography (30% EtOAc/hexane) to afford the title 
compound 161b (36.0 mg, 51%) as a pale yellow oil; νmax / cm
-1: 2936 (w), 1698 (s), 1649 (s), 
1515 (s), 1453 (m), 1406 (s), 1261 (s), 1237 (s), 1029 (s), 699 (s); 1H NMR (CDCl3, 400 MHz): δ 
7.31 – 7.11 (m, 10H, 2 × C14-H, 2 × C15-H, 2 × C21-H, 2 × C22-H, C16-H and C23-H), 6.66 – 
6.62 (m, 2H, C1-H and C6-H), 6.47 (dd, J = 8.1, 2.1 Hz, 1H, C7-H), 5.78 (dd, J = 7.0, 1.9 Hz, 1H, 
C25-H), 5.20 (dd, J = 7.0, 6.1 Hz, 1H, C24-H), 5.13 (d, J = 14.6 Hz, 1H, C12-HaHb), 4.92 (d, J = 
14.6 Hz, 1H, C12-HaHb), 3.93 (ddd, J = 13.5, 7.7 Hz, 7.7 Hz, 1H, C10-HaHb), 3.82 (s, 3H, C3-H3 
or C4-H3), 3.80 (s, 3H, C3-H3 or C4-H3), 3.59 (ddd, J = 13.5, 7.2, 6.1 Hz, 1H, C10-HaHb), 3.32 
(dd, J = 14.3, 6.5 Hz, 1H, C19-HaHb), 3.14 – 3.06 (m, 1H, C18-H), 2.89 (dd, J = 14.3, 8.3 Hz, 1H, 
C19-HaHb), 2.78 – 2.72 (m, 2H, C9-H2); 
13C NMR (CDCl3, 126 MHz): δ 171.2 (C17), 153.7 (C11), 
149.1, 147.9 (C2 and C5), 138.8, 137.9 (C13 and C20), 130.5, 129.7, 129.2, 128.7, 128.5, 128.0, 
127.3, 126.6 (C8, C14, C15, C16, C21, C22, C23 and C25), 121.0 (C7), 118.3 (C24), 111.9, 111.3 
(C6 and C1), 56.0, 56.0 (C3 and C4), 51.5 (C10), 48.4 (C12), 44.9 (C18), 34.3 (C19), 34.0 (C9); 
HRMS: (ESI+) calculated for C29H30N2NaO4: 493.2098, found [M+Na]
+: 493.2083. 
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(2S*,10bS*)-2-Benzyl-8,9-dimethoxy-1,5,6,10b-tetrahydropyrrolo[2,1-a]isoquinolin-3(2H)-
one (162b) and (2S*,10bR*)-2-Benzyl-8,9-dimethoxy-1,5,6,10b-tetrahydropyrrolo[2,1-
a]isoquinolin-3(2H)-one (162') 
 
A reaction tube with a solution of diazepane 161b (30.0 mg, 0.06 mmol) and TFA (50 μL, 0.64 
mmol) in DCM (0.6 mL) was fitted with a rubber septum and heated to 60 °C for 9 h. The reaction 
was cooled to r.t., concentrated in vacuo, redissolved in 1,2-DCB (0.6 mL) and heated to 150 °C 
for 24 h. The mixture was cooled to room temperature, concentrated in vacuo and the residue was 
purified by flash column chromatography (66% EtOAc/hexane) to afford the title compound 162b 
(12.8 mg, 59%, 5:1 d.r.) as a pale brown oil. 
Data for the mixture of compounds: νmax / cm
-1: 2932 (w), 1681 (s), 1512 (s), 1453 (s), 1429 (s), 
1254 (s), 1227 (s), 1116 (s), 731 (s); HRMS: (ESI+) calculated for C21H23NNaO3: 360.1570, found 
[M+Na]+: 360.1567. 
Data for the major compound 162b: 1H NMR (CDCl3, 400 MHz): δ 7.35 – 7.15 (m, 5H, 2 × C17-
H, 2 × C18-H and C19-H), 6.59 (s, 1H, C9-H), 6.47 (s, 1H, C4-H), 4.56 (dd, J = 9.6, 6.4 Hz, 1H, 
C11-H), 4.39 – 4.25 (m, 1H, C1-HaHb), 3.84 (s, 3H, C6-H3), 3.81 (s, 3H, C8-H3), 3.43 (dd, J = 
13.9, 3.8 Hz, 1H, C15-HaHb), 3.06 – 2.80 (m, 3H, C1-HaHb, C13-H and C2-HaHb), 2.72 – 2.53 (m, 
2H, C2-HaHb and C12-HaHb), 2.47 (dd, J = 13.9, 10.8 Hz, 1H, C15-HaHb), 1.48 (ddd, J = 11.7, 
9.6, 9.6 Hz, 1H, C12-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 174.0 (C14), 148.2, 148.0 (C5 and 
C7), 139.9 (C16), 129.1, 128.9, 128.6, 126.4, 125.5 (C3, C10, C17, C18 and C19), 111.8 (C9), 
107.7 (C4), 56.2, 56.0 (C6 and C8), 54.7 (C11), 45.1 (C13), 37.2 (C1), 37.1 (C15), 35.3 (C2), 28.3 
(C12). 
Data for the minor compound 162b': Characteristic signals only: 1H NMR (CDCl3, 400 MHz): δ 
6.56 (s, 1H, C9-H), 6.44 (s, 1H, C4-H), 3.82 (s, 3H, C6-H3), 3.80 (s, 3H, C8-H3). 
 




General procedure B: Hepta-3,5-dien-1-ol 169a (mixture of geometric isomers (3E,5E):(3Z,5E) 
= 4:1, 1.62 g, 14.44 mmol, prepared according to the literature procedure264 from trans-
crotonaldehyde) was employed. Flash column chromatography (100% toluene) afforded the 
corresponding tosylate 170a (2.23 g, 58%) as a colourless oil; νmax / cm
-1: 2916 (w), 1359 (s), 1189 
(s), 1176 (s), 988 (s). This compound is unstable and was used in subsequent reaction without 
further characterisation. 
In a sealed reaction tube, a solution of cyclopropylamine (1.04 mL, 15.02 mmol) and tosylate 170a 
(1.00 g, 3.75 mmol) in MeCN (10 mL) was heated to 90 °C for 18 h. The reaction was cooled to 
r.t., trifluoroacetic acid (0.43 mL, 5.63 mmol) was added (due to intermediate amine’s volatility) 
and the mixture was concentrated in vacuo. The residue was dissolved in dry DCM (50 mL) and 
cooled down to 0 °C. Triethylamine (1.05 mL, 7.50 mmol) and cyclohexyl isocyanate (0.48 mL, 
3.75 mmol) were added at 0 °C, the reaction mixture was warmed to r.t. and stirred for 18 h. The 
solution was washed with water (20 mL), aq. 1.0 M HCl (20 mL), sat. aq. NaHCO3 (20 mL) and 
brine (20 mL). The organic layer was dried over MgSO4 and concentrated in vacuo. The residue 
was purified by flash column chromatography (20% EtOAc/hexane) to afford the title compound 
167a (0.62 g, 60% over 2 steps, mixture of geometric isomers A:B = 10:1) as a colourless oil. 
Data for the mixture of geometric isomers: νmax / cm
-1: 2928 (s), 2853 (m), 1644 (s), 1508 (s), 1450 
(m), 987 (m); HRMS: (ESI+) calculated for C17H29N2O: 277.2274, found [M+H]
+: 277.2270. 
Data for the major geometric isomer A: 1H NMR (CDCl3, 400 MHz): δ 6.09 – 5.94 (m, 2H, C3-H 
and C4-H), 5.63 – 5.47 (m, 2H, C2-H and C5-H), 5.08 (br. d, J = 8.1 Hz, 1H, N11-H), 3.71 – 3.59 
(m, 1H, C12-H), 3.35 (t, J = 7.2 Hz, 2H, C7-H2), 2.48 – 2.39 (m, 1H, C8-H), 2.35 – 2.26 (m, 2H, 
C6-H2), 1.98 – 1.85 (m, 2H, 2 × C13-HaHb), 1.80 – 1.54 (m, 7H, 2 × C14-HaHb, C15-H2 and C1-
H3), 1.44 – 1.31 (m, 2H, 2 × C14-HaHb), 1.24 – 1.06 (m, 2H, 2 × C13-HaHb), 0.84 – 0.78 (m, 2H, 
2 × C9-HaHb), 0.71 – 0.65 (m, 2H, 2 × C9-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 158.2 (C10), 
132.1 (C4), 131.7 (C3), 128.9 (C5), 127.5 (C2), 49.0 (C12), 46.7 (C7), 34.1 (C13), 31.9 (C6), 27.6 
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(C8), 25.9 (C15), 25.1 (C14), 18.1 (C1), 8.8 (C9) This compound is unstable and was stored as a 
frozen matrix in benzene. 
Data for the minor geometric isomer B: Characteristic signals only: 1H NMR (CDCl3, 400 MHz): 





An oven dried reaction tube, fitted with a magnetic stirrer, was charged with protected 
cyclopropylamine 167a (27.6 mg, 0.10 mmol), P(4-F-C6H4)3 (4.7 mg, 15 mol%), [Rh(cod)2]OTf 
(3.5 mg, 7.5 mol%), dimethyl fumarate (14.4 mg, 0.10 mmol) and BHT (2.2 mg, 0.01 mmol). The 
tube was fitted with a rubber septum and purged with argon. Anhydrous PhCN (1.00 mL) was 
added via syringe. The reaction vessel was purged with CO for 10 minutes and then the solution 
was sparged with CO for approx. 20 seconds. The mixture was heated at 140 °C for 72 hours, 
under a CO atmosphere (1 atm). The mixture was cooled to room temperature, concentrated in 
vacuo and the residue was purified by flash column chromatography (20% MeCN/DCM) to afford 
the title compound 171a (9.1 mg, 51%, single diastereomer) as a pale yellow oil; νmax / cm
-1: 2957 
(w), 2930 (w), 1683 (s), 1408 (s), 1285 (m), 692 (m); 1H NMR (CDCl3, 400 MHz): δ 5.59 (ddd, J 
= 9.7, 3.2, 3.2 Hz, 1H, C4-H), 5.50 – 5.43 (m, 1H, C5-H), 4.17 – 4.10 (m, 1H, C11-H), 3.60 (ddd, 
J = 11.7, 8.3, 8.3 Hz, 1H, C1-HaHb), 3.03 – 2.93 (m, 1H, C1-HaHb), 2.77 – 2.67 (m, 1H, C8-H), 
2.57 (dd, J = 17.7, 10.4 Hz, 1H, C9-HaHb), 2.46 – 2.39 (m, 1H, C3-H), 2.34 – 2.14 (m, 3H, C2-
HaHb, C6-H and C9-HaHb), 2.02 – 1.92 (m, 1H, C2-HaHb), 1.08 (d, J = 7.2 Hz, 3H, C7-H3); 
13C 
NMR (CDCl3, 101 MHz): δ 177.3 (C10), 134.9 (C4), 132.5 (C5), 66.0 (C11), 41.3 (C1), 35.9 (C3), 
35.2 (C9), 33.6 (C8), 32.7 (C2), 30.7 (C6), 17.6 (C7); HRMS: (ESI+) calculated for C11H16NO: 
178.1226, found [M+H]+: 178.1224. 
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The structure of 171a was corroborated by HH Cosy experiments (as indicated on the compound 
structure. HH Cosy correlations were observed between C1-H and C2-H, C2-H and C3-H, C3-H 
and C4-H, C4-H and C5-H, C5-H and C6-H, C6-H and C7-H, C8-H and C9-H, C8-H and C11-
H, C3-H and C11-H.  
The relative stereochemistry of C11-H, C8-H and C3-H of 171a was corroborated by using 
quantifiable nOe analysis. In quantifiable nOe analysis, the determination of the interproton 
distances is based on the comparison of relative nOe intensities instead of absolute intensities. The 
advantage of this method is the minimisation of the perturbations that affect all of the spins. The 
relative stereochemistry of C8-H and C6-H of 171a was corroborated by nOe experiments (as 
indicated on the compound structure). nOe was observed between C7-H3 and C9-Hb, C8-H and 
C6-H; at the same time, no nOe was observed between C9-Hb and C8-H.  
Quantifiable nOe analysis  
1-Dimensional transient nOe spectra were acquired on a 500MHz Bruker Avance IIIHD NMR 
spectrometer equipped with a DCH 13C-optimised cryoprobe. Chemical-shift-selective filter nOe 
pulse sequence (‘selcssfnozs’) from the Bruker Top Spin library was used with a 500ms nOe 
mixing time and otherwise using the same spectrum parameters as for 1H spectra. 
nOe-distance Analysis was carried out in collaboration with Prof. Craig Butts at Bristol. nOe-
distance analysis on 171a confirmed the relative stereochemistry of C3-H, C8-H and C11-H using 
the relationship between nOe intensity and internuclear distance in transient nOe experiments. The 
underpinning method used is based on that described by Butts et al115 which assumes that all 
interproton distances between nuclei X and Y (rXY) are related to the intensity of the nOe signal 
between them (ηXY) by the relationship: ηXY α rXY
-6, and that the effects of differential relaxation 
between all nuclei in the molecule can be corrected for by measuring nOe integrals relative to the 
intensity of the irradiated peak–the so-called PANIC method.265 
In this case the PANIC-corrected nOe intensities from irradiation of C11-H to C3-H and C8-H, 
gave rise to almost identical internuclear distances, which were established to be ~2.3Å after 
calibration against the known nOe-distance for C1-Ha-C1-Hb (~1.83Å). Molecular mechanics 
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modelling on 171a found a single low energy conformer with C11-H-C3-H and C11-H-C8-H 
distances of 2.53Å and 2.34Å respectively, which are within the expected error limits of nOe-
distance analysis (For comparison, an nOe-distance of >3Å would have been expected for C3-H 
or C8-H in alternative diastereomers (trans relationship)). Other measurable nOe-distances were 
also found to fit with the proposed structure, however the absolute intensities of the nOes in the 
datasets for compound 171a were weak.  












C11-H C3-H 4.77 1.259      2.30 
 
2.53 8.92% 
C11-H C8-H 4.88 1.254      2.30 
 
2.34 1.90% 
C1-Haa C1-Hb 19.01 1.000      1.83 
 
1.83 0.00% 
a C1-Ha-C1-Hb (methylene) was used as the reference distance, with measured C11-H nOe-




A suspension of (3-hydroxypropyl)triphenylphosphonium bromide (4.82 g, 12.00 mmol, prepared 
according to the literature procedure266) in dry THF (25 mL) was cooled to 0 °C and n-BuLi (16.7 
mL, 1.44 M in hexanes) was added dropwise. The solution was stirred at 0 °C for 30 min and then 
(E)-3-(4-fluorophenyl)acrylaldehyde (1.80 g, 12.00 mmol, prepared according to the literature 
procedure267 from 4-fluorobenzaldehyde) in dry THF (8 mL) was added dropwise and the solution 
was stirred at 0 °C for 2.5 h. The reaction was diluted with Et2O (30 mL) and washed with sat. aq. 
NH4Cl (30 mL) and brine (30 mL). The organic layer was dried over MgSO4 and concentrated in 
vacuo. The residue was purified by flash column chromatography (20-40% EtOAc/hexane) 
afforded the title compound 169b (1.13 g, 49%, mixture of geometric isomers A:B = 4:1) as a 
colourless oil. 
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Data for the mixture of geometric isomers: νmax / cm
-1: 3270 (br. m), 2945 (m), 1508 (s), 1248 (s), 
1050 (s), 982 (s), 834 (m); HRMS: (ESI+) calculated for C12H13FO: 193.1023, found [M+H]
+: 
193.1019.  
Data for the major geometric isomer A: 1H NMR (CDCl3, 400 MHz): δ 7.37 – 7.31 (m, 2H, 2 × 
C4-H), 7.04 – 6.95 (m, 2H, 2 × C3-H), 6.67 (dd, J = 15.7, 10.4 Hz, 1H, C7-H), 6.45 (d, J = 15.7 
Hz, 1H, C6-H), 6.30 (dd, J = 15.3, 10.4 Hz, 1H, C8-H), 5.79 (dt, J = 15.3, 7.2 Hz, 1H, C9-H), 3.77 
– 3.69 (m, 2H, C11-H2), 2.46 – 2.39 (m, 2H, C10-H2); 
13C NMR (CDCl3, 126 MHz): δ 162.3 (d, 
J = 246.8 Hz, C2), 133.7 (d, J = 3.2 Hz, C5), 133.4 (C8), 130.9 (C9), 130.1 (C6), 128.7 (d, J = 2.4 
Hz, C7), 127.8 (d, J = 7.9 Hz, C4), 115.68 (d, J = 21.7 Hz, C3), 62.1 (C11), 36.4 (C10); 19F NMR 
(CDCl3, 376 MHz): -114.48 (td, J = 8.8, 4.5 Hz, F1). 
Data for the minor geometric isomer B: Characteristic signals only: δ 6.52 (d, J = 15.6 Hz, 1H, 
C7-H), 2.60 – 2.52 (m, 2H, C10-H2);





General procedure B: 6-(4-Fluorophenyl)hexa-3,5-dien-1-ol 169b (mixture of geometric isomers 
A:B = 4:1, 1.13 g, 5.88 mmol) was employed. Flash column chromatography (100% toluene) 
afforded the corresponding tosylate 170b (1.10 g, 54%) as a colourless oil. This compound is 
unstable and was used in subsequent reaction without further characterisation. 
In a sealed reaction tube, a solution of cyclopropylamine (0.40 mL, 6.93 mmol) and tosylate 170b 
(0.60 g, 1.73 mmol) in MeCN (5 mL) was heated to 90 °C for 18 h. The reaction was cooled to r.t. 
and concentrated in vacuo. The residue was diluted with DCM (10 mL) and washed with sat. aq. 
NaHCO3 (20 mL). The organic layer was dried over MgSO4 and cooled down to 0 °C. 
Triethylamine (0.48 mL, 3.46 mmol) and cyclohexyl isocyanate (0.22 mL, 1.73 mmol) were added 
at 0 °C, the reaction mixture was warmed to r.t. and stirred for 18 h. The solution was washed with 
water (20 mL), aq. 1.0 M HCl (20 mL), sat. aq. NaHCO3 (20 mL) and brine (20 mL). The organic 
layer was dried over MgSO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography (30% EtOAc/hexane) to afford the title compound 167b as a single isomer (101.0 
mg, 16%) as a colourless oil; νmax / cm
-1: 2928 (m), 2853 (w), 1651 (m), 1507 (s), 1228 (m), 987 
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(w), 834 (w); 1H NMR (CDCl3, 500 MHz): δ 7.34 – 7.30 (m, 2H, 2 × C4-H), 6.98 (t, J = 8.7 Hz, 
2H, 2 × C3-H), 6.65 (dd, J = 15.7, 10.4 Hz, 1H, C7-H), 6.39 (d, J = 15.7 Hz, 1H, C6-H), 6.22 (dd, 
J = 15.0, 10.4 Hz, 1H, C8-H), 5.80 (dt, J = 15.0, 7.3 Hz, 1H, C9-H), 5.10 (d, J = 8.0 Hz, 1H, N15-
H), 3.70 – 3.61 (m, 1H, C16-H), 3.41 (t, J = 7.0 Hz, 2H, C11-H2), 2.47 – 2.37 (m, 3H, C12-H and 
C10-H2), 1.96 – 1.89 (m, 2H, 2 × C17-HaHb), 1.70 – 1.58 (m, 3H, C19-HaHb and 2 × C18-HaHb), 
1.43 – 1.32 (m, 2H, 2 × C18-HaHb), 1.22 – 1.07 (m, 3H, C19-HaHb and 2 × C17-HaHb), 0.85 – 0.80 
(m, 2H, 2 × C13-HaHb), 0.72 – 0.68 (m, 2H, 2 × C13-HaHb); 
13C NMR (CDCl3, 126 MHz): δ 
162.21 (d, J = 246.6 Hz, C2), 158.3 (C14), 133.86 (d, J = 3.2 Hz, C5), 132.8 (C9), 132.1 (C8), 
129.3 (C6), 129.14 (d, J = 2.4 Hz, C7), 127.73 (d, J = 7.9 Hz, C4), 115.62 (d, J = 21.6 Hz, C3), 
49.1 (C16), 46.6 (C11), 34.1 (C17), 32.3 (C10), 27.7 (C12), 25.9 (C19), 25.1 (C18), 8.8 (C13); 19F 
NMR (CDCl3, 376 MHz): -114.79 (tt, J = 9.0, 5.3 Hz, F1); HRMS: (ESI
+) calculated for 
C22H30FN2O: 357.2337, found [M+H]
+: 357.2336. This compound is unstable and was stored as 




An oven dried reaction tube, fitted with a magnetic stirrer, was charged with protected 
cyclopropylamine 167b (35.6 mg, 0.10 mmol), P(4-F-C6H4)3 (4.7 mg, 15 mol%), [Rh(cod)2]OTf 
(3.5 mg, 7.5 mol%), dimethyl fumarate (14.4 mg, 0.10 mmol) and BHT (2.2 mg, 0.01 mmol). The 
tube was fitted with a rubber septum and purged with argon. Anhydrous PhCN (1.00 mL) was 
added via syringe. The reaction vessel was purged with CO for 10 minutes and then the solution 
was sparged with CO for approx. 20 seconds. The mixture was heated at 140 °C for 72 hours, 
under a CO atmosphere (1 atm). The mixture was cooled to room temperature, concentrated in 
vacuo and the residue was purified by flash column chromatography (20% MeCN/DCM, then 90% 
EtOAc/hexane) to afford the title compound 171b (12.1 mg, 47%) as a pale yellow oil;  
νmax / cm
-1: 2928 (w), 1687 (s), 1510 (s), 1410 (m), 1222 (s), 1160 (w), 822 (m); 1H NMR (CDCl3, 
400 MHz): δ 7.20 (dd, J = 8.5, 5.3 Hz, 2H, 2 × C8-H), 7.04 (dd, J = 8.5, 8.5 Hz, 2H, 2 × C9-H), 
6.11 (dt, J = 9.8, 2.8 Hz, 1H, C4-H), 5.68 (d, J = 9.8 Hz, 1H, C5-H), 4.27 (dd, J = 8.4, 6.4 Hz, 1H, 
C15-H), 3.62 (dt, J = 11.7, 8.6 Hz, 1H, C1-HaHb), 3.56 – 3.51 (m, 1H, C6-H), 3.08 – 2.94 (m, 2H, 
C12-H and C1-HaHb), 2.62 – 2.56 (m, 1H, C3-H), 2.40 – 2.28 (m, 2H, C2-HaHb and C13-HaHb), 
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2.17 – 2.02 (m, 2H, C2-HaHb and C13-HaHb); 
13C NMR (CDCl3, 126 MHz): δ 176.6 (C14), 161.8 
(d, J = 245.3 Hz, C10), 137.4 (d, J = 3.3 Hz, C7), 133.7 (C5), 131.2 (C4), 129.6 (d, J = 7.9 Hz, 
C8), 115.7 (d, J = 21.2 Hz, C9), 64.9 (C15), 41.3, 41.2 (C1 and C6), 36.3 (C3), 35.9, 34.92 (d, J = 
1.2 Hz), 32.8 (C2, C12 and C13); 19F NMR (CDCl3, 376 MHz): -116.15 (tt, J = 9.2, 5.2 Hz, F11); 
HRMS: (ESI+) calculated for C16H17NOF: 258.1289, found [M+H]
+: 258.1283. The relative 




In a sealed reaction tube, a solution of cyclopropylamine (1.10 mL, 15.85 mmol) and (E)-hexa-
3,5-dien-1-yl 4-methylbenzenesulfonate (1.00 g, 3.96 mmol, prepared according to the literature 
procedure268) in MeCN (10 mL) was heated to 90 °C for 18 h. The reaction was cooled to r.t. and 
concentrated in vacuo. The residue was diluted with DCM (10 mL) and washed with sat. aq. 
NaHCO3 (20 mL). The organic layer was dried over MgSO4 and cooled down to 0 °C. 
Triethylamine (2.21 mL, 15.84 mmol) and cyclohexyl isocyanate (1.01 mL, 7.92 mmol) were 
added at 0 °C, the reaction mixture was warmed to r.t. and stirred for 18 h. The solution was 
washed with water (20 mL), aq. 1.0 M HCl (20 mL), sat. aq. NaHCO3 (20 mL) and brine (20 mL). 
The organic layer was dried over MgSO4 and concentrated in vacuo. Flash column 
chromatography (20% EtOAc/hexane) of the crude afforded the title compound 172 (1.20 g, 58% 
over two steps) as a pale yellow oil; νmax / cm
-1: 2928 (s), 2853 (m), 1645 (s), 1510 (s), 1451 (m), 
1356 (m), 1279 (m), 1258 (m), 1003 (m); 1H NMR (CDCl3, 400 MHz): δ 6.30 (ddd, J = 16.6, 10.2, 
10.2 Hz, 1H, C2-H), 6.09 (dd, J = 15.1, 10.2 Hz, 1H, C3-H), 5.68 (dt, J = 15.1, 7.3 Hz, 1H, C4-
H), 5.08 (d, J = 16.6 Hz, 1H, C1-Htrans), 5.08 (s, 1H, N10-H), 4.96 (d, J = 10.1 Hz, 1H, C1-Hcis), 
3.70 – 3.59 (m, 1H, C11-H), 3.36 (t, J = 7.0 Hz, 2H, C6-H2), 2.42 (tt, J = 6.9, 3.8 Hz, 1H, C7-H), 
2.38 – 2.30 (m, 2H, C5-H2), 1.97 – 1.88 (m, 2H, 2 × C12-HaHb), 1.72 – 1.54 (m, 3H, C14-HaHb 
and 2 × C13-HaHb), 1.44 – 1.31 (m, 2H, 2 × C13-HaHb), 1.26 – 1.07 (m, 3H, C14-HaHb and 2 × 
C12-HaHb), 0.84 – 0.78 (m, 2H, 2 × C8-HaHb), 0.71 – 0.65 (m, 2H, 2 × C8-HaHb); 
13C NMR 
(CDCl3, 101 MHz): δ 158.2 (C9), 137.3 (C2), 132.7 (C3), 132.4 (C4), 115.4 (C1), 49.0 (C11), 46.5 
(C6), 34.1 (C12), 31.9 (C5), 27.6 (C7), 25.9 (C14), 25.1 (C13), 8.8 (C8); HRMS: (ESI+) calculated 
for C16H27N2O: 263.2118, found [M+H]
+: 263.2115. 
 




In a sealed reaction tube, a solution of cyclopropylamine (1.14 mL, 16.52 mmol) and (E)-5-
methylhexa-3,5-dien-1-yl 4-methylbenzenesulfonate (1.10 g, 4.13 mmol, prepared according to 
the literature procedure269) in MeCN (10 mL) was heated to 90 °C for 18 h. The reaction was 
cooled to r.t. and concentrated in vacuo. The residue was diluted with DCM (10 mL) and washed 
with sat. aq. NaHCO3 (20 mL). The organic layer was dried over MgSO4 and cooled down to 0 
°C. Triethylamine (1.15 mL, 8.26 mmol) and cyclohexyl isocyanate (0.53 mL, 4.13 mmol) were 
added at 0 °C, the reaction mixture was warmed to r.t. and stirred for 18 h. The solution was 
washed with water (20 mL), aq. 1.0 M HCl (20 mL), sat. aq. NaHCO3 (20 mL) and brine (20 mL). 
The organic layer was dried over MgSO4 and concentrated in vacuo. Flash column 
chromatography (20% EtOAc/hexane) of the crude afforded the title compound 173 (428.0 mg, 
37% over two steps) as a colourless oil; νmax / cm
-1: 2927 (s), 2853 (m), 1642 (s), 1508 (s), 1451 
(m), 1280 (m), 1257 (m), 966 (m); 1H NMR (CDCl3, 500 MHz): δ 6.18 (d, J = 15.4 Hz, 1H, C4-
H), 5.64 (dt, J = 15.4, 7.2 Hz, 1H, C5-H), 5.09 (br. d, J = 7.9j Hz, 1H, N11-H), 4.86 (s, 2H, C3-
H2), 3.70 – 3.59 (m, 1H, C12-H), 3.39 (t, J = 7.2 Hz, 2H, C7-H2), 2.45 – 2.32 (m, 3H, C8-H and 
C6-H2), 1.97 – 1.87 (m, 2H, 2 × C13-HaHb), 1.82 (s, 3H, C1-H3), 1.72 – 1.54 (m, 3H, C15-HaHb 
and 2 × C14-HaHb), 1.44 – 1.31 (m, 2H, 2 × C14-HaHb), 1.24 – 1.07 (m, 3H, C15-HaHb and 2 × 
C13-HaHb), 0.85 – 0.78 (m, 2H, 2 × C9-HaHb), 0.71 – 0.66 (m, 2H, 2 × C9-HaHb); 
13C NMR 
(CDCl3, 126 MHz): δ 158.2 (C10), 142.3 (C2), 134.6 (C4), 128.1 (C5), 114.8 (C3), 49.1 (C12), 
46.6 (C7), 34.0 (C13), 32.1 (C6), 27.6 (C8), 25.9 (C15), 25.1 (C14), 18 .8 (C1), 8.8 (C9); HRMS: 
(ESI+) calculated for C17H29N2O: 277.2274, found [M+H]
+: 277.2261. 
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General procedure D: N-Benzhydrylcyclopropanamine 202b (1.80 g, 8.06 mmol, prepared 
according to the literature procedure270) and 2-nitrobenzoyl chloride (1.28 mL, 9.67 mmol) were 
employed to afford amide 203b (2.08 g, 69%) which was used in the next step without further 
purification. Amide 203b (2.08 g, 5.59 mmol) was dissolved in AcOH:EtOH (1:2, 15:30 mL) and 
iron (0.78 g, 13.96 mmol) was added at r.t. The reaction mixture was heated to 85 °C for 18 h, 
cooled to r.t. and concentrated in vacuo. 1.0 M aq. NaOH was added to adjust pH to ~10 and the 
solution was extracted with EtOAc (3 × 30 mL). The organic extracts were combined, washed 
with brine (30 mL), dried over MgSO4 and concentrated in vacuo. Flash column chromatography 
(3-10% EtOAc/pentane) afforded the title compound 195b (1.05 g, 55%) as a colourless solid; 
m.p. 150-151 °C (DCM/hexane); νmax / cm
-1: 3448 (br. w), 3356 (br. w), 3027 (w), 1617 (s), 1589 
(s), 1493 (s), 1394 (s), 1326 (m), 1268 (m), 1031 (m); 1H NMR (CDCl3, 400 MHz): δ 7.38 – 7.27 
(m, 10H, 2 × C11-H, 2 × C12-H and C13-H), 7.17 (dd, J = 7.6, 1.6 Hz, 1H, C4-H), 7.14 (td, J = 
7.9, 1.6 Hz, 1H, C2-H), 6.78 (s, 1H, C9-H), 6.72 (dd, J = 7.9, 1.0 Hz, 1H, C1-H), 6.66 (td, J = 7.6, 
1.0 Hz, 1H, C3-H), 4.40 (br. s, 2H, N7-H2), 2.23 (tt, J = 7.0, 4.0 Hz, 1H, C14-H), 0.65 – 0.59 (m, 
2H, 2 × C15-HaHb), 0.34 – 0.27 (m, 2H, 2 × C15-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 173.3 
(C8), 145.6 (C6), 139.6 (C10), 130.3 (C2), 129.1 (C12), 128.2 (C11), 127.6 (C4), 127.3 (C13), 
122.2 (C5), 117.1 (C3), 116.6 (C1), 65.0 (C9), 31.2 (C14), 9.6 (C15); HRMS: (ESI+) calculated 
for C23H23N2O: 343.1805, found [M+H]
+: 343.1802. 
  




N-Cyclopropyl-2-nitrobenzamide 203e (0.60 g, 2.91 mmol, prepared according to the literature 
procedure271) was dissolved in dry THF (7 mL) and the solution was cooled to 0 °C. NaH (0.58 g, 
14.55 mmol, 60% dispersion in mineral oil) was added batchwise and the reaction was stirred at 0 
°C for 1 h. Methyl iodide (0.91 mL, 14.55 mmol) was added dropwise, the solution was warmed 
to r.t. and stirred for 18 h. Water (30 mL) was added and the solution was extracted with Et2O (3 
× 20 mL). The organic extracts were combined, washed with brine (30 mL), dried over MgSO4 
and concentrated in vacuo. The residue was purified by flash column chromatography (3-10% 
EtOAc/hexane) to afford the title compound 203d (0.59 g, 92%, 1:0.18 mixture of rotamers A:B) 
as a colourless oil; νmax / cm
-1: 1641 (s), 1523 (s), 1344 (s), 1288 (m), 1032 (m), 851 (m), 713 (s); 
1H NMR (CDCl3, 400 MHz, major rotamer only): δ 8.14 (dd, J = 8.3, 1.3 Hz, 1H, C1-H), 7.68 (td, 
J = 7.5, 1.1 Hz, 1H, C4-H), 7.56 – 7.50 (m, 1H, C2-H), 7.40 (dd, J = 7.5, 1.3 Hz, 1H, C3-H), 3.12 
(s, 3H, C8-H3), 2.49 – 2.42 (m, 1H, C9-H), 0.53 – 0.41 (m, 4H, 2 × C10-H2); 
13C NMR (CDCl3, 
101 MHz, major rotamer only): δ 169.7 (C7), 145.2 (C6), 134.5 (C5), 134.0 (C4), 129.5 (C2), 
128.6 (C3), 124.4 (C1), 34.4 (C8), 31.7 (C9), 8.6 (C10); HRMS: (ESI+) calculated for C11H15N2O: 




Amide 203d (0.50 g, 2.27 mmol) was dissolved in AcOH:EtOH (1:2, 5:10 mL) and iron (0.32 g, 
5.68 mmol) was added at r.t. The reaction mixture was heated to 90 °C for 2 h, cooled to r.t., stirred 
for 16 h and concentrated in vacuo. 1.0 M aq. NaOH was added to adjust pH to ~10 and the solution 
was extracted with EtOAc (3 × 20 mL). The organic extracts were combined, washed with brine 
(20 mL), dried over MgSO4 and concentrated in vacuo. Flash column chromatography (40% 
EtOAc/pentane) afforded the title compound 195d (0.39 g, 91%) as a pale yellow oil; νmax / cm
-1: 
3449 (br. w), 3348 (br. w), 3008 (br. w), 1615 (s), 1586 (s), 1384 (s), 1362 (s); 1H NMR (CDCl3, 
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400 MHz): δ 7.18 (dd, J = 8.0, 1.6 Hz, 1H, C2-H or C4-H), 7.13 (td, J = 7.6, 1.6 Hz, 1H, C2-H or 
C4-H), 6.71 – 6.65 (m, 2H, C1-H and C3-H), 4.42 (br. s, 2H, N7-H2), 3.06 (s, 3H, C9-H3), 2.79 
(tt, J = 7.0, 4.0 Hz, 1H, C10-H), 0.66 – 0.49 (m, 4H, 2 × C1-H2); 
13C NMR (CDCl3, 101 MHz): δ 
172.6 (C8), 145.7 (C6), 130.4, 128.1 (C2 and C4), 121.2 (C5), 116.9, 116.5 (C1 and C3), 35.3 





N-Cyclopropyl-2-nitrobenzamide 203e (1.10 g, 5.33 mmol, mmol, prepared according to the 
literature procedure271) was dissolved in AcOH:EtOH (1:2, 8:16 mL) and iron (0.74 g, 13.30 
mmol) was added at r.t. The reaction mixture was heated to 90 °C for 2 h, cooled to r.t. and 
concentrated in vacuo. 1.0 M aq. NaOH was added to adjust pH to ~10 and the solution was 
extracted with EtOAc (3 × 20 mL). The organic extracts were combined, washed with brine (20 
mL), dried over MgSO4 and concentrated in vacuo. The residue was purified by recrystallization 
(DCM/hexane, 2 crops) to afford the title compound 195e (0.84 g, 89%) as a colourless solid; m.p. 
147-148 °C (DCM/hexane); νmax / cm
-1: 3422 (br. m), 3301 (s), 1634 (m), 1620 (s), 1588 (m), 1523 
(s), 1303 (m); 1H NMR (CDCl3, 400 MHz): δ 7.23 (dd, J = 7.9, 1.5 Hz, 1H, C4-H), 7.18 (ddd, J = 
8.5, 7.2, 1.5 Hz, 1H, C2-H), 6.66 (dd, J = 8.3, 1.1 Hz, 1H, C1-H), 6.60 (ddd, J = 8.1, 7.2, 1.2 Hz, 
1H, C3-H), 6.18 (br. s, 1H, N9-H), 5.56 (br. s, 2H, N7-H2), 2.83 (tt, J = 7.0, 3.8 Hz, 1H, C10-H), 
0.88 – 0.81 (m, 2H, 2 × C11-HaHb), 0.62 – 0.56 (m, 2H, 2 × C11-HaHb); 
13C NMR (CDCl3, 101 
MHz): δ 170.8 (C8), 148.8 (C5), 132.3 (C2), 127.0 (C4), 117.3 (C1), 116.4 (C3), 115.6 (C7), 22.8 
(C10), 6.7 (C11); HRMS: (ESI+) calculated for C10H13N2O: 177.1022, found [M+H]
+: 100.1030. 
  




General procedure F: In a modification to the general procedure, the reaction was heated to  
140 °C. 2-Amino-N-cyclopropylbenzamide 195e (17.6 mg, 0.10 mmol) was employed. Flash 
column chromatography (20-30% EtOAc/hexane) afforded the title compound 198e (5.2 mg, 30%) 
as a colourless solid; m.p. 230-231 °C (DCM/hexane); 1H NMR (CDCl3, 400 MHz): δ 11.80 (br. 
s, 1H, N13-H), 8.29 (dd, J = 8.0, 1.3 Hz, 1H, C3-H), 7.77 (ddd, J = 8.2, 7.0, 1.3 Hz, 1H, C1-H), 
7.70 (d, J = 8.2 Hz, 1H, C6-H), 7.47 (ddd, J = 8.0, 7.0, 1.2 Hz, 1H, C2-H), 2.87 (q, J = 7.3 Hz, 2H, 
C11-H2), 1.46 (t, J = 7.3 Hz, 3H, C12-H3); 
13C NMR (CDCl3, 101 MHz): δ 164.4 (C7), 157.7 (C9), 
149.5 (C5), 134.8, 127.2, 126.4, 126.3 (C1, C2, C3, and C6), 120.5 (C4), 29.2 (C11), 11.6 (C12). 





To a solution of N-benzylcyclopropanamine (2.00 g, 13.61 mmol, prepared according to the 
literature procedure50) and potassium carbonate (2.57 g, 16.33 mmol) in dry DCM (30 mL) under 
a nitrogen atmosphere, bromoacetyl bromide (1.42 mL, 16.33 mmol) was added dropwise at 0 °C. 
The reaction was warmed to room temperature and stirred for 18 h. Water (30 mL) was added and 
the solution was extracted with DCM (3 × 30 mL). The organic extracts were combined, washed 
with brine (30 mL), dried over MgSO4 and concentrated in vacuo to afford 2-bromoacetamide 207 
(3.63, 99%) as a pale yellow oil which was used in the following step without further purification; 
νmax / cm
-1: 1652 (s), 1428 (m), 1400 (s), 1372 (m), 1212 (m), 1031 (m), 696 (s); 1H NMR (CDCl3, 
400 MHz): δ 7.35 – 7.23 (m, 5H, 2 × C7-H, 2 × C8-H and C9-H), 4.62 (s, 2H, C5-H2), 4.18 (s, 2H, 
C4-H2), 2.70 (tt, J = 6.8, 4.2 Hz, 1H, C2-H), 0.92 – 0.84 (m, 4H, 2 × C1-H2); 
13C NMR (CDCl3, 
101 MHz): δ 169.5 (C3), 137.5 (C6), 128.7, 128.0 (C7 and C8), 127.5 (C9), 50.4 (C5), 30.3 (C2), 
27.5 (C4), 9.2 (C1); HRMS: (ESI+) calculated for C12H15NOBr: 268.0332, found [M+H]
+: 
238.0334. 





General procedure E: In a modification to the general procedure, toluene (10 mL) and aniline 
(40 mL) were used. N-Benzyl-2-bromo-N-cyclopropylacetamide 207 (6.37 g, 23.76 mmol) was 
employed and the reaction was stirred at 80 °C for 18 h. The residue was purified twice by 
recrystallization (DCM/hexane) to afford the title compound 199a (2.98 g, 45%) as a colourless 
solid; m.p. 109-110 °C (DCM/hexane); νmax / cm
-1: 3388 (br. w), 1660 (s), 1604 (s), 1507 (s), 1404 
(s), 750 (m), 694 (m); 1H NMR (CDCl3, 400 MHz): δ 7.35 – 7.17 (m, 7H, 2 × C8-H, 2 × C12-H, 
2 × C13-H and C14-H), 6.73 (t, J = 7.3 Hz, 1H, C9-H), 6.66 (d, J = 7.9 Hz, 2H, 2 × C7-H), 4.91 
(br. s, 1H, N5-H), 4.66 (s, 2H, C10-H2), 4.12 (s, 2H, C4-H2), 2.61 (tt, J = 6.8, 4.1 Hz, 1H, C2-H), 
0.97 – 0.81 (m, 4H, 2 × C1-H2); 
13C NMR (CDCl3, 101 MHz): δ 172.4 (C3), 147.7 (C6), 137.8 
(C11), 129.4 (C8), 128.7, 127.9 (C12 and C13), 127.5 (C14), 117.7 (C9), 113.1 (C7), 50.4 (C4), 





General procedure E: N-Benzyl-2-bromo-N-cyclopropylacetamide 207 (1.00 g, 3.73 mmol) and 
p-anisidine (2.30 g, 18.65 mmol) were employed and the reaction was stirred at 90 °C for 3 h. The 
residue was purified by flash column chromatography (30% EtOAc/toluene) to afford the title 
compound 199b (0.51 g, 48%) as an off-white solid; m.p. 88-89 °C (DCM/hexane); νmax / cm
-1: 
3372 (br. w), 2935 (br. w), 2831 (w), 1659 (s), 1513 (s), 1396 (m), 1234 (s), 1036 (m); 1H NMR 
(CDCl3, 400 MHz): δ 7.33 – 7.21 (m, 5H, 2 × C13-H, 2 × C14-H and C15-H), 6.80 (d, J = 8.8 Hz, 
2H, 2 × C7-H), 6.63 (d, J = 8.8 Hz, 2H, 2 × C8-H), 4.65 (s, 2H, C11-H2), 4.63 (br. s, 1H, N5-H), 
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4.09 (s, 2H, C4-H2), 3.75 (s, 3H, C10-H3), 2.60 (tt, J = 6.9, 4.0 Hz, 1H, C2-H), 0.94 – 0.81 (m, 
4H, 2 × C1-H2); 
13C NMR (CDCl3, 101 MHz): δ 172.6 (C3), 152.3 (C9), 142.0 (C6), 137.7 (C12), 
128.6 (C14), 127.8 (C13), 127.3 (C15), 114.9 (C7), 114.3 (C8), 55.8 (C10), 50.2 (C11), 47.3 (C4), 






General procedure E: N-Benzyl-2-bromo-N-cyclopropylacetamide 207 (1.00 g, 3.73 mmol) and 
o-anisidine (2.30 g, 18.65 mmol) were employed and the reaction was stirred at 90 °C for 5 h. The 
residue was purified by recrystallization (DCM/hexane) to afford the title compound 199c (0.75 
g, 65%) as a colourless solid; m.p. 134-135 °C (DCM/hexane); νmax / cm
-1: 3407 (br. w), 1657 (s), 
1601 (s), 1515 (s), 1401 (s), 1245 (m), 1221 (s), 1027 (s); 1H NMR (CDCl3, 500 MHz): δ 7.36 – 
7.25 (m, 5H, C1-H, 2 × C2-H and 2 × C3-H), 6.92 – 6.87 (m, 1H, C13-H), 6.84 – 6.80 (m, 1H, 
C12-H), 6.75 – 6.70 (m, 1H, C14-H), 6.56 (d, J = 7.6 Hz, 1H, C15-H), 5.41 (br. s, 1H, N10-H), 
4.69 (s, 2H, C5-H2), 4.17 (d, J = 3.9 Hz, 2H, C9-H2), 3.89 (s, 3H, C17-H3), 2.64 (tt, J = 6.7, 4.2 
Hz, 1H, C6-H), 0.98 – 0.84 (m, 4H, 2 × C7-H2); 
13C NMR (CDCl3, 126 MHz): δ 172.5 (C8), 147.4 
(C11), 138.0, 137.8 (C4 and C16), 128.7, 128.0 (C2 and C3), 127.4 (C1), 121.2 (C13), 117.0 
(C14), 110.0 (C15), 109.7 (C12), 55.6 (C17), 50.3 (C5), 46.4 (C9), 29.0 (C6), 8.8 (C7); HRMS: 
(ESI+) calculated for C19H23N2O2: 311.1754, found [M+H]
+: 311.1752. 
  




General procedure E: N-Benzyl-2-bromo-N-cyclopropylacetamide 207 (1.00 g, 3.73 mmol) and 
3,5-xylidine (2.26 g, 18.65 mmol) were employed and the reaction was stirred at 90 °C for 2 h. 
The residue was purified by flash column chromatography (5-20% EtOAc/hexane) to afford the 
title compound 199d (0.86 g, 75%) as a pale yellow oil; νmax / cm
-1: 3357 (br. w), 2940 (w), 1657 
(s), 1476 (m), 1398 (s), 1265 (s), 1030 (m); 1H NMR (CDCl3, 400 MHz): δ 7.33 – 7.20 (m, 5H, 
C1-H, 2 × C2-H and 2 × C3-H), 6.99 (d, J = 7.4 Hz, 2H, 2 × C13-H), 6.80 (t, J = 7.5 Hz, 1H, C14-
H), 4.76 (br. s, 1H, N10-H), 4.64 (s, 2H, C5-H2), 4.05 (s, 2H, C9-H2), 2.49 (tt, J = 6.8, 4.0 Hz, 1H, 
C6-H), 2.36 (s, 6H, 2 × C15-H3), 0.86 – 0.73 (m, 4H, 2 × C7-H2); 
13C NMR (CDCl3, 101 MHz): 
δ 173.6 (C8), 147.1 (C11), 137.8 (C4), 128.8 (C13), 128.6 (C2 or C3), 128.2 (C12), 127.8 (C2 or 
C3), 127.3 (C1), 121.2 (C14), 51.0 (C9), 50.3 (C5), 28.8 (C6), 19.1 (C15), 8.5 (C7); HRMS: (ESI+) 





General procedure E: N-Benzyl-2-bromo-N-cyclopropylacetamide 207 (0.99 g, 3.69 mmol) and 
4-(trifluoromethyl)aniline (0.60 g, 3.69 mmol) were employed and the reaction was stirred at 90 
°C for 5 h. The residue was purified by recrystallization (DCM/hexane) to afford the title 
compound 199e (0.51 g, 41%) as a colourless solid; m.p. 147-148 °C (DCM/hexane); νmax / cm
-1: 
3350 (m), 1657 (s), 1616 (s), 1406 (m), 1330 (s), 1290 (m), 1097 (s), 1066 (s), 727 (m); 1H NMR 
(CDCl3, 400 MHz): δ 7.42 (d, J = 8.3 Hz, 2H, 2 × C13-H), 7.36 – 7.22 (m, 5H, C1-H, 2 × C2-H 
and 2 × C3-H), 6.64 (d, J = 8.3 Hz, 2H, 2 × C12-H), 5.30 (br. s, 1H, N10-H), 4.67 (s, 2H, C5-H2), 
4.13 (d, J = 4.3 Hz, 2H, C9-H2), 2.62 (tt, J = 6.9, 4.0 Hz, 1H, C6-H), 0.99 – 0.84 (m, 4H, 2 × C7-
H2); 
13C NMR (CDCl3, 126 MHz): δ 171.69 (C8), 149.85 (C11), 137.66 (C4), 128.80, 127.93 (C2 
and C3), 127.58 (C1), 126.79 (q, J = 3.7 Hz, C13), 125.12 (q, J = 270.3 Hz, C15), 119.14 (q, J = 
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32.6 Hz, C14), 112.21 (C12), 50.49 (C5), 45.82 (C9), 29.02 (C6), 8.81 (C7); 19F NMR (376 MHz, 
CDCl3) δ -62.40; HRMS: (ESI






To a sealed tube containing a solution of primary amine 193 (0.30 g, 1.47 mmol, provided by Dr 
Calow) in dimethyl sulfoxide (1.5 mL), hexafluorobenzene (0.16 mL, 1.40 mmol) and potassium 
fluoride (0.08 g, 2.20 mmol) were added. The tube was sealed and heated to 100 °C for 18 h. The 
solution was cooled to r.t. and water (10 mL) and EtOAc (10 mL) were added. The layers were 
separated and the organic portion was washed with water (3 × 5 mL). The organic layer was dried 
over MgSO4 and concentrated in vacuo. The residue was purified by flash column chromatography 
(40% EtOAc/hexane) to afford the title compound 199f (0.43 g, 83%) as a yellow oil; νmax / cm
-1: 
3358 (br. w), 1664 (s), 1522 (s), 1405 (s), 1267 (m), 1025 (s), 965 (m); 1H NMR (CDCl3, 400 
MHz): δ 7.35 – 7.20 (m, 5H, C1-H, 2 × C2-H and 2 × C3-H), 4.95 (br. s, 1H, N10-H), 4.64 (s, 2H, 
C5-H2), 4.34 (s, 2H, C9-H2), 2.56 (tt, J = 7.2, 4.1 Hz, 1H, C6-H), 0.95 – 0.77 (m, 4H, 2 × C7-H2); 
13C NMR (CDCl3, 101 MHz): δ 171.9 (C8), 137.6 (C4), 128.8 (C2), 127.9 (C3), 127.6 (C1), 50.5 
(C5), 48.0 (C9), 28.9 (C6), 8.8 (C7); The aromatic signals corresponding to the pentafluorophenyl 
group could not be resolved due to their weak intensity; 19F NMR (CDCl3, 376 MHz): δ -159.94 
– -160.07 (m, F11), -164.46 – -164.62 (m, F12), -172.09 (tt, J = 22.0, 6.7 Hz, F13); HRMS: (ESI+) 
calculated for C18H15F5N2NaO: 393.0997, found [M+Na]
+: 393.0988. 
  




General procedure F: In a modification to the general procedure, sodium tert-butoxide (5 mol%) 
was used and the reaction was stirred at 160 °C. N-Benzyl-N-cyclopropyl-2-
(phenylamino)acetamide 199a (28.0 mg, 0.10 mmol) was employed. Flash column 
chromatography (5-10% acetone/toluene) afforded the title compound 200a (14.2 mg, 46%) as a 
light brown oil; νmax / cm
-1: 1653 (s), 1493 (m), 1454 (m), 1402 (s), 1216 (s), 724 (s), 698 (s); 1H 
NMR (CDCl3, 400 MHz): δ 7.42 – 7.23 (m, 10H, 2 × C2-H, 2 × C3-H, 2 × C13-H, 2 × C14-H, 
C1-H and C15-H), 6.39 (d, J = 7.2 Hz, 1H, C6-H), 5.59 (td, J = 8.1, 7.2 Hz, 1H, C7-H), 4.68 (s, 
2H, C5-H2), 4.42 (s, 2H, C10-H2), 3.05 (dd, J = 8.2, 1.1 Hz, 2H, C8-H2); 
13C NMR (CDCl3, 101 
MHz): δ 166.8 (C11), 166.5 (C9), 145.2 (C12), 135.7 (C4), 132.7 (C6), 129.4 (C14), 129.0, 128.9 
(C3 and C2), 128.3, 127.3 (C1 and C15), 126.8 (C13), 116.8 (C7), 56.8 (C10), 50.2 (C5), 36.8 





General procedure F: N-Benzyl-N-cyclopropyl-2-((4-methoxyphenyl)amino)acetamide 199b 
(31.0 mg, 0.10 mmol) was employed. Flash column chromatography (5-10% acetone/toluene) 
afforded the title compound 200b (10.4 mg, 31%) as a light brown oil; νmax / cm
-1: 2940 (br. w), 
1658 (s), 1499 (s), 1455 (s), 1407 (s), 1266 (m), 1242 (m); 1H NMR (CDCl3, 400 MHz): δ 7.39 – 
7.27 (m, 5H, 2 × C2-H, 2 × C3-H and C1-H), 7.22 – 7.17 (m, 2H, 2 × C13-H), 6.92 – 6.87 (m, 2H, 
2 × C14-H), 6.37 (d, J = 7.2 Hz, 1H, C6-H), 5.57 (td, J = 8.1, 7.2 Hz, 1H, C7-H), 4.67 (s, 2H, C5-
H2), 4.39 (s, 2H, C10-H2), 3.80 (s, 3H, C16-H3), 3.04 (dd, J = 8.1, 1.1 Hz, 2H, C8-H2); 
13C NMR 
(CDCl3, 126 MHz): δ 166.9 (C11), 166.7 (C9), 158.5 (C15), 138.1 (C12), 135.8 (C4), 132.6 (C6), 
129.0 (C3), 128.9 (C2), 128.3 (C1), 127.8 (C13), 116.9 (C7), 114.7 (C14), 57.1 (C10), 55.6 (C16), 
50.2 (C5), 36.7 (C8); HRMS: (ESI+) calculated for C20H20N2NaO3: 359.1366, found [M+Na]
+: 
359.1360. 




General procedure F: N-Benzyl-N-cyclopropyl-2-((2-methoxyphenyl)amino)acetamide 199c 
(31.0 mg, 0.10 mmol) was employed. Flash column chromatography (5% acetone/toluene) 
afforded the title compound 200c (14.1 mg, 42%) as a colourless solid; m.p. 139-140 °C 
(DCM/Et2O/hexane); νmax / cm
-1: 2938 (br. w), 1658 (s), 1499 (s), 1455 (s), 1405 (s), 1266 (m), 
1241 (m), 1214 (m); 1H NMR (CDCl3, 500 MHz): δ 7.38 – 7.24 (m, 7H, C1-H, C13-H, C15-H, 2 
× C2-H and 2 × C3-H), 6.97 (td, J = 7.6, 1.2 Hz, 1H, C14-H), 6.93 (dd, J = 8.2, 1.2 Hz, 1H, C16-
H), 6.35 (d, J = 7.3 Hz, 1H, C11-H), 5.58 (td, J = 8.1, 7.3 Hz, 1H, C10-H), 4.86 (br. s, 1H, C5-
H2), 4.59 (br. s, 1H, C7-H2), 4.50 (br. s, 1H, C5-H2), 4.00 (br. s, 1H, C7-H2), 3.80 (s, 3H, C18-H3), 
3.06 (d, J = 8.1 Hz, 2H, C9-H2); 
13C NMR (CDCl3, 126 MHz): δ 167.0 (C6), 166.6 (C8), 154.5 
(C17), 135.9 (C4), 133.9 (C12), 132.4 (C11), 129.1, 129.0 (C13 and C15), 129.0, 128.9 (C2 and 
C3), 128.2 (C1), 121.3 (C14), 116.9 (C10), 112.1 (C16), 56.4 (C7), 55.9 (C18), 50.1 (C5), 36.5 
(C9); HRMS: (ESI+) calculated for C20H21N2O3: 337.1547, found [M+H]
+: 337.1551. The 
structure of 200c was determined unambiguously by X-ray crystallography. 
 
Crystal image of 200c generated in Olex2, ellipsoids at 50% probability, hydrogen atoms omitted 
for clarity; Crystal data for 200c: C20H20N2O3, MW = 336.38, orthorhombic, space group P212121, 
a = 7.7872(10) Å, b = 9.6572(12) Å, c = 22.965(3) Å, V = 1727.1(4) Å3, α = 90.00°, β = 90.00°, γ 
= 90.00°, Z = 4, Dc = 1.294 g/cm
3, Mo-Kα radiation, λ = 0.71073 Å, μ = 0.088 mm-1, T = 100 K; 
colourless block, crystal size 0.35 × 0.305 × 0.2 mm3, Bruker Apex II diffractometer, 8460 
reflections were collected, 4057 were unique, Rint = 0.0312; refinement on F
2 gave R1 = 0.0422 
and wR2 = 0.0881, GOF = 1.028 for 227 refined parameters. 
  




General procedure F: N-Benzyl-N-cyclopropyl-2-((2,6-dimethylphenyl)amino)acetamide 199d 
(30.8 mg, 0.10 mmol) was employed. Flash column chromatography (5-10% acetone/toluene) 
afforded the title compound 200d (10.0 mg, 30%) as a light brown oil; νmax / cm
-1: 2924 (br. w), 
1656 (s), 1456 (m), 1405 (s), 1212 (m); 1H NMR (CDCl3, 400 MHz): δ 7.39 – 7.30 (m, 5H, C1-H, 
2 × C2-H and 2 × C3-H), 7.15 – 7.07 (m, 3H, C15-H and 2 × C14-H), 6.42 (d, J = 7.1 Hz, 1H, 
C11-H), 5.62 (td, J = 8.3, 7.1 Hz, 1H, C10-H), 4.69 (s, 2H, C5-H2), 4.17 (s, 2H, C7-H2), 3.06 (dd, 
J = 8.3, 1.1 Hz, 2H, C9-H2), 2.23 (s, 6H, 2 × C16-H3); 
13C NMR (CDCl3, 101 MHz): δ 166.3 (C6), 
165.7 (C8), 142.9 (C12), 135.6 (C4), 135.1 (C13), 132.7 (C11), 129.0, 128.9 (C2 and C3), 128.8 
(C14), 128.3 (C1), 128.1 (C15), 116.8 (C10), 56.1 (C7), 50.2 (C5), 36.1 (C9), 18.0 (C16); HRMS: 






General procedure F: N-Benzyl-N-cyclopropyl-2-((4-(trifluoromethyl)phenyl)-amino)-
acetamide 199e (34.8 mg, 0.10 mmol) was employed. Flash column chromatography (5% 
acetone/toluene) afforded the title compound 200e (6.4 mg, 17%) as a pale brown oil; νmax / cm
-1: 
1659 (s), 1401 (m), 1321 (s), 1163 (s), 1108 (s), 1066 (m), 722 (m); 1H NMR (CDCl3, 400 MHz): 
δ 7.67 – 7.63 (m, 2H, 2 × C14-H), 7.48 – 7.44 (m, 2H, 2 × C13-H), 7.39 – 7.31 (m, 5H, C1-H, 2 × 
C2-H and 2 × C3-H), 6.42 (dt, J = 7.2, 1.2 Hz, 1H, C6-H), 5.60 (td, J = 8.1, 7.2 Hz, 1H, C7-H), 
4.69 (s, 2H, C5-H2), 4.44 (s, 2H, C10-H2), 3.05 (dd, J = 8.1, 1.2 Hz, 2H, C8-H2); 
13C NMR (CDCl3, 
126 MHz): δ 166.6, 166.5 (C9 and C11), 148.0 (C12), 135.6 (C4), 133.0 (C6), 129.21 (q, J = 32.8 
Hz, C15), 129.0, 129.0 (C2 and C3), 128.4 (C1), 127.2 (C13), 126.53 (q, J = 3.7 Hz, C14), 123.98 
(q, J = 271.7 Hz, C16), 116.7 (C7), 56.3 (C10), 50.3 (C5), 36.8 (C8); 19F NMR (376 MHz, CDCl3) 
δ -60.87; HRMS: (ESI+) calculated for C20H18F3N2O2: 375.1315, found [M+H]
+: 375.1317. 




To a sealed tube containing a solution of 2-bromoacetamide 207 (1.00 g, 1.47 mmol) in ethanol (5 
mL), methylamine solution (40% in H2O, 5 mL) was added. The tube was sealed and heated to 65 
°C for 18 h. The solution was cooled to r.t., the solvent was removed in vacuo and the residue was 
redissolved in EtOAc (20 mL) and washed with sat. aq. NaHCO3 (20 mL). The aqueous portion 
was further extracted with EtOAc (2 × 10 mL) and the organic extracts were combined, washed 
with brine (20 mL), dried over MgSO4 and concentrated in vacuo. The residue was purified by 
flash column chromatography (0-10% MeOH/EtOAc) to afford the title compound 208 (0.30 g, 
37%) as a yellow oil; νmax / cm
-1: 3337 (br. w), 2940 (w), 1652 (s), 1402 (s), 1374 (s), 1264 (s), 
1031 (m); 1H NMR (CDCl3, 400 MHz): δ 7.33 – 7.20 (m, 5H, C1-H, 2 × C2-H and 2 × C3-H), 
4.62 (s, 2H, C5-H2), 3.62 (s, 2H, C9-H2), 2.52 (tt, J = 7.1, 4.2 Hz, 1H, C6-H), 2.47 (s, 3H, C11-
H3), 2.31 (s, 1H, N10-H), 0.87 – 0.73 (m, 4H, 2 × C7-H2); 
13C NMR (CDCl3, 101 MHz): δ 174.1 
(C8), 138.1 (C4), 128.6 (C2), 127.9 (C3), 127.3 (C1), 53.3 (C9), 50.1 (C5), 36.6 (C11), 29.1 (C6), 





To a solution of N-Benzyl-2-bromo-N-cyclopropylacetamide 207 (0.76 g, 2.83 mmol) in toluene 
(30 mL), benzylamine (1.24 mL, 11.34 mmol) and K2CO3 (1.65 g, 11.90 mmol) were added. The 
reaction mixture was heated at 80 °C for 18 h, concentrated in vacuo and then water (30 mL) was 
added. The solution was extracted with EtOAc (3 × 30) and then the organic extracts were 
combined, washed with brine (30 mL), dried over MgSO4 and concentrated in vacuo. The residue 
was purified by flash column chromatography (80% EtOAc/hexane) to afford the title compound 
209 (0.51 g, 61%) as a colourless oil; νmax / cm
-1: 3328 (br. w), 1653 (s), 1453 (m), 1404 (s), 1264 
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(m), 1030 (m); 1H NMR (CDCl3, 400 MHz): δ 7.38 – 7.21 (m, 10H, 2 × C8-H, 2 × C9-H, 2 × C13-
H, 2 × C14-H, C10-H and C15-H), 4.62 (s, 2H, C11-H2), 3.84 (s, 2H, C6-H2), 3.66 (s, 2H, C4-H2), 
2.47 (tt, J = 6.8, 4.2 Hz, 1H, C2-H), 0.81 – 0.67 (m, 4H, 2 × C1-H2); 
13C NMR (CDCl3, 101 MHz): 
δ 174.3 (C3), 140.1 (C7), 138.2 (C12), 128.6, 128.5, 128.4, 127.9, 127.3, 127.1 (C8, C9, C10, C13, 
C14 and C15), 53.8 (C6), 50.6 (C4), 50.1 (C11), 29.1 (C2), 8.9 (C1); HRMS: (ESI+) calculated for 





To a solution of N-(tert-butoxycarbonyl)-proline (1.46 g, 6.79 mmol) in DCM (0.3 M), EDCI (1.43 
g, 7.47 mmol) was added and the reaction was stirred at r.t. for 10 min. Then, N-
benzylcyclopropanamine (1.00 g, 6.79 mmol) and 4-dimethylaminopyridine (0.08 g, 0.68 mmol) 
were added and the reaction was stirred at r.t. for 18 h, washed with 2.0 M aq. HCl (30 mL), water 
(30 mL), sat. aq. NaHCO3 (30 mL), and brine (30 mL). Organic layer was dried over MgSO4 and 
concentrated in vacuo. The resulting amide 212 was isolated as a colourless solid (1.15 g, 49%) 
and used in the next step without purification. tert-Butyl 2-(benzyl(cyclopropyl)carbamoyl)-
pyrrolidine-1-carboxylate 212 (0.60 g, 1.74 mmol) in DCM (3 mL) was treated with TFA (1.3 mL, 
17.41 mmol) and the solvent was removed in vacuo after 1h. The residue was dissolved in DCM 
(30 mL), water (30 mL) and K2CO3 (approx. 1.0 g) were added and layers were separated. The 
aqueous portion was further extracted with DCM (2 × 20 mL) and the organic extracts were 
combined, washed with brine (30 mL), dried over MgSO4 and concentrated in vacuo. The residue 
was purified by flash column chromatography (1% MeOH/DCM) to afford the title compound 213 
(0.41 g, 97%) as a colourless oil; νmax / cm
-1: 3430 (br. w), 2969 (br. m), 1649 (s), 1451 (s), 1400 
(s), 1373 (s), 1200 (s), 1173 (s), 1127 (s); 1H NMR (CDCl3, 400 MHz): δ 7.33 – 7.17 (m, 5H, 2 × 
C11-H, 2 × C12-H and C13-H), 5.45 (br. s, 1H, N8-H), 4.89 (d, J = 14.6 Hz, 1H, C9-HaHb), 4.72 
(dd, J = 8.4, 7.0 Hz, 1H, C4-H), 4.31 (d, J = 14.6 Hz, 1H, C9-HaHb), 3.28 (dt, J = 11.1, 6.6 Hz, 
1H, C7-HaHb), 3.11 (dt, J = 11.1, 7.0 Hz, 1H, C7-HaHb), 2.57 – 2.50 (m, 1H, C2-H), 2.29 (dtd, J 
= 12.5, 8.4, 6.2 Hz, 1H, C5-HaHb), 2.03 – 1.81 (m, 2H, C6-H2), 1.78 – 1.68 (m, 1H, C5-HaHb), 
0.99 – 0.89 (m, 2H, C1-H2), 0.86 – 0.77 (m, 2H, C1’-H2); 
13C NMR (CDCl3, 101 MHz): δ 175.0 
(C3), 137.6 (C10), 128.8, 127.8 (C11 and C12), 127.5 (C13), 58.8 (C4), 50.8 (C9), 47.3 (C7), 30.2 
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(C5), 29.6 (C2), 26.1 (C6), 10.1 (C1), 8.3 (C1’); HRMS: (ESI+) calculated for C15H21N2O: 




To a solution of N-(3,4-dimethoxyphenethyl)cyclopropanamine 217 (1.50 g, 6.78 mmol, prepared 
according to the literature procedure50) and potassium carbonate (1.12 g, 8.13 mmol) in dry DCM 
(15 mL) under a nitrogen atmosphere, bromoacetyl bromide (0.71 mL, 8.13 mmol) was added 
dropwise at 0 °C. The reaction was warmed to room temperature and stirred for 18 h. Water (30 
mL) was added and the solution was extracted with DCM (3 × 20 mL). The organic extracts were 
combined, washed with brine (30 mL), dried over MgSO4 and concentrated in vacuo to afford 2-
bromoacetamide 218 (1.96, 84%) as a brown oil which was used in the following step without 
further purification. 
General procedure E: 2-Bromo-N-cyclopropylacetamide 218 (1.50 g, 4.38 mmol) and aniline 
(15 mL) were employed and the reaction was stirred at 90 °C for 4 h. The residue was purified by 
flash column chromatography (20-40% EtOAc/hexane) to afford the title compound 219(0.83 g, 
54%) as an off-white solid; m.p. 122-123 °C; νmax / cm
-1: 3383 (br. w), 1655 (s), 1602 (s), 1508 
(s), 1406 (s), 1260 (s), 1235 (s), 1027 (s), 750 (s); 1H NMR (CDCl3, 400 MHz): δ 7.20 (dd, J = 
8.5, 7.3 Hz, 2H, 2 × C18-H), 6.81 – 6.70 (m, 4H, C4-H, C7-H and 2 × C17-H), 6.67 – 6.61 (m, 
2H, C3-H and C19-H), 4.87 (br. s, 1H, N15-H), 4.02 (s, 2H, C14-H2), 3.86 (s, 3H, C1-H3 or C2-
H3), 3.86 (s, 3H, C1-H3 or C2-H3), 3.65 (t, J = 7.5 Hz, 2H, C10-H2), 2.84 (t, J = 7.5 Hz, 2H, C9-
H2), 2.49 (tt, J = 6.9, 4.1 Hz, 1H, C11-H), 0.93 – 0.86 (m, 2H, 2 × C12-HaHb), 0.74 – 0.69 (m, 2H, 
2 × C12-HaHb); 
13C NMR (CDCl3, 126 MHz): δ 172.1 (C13), 149.1, 147.8, 147.7 (C5, C6 and 
C16), 131.9 (C8), 129.4 (C18), 120.9, 117.7 (C3 and C19), 113.1 (C17), 112.2, 111.4 (C4 and C7), 
56.0 (C1 and C2), 49.2 (C10), 46.4 (C14), 34.0 (C9), 29.4 (C11), 8.9 (C12); HRMS: (ESI+) 








General procedure F: Acetamide 219 (35.4 mg, 0.10 mmol) was employed. Flash column 
chromatography (1-10% acetone/toluene) afforded the title compound 220 (15.1 mg, 40%) as a 
brown oil; νmax / cm
-1: 2934 (w), 1658 (s), 1515 (s), 1453 (m), 1405 (s), 1262 (s), 1236 (s), 1215 
(s), 1154 (m); 1H NMR (CDCl3, 400 MHz): δ 7.42 – 7.36 (m, 2H, 2 × C19-H), 7.31 – 7.24 (m, 3H, 
C20-H and 2 × C18-H), 6.82 – 6.73 (m, 3H, C3-H, C4-H and C7-H), 6.31 (d, J = 7.3 Hz, 1H, C11-
H), 5.60 (q, J = 7.9 Hz, 1H, C12-H), 4.36 (s, 2H, C15-H2), 3.88 (s, 3H, C1-H3 or C2-H3), 3.86 (s, 
3H, C1-H3 or C2-H3), 3. 76 (t, J = 7.7 Hz, 2H, C10-H2), 3.24 (d, J = 8.1 Hz, 2H, C13-H2), 2.87 (t, 
J = 7.7 Hz, 2H, C9-H2); 
13C NMR (CDCl3, 101 MHz): δ 166.8 (C16), 166.4 (C14), 149.2 (C5 or 
C6), 148.0 (C5 or C6), 145.1 (C17), 133.2 (C11), 130.6 (C8), 129.4 (C19), 127.3 (C20), 126.7 
(C18), 120.8 (C3), 116.1 (C12), 112.0 (C7), 111.4 (C4), 56.8 (C15), 56.1 (C1 or C2), 56.0 (C1 or 
C2), 48.1 (C10), 37.1 (C13), 33.7 (C9); HRMS: (ESI+) calculated for C22H24N2NaO4: 403.1628, 





A solution of compound 220 (57.1 mg, 0.15 mmol) and TFA (0.12 mL, 1.50 mmol) in DCM (1.5 
mL) was heated in a sealed tube at 60 °C for 24 h. The reaction mixture was cooled to r.t. and sat. 
aq. NaHCO3 (20 mL) was added. The solution was extracted with DCM (3 × 10 mL) and the 
organic extracts were combined, dried over MgSO4 and concentrated in vacuo. The residue was 
purified by column chromatography (100% EtOAc) to yield the title compound 219 (42.8 mg, 
75%) as a colorless solid; m.p. 242-243 °C (DCM/hexane); νmax / cm
-1: 2935 (w), 1644 (s), 1518 
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(s), 1443 (s), 1256 (s), 1210 (s), 1123 (s); 1H NMR (CDCl3, 500 MHz): δ 7.44 – 7.39 (m, 2H, 2 × 
C5-H), 7.32 – 7.26 (m, 3H, C6-H and 2 × C4-H), 6.66 (s, 1H, C19-H), 6.59 (s, 1H, C14-H), 5.29 
(br. s, 1H, C10-H), 4.67 (br. s, 2H, C2-H2), 4.41 (br, s, 1H, C12-HaHb), 3.88 (s, 3H, C16/18-H3), 
3.87 (s, 3H C16/18-H3), 3.37 – 3.25 (br. m, 1H, C12-HaHb), 2.93 – 2.75 (m, 4H, C9-H2 and C11-
H2), 2.35 – 2.18 (m, 2H, C8-H2); 
13C NMR (DMSO-d6, 126 MHz, 80 °C): δ 172.4 (C7), 168.1 
(C1), 147.8, 147.7 (C15 and C17), 143.2 (C3), 128.7 (C20), 128.2 (C5), 126.7, 126.7 (C4 and 
C13), 125.9 (C6), 112.0 (C19), 111.3 (C14), 56.3, 55.9 (C16 and C18), 55.6 (C2), 54.2 (C10), 38.6 
(C12), 35.6 (C11), 34.2 (C8), 27.0 (C9); HRMS: (ESI+) calculated for C22H25N2O4: 381.1809, 




To a solution of amine 193 (0.20 g, 0.98 mmol, provided by Dr Calow), pyridine (0.12 mL, 1.47 
mmol) and DMAP (12 mg, 0.10 mmol) in dry DCM (3 mL), tosyl chloride (0.22 g, 1.17 mmol) 
was added at 0 °C. The reaction was stirred for 24 h at r.t. Water (10 mL) was added and the 
solution was extracted with Et2O (3 × 10 mL). The organic extracts were combined, dried over 
MgSO4 and concentrated in vacuo. The residue was purified by flash column chromatography 
(40% EtOAc/hexane) to afford the title compound 222 (0.12 g, 34%) as a colourless solid; m.p. 
115-116 °C (DCM/hexane); νmax / cm
-1: 3224 (br. w), 1652 (s), 1398 (s), 1374 (s), 1334 (s), 1160 
(s); 1H NMR (CDCl3, 400 MHz): δ 7.77 (d, J = 8.3 Hz, 2H, 2 × C12-H), 7.33 – 7.22 (m, 5H, C1-
H, 2 × C2-H and 2 × C13-H), 7.07 – 7.02 (m, 2H, 2 × C3-H), 5.72 (t, J = 4.5 Hz, 1H, N10-H), 4.49 
(s, 2H, C5-H2), 3.99 (d, J = 4.5 Hz, 2H, C9-H2), 2.43 (s, 3H, C15-H3), 2.42 – 2.37 (m, 1H, C6-H), 
0.86 – 0.80 (m, 2H, 2 × C7-HaHb), 0.70 – 0.64 (m, 2H, 2 × C7-HaHb); 
13C NMR (CDCl3, 101 
MHz): δ 170.1 (C8), 143.7 (C14), 137.3 (C4), 136.2 (C11), 129.8 (C13), 128.7 (C2), 127.7 (C3), 
127.5 (C1), 127.4 (C12), 50.4 (C5), 44.7 (C9), 28.8 (C6), 21.7 (C15), 8.7 (C7); HRMS: (MALDI) 









To a solution of amine 193 (0.50 g, 2.45 mmol, provided by Dr Calow) and Et3N (0.51 mL, 3.67 
mmol) in dry DCM (3 mL), dimethylcarbamyl chloride (0.34 mL, 3.67 mmol) was added at 0 °C. 
The reaction was stirred for 24 h at r.t. Water (10 mL) was added and the solution was extracted 
with DCM (3 × 10 mL). The organic extracts were combined, dried over MgSO4 and concentrated 
in vacuo. The residue was purified by flash column chromatography (50-100% EtOAc/hexane, 
then 5% MeOH/EtOAc) to afford the title compound 223 (0.29 g, 43%) as a colourless oil; νmax / 
cm-1: 3351 (br. w), 2931 (br. w), 1642 (s), 1532 (s), 1413 (s), 1267 (m), 1218 (m); 1H NMR (CDCl3, 
400 MHz): δ 7.33 – 7.17 (m, 5H, C1-H, 2 × C2-H and 2 × C3-H), 5.50 (br. t, J = 4.1 Hz, 1H, N10-
H), 4.61 (s, 2H, C5-H2), 4.28 (d, J = 4.1 Hz, 2H, C9-H2), 2.94 (s, 6H, 2 × C12-H3), 2.57 (tt, J = 
6.9, 4.0 Hz, 1H, C6-H), 0.92 – 0.76 (m, 4H, 2 × C7-H2); 
13C NMR (CDCl3, 101 MHz): δ 172.7 
(C8), 158.4 (C11), 137.8 (C4), 128.7 (C2), 127.7 (C3), 127.4 (C1), 50.4 (C5), 44.0 (C9), 36.3 






To a solution of triphosgene (2.93 g, 9.86 mmol) in dry DCM (25 mL) was added pyridine (3.19 
mL, 39.43 mmol) dropwise at 0 °C. The reaction was stirred for 10 min and then N-methyl-2-
nitroaniline (3.00 g, 19.72 mmol) in DCM (25 ml) was added. The reaction mixture was warmed 
to r.t. and stirred for 4 h. The solution was washed with 1.0 M aq. HCl (3 × 30 mL), water (40 
mL), dried over MgSO4 and then concentrated in vacuo to afford carbamic chloride 230 (3.70 g, 
87%) as a brown oil which was used without further purification. Carbamic chloride 230 (1.50 g, 
6.99 mmol) was dissolved in dry DCM (25 mL), then N-benzylcyclopropanamine (1.03 g, 6.99 
mmol) and DMAP (1.71 g, 13.98 mmol) were added and the reaction was stirred for 18 h at r.t. 
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The solution was washed with 1.0 M aq. HCl (30 mL), sat. aq. NaHCO3 (30 mL), water (30 mL), 
brine (30 mL), dried over MgSO4 and then concentrated in vacuo. The residue was purified by 
flash column chromatography (50% EtOAc/hexane) to afford the title compound 229 (1.82 g, 
80%) as a bright yellow oil; νmax / cm
-1: 2924 (w), 1651 (s), 1604 (m), 1526 (s), 1358 (s), 1294 
(m), 702 (m); 1H NMR (CDCl3, 400 MHz): δ 7.92 (dd, J = 8.2, 1.6 Hz, 1H, C14-H), 7.44 (ddd, J 
= 7.8, 7.8, 1.6 Hz, 1H, C12-H), 7.32 – 7.19 (m, 6H, C13-H, C9-H, 2 × C7-H and 2 × C8-H), 7.10 
(dd, J = 7.8, 1.4 Hz, 1H, C11-H), 4.26 (s, 2H, C5-H2), 3.29 (s, 3H, C1-H3), 1.74 (tt, J = 6.7, 3.9 
Hz, 1H, C3-H), 0.66 – 0.58 (m, 2H, 2 × C4-HaHb), 0.45 – 0.38 (m, 2H, 2 × C11-HaHb); 
13C NMR 
(CDCl3, 101 MHz): δ 161.0 (C2), 145.0 (C15), 140.1 (C10), 137.8 (C6), 133.9 (C12), 129.1 (C11), 
128.7, 128.6, 127.4, 126.4 (C7, C8, C9 and C13), 126.0 (C14), 53.2 (C5), 40.0 (C1), 30.8 (C3), 





To a solution of 229 (1.87 g, 5.75 mmol) in EtOAc (40 mL), stannous chloride dihydrate (6.49 g, 
6.49 mmol) was added and the reaction was stirred a 50 °C for 6 h. The reaction mixture was 
cooled to r.t., sat. aq. NaHCO3 (100 mL) was added and the mixture was stirred at r.t. for 40 min. 
Then, the solution was extracted with EtOAc (3 × 70 mL). The organic extracts were combined, 
washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo. The residue was purified 
by flash column chromatography (30-50% EtOAc/pentane) to afford the title compound 226 (0.52 
g, 31%) as a colourless oil; νmax / cm
-1: 3453 (br. w), 3342 (br. m), 1621 (s), 1502 (s), 1425 (s), 
1388 (s), 1310 (s), 1113 (m), 1029 (m); 1H NMR (CDCl3, 400 MHz): δ 7.34 – 7.22 (m, 5H, 2 × 
C14-H, 2 × C15-H and C16-H), 6.99 (ddd, J = 8.0, 7.3, 1.5 Hz, 1H, C4-H), 6.71 (dd, J = 3.4, 1.5 
Hz, 1H, C3-H), 6.69 (dd, J = 3.2, 1.5 Hz, 1H, C6-H), 6.57 (td, J = 7.6, 1.5 Hz, 1H, C5-H), 4.37 
(br. s, 2H, C12-H2), 3.78 (br. s, 2H, N1-H2), 3.06 (s, 3H, C8-H3), 1.83 (tt, J = 6.7, 3.9 Hz, 1H, 
C10-H), 0.65 – 0.56 (m, 2H, 2 × C11-HaHb), 0.54 – 0.48 (m, 2H, 2 × C11-HaHb); 
13C NMR (CDCl3, 
101 MHz): δ 163.2 (C9), 142.0 (C2), 138.6 (C13), 131.8 (C7), 128.5, 128.4 (C14 and C15), 127.5 
(C4), 127.2 (C16), 127.0 (C6), 118.7 (C5), 116.1 (C3), 53.0 (C12), 37.4 (C8), 30.7 (C10), 9.3 
(C11); HRMS: (ESI+) calculated for C18H22N3O: 296.1757, found [M+H]
+: 296.1764. 




To a solution of glycolic acid (0.62 g, 8.15 mmol) in DMF (12 mL), EDCI (1.95 g, 10.19 mmol) 
was added and the reaction mixture was stirred at r.t. for 10 min. HOBt (1.66 g, 10.19 mmol, 20 
wt.% H2O), N-methylmorpholine (2.24 mL, 20.38 mmol) and N-benzylcyclopropanamine (1.00 g, 
6.79 mmol) were added and the reaction mixture was stirred at r.t. for 18 h. Water (30 mL) was 
added and aqueous layer was extracted with DCM (3 × 30 mL). The organic extracts were 
combined, washed with 1.0 M aq. HCl (30 mL), brine (40 mL), dried over Na2SO4 and 
concentrated in vacuo. The residue was purified by flash column chromatography (30-40% 
EtOAc/pentane) to afford the title compound 233a (0.62 g, 45%) as a colourless oil; νmax / cm
-1: 
3432 (br. m), 2927 (w), 1652 (s), 1375 (s), 1292 (s), 1097 (s), 1081 (s), 1031 (s); 1H NMR (CDCl3, 
400 MHz): δ 7.35 – 7.22 (m, 5H, 2 × C8-H, 2 × C9-H and C10-H), 4.64 (s, 2H, C6-H2), 4.38 (d, J 
= 4.5 Hz, 2H, C4-H2), 3.56 (t, J = 4.5 Hz, 1H, O5-H), 2.47 (tt, J = 6.9, 4.1 Hz, 1H, C2-H), 0.87 – 
0.74 (m, 4H, 2 × C1-H2); 
13C NMR (CDCl3, 101 MHz): δ 175.2 (C3), 137.5 (C7), 128.8, 128.0 
(C8 and C9), 127.6 (C10), 61.1 (C4), 50.5 (C6), 28.1 (C2), 8.2 (C1); HRMS: (ESI+) calculated for 
C12H16NO2: 206.1176, found [M+H]
+: 206.1179. 
  




A solution of N-benzylcyclopropanamine (0.50 g, 3.40 mmol) and β-propiolactone (0.75 mL, 
11.80 mmol) in toluene (7 mL) was heated to 105 °C for 15 min. The reaction was cooled to r.t. 
and concentrated in vacuo. Et2O (20 mL) and water (20 mL) were added, the layers were separated 
and the organic portion was further washed with water (2 × 10 mL). The organic extract was dried 
over MgSO4 and concentrated in vacuo. The residue was purified by flash column chromatography 
(1-2% MeOH/DCM) to afford the title compound 233b (0.13 g, 17%) as a colourless oil; νmax / 
cm-1: 3417 (br. m), 2939 (w), 1630 (s), 1407 (s), 1373 (s), 1032 (s); 1H NMR (CDCl3, 400 MHz): 
δ 7.34 – 7.20 (m, 5H, 2 × C9-H, 2 × C10-H and C11-H), 4.61 (s, 2H, C7-H2), 3.92 (q, J = 5.7 Hz, 
2H, C5-H2), 3.49 (t, J = 6.6 Hz, 1H, O6-H), 2.81 (t, J = 5.3 Hz, 2H, C4-H2), 2.55 (tt, J = 7.0, 4.1 
Hz, 1H, C2-H), 0.89 – 0.75 (m, 4H, 2 × C1-H2); 
13C NMR (CDCl3, 101 MHz): δ 176.0 (C3), 138.1 
(C8), 128.7, 127.7 (C9 and C10), 127.3 (C11), 58.9 (C5), 49.8 (C7), 36.4 (C4), 30.1 (C2), 9.3 
(C1); HRMS: (ESI+) calculated for C13H17NNaO2: 242.1151, found [M+Na]
+: 242.1143. 
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4-Phenylbut-3-ynoic acid (0.50 g, 3.12 mmol, prepared according to the literature procedure273) 
was dissolved in DCM (6 mL), treated with oxalyl chloride (0.30 mL, 3.44 mmol), a drop of DMF 
and stirred at r.t. for 1 h. DCM and an excess of oxalyl chloride were removed in vacuo and the 
corresponding acyl chloride was dissolved in DCM (2 mL). The solution was added dropwise to 
N-benzylcyclopropanamine (0.51 g, 3.44 mmol) and TEA (0.48 mL, 3.44 mmol) in DCM (4 mL) 
at 0 °C, the reaction was warmed to r.t. and stirred for 18 h. Sat. aq. NaHCO3 (20 mL) and DCM 
(10 mL) were added, the layers were separated and the aqueous portion was further extracted with 
DCM (2 × 15 mL). The organic extracts were combined, washed with 1.0 M aq. HCl (20 mL), 
dried over MgSO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography (5-10% EtOAc/hexane) to afford the title compound 273 (0.30 g, 33%, 1:0.88 
mixture of rotamers A:B) as an orange oil; νmax / cm
-1: 1720 (m), 1654 (s), 1566 (s), 1453 (s), 1403 
(s), 1369 (s), 1269 (s), 1029 (m), 753 (s); 1H NMR (CDCl3, 400 MHz): δ 7.44 – 7.05 (m, 20H, C1-
H, C15-H, 2 × C2-H, 2 × C3-H, 2 × C13-H and 2 × C14-H, A+B), 4.65 (s, 2H, C11-H2, B), 4.60 
(s, 2H, C11-H2, A), 3.86 (s, 2H, C7-H2, B), 3.79 (s, 2H, C7-H2, A), 2.79 – 2.72 (m, 1H, C9-H, B), 
2.45 – 2.37 (m, 1H, C9-H, A), 0.94 – 0.61 (m, 8H, 2 × C10-H2, A+B); 
13C NMR (CDCl3, 126 
MHz): δ 170.2 (C8, B), 170.0 (C8, A), 138.0 (C12, B), 137.8 (C12, A), 131.8, 129.8, 129.5, 129.0, 
128.7, 128.6, 128.5, 128.3, 128.2, 128.2, 128.0, 127.9, 127.4, 127.3 (C1, C2, C3, C4, C13, C14 
and C15, A+B), 93.9 (C5, B), 89.7 (C5, A), 83.6 (C6, B), 82.7 (C6, A), 50.5 (C7, B), 50.3 (C11, 
B), 50.1 (C11, A), 48.7 (C11, A), 30.5 (C9, A), 30.4 (C9, B), 9.4 (C10, B), 9.1 (C10, A); HRMS: 
(ESI+) calculated for C20H20NO: 290.1539, found [M+H]
+: 290.1532. 
Analysis of the NMR spectra also indicated trace amounts of unseparable impurity 273'. 
Data for 273' (characteristic signals only): 1H NMR (CDCl3, 400 MHz): δ 14.62 (s, 1H, O18-H), 
5.47 (s, 1H, C16-H); 13C NMR (CDCl3, 126 MHz): δ 202.7 (C17). 
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1-(Phenylethynyl)cyclopentane-1-carboxylic acid (279a') 
 
To a solution of ester 279a (1.00 g, 4.38 mmol, prepared according to the literature procedure262) 
in MeOH (8 mL) was added 4.0 M aq. NaOH (5.5 mL) and the reaction was stirred at r.t. for 16 h. 
The reaction mixture was concentrated in vacuo, diluted with water (20 mL) and extracted with 
Et2O (20 mL). The aqueous portion was adjusted to pH 2 by addition of 6.0 M aq. HCl and then 
extracted with Et2O (3 × 20 mL). The organic extracts were combined, dried over MgSO4 and 
concentrated in vacuo to afford the title compound 279a' (0.92 g, 98%) as a colourless solid; m.p. 
78-79 °C (DCM/hexane); νmax / cm
-1: 2957 (br. m), 1703 (s), 1273 (m), 755 (m), 690 (m); 1H NMR 
(CDCl3, 400 MHz): δ 10.41 (br. s, 1H, O9-H), 7.45 – 7.40 (m, 2H, 2 × C3-H), 7.32 – 7.27 (m, 3H, 
C1-H and 2 × C2-H), 2.40 – 2.27 (m, 2H, 2 × C10-HaHb), 2.23 – 2.09 (m, 2H, 2 × C10-HaHb), 1.98 
– 1.75 (m, 4H, 2 × C11-H2); 
13C NMR (CDCl3, 101 MHz): δ 179.6 (C8), 131.9 (C3), 128.3 (C2), 
128.2 (C1), 123.2 (C4), 90.7 (C6), 82.9 (C5), 48.9 (C7), 39.5 (C10), 25.1 (C11); HRMS: (ESI-) 





General procedure G: N-Benzylcyclopropanamine (0.34 g, 2.31 mmol) and acid 279a' (0.50 g, 
2.33 mmol) were employed and the residue was purified by flash column chromatography (5% 
EtOAc/hexane) to afford the title compound 277a (0.61 g, 77%) as a colourless oil; νmax / cm
-1: 
2955 (m), 1645 (s), 1491 (m), 1453 (m), 1389 (s), 756 (s), 692 (s); 1H NMR (DMSO-d6, 500 MHz, 
80 °C): δ 7.34 – 7.19 (m, 10H, C1-H, C17-H, 2 × C2-H, 2 × C3-H, 2 × C15-H and 2 × C16-H), 
4.73 (br. s, 2H, C13-H2), 3.06 – 2.93 (br. m, 1H, C11-H), 2.41 – 2.33 (m, 2H, 2 × C8-HaHb), 2.19 
– 2.10 (m, 2H, 2 × C8-HaHb), 1.88 – 1.78 (m, 2H, 2 × C9-HaHb), 1.76 – 1.66 (m, 2H, 2 × C9-
HaHb), 0.79 – 0.69 (m, 4H, 2 × C12-H2); 
13C NMR (DMSO-d6, 126 MHz, 80 °C): δ 172.39 (C10), 
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138.15 (C14), 130.68, 128.02, 127.89, 127.70, 126.31, 126.25 (C1, C2, C3, C15, C16 and C17), 
122.36 (C4), 92.71 (C5), 82.57 (C6), 49.54 (C7), 48.08 (C13), 38.87 (C8), 30.30 (C11), 23.97 





General procedure I: Amide 277a (34.3 mg, 0.10 mmol) was employed. Flash column 
chromatography (30% EtOAc/hexane) afforded the title compound 280a (27.9 mg, 75%) as a pale 
brown oil; νmax / cm
-1: 2947 (m), 1693 (s), 1674 (s), 1443 (m), 1417 (s), 1313 (m), 1269 (m), 1174 
(m); 1H NMR (CDCl3, 400 MHz): δ 7.41 – 7.27 (m, 8H, C9-H, C19-H, 2 × C7-H, 2 × C8-H and 2 
× C18-H), 7.06 – 7.00 (m, 2H, 2 × C17-H), 5.09 (d, J = 14.9 Hz, 1H, C5-HaHb), 4.23 (dd, J = 11.8, 
4.2 Hz, 1H, C10-H), 4.11 (d, J = 14.9 Hz, 1H, C5-HaHb), 2.73 (ddd, J = 17.8, 4.5, 2.2 Hz, 1H, 
C12-HaHb), 2.51 – 2.43 (m, 1H, C11-HaHb), 2.43 – 2.32 (m, 1H, C12-HaHb), 2.15 – 2.07 (m, 1H, 
C2-HaHb), 1.96 – 1.48 (m, 7H, C1-H2, C1'-HaHb, C2'-H2, C2-HaHb and C11-HaHb), 0.74 – 0.61 
(m, 1H, C1'-HaHb); 
13C NMR (CDCl3, 126 MHz): δ 196.9 (C13), 178.9 (C4), 163.5 (C15), 136.2 
(C6), 134.9 (C14), 134.1 (C16), 130.2 (C17), 129.1, 128.2, 128.1 (C7, C8 and C18), 128.0, 128.0 
(C9 and C19), 56.9 (C10), 54.9 (C3), 44.1 (C5), 42.1 (C2), 35.9 (C12), 34.2 (C2'), 28.2 (C11), 
27.4 (C1'), 27.2 (C1); HRMS: (ESI+) calculated for C25H26NO2: 372.1958, found [M+H]
+: 
372.1948. 
General procedure J: Amide 277a (34.3 mg, 0.10 mmol) was employed. Flash column 
chromatography (50% EtOAc/hexane) afforded the title compound (S)-280a (24.5 mg, 66%) as a 
colourless oil. The enantiopurity of this compound was determined by chiral SFC against a racemic 
standard. 
[𝛼]D
23.8 = -48.1 (c = 0.11, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IB column (25 cm), CO2:MeOH 80:20, 2 mL/min, 140 bars, 
40 °C). Retention times: 9.6 minutes (major), 11.0 minutes (minor), e.r. = 92:8. 
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1-(Phenylethynyl)cyclohexane-1-carboxylic acid (279b') 
 
To a solution of ester 279b (2.08 g, 8.58 mmol, prepared according to the literature procedure262) 
in MeOH (17 mL) was added 4.0 M aq. NaOH (10.7 mL) and the reaction was stirred at r.t. for 16 
h. The reaction mixture was concentrated in vacuo, diluted with water (20 mL) and extracted with 
Et2O (20 mL). The aqueous portion was adjusted to pH 2 by addition of 6.0 M aq. HCl and then 
extracted with Et2O (3 × 20 mL). The organic extracts were combined, dried over MgSO4 and 
concentrated in vacuo to afford the title compound 279b' (1.65 g, 84%) as a colourless solid; m.p. 
72-73 °C (CDCl3); νmax / cm
-1: 2933 (m), 1704 (s), 1444 (m), 1284 (m), 1258 (m), 755 (m); 1H 
NMR (CDCl3, 400 MHz): δ 7.49 – 7.43 (m, 2H, 2 × C3-H), 7.33 – 7.27 (m, 3H, C1-H and 2 × C2-
H), 2.11 – 2.01 (m, 2H, 2 × C9-HaHb), 1.93 – 1.61 (m, 7H, 2 × C9-HaHb, 2 × C10-H2 and C11-
HaHb), 1.36 – 1.22 (m, 1H, C11-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 179.6 (C8), 131.9 (C3), 
128.3 (C2), 128.3 (C1), 123.2 (C4), 89.1 (C6), 85.0 (C5), 44.4 (C7), 34.8 (C9), 25.5 (C11), 22.6 





General procedure G: N-Benzylcyclopropanamine (0.36 g, 2.45 mmol) and acid 279b' (0.56 g, 
2.45 mmol) were employed and the residue was purified by flash column chromatography (5% 
EtOAc/hexane) to afford the title compound 277b (0.67 g, 77%) as a pale yellow oil; νmax / cm
-1: 
2932 (m), 1651 (s), 1386 (m), 756 (m), 692 (m); 1H NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.34 
– 7.19 (m, 10H, C1-H, C18-H, 2 × C2-H, 2 × C3-H, 2 × C16-H and 2 × C17-H), 4.81 (s, 2H, C14-
H2), 3.03 – 2.95 (m, 1H, C12-H), 2.10 – 2.02 (m, 2H, 2 × C8-HaHb), 1.95 – 1.87 (m, 2H, 2 × C8-
HaHb), 1.82 – 1.71 (m, 2H, 2 × C9-HaHb), 1.70 – 1.61 (m, 3H, 2 × C9-HaHb and C10-HaHb), 1.34 
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– 1.23 (m, 1H, C10-HaHb), 0.73 – 0.69 (m, 2H, 2 × C13-H2); 
13C NMR (DMSO-d6, 126 MHz, 110 
°C): δ 172.8 (C11), 138.0 (C15), 130.4, 127.8, 127.6, 127.5, 126.2, 126.0 (C1, C2, C3, C16, C17 
and C18), 122.2 (C4), 90.4 (C6), 86.1 (C5), 49.8 (C14), 43.1 (C7), 34.9 (C8), 30.3 (C12), 24.5 





and 1'-benzyl-5'-hydroxy-4'-phenylspiro[cyclohexane-1,3'-indolin]-2'-one (281b) 
 
General procedure I: In a modification to the general procedure, 10 mol% [Rh(cod)2]OTf and 
20 mol% PPh3 were used and the reaction was heated for 72 h. Amide 277b (35.8 mg, 0.10 mmol) 
was employed. Flash column chromatography (30% EtOAc/hexane) afforded cyclohexenone 
280b (10.2 mg, 26%) and phenol 281b (7.5 mg, 20%) as pale yellow oils. 
General procedure I: Amide 277b (35.8 mg, 0.10 mmol) was employed. Flash column 
chromatography (30% EtOAc/hexane) afforded the title compound 280b (29.9 mg, 78%) as a pale 
brown oil. 
Data for 280b: νmax / cm
-1: 2924 (m), 1674 (s), 1414 (m), 1258 (m), 1078 (m), 910 (m); 1H NMR 
(CDCl3, 400 MHz): δ 7.41 – 7.23 (m, 8H, C10-H, C20-H, 2 × C8-H, 2 × C9-H and 2 × C19-H), 
7.04 – 6.99 (m, 2H, 2 × C18-H), 5.11 (d, J = 14.9 Hz, 1H, C6-HaHb), 4.18 (dd, J = 11.7, 4.2 Hz, 
1H, C11-H), 4.06 (d, J = 14.9 Hz, 1H, C6-HaHb), 2.71 (ddd, J = 17.9, 4.5, 2.3 Hz, 1H, C13-HaHb), 
2.49 – 2.42 (m, 1H, C12-HaHb), 2.40 – 2.20 (m, 2H, C2-HaHb and C13-HaHb), 1.97 – 1.47 (m, 6H, 
C1-H2, C2'-H2, C3-HaHb and C12-HaHb), 1.45 – 1.36 (m, 1H, C3'-HaHb), 1.24 – 1.15 (m, 1H, C2-
HaHb), 1.09 (td, J = 13.2, 4.7 Hz, 1H, C3'-HaHb), 0.86 – 0.72 (m, 1H, C3-HaHb); 
13C NMR (CDCl3, 
101 MHz): δ 197.2 (C14), 176.5 (C5), 162.5 (C16), 136.3 (C7), 135.6 (C15), 134.3 (C17), 130.1 
(C18), 129.1, 128.1, 128.0 (C8, C9, C10, C19 and C20), 55.6 (C11), 48.6 (C4), 43.6 (C6), 35.8 
(C13), 35.1 (C1), 30.1 (C3), 28.2 (C12), 25.1 (C3'), 21.6 (C2), 20.9 (C2'); HRMS: (ESI+) 
calculated for C26H28NO2: 386.2115, found [M+H]
+: 386.2112. 
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General procedure J: In a modification to the general procedure, the reaction was heated to  
120 °C. Amide 277b (35.8 mg, 0.10 mmol) was employed. Flash column chromatography (40% 
EtOAc/hexane) afforded the title compound (S)-280b (26.8 mg, 69%) as a yellow oil. The 
enantiopurity of this compound was determined by chiral SFC against a racemic standard. 
[𝛼]D
23.9 = -20.5 (c = 0.57, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IB column (25 cm), CO2:MeOH 88:12, 2 mL/min, 140 bars, 
40 °C). Retention times: 16.7 minutes (major), 21.3 minutes (minor), e.r. = 86:14. 
Data for 281b: νmax / cm
-1: 3356 (br. m), 2924 (s), 1675 (s), 1613 (s), 1458 (s), 1340 (s), 1075 (s); 
1H NMR (CDCl3, 400 MHz): δ 7.49 – 7.16 (m, 10H, C10-H, C20-H, 2 × C8-H, 2 × C9-H, 2 × 
C18-H and 2 × C19-H), 6.69 (d, J = 8.4 Hz, 1H, C12-H), 6.52 (d, J = 8.4 Hz, 1H, C13-H), 4.81 (s, 
2H, C6-H2), 4.16 (s, 1H, O21-H), 2.18 – 2.03 (m, 2H, 2 × C2-HaHb), 1.62 – 1.53 (m, 5H, C1-HaHb 
and 2 × C3-H2), 1.34 – 1.26 (m, 2H, 2 × C2-HaHb), 0.69 – 0.55 (m, 1H, C1-HaHb); 
13C NMR 
(CDCl3, 101 MHz): δ 179.9 (C5), 149.4 (C14), 136.6, 135.3, 132.8, 132.8, 131.5, 129.2, 129.1, 
128.9, 127.6, 127.3, 126.6 (C7, C8, C9, C10, C11, C15, C16, C17, C18, C19 and C20), 113.3 
(C12), 109.1 (C13), 48.8 (C4), 43.2 (C6), 32.4 (C3), 25.3 (C1), 20.5 (C2); HRMS: (ESI+) 





General procedure G: N-Benzylcyclopropanamine (0.61 g, 4.12 mmol) and 2,2-dimethyl-4-
phenylbut-3-ynoic acid (0.78 g, 4.12 mmol, prepared according to the literature procedure274) was 
employed. Flash column chromatography (30% EtOAc/hexane) afforded the title compound 277c 
(1.04 g, 79%) as a colourless solid; m.p. 47-48 °C (DCM/hexane); νmax / cm
-1: 2985 (m), 1643 (s), 
1394 (s), 1361 (m), 756 (s), 691 (s); 1H NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.34 – 7.19 (m, 
10H, C1-H, C16-H, 2 × C2-H, 2 × C3-H, 2 × C14-H and 2 × C15-H), 4.79 (s, 2H, C12-H2), 3.08 
– 3.00 (m, 1H, C10-H), 1.60 (s, 6H, 2 × C8-H3), 0.78 – 0.71 (m, 4H, 2 × C11-H2); 
13C NMR 
(DMSO-d6, 126 MHz, 110 °C): δ 172.9 (C9), 138.0 (C13), 130.4, 127.7, 127.7, 127.5, 126.1, 126.0 
(C1, C2, C3, C14, C15 and C16), 122.2 (C4), 92.7 (C6), 82.8 (C5), 49.8 (C12), 37.3 (C7), 30.5 
(C10), 28.1 (C8), 7.2 (C11); HRMS: (ESI+) calculated for C22H24NO: 318.1852, found [M+H]
+: 
318.1847. 




General procedure I: Amide 277c (31.7 mg, 0.10 mmol) was employed. Flash column 
chromatography (40% EtOAc/hexane) afforded the title compound 277c (26.5 mg, 77%) as a 
colourless oil; νmax / cm
-1: 2930 (w), 1697 (s), 1674 (s), 1418 (m), 1242 (m), 701 (s); 1H NMR 
(CDCl3, 400 MHz): δ 7.40 – 7.25 (m, 8H, C1-H, C18-H, 2 × C2-H, 2 × C16-H and 2 × C17-H), 
7.05 – 7.00 (m, 2H, 2 × C3-H), 5.11 (d, J = 14.9 Hz, 1H, C14-HaHb), 4.23 (dd, J = 11.7, 4.4 Hz, 
1H, C9-H), 4.11 (d, J = 14.9 Hz, 1H, C14-HaHb), 2.73 (ddd, J = 17.7, 4.4, 2.4 Hz, 1H, C7-HaHb), 
2.50 (dtd, J = 11.7, 4.8, 2.4 Hz, 1H, C8-HaHb), 2.38 (ddd, J = 17.7, 14.1, 4.8 Hz, 1H, C7-HaHb), 
1.82 (dtd, J = 14.1, 11.7, 4.4 Hz, 1H, C8-HaHb), 1.34 (s, 3H, C12-H3), 0.82 (s, 3H, C12'-H3); 
13C 
NMR (CDCl3, 101 MHz): δ 196.8 (C6), 177.4 (C13), 162.4 (C10), 136.1, 136.0 (C5 and C15), 
134.1 (C4), 129.9 (C3), 129.1, 128.1, 128.1, 128.1 (C1, C2, C16, C17 and C18), 55.8 (C9), 46.0 
(C11), 44.1 (C14), 35.8 (C7), 28.4 (C8), 26.2 (C12), 21.9 (C12'); HRMS: (ESI+) calculated for 
C23H24NO2: 346.1802, found [M+H]
+: 346.1786. 
General procedure J: Amide 279c (31.7 mg, 0.10 mmol) was employed. Flash column 
chromatography (40% EtOAc/hexane) afforded the title compound (S)-277c (26.3 mg, 76%) as a 
colourless oil. The enantiopurity of this compound was determined by chiral SFC against a racemic 
standard. 
[𝛼]D
23.7 = -22.9 (c = 0.41, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IB column (25 cm), CO2:MeOH 88:12, 2 mL/min, 140 bars, 
40 °C). Retention times: 13.4 minutes (major), 15.0 minutes (minor), e.r. = 95:5. 
  




General procedure G: N-Benzylcyclopropanamine (2.96 g, 20.07 mmol) and 2,2-dimethyl-4-
(trimethylsilyl)but-3-ynoic acid 284 (3.70 g, 20.07 mmol, prepared according to the literature 
procedure275) were employed and the residue was purified by flash column chromatography (20% 
EtOAc/hexane) to afford the title compound 285 (4.69 g, 75%) as a colourless solid; m.p. 57-58 
°C (DCM/hexane);  νmax / cm
-1: 2959 (w), 2155 (w), 1650 (s), 1395 (m), 1249 (m), 878 (m), 840 
(s); 1H NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.35 – 7.30 (m, 2H, 2 × C11-H or 2 × C12-H), 7.26 
– 7.20 (m, 3H, C13-H and 2 × C11-H or 2 × C12-H), 4.75 (s, 2H, C9-H2), 3.03 – 2.96 (br. m, 1H, 
C7-H), 1.49 (s, 6H, 2 × C5-H3), 0.72 – 0.67 (m, 4H, 2 × C8-H2), 0.05 (s, 9H, 3 × C1-H3); 
13C NMR 
(DMSO-d6, 126 MHz, 110 °C): δ 172.6 (C6), 137.9 (C10), 127.6, 126.1 (C11 and C12), 126.0 
(C13), 109.4 (C2), 86.9 (C3), 49.6 (C9), 37.5 (C4), 30.4 (C7), 27.9 (C5), 7.2 (C8), -0.9 (C1); 





Trimethylsilyl alkyne 285 (3.50 g, 11.16 mmol) was dissolved in MeOH (22 mL) and the solution 
was cooled to 0°C. Potassium carbonate (4.63 g, 33.49 mmol) was added at once, the reaction was 
warmed to r.t. and stirred for 2 h. The reaction mixture was concentrated in vacuo, diluted with 
1M HCl (50 mL) and extracted with EtOAc (3 × 30 mL). The organic extracts were combined, 
dried over MgSO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography (10% EtOAc/hexane) to afford the title compound 286 (2.21 g, 82%) as a 
colourless oil; νmax / cm
-1: 3288 (w), 3235 (w), 2987 (w), 1644 (s), 1396 (s), 1168 (w), 1029 (m), 
698 (m); 1H NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.33 – 7.29 (m, 2H, 2 × C11-H), 7.24 – 7.19 
(m, 3H, C12-H and 2 × C10-H), 4.70 (s, 2H, C8-H2), 3.02 – 2.97 (br. m, 1H, C6-H), 2.90 (br. s, 
1H, C1-H), 1.50 (s, 6H, 2 × C4-H3), 0.72 – 0.68 (m, 4H, 2 × C7-H2); 
13C NMR (DMSO-d6, 126 
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MHz, 110 °C): δ 172.7 (C5), 138.0 (C9), 127.6 (C11), 126.1 (C10), 126.0 (C12), 86.9 (C2), 73.2 
(C1), 49.6 (C8), 36.6 (C3), 30.5 (C6), 28.0 (C4), 7.3 (C7); HRMS: (ESI+) calculated for C16H20NO: 




General procedure H: Aminocyclopropane 286 (200.0 mg, 0.83 mmol) and 1-chloro-4-
iodobenzene (217.0 mg, 0.91 mmol) were employed and the reaction was stirred for 2 h at r.t. 
Flash column chromatography (10% EtOAc/hexane) afforded alkyne 277d (261.4 mg, 89%) as an 
orange solid; m.p. 83-84 °C (DCM/hexane); νmax / cm
-1: 2986 (w), 1646 (s), 1490 (m), 1397 (s), 
1089 (m), 828 (m); 1H NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.35 – 7.29 (m, 4H, 2 × C2-H and 
2 × C3-H), 7.25 – 7.19 (m, 5H, 2 × C14-H, 2 × C15-H and C16-H), 4.78 (s, 2H, C12-H2), 2.98 (br. 
s, overlapped by water, 1H, C10-H), 1.59 (s, 6H, 2 × C8-H3), 0.74 – 0.70 (m, 4H, 2 × C11-H2); 
13C NMR (DMSO-d6, 126 MHz, 110 °C): δ 172.8 (C9), 138.0 (C14), 132.6 (C1), 132.2, 128.0, 
127.8, 126.1 (C2, C3, C14 and C15), 126.1 (C16), 121.0 (C4), 93.9 (C6), 81.7 (C5), 49.9 (C12), 
37.3 (C7), 30.5 (C10), 28.0 (C8), 7.3 (C11); HRMS: (ESI+) calculated for C22H23
35ClNO: 





General procedure I: Amide 277d (35.2 mg, 0.10 mmol) was employed. Flash column 
chromatography (30% EtOAc/hexane) afforded the title compound 280d (29.2 mg, 77%) as a pale 
yellow oil; νmax / cm
-1: 2929 (w), 1695 (s), 1674 (s), 1418 (m), 1242 (m), 1088 (m), 728 (s), 702 
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(s); 1H NMR (CDCl3, 400 MHz): δ 7.39 – 7.28 (m, 5H, C18-H, 2 × C17-H and 2 × C16-H), 7.28 
– 7.23 (m, 2H, 2 × C2-H), 6.99 – 6.93 (m, 2H, 2 × C3-H), 5.10 (d, J = 14.9 Hz, 1H, C14-HaHb), 
4.21 (dd, J = 11.7, 4.4 Hz, 1H, C9-H), 4.09 (d, J = 14.9 Hz, 1H, C14-HaHb), 2.71 (ddd, J = 17.8, 
4.4, 2.4 Hz, 1H, C7-HaHb), 2.52 – 2.45 (m, 1H, C8-HaHb), 2.36 (ddd, J = 17.8, 14.3, 4.9 Hz, 1H, 
C7-HaHb), 1.80 (dtd, J = 14.3, 11.7, 4.4 Hz, 1H, C8-HaHb), 1.32 (s, 3H, C12-H3), 0.85 (s, 3H, 
C12'-H3); 
13C NMR (CDCl3, 101 MHz): δ 196.5 (C6), 177.1 (C13), 163.1 (C10), 135.9 (C15), 
135.0 (C5), 134.3 (C4), 132.5 (C1), 131.3 (C3), 129.1, 128.5, 128.1, 128.1 (C2, C16, C17 and 
C18), 55.8 (C9), 46.0 (C11), 44.2 (C14), 35.8 (C7), 28.4 (C8), 26.2 (C12), 22.1 (C12'); HRMS: 
(ESI+) calculated for C23H22
35ClNNaO2: 402.1231, found [M+Na]
+: 402.1240. 
General procedure J: Amide 277d (35.2 mg, 0.10 mmol) was employed. Flash column 
chromatography (40% EtOAc/hexane) afforded the title compound (S)-280d (19.5 mg, 51%) as a 
colourless solid, m.p. 214-215 °C (DCM/hexane). The enantiopurity of this compound was 
determined by chiral SFC against a racemic standard. The structure and absolute configuration of 
this compound was determined unambiguously by X-ray crystallography. 
 
Crystal image of (S)-280d generated in Olex2, ellipsoids at 50% probability; Crystal data for 
(S)-280d: C23H22ClNO2, MW = 379.86, orthorhombic, space group P212121, a = 8.9513(2) Å, b = 
11.5502(3) Å, c = 18.9200(4) Å, V = 1956.13(8) Å3, α = 90.00°, β = 90.00°, γ = 90.00°, Z = 4, Dc 
= 1.290 g/cm3 , Mo-Kα radiation, λ = 0.71073 Å, μ = 0.213 mm-1, T = 100 K; colourless block, 
crystal size 0.467 × 0.378 × 0.256 mm3, Bruker Apex II diffractometer, 44550 reflections were 
collected, 5790 were unique, Rint = 0.0445; refinement on F
2 gave R1 = 0.0330 and wR2 = 0.0822, 
GOF = 1.030 for 246 refined parameters; flack parameter -0.04(2). 
[𝛼]D
24.2 = -30.8 (c = 0.26, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IB column (25 cm), CO2:MeOH 88:12, 2 mL/min, 140 bars, 
40 °C). Retention times: 14.9 minutes (minor), 15.6 minutes (major), e.r. = 93:7. 
 
 




General procedure H: Aminocyclopropane 286 (200.0 mg, 0.83 mmol) and 4-iodoanisole (213.4 
mg, 0.91 mmol) were employed and the reaction was stirred for 2 h at r.t. Flash column 
chromatography (10% EtOAc/hexane) afforded alkyne 277e (246.1 mg, 85%) as an orange solid; 
m.p. 60-61 °C (DCM/hexane); νmax / cm
-1: 2935 (w), 1645 (s), 1509 (s), 1247 (s), 1167 (s), 1029 
(m), 831 (s); 1H NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.33 – 7.20 (m, 5H, 2 × C15-H, 2 × C16-
H and C17-H), 7.18 – 7.13 (m, 2H, 2 × C4-H), 6.87 – 6.83 (m, 2H, 2 × C3-H), 4.79 (s, 2H, C13-
H2), 3.77 (s, 3H, C1-H3), 3.07 – 3.00 (br. m, 1H, C11-H), 1.59 (s, 6H, 2 × C9-H3), 0.76 – 0.69 (m, 
4H, 2 × C12-H2); 
13C NMR (DMSO-d6, 126 MHz, 110 °C): δ 173.1 (C10), 158.9 (C2), 138.0 
(C14), 131.9 (C4), 127.6, 126.1 (C15 and C16), 126.0 (C17), 114.3 (C5), 113.7 (C3), 91.1 (C7), 
82.7 (C6), 54.8 (C1), 49.8 (C13), 37.3 (C8), 30.4 (C11), 28.1 (C9), 7.2 (C12); HRMS: (ESI+) 






General procedure I: Amide 277e (34.7 mg, 0.10 mmol) was employed. Flash column 
chromatography (30% EtOAc/hexane) afforded the title compound 280e (27.1 mg, 72%) as a 
colourless solid; m.p. 160-161 °C (DCM/hexane); νmax / cm
-1: 2931 (w), 1694 (s), 1673 (s), 1510 
(s), 1418 (m), 1243 (s), 1173 (s), 726 (s); 1H NMR (CDCl3, 400 MHz): δ 7.39 – 7.23 (m, 5H, C19-
H, 2 × C17-H and 2 × C18-H), 6.96 – 6.85 (m, 4H, 2 × C3-H and 2 × C4-H), 5.09 (d, J = 14.9 Hz, 
1H, C15-HaHb), 4.20 (dd, J = 11.7, 4.4 Hz, 1H, C10-H), 4.09 (d, J = 14.9 Hz, 1H, C15-HaHb), 3.80 
(s, 3H, C1-H3), 2.71 (ddd, J = 17.8, 4.4, 2.3 Hz, 1H, C8-HaHb), 2.51 – 2.43 (m, 1H, C9-HaHb), 
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2.35 (ddd, J = 17.8, 14.2, 4.9 Hz, 1H, C8-HaHb), 1.85 – 1.72 (m, 1H, C9-HaHb), 1.33 (s, 3H, C13-
H3), 0.85 (s, 3H, C13'-H3); 
13C NMR (CDCl3, 101 MHz): δ 197.1 (C7), 177.5 (C14), 162.6 (C11), 
159.4 (C2), 136.0 (C16), 135.7 (C6), 131.0 (2 signals, C4 and C19), 129.1, 128.1 (C17 and C18), 
126.1 (C5), 113.6 (C3), 55.8 (C10), 55.3 (C1), 46.0 (C12), 44.1 (C15), 35.8 (C8), 28.4 (C9), 26.2 
(C13), 22.0 (C13'); HRMS: (ESI+) calculated for C24H25NNaO3: 398.1727, found [M+Na]
+: 
398.1725. The structure and relative stereochemistry of this compound was determined 
unambiguously by X-ray crystallography. 
 
Crystal image of 280e generated in Olex2, ellipsoids at 50% probability, hydrogen atoms and the 
water solvent molecule omitted for clarity; Crystal data for 280e: C24H27NO4, MW = 393.46, 
orthorhombic, space group P21/c, a = 9.4740(7) Å, b = 11.4261(8) Å, c = 19.3296(16) Å, V = 
2037.0(3) Å3, α = 90.00°, β = 103.220(5)°, γ = 90.00°, Z = 4, Dc = 1.283 g/cm
3 , Mo-Kα radiation, 
λ = 0.71073 Å, μ = 0.087 mm-1, T = 100 K; colourless plate, crystal size 0.419 × 0.344 × 0.149 
mm3, Bruker Apex II diffractometer, 18092 reflections were collected, 4836 were unique, Rint = 
0.0727; refinement on F2 gave R1 = 0.0583 and wR2 = 0.1673, GOF = 1.012 for 268 refined 
parameters. 
General procedure J: Amide 277e (34.7 mg, 0.10 mmol) was employed. Flash column 
chromatography (40% EtOAc/hexane) afforded the title compound (S)-280e (22.1 mg, 59%) as a 
colourless oil. The enantiopurity of this compound was determined by chiral SFC against a racemic 
standard. 
[𝛼]D
23.9 = -55.1 (c = 0.13, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IA column (25 cm), CO2:MeOH 88:12, 2 mL/min, 140 bars, 









General procedure H: Aminocyclopropane 286 (200.0 mg, 0.83 mmol) and 1-iodonaphthalene 
(231.2 mg, 0.91 mmol) were employed and the reaction was stirred for 3 h at r.t. Flash column 
chromatography (10% EtOAc/hexane) afforded alkyne 277f (277.1 mg, 91%) as an orange oil; 
νmax / cm
-1: 2984 (w), 1643 (s), 1394 (s), 1165 (m), 799 (s), 774 (s); 1H NMR (DMSO-d6, 500 
MHz, 110 °C): δ 8.15 (br. d, J = 8.3 Hz, 1H, C8-H), 7.95 – 7.91 (m, 1H, C5-H), 7.89 (br. d, J = 
8.0 Hz, 1H, C3-H), 7.61 – 7.53 (m, 2H, C1-H and C7-H), 7.47 – 7.40 (m, 2H, C2-H and C6-H), 
7.30 – 7.17 (m, 5H, 2 × C20-H, 2 × C21-H and C22-H), 4.83 (s, 2H, C18-H2), 3.11 (br. s, 1H, 
C16-H), 1.72 (s, 6H, 2 × C14-H3), 0.80 – 0.70 (m, 4H, 2 × C17-H2); 
13C NMR (DMSO-d6, 126 
MHz, 110 °C): δ 173.0 (C15), 138.0 (C19), 132.4, 132.2 (C4 and C9), 129.4, 128.0, 127.8, 127.7, 
126.4, 126.2, 126.1, 125.9, 124.8, 124.7 (C1, C2, C3, C5, C6, C7, C8, C20, C21 and C22), 119.6 
(C10), 97.8 (C12), 81.0 (C11), 49.8 (C18), 37.8 (C13), 30.6 (C16), 28.3 (C14), 7.3 (C17); HRMS: 






General procedure I: Amide 277f (36.7 mg, 0.10 mmol) was employed. Flash column 
chromatography (30-40% EtOAc/hexane) afforded the title compound 280f (20.7 mg, 52%) as a 
colourless oil. The product was obtained as a mixture of diastereomers (A:B, 1:2.6) due to restricted 
rotation around the C1-C2 bond; νmax / cm
-1: 1696 (s), 1673 (s), 1644 (m), 1418 (m), 1242 (m), 
801 (m), 777 (m), 733 (m), 709 (m); 1H NMR (CDCl3, 400 MHz): δ 7.89 – 7.84 (m, 4H, 2 × Ar-
H, A+B), 7.51 – 7.28 (m, 18H, 9 × Ar-H, A+B), 7.18 (d, J = 7.0 Hz, 1H, Ar-H, B), 7.14 (d, J = 7.2 
Hz, 1H, Ar-H, A), 5.17 (d, J = 14.9 Hz, 1H, C11-HaHb, B), 5.17 (d, J = 14.9 Hz, C11-HaHb, A), 
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4.40 – 4.28 (m, 2H, C6-H, A+B), 4.16 – 4.09 (m, 2H, C11-HaHb, A+B), 2.89 – 2.75 (m, 2H, C4-
HaHb, A+B), 2.66 – 2.53 (m, 2H, C5-HaHb, A+B), 2.52 – 2.40 (m, 2H, C4-HaHb, A+B), 2.09 – 1.89 
(m, 2H, C5-HaHb, A+B), 1.36 (s, 3H, C9-H3, B), 0.98 (s, 3H, C9-H3, A), 0.82 (s, 3H, C9’-H3, A), 
0.56 (s, 3H, C9'-H3, B); 
13C NMR (CDCl3, 126 MHz): δ 196.6 (C3, A), 196.3 (C3, B), 177.5 (C10, 
A), 177.4 (C10, B), 164.0 (C7, B), 163.7 (C7, A), 136.0 (C12, A), 136.0 (C12, B), 134.7, 134.2, 
133.7, 133.4, 132.6, 132.4, 132.0, 131.3, 129.2, 129.0, 128.7, 128.6, 128.2, 128.2, 128.2, 128.1, 
127.8, 126.5, 126.1, 126.0, 125.5, 125.3, 125.1, 125.0 (2 × Ar-C, 10 × Ar-CH, C1 and C2, A+B), 
56.1 (C6, B), 55.9 (C6, A), 46.2 (C8, A), 46.1 (C8, B), 44.2 (C11, B), 44.2 (C11, A), 36.0 (C4, A), 
35.9 (C4, B), 28.6 (C5, B), 28.3 (C5, A), 26.0 (C9, B), 23.8 (C9, A), 23.1 (C9', A), 20.7 (C9’, B); 
HRMS: (ESI+) calculated for C27H26NO2: 396.1958, found [M+H]
+: 396.1968. 
General procedure J: Amide 277f (36.7 mg, 0.10 mmol) was employed. Flash column 
chromatography (40% EtOAc/hexane) afforded the title compound (S)-280f (12.8 mg, 32%) as a 
colourless oil. The product was obtained as a mixture of diastereomers (A:B, 1:2). The 
enantiopurity of this compound was determined by chiral SFC against a racemic standard. 
[𝛼]D
23.8 = -6.93 (c = 0.47, CHCl3, mixture of diastereomers). 
Chiral SFC: (DAICEL CHIRALPAK-IA column (25 cm), CO2:MeOH 88:12, 2 mL/min, 140 bars, 
40 °C). Retention times: major diastereomer – 11.2 minutes (minor), 16.0 minutes (major), e.r. = 




General procedure H: Aminocyclopropane 286 (200.0 mg, 0.83 mmol) and 3-bromothiophene 
(85 L, 0.91 mmol) were employed and the reaction was stirred for 16 h at 60 °C. Flash column 
chromatography (10% EtOAc/hexane) afforded alkyne 277g (263.1 mg, 98%) as an orange solid; 
m.p. 74-75 °C (DCM/hexane); νmax / cm
-1: 2985 (w), 1644 (s), 1396 (s), 1361 (m), 783 (m); 1H 
NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.47 – 7.42 (m, 2H, C2-H and C3-H), 7.34 – 7.20 (m, 5H, 
2 × C14-H, 2 × C15-H and C16-H), 6.92 (dd, J = 4.9, 1.3 Hz, 1H, C1-H), 4.78 (s, 2H, C12-H2), 
3.00 (br. s, overlapped by water, 1H, C10-H), 1.58 (s, 6H, 2 × C8-H3), 0.75 – 0.70 (m, 4H, 2 × 
C11-H2); 
13C NMR (DMSO-d6, 126 MHz, 110 °C): δ 173.0 (C9), 138.0 (C13), 128.8, 128.1, 127.7, 
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126.2, 126.1, 125.6 (C1, C2, C3, C14, C15 and C16), 121.1 (C4), 91.9 (C6), 78.3 (C5), 49.9 (C12), 
37.3 (C7), 30.5 (C10), 28.1 (C8), 7.3 (C11); HRMS: (ESI+) calculated for C20H22NOS: 324.1417, 





General procedure I: Amide 277g (32.3 mg, 0.10 mmol) was employed. Flash column 
chromatography (40% EtOAc/hexane) afforded the title compound 280g (30.9 mg, 88%) as a 
yellow oil; νmax / cm
-1: 1694 (s), 1673 (s), 1645 (m), 1417 (s), 1241 (m), 1196 (m), 732 (s), 697 
(s); 1H NMR (CDCl3, 400 MHz): δ 7.39 – 7.22 (m, 6H, C2-H, C18-H, 2 × C16-H and 2 × C17-
H), 7.00 (dd, J = 2.9, 1.3 Hz, 1H, C3-H), 6.81 (dd, J = 5.0, 1.3 Hz, 1H, C1-H), 5.09 (d, J = 15.0 
Hz, 1H, C14-HaHb), 4.20 (dd, J = 11.7, 4.4 Hz, 1H, C9-H), 4.08 (d, J = 15.0 Hz, 1H, C14-HaHb), 
2.76 – 2.65 (m, 1H, C7-HaHb), 2.51 – 2.42 (m, 1H, C8-HaHb), 2.41 – 2.28 (m, 1H, C7-HaHb), 1.86 
– 1.72 (m, 1H, C8-HaHb), 1.36 (s, 3H, C12-H3), 0.88 (s, 3H, C12'-H3); 
13C NMR (CDCl3, 126 
MHz): δ 196.5 (C6), 177.4 (C13), 163.8 (C10), 135.9 (C15), 133.6 (C4), 131.2 (C5), 129.4 (C2), 
129.1, 128.1, 128.0 (C16, C17 and C18), 125.3 (C1), 124.7 (C3), 56.0 (C9), 46.0 (C11), 44.1 
(C14), 35.8 (C7), 28.4 (C8), 26.3 (C12), 21.4 (C12'); HRMS: (ESI+) calculated for 
C21H21NNaO2S: 374.1185, found [M+Na]
+: 374.1196. 
General procedure J: Amide 277g (32.3 mg, 0.10 mmol) was employed. Flash column 
chromatography (40% EtOAc/hexane) afforded the title compound (S)-280g (25.0 mg, 71%) as a 
colourless oil. The enantiopurity of this compound was determined by chiral SFC against a racemic 
standard. 
[𝛼]D
23.7 = -27.4 (c = 0.38, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IA column (25 cm), CO2:MeOH 88:12, 2 mL/min, 140 bars, 
40 °C). Retention times: 7.5 minutes (minor), 10.6 minutes (major), e.r. = 93:7. 
 




To a solution of terminal alkyne 286 (200.0 mg, 0.83 mmol) in THF (0.1 M) at -78 °C was added 
n-BuLi (1.00 mmol, 1.5 M in hexanes) and the solution was stirred for 1 h under nitrogen. Methyl 
iodide (103 L, 1.66 mmol) was added and the reaction was slowly warmed to r.t. and stirred for 
16 h. Sat. aq. NH4Cl (20 mL) was added and the solution was extracted with EtOAc (3 × 10 mL). 
The organic extracts were combined, washed with brine (20 mL), dried over MgSO4 and 
concentrated in vacuo. Flash column chromatography (10% EtOAc/hexane) afforded alkyne 277h 
(144.5 mg, 68%) as a colourless oil; νmax / cm
-1: 2983 (m), 2935 (m); 1643 (s), 1454 (m), 1394 (s), 
1237 (s), 1167 (m), 1027 (m), 1001 (s), 727 (s), 670 (s); 1H NMR (DMSO-d6, 500 MHz, 110 °C): 
δ 7.36 – 7.19 (m, 5H, 2 × C11-H, 2 × C12-H and C13-H), 4.75 (s, 2H, C9-H2), 2.96 (br. s, 1H, C7-
H), 1.63 (s, 3H, C1-H3), 1.45 (s, 6H, 2 × C5-H3), 0.70 – 0.66 (m, 4H, 2 × C8-H2); 
13C NMR 
(DMSO-d6, 126 MHz, 110 °C): δ 173.5 (C6), 138.2 (C10), 127.7, 126.1 (C11 and C12), 126.0 
(C13), 82.2 (C3), 78.7 (C2), 49.7 (C9), 36.7 (C7), 30.4 (C4), 28.2 (C5), 7.0 (C8), 2.3 (C1); HRMS: 





General procedure I: Amide 277h (25.5 mg, 0.10 mmol) was employed. Flash column 
chromatography (30-40% EtOAc/hexane) afforded the title compound 280h (19.1 mg, 67%) as a 
colourless oil; νmax / cm
-1: 1698 (s), 1670 (s), 1652 (s), 1419 (m), 1316 (m), 1246 (m), 704 (m); 1H 
NMR (CDCl3, 400 MHz): δ 7.35 – 7.19 (m, 5H, C15-H, 2 × C13-H and 2 × C14-H), 5.01 (d, J = 
15.0 Hz, 1H, C11-HaHb), 4.10 (d, J = 15.0 Hz, 1H, C11-HaHb), 4.02 – 3.95 (m, 1H, C6-H), 2.59 
(ddd, J = 18.0, 4.6, 2.1 Hz, 1H, C4-HaHb), 2.38 – 2.29 (m, 1H, C5-HaHb), 2.20 (ddd, J = 18.0, 14.1, 
5.0 Hz, 1H, C4-HaHb), 1.86 (d, J = 2.1 Hz, 3H, C1-H3), 1.68 – 1.56 (m, 1H, C5-HaHb), 1.54 (s, 
3H, C9-H3), 1.34 (s, 3H, C9'-H3); 
13C NMR (CDCl3, 101 MHz): δ 197.5 (C3), 177.8 (C10), 160.5 
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(C7), 136.0 (C12), 129.7 (C2), 129.0, 128.0, 128.0 (C13, C14 and C15), 56.0 (C6), 45.3 (C8), 44.2 
(C11), 35.5 (C4), 28.4 (C5), 23.1 (C9), 22.8 (C9'), 10.9 (C1); HRMS: (ESI+) calculated for 
C18H21NNaO2: 306.1465, found [M+Na]
+: 306.1470. 
General procedure J: Amide 277h (25.5 mg, 0.10 mmol) was employed. Flash column 
chromatography (50% EtOAc/hexane) afforded the title compound (S)-280h (19.9 mg, 70%) as a 
colourless oil. The enantiopurity of this compound was determined by chiral SFC against a racemic 
standard. 
[𝛼]D
24.2 = -72.1 (c = 0.23, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IB column (25 cm), CO2:MeOH 94:6, 2 mL/min, 140 bars, 




General procedure I: Amide 285 (31.4 mg, 0.10 mmol) was employed. Flash column 
chromatography (50% EtOAc/hexane) afforded the title compound 287 (19.3 mg, 72%) as a pale 
yellow oil; νmax / cm
-1: 2967 (w), 1676 (s), 1413 (m), 1233 (m), 1191 (m), 703 (m); 1H NMR 
(CDCl3, 400 MHz): δ 7.37 – 7.21 (m, 5H, 2 × C12-H, 2 × C13-H and C14-H), 5.90 (d, J = 1.2 Hz, 
1H, C1-H), 5.07 (d, J = 15.0 Hz, 1H, C10-HaHb), 4.09 (ddd, J = 11.7, 4.7, 2.3 Hz, 1H, C5-H), 4.01 
(d, J = 15.0 Hz, 1H, C10-HaHb), 2.58 – 2.50 (m, 1H, C3-HaHb), 2.39 (dtd, J = 11.7, 4.7, 2.3 Hz, 
1H, C4-HaHb), 2.25 (ddd, J = 17.6, 14.3, 4.7 Hz, 1H, C3-HaHb), 1.71 – 1.59 (m, 1H, C4-HaHb), 
1.35 (s, 3H, C8-H3), 1.28 (s, 3H, C8'-H3); 
13C NMR (CDCl3, 101 MHz): δ 197.4 (C2), 177.0 (C9), 
169.2 (C6), 135.9 (C11), 129.1, 129.1, 128.1 (C12, C13 and C14), 121.1 (C1), 55.1 (C5), 44.8 
(C7), 44.1 (C10), 35.7 (C3), 28.8 (C4), 25.3 (C8), 21.5 (C8'); HRMS: (ESI+) calculated for 
C17H19NNaO2: 292.1308, found [M+Na]
+: 292.1308. 
General procedure J: In a modification to the general procedure, the reaction was heated to 120 
°C. Amide 285 (31.4 mg, 0.10 mmol) was employed. Flash column chromatography (50% 
EtOAc/hexane) afforded the title compound (S)-287 (18.4 mg, 68%) as a yellow oil. The 
enantiopurity of this compound was determined by chiral SFC against a racemic standard. 
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[𝛼]D
23.6 = -51.3 (c = 0.07, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IB column (25 cm), CO2:MeOH 88:12, 2 mL/min, 140 bars, 




Aminocyclopropane 289 was prepared by Curley. General procedure G: 
N-Benzylcyclopropanamine (0.49 g, 3.30 mmol) and acid 289' (0.60 g, 3.30 mmol, prepared 
according to the literature procedure276) were employed and the residue was purified by flash 
column chromatography (20% EtOAc/hexane) to afford the title compound 289 (0.51, 50%) as a 
colourless oil; νmax / cm
-1: 2956 (m), 2831 (m), 1633 (m), 1406 (m), 1249 (m), 1026 (s), 841(s), 
697 (m); 1H NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.35 – 7.19 (m, 5H, 2 × C11-H, 2 × C12-H 
and C13-H), 4.62 (s, 2H, C9-H2), 2.98 – 2.92 (m, 1H, C7-H), 1.44 – 1.36 (m, 2H, 2 × C5-HaHb), 
1.21 – 1.15 (m, 2H, 2 × C5-HaHb), 0.86 – 0.76 (m, 4H, 2 × C8-H2), 0.09 (s, 9H, 3 × C1-H3); 
13C 
NMR (DMSO-d6, 126 MHz, 110 °C): 169.5 (C6), 137.8 (C10), 127.8, 126.5, 126.3 (C11, C12 and 
C13), 107.0 (C2), 82.8 (C3), 50.0 (C9), 30.8 (C7), 17.7 (C4), 17.2 (C5), 8.2 (C8), -0.7 (C1); 





General procedure I: Amide 289 (31.2 mg, 0.10 mmol) was employed. Flash column 
chromatography (50% EtOAc/hexane) afforded the title compound 290 (14.4 mg, 54%) as a pale 
yellow oil; νmax / cm
-1: 2925 (w), 1657 (s), 1672 (s), 1435 (m), 1411 (m), 1353 (m), 1231 (m), 
1193 (m), 733 (s), 702 (s); 1H NMR (CDCl3, 400 MHz): δ 7.38 – 7.24 (m, 5H, 2 × C12-H, 2 × 
C13-H and C14-H), 5.53 (dd, J = 2.5, 1.0 Hz, 1H, C1-H), 4.95 (d, J = 15.0 Hz, 1H, C10-HaHb), 
4.27 (d, J = 15.0 Hz, 1H, C10-HaHb), 4.24 (ddd, J = 11.8, 4.4, 2.4 Hz, 1H, C5-H), 2.60 – 2.53 (m, 
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1H, C3-HaHb), 2.38 (dtd, J = 11.8, 4.7, 2.4 Hz, 1H, C4-HaHb), 2.24 (ddd, J = 17.7, 13.9, 4.7 Hz, 
1H, C3-HaHb), 1.86 – 1.69 (m, 3H, C4-HaHb, C8-HaHb, C8'-HaHb), 1.31 (d, J = 4.4 Hz, 2H, C8-
HaHb, C8'-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 196.7 (C2), 174.1 (C9), 166.8 (C6), 136.2 (C11), 
129.1, 128.2, 128.1 (C12, C13 and C14), 116.2 (C1), 57.9 (C5), 45.1 (C10), 36.2 (C3), 29.0 (C4), 
28.0 (C7), 23.7 (C8), 17.5 (C8'); HRMS: (ESI+) calculated for C17H18NO2: 268.1332, found 
[M+H]+: 268.1332. 
General procedure J: Amide 289 (31.2 mg, 0.10 mmol) was employed. Flash column 
chromatography (50% EtOAc/hexane) afforded the title compound (S)-290 (15.4 mg, 57%) as a 
yellow oil. The enantiopurity of this compound was determined by chiral SFC against a racemic 
standard. 
[𝛼]D
23.8 = -9.0 (c = 0.25, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IB column (25 cm), CO2:MeOH 88:12, 2 mL/min, 140 bars, 




General procedure G: N-Butylcyclopropanamine (0.18 g, 1.59 mmol) and 2,2-dimethyl-4-
phenylbut-3-ynoic acid (0.30 g, 1.59 mmol, prepared according to the literature procedure274) were 
employed and the residue was purified by flash column chromatography (5-10% EtOAc/hexane) 
to afford the title compound 277i (0.21 g, 47%) as a colourless oil; νmax / cm
-1: 2957 (m), 2934 
(m), 1648 (s), 1465 (m), 1399 (s), 1289 (m), 756 (s), 692 (s); 1H NMR (DMSO-d6, 500 MHz, 110 
°C): δ 7.38 – 7.33 (m, 5H, 2 × C2-H, 2 × C3-H and C1-H), 3.49 (t, J = 7.6 Hz, 2H, C12-H2), 2.94 
(br. s, 1H, C10-H), 1.62 – 1.55 (m, 2H, C13-H2), 1.52 (s, 6H, 2 × C8-H3), 1.32 – 1.24 (m, 2H, 
C14-H2), 0.88 – 0.80 (m, 5H, C15-H3 and 2 × C11-HaHb), 0.71 – 0.65 (m, 2H, 2 × C11-HaHb); 
13C 
NMR (DMSO-d6, 126 MHz, 110 °C): δ 172.3 (C9), 130.5, 128.0 (C2 and C3), 127.6 (C1), 122.4 
(C4), 93.0 (C6), 82.4 (C5), 46.2 (C12), 37.1 (C7), 29.7 (C13), 29.4 (C10), 28.0 (C8), 19.0 (C14), 
12.9 (C15), 7.3 (C11); HRMS: (ESI+) calculated for C19H26NO: 284.2009, found 
[M+H]+:284.2009. 
 




General procedure I: Amide 277i (28.3 mg, 0.10 mmol) was employed. Flash column 
chromatography (35% EtOAc/hexane) afforded the title compound 280i (21.9 mg, 70%) as a pale 
yellow oil; νmax / cm
-1: 2957 (m), 2930 (m), 2871 (m), 1694 (s), 1674 (s), 1644 (m), 1462 (m), 
1422 (m), 1241 (m), 1201 (m), 755 (m), 705 (s); 1H NMR (CDCl3, 400 MHz): δ 7.39 – 7.32 (m, 
3H, 2 × C2-H and C1-H), 7.06 – 7.00 (m, 2H, 2 × C3-H), 4.43 (dd, J = 11.6, 4.1 Hz, 1H, C9-H), 
3.69 (ddd, J = 13.8, 8.7, 7.3 Hz, 1H, C14-HaHb), 3.09 (ddd, J = 13.8, 8.5, 5.2 Hz, 1H, C14-HaHb), 
2.85 – 2.76 (m, 1H, C7-HaHb), 2.61 – 2.46 (m, 2H, C7-HaHb and C8-HaHb), 1.91 – 1.78 (m, 1H, 
C8-HaHb), 1.65 – 1.48 (m, 2H, C15-H2), 1.41 – 1.31 (m, 2H, C16-H2), 1.30 (s, 3H, C12-H3), 0.95 
(t, J = 7.3 Hz, 3H, C17-H3), 0.74 (s, 3H, C12'-H3); 
13C NMR (CDCl3, 101 MHz): δ 196.9 (C6), 
177.0 (C13), 163.0 (C10), 136.0 (C5), 134.1 (C4), 129.9 (C3), 128.1 (C1 and C2), 56.3 (C9), 46.0 
(C11), 39.9 (C14), 35.9 (C7), 29.5 (C15), 28.6 (C8), 26.4 (C12), 21.9 (C12'), 20.2 (C16), 13.9 
(C17); HRMS: (ESI+) calculated for C20H26NO2: 312.1958, found [M+H]
+: 312.1958. 
General procedure J: Amide 277i (28.3 mg, 0.10 mmol) was employed. Flash column 
chromatography (40% EtOAc/hexane) afforded the title compound (S)-280i (16.1 mg, 52%) as a 
colourless oil. The enantiopurity of this compound was determined by chiral SFC against a racemic 
standard. 
[𝛼]D
24.2 = 16.7 (c = 0.23, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IB column (25 cm), CO2:MeOH 94:6, 2 mL/min, 140 bars, 
40 °C). Retention times: 12.9 minutes (major), 13.5 minutes (minor), e.r. = 91:9. 
  




General procedure G: Cyclopropylamine (0.11 mL, 1.59 mmol) and 2,2-dimethyl-4-phenylbut-
3-ynoic acid 295 (0.30 g, 1.59 mmol) were employed and the residue was purified by 
recrystallization from DCM/hexane (two crops) to afford the title compound 296 (0.30 g, 83%) as 
a colourless solid; m.p. 57-58 °C (DCM/hexane); νmax / cm
-1: 3328 (br. w), 2977 (m), 1659 (s), 
1490 (s), 1269 (m), 1024 (m), 755 (s), 691 (s); 1H NMR (CDCl3, 500 MHz): δ 7.43 – 7.38 (m, 2H, 
2 × C3-H), 7.35 – 7.30 (m, 3H, 2 × C2-H and C1-H), 6.77 (br. s, 1H, N10-H), 2.76 – 2.70 (m, 1H, 
C11-H), 1.51 (s, 6H, 2 × C8-H3), 0.81 – 0.75 (m, 2H, 2 × C12-HaHb), 0.55 – 0.48 (m, 2H, 2 × C12-
HaHb); 
13C NMR (CDCl3, 126 MHz): δ 175.0 (C9), 131.7, 128.6, 128.5 (C2, C3 and C4), 122.6 
(C1), 92.4 (C6), 84.9 (C5), 39.3 (C7), 27.7 (C8), 23.1 (C11), 6.8 (C12); HRMS: (ESI+) calculated 
for C15H18NO: 228.1383, found [M+H]
+: 228.1375. 
 
2,2-Dimethyl-5-phenylpent-4-ynoic acid (300) 
 
Dry diisopropylamine (1.11 mL, 7.84 mmol) was dissolved in dry THF (20 mL) and cooled to -78 
°C and n-BuLi (5.41 mL, 1.45 M solution in hexanes) was added dropwise. The mixture was stirred 
30 min at -78 °C. Methyl isobutyrate (0.88 mL, 7.69 mmol) was added dropwise and the reaction 
was stirred for 45 min at -78 °C. (3-Bromoprop-1-yn-1-yl)benzene 299 (1.80 g, 9.23 mmol, 
prepared according to the literature procedure277) was added dropwise and then the mixture was 
warmed up to r.t. and stirred for 18 h. Sat. aq. NH4Cl (30 mL) was added, the layers were separated 
and the aqueous portion was further extracted with Et2O (3 × 20 mL). The organic extracts were 
combined, washed with brine, dried over MgSO4 and concentrated in vacuo. The residue was 
dissolved in MeOH (14 mL), 4.0 M aq. NaOH (9 mL) was added and the reaction was stirred at 
r.t. for 3 h. The reaction mixture was concentrated in vacuo, diluted with water (20 mL) and 
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extracted with Et2O (20 mL). The aqueous portion was adjusted to pH 2 by addition of 6.0 M aq. 
HCl and then extracted with Et2O (3 × 20 mL). The organic extracts were combined, dried over 
MgSO4 and concentrated in vacuo to afford the title compound 300 (1.27 g, 81% over two steps) 
as a colourless solid; νmax / cm
-1: 2928 (m), 1699 (s); 1491 (m), 1473 (m), 1227 (m), 1160 (m), 755 
(s), 691 (s); 1H NMR (CDCl3, 400 MHz): δ 7.40 – 7.36 (m, 2H, 2 × C3-H), 7.28 – 7.24 (m, 3H, 2 
× C2-H and C1-H), 2.68 (s, 2H, C7-H2), 1.37 (s, 6H, 2 × C9-H3); 
13C NMR (CDCl3, 126 MHz): δ 
183.0 (C10), 131.8, 128.3 (C2 and C3), 127.9 (C1), 123.7 (C4), 86.4 (C6), 83.1 (C5), 42.5 (C7), 
30.4 (C8), 24.6 (C9). The spectroscopic properties of this compound were consistent with the data 




General procedure G: N-Benzylcyclopropanamine (0.92 g, 6.30 mmol) and acid 300 (1.27 g, 
6.30 mmol) were employed. Flash column chromatography (5% EtOAc/hexane) afforded the title 
compound 301 (0.72 g, 34%) as a pale yellow oil; νmax / cm
-1: 2969 (w), 1628 (s), 1392 (m), 1363 
(s), 1249 (m), 1030 (m), 756 (s); 1H NMR (CDCl3, 400 MHz): δ 7.42 – 7.36 (m, 2H, 2 × C3-H), 
7.31 – 7.26 (m, 3H, 2 × C2-H and C1-H), 7.23 – 7.16 (m, 5H, 2 × C15-H, 2 × C16-H and C17-H), 
4.69 (s, 2H, C13-H2), 2.88 (s, 2H, C7-H2), 2.87 – 2.78 (m, 1H, C11-H), 1.51 (s, 6H, 2 × C9-H3), 
0.86 – 0.76 (m, 4H, 2 × C12-H2); 
13C NMR (CDCl3, 101 MHz): δ 179.0 (C10), 138.6 (C14), 131.8 
(C3), 128.6, 128.3, 127.8, 127.1, 127.0 (C1, C2, C15, C16 and C17), 123.9 (C4), 88.0 (C6), 82.8 
(C5), 52.3 (C13), 44.2 (C8), 32.6 (C7), 31.6 (C11), 26.1 (C9), 9.8 (C12); HRMS: (ESI+) calculated 
for C23H26NO: 332.2009, found [M+H]
+: 332.2020. 
  




An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate 301 (33.1 mg, 0.10 mmol), [Rh(cod)2]OTf (4.7 mg, 0.01 mmol) and PPh3 (5.2 mg, 0.02 
mmol). The tube was fitted with a rubber septum and purged with argon. Argon sparged anhydrous 
1,2-DCB (1.0 mL) was added and the reaction was sparged with CO for ca. 10 seconds. The tube 
was heated to 130 °C, under a CO atmosphere (1 balloon) and stirred for 72 h. The mixture was 
cooled to r.t. and concentrated in vacuo. An in situ yield (55%) was obtained by using 1,4-
dinitrobenzene as an internal standard for 1H NMR spectroscopy. The residue was purified by flash 
column chromatography (10% EtOAc/hexane) to afford a mixture of (E)- and (Z)-303 (10.3 mg, 
51%, (E):(Z)=1:2.6) as a colourless oil; νmax / cm
-1: 1798 (s), 1690 (m), 1551 (s), 1340 (m), 1068 
(s), 938 (m); 1H NMR (CDCl3, 500 MHz): δ 7.60 – 7.57 (m, 2H, 2 × C8-H, (E)- and (Z)-303), 7.39 
–7.19 (m, 3H, 2 × C9-H and C10-H, (E)- and (Z)-303), 6.38 (t, J = 2.1 Hz, 1H, C6-H, (E)-303), 
5.58 (t, J = 1.6 Hz, 1H, C6-H, (Z)-303), 3.03 (d, J = 2.1 Hz, 2H, C1-H2, (E)-303), 2.87 (d, J = 1.6 
Hz, 2H, C1-H2, (Z)-303), 1.38 (s, 3H, C3-H3, (Z)-303), 1.37 (s, 3H, C3-H3, (E)-303); 
13C NMR 
(CDCl3, 126 MHz): δ 180.3 (C4, (Z)-303), 179.7 (C4, (E)-303), 149.0 (C5, (E)-303), 146.2 (C5, 
(Z)-303), 134.6 (C7, (E)-303), 134.1 (C7, (Z)-303), 128.8, 128.6, 128.5, 128.0, 126.9, 126.8 (C8, 
C9 and C10, (E)- and (Z)-303), 107.7 (C6, (E)-303), 105.4 (C6, (Z)-303), 42.4 (C1, (Z)-303), 40.8 
(C1, (E)-303), 40.1 (C2, (E)-303), 39.4 (C2, (Z)-303), 25.2 (C3, (E)-303), 24.8 (C3, (Z)-303); MS: 
(APCI+) 203.11 ([M+H]+, 100%).The spectroscopic properties of (Z)-303 were consistent with the 
data available in the literature.279 
  




To a stirring solution of N-Benzylcyclopropanamine (1.47 g, 10.0 mmol), DCC (2.27 g, 11.0 
mmol) and DMAP (1.2 mg, 0.01 mmol) in DCM (30 mL) at 0 °C was added acid 305 (0.67 mL, 
10.8 mmol) in DCM (10 mL). The reaction was stirred for 2 h before being filtered through a pad 
of celite, washing with DCM (2 × 10 mL). The organic solution was concentrated in vacuo. FCC 
(15% EtOAc/hexane) provided the title compound (2.00 g, quantitative, 3:1 mixture of rotamers 
A:B) as a pale yellow solid; m.p. 102–105 °C (CHCl3); νmax / cm
-1: 3206 (m), 2096 (m), 1615 (s), 
1395 (m), 1303 (m); 1H NMR (CDCl3, 400 MHz): δ 7.38–7.25 (10H, m, C8-H, C9-H, C10-H, 
A+B), 4.77 (2H, s, C6-H2, B), 4.60 (2H, s, C6-H2, A), 3.20 (1H, s, C5-H, A), 3.08 (1H, s, C5-H, 
B), 2.66 (1H, m, C2-H, A), 2.52 (1H, m, C2-H, B), 0.88–0.87 (4H, m, C1-H2, A), 0.82 (2H, m, 
C1-H2, B), 0.69 (2H, m, C1-H2, B); 
13C NMR (CDCl3, 101 MHz): δ 155.9 (C3, A), 155.2 (C3, B), 
136.9 (C7, A), 136.8 (C7, B), 128.8, 128.6, 128.0, 127.8, 127.5, 127.2 (C8, C9, C10, A+B), 80.2 
(C5, A), 78.7 (C4, A), 77.1 (C5, B), 76.6 (C4, B), 53.4 (C6, B), 49.8 (C6, A), 30.3 (C2, A), 28.1 
(C2, B), 9.2 (C1, A), 7.1 (C1, B); HRMS: (ESI+) Calculated for C13H14NO: 200.1070. Found [M 




An oven dried reaction tube, fitted with a magnetic stirrer, was charged with amide 306 (1.00 g, 
5.00 mmol) and iodobenzene (0.67 mL, 6.00 mmol) were dissolved in dry TEA (10 mL) and the 
solution was sparged with argon. Pd(PPh3)2Cl2 (70.2 mg, 2 mol%) and CuI (19.1 mg, 2 mol%) 
were added, the tube was sealed and the reaction mixture was heated at 80 °C for 16 h. The mixture 
was cooled to r.t., filtered through a pad of silica, rinsed with DCM (30 mL) and concentrated in 
vacuo. Flash column chromatography (20% EtOAc/hexane) afforded the title compound 307 (0.59 
g, 43%, 1:0.33 mixture of rotamers A:B) as a yellow oil; νmax / cm
-1: 2216 (m), 1628 (s), 1490 (m), 
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1399 (s), 1303 (m), 758 (m), 690 (m); 1H NMR (CDCl3, 500 MHz): δ 7.58 – 7.54 (m, 2H, 2 × C3-
H, A), 7.48 – 7.26 (m, 18H, 2 × C3-H, B and 2 × C2-H, 2 × C12-H, 2 × C13-H, C1-H, C14-H, 
A+B), 4.84 (s, 2H, C10-H2, B), 4.66 (s, 2H, C10-H2, A), 2.73 (tt, J = 6.8, 4.1 Hz, 1H, C8-H, A), 
2.59 (tt, J = 7.1, 4.2 Hz, 1H, C8-H, B), 0.98 – 0.90 (m, 4H, 2 × C9-H2, A), 0.87 – 0.82 (m, 2H, 2 × 
C9-HaHb, B), 0.75 – 0.71 (m, 2H, 2 × C9-HaHb, B); 
13C NMR (CDCl3,126 MHz): δ 157.2 (C7, A), 
156.6 (C7, B), 137.4 (C11, A+B), 132.6 (C3, A+B), 130.2, 130.1, 128.9, 128.7, 128.7, 128.6, 128.2, 
127.8, 127.5, 127.4 (C1, C2, C12, C13 and C14, A+B), 121.1 (C4, A), 120.6 (C4, B), 91.5 (C5, A), 
90.0 (C5, B), 83.2 (C6, A), 82.6 (C6, B), 53.8 (C10, B), 49.9 (C10, A), 30.5 (C8, A), 28.4 (C8, B), 






An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate 307 (27.5 mg, 0.10 mmol), [Rh(cod)Cl]2 (2.5 mg, 0.005 mmol) and PPh3 (5.2 mg, 0.02 
mmol). The tube was fitted with a rubber septum and purged with argon. Anhydrous 1,2-DCB (1.0 
mL) was added and the reaction was sparged with CO for ca. 10 seconds. The tube was heated to 
130 °C, under a CO atmosphere (1 balloon) and stirred for 72 h. The mixture was cooled to r.t. 
and concentrated in vacuo. The residue was purified by flash column chromatography (10-25% 
EtOAc/hexane) to afford 308 (4.7 mg, 15%) as a yellow oil; νmax / cm
-1: 2925 (w), 1746 (s), 1684 
(s), 1379 (m), 1139 (m), 741 (m), 694 (m); 1H NMR (CDCl3, 400 MHz): δ 7.72 – 7.66 (m, 2H, 2 
× C14-H), 7.45 – 7.30 (m, 8H, C7-H, C16-H, 2 × C5-H, 2 × C6-H and 2 × C15-H), 4.64 (d, J = 
14.8 Hz, 1H, C3-HaHb), 4.51 (d, J = 14.8 Hz, 1H, C3-HaHb), 4.12 (dd, J = 11.4, 4.6 Hz, 1H, C8-
H), 2.70 (ddd, J = 18.9, 4.9, 2.0 Hz, 1H, C10-HaHb), 2.43 (ddd, J = 18.9, 13.9, 4.9 Hz, 1H, C10-
HaHb), 2.10 (dtd, J = 11.8, 4.6, 2.0 Hz, 1H, C9-HaHb), 1.74 (dtd, J = 13.9, 11.4, 4.9 Hz, 1H, C9-
HaHb); 
13C NMR (CDCl3, 101 MHz): δ 196.6 (C11), 160.6 (C2), 154.6 (C1), 135.2 (C4), 132.7 
(C13), 130.4 (C12), 130.3 (C14), 129.8, 129.2, 128.8, 128.5, 128.4 (C5, C6, C7, C15 and C16), 
56.3 (C8), 46.7 (C3), 36.8 (C10), 28.2 (C9); HRMS: (ESI+) calculated for C20H18NO2: 304.1332, 
found [M+H]+: 304.1322. 




To a stirring solution of N-benzyl-1-cyclopropylmethanamine (0.81 g, 5.0 mmol) and DCC (1.24 
g, 6.0 mmol) in DCM (50 mL) at 0 °C was added acid 305 (0.37 mL, 6.0 mmol). The reaction was 
allowed to slowly warm up to r.t. while being stirred for 2 h. The organic solution was washed 
with 2.0 M aq. HCl (10 mL), then with sat. aq. NaHCO3 (30 mL), the layers were separated and 
the aqueous portion was further extracted with DCM (3 × 10 mL). The organic extracts were 
combined, washed with brine, dried over MgSO4 and concentrated in vacuo. Flash column 
chromatography (20% EtOAc/hexane) afforded the title compound 309 (0.61 g, 57%, 1:1 mixture 
of rotamers A:B) as a yellow oil; νmax / cm
-1: 3213 (w), 2100 (m), 1621 (s), 1425 (s), 1244 (m), 729 
(s), 696 (s); 1H NMR (CDCl3, 400 MHz): δ 7.38 – 7.18 (m, 10H, C11-H, 2 × C9-H and 2 × C10-
H, A+B), 4.91 (s, 2H, C7-H2, A or B), 4.74 (s, 2H, C7-H2, A or B), 3.38 (d, J = 6.9 Hz, 2H, C4-H2, 
A or B), 3.20 (d, J = 7.0 Hz, 2H, C4-H2, A or B), 3.12 (s, 1H, C1-H, A or B), 3.09 (s, 1H, C1-H, A 
or B), 1.04 – 0.86 (m, 2H, C5-H, A+B), 0.57 – 0.40 (m, 4H, 2 × C6-HaHb, A+B), 0.27 – 0.19 (m, 
2H, 2 × C6-HaHb, A or B), 0.18 – 0.11 (m, 2H, 2 × C6-HaHb, A or B); 
13C NMR (CDCl3, 101 MHz): 
δ 153.8, 153.6 (C3, A+B), 136.5, 136.3 (C8, A+B), 128.9, 128.7, 128.1, 127.9, 127.6, 127.4 (C9, 
C10 and C11, A+B), 79.3, 79.0 (C1, A+B), 76.2, 76.1 (C2, A+B), 52.5 (C4, A), 52.4 (C7, A), 48.1 
(C4, B), 47.3 (C7, B), 10.2, 9.1 (C5, A+B), 3.9, 3.7 (C6, A+B); HRMS: (ESI+) calculated for 





General procedure H: Amide 309 (0.40 g, 1.88 mmol) and phenyl iodide (0.25 mL, 2.25 mmol) 
were employed and the reaction was stirred for 16 h at 80 °C. Flash column chromatography (10% 
EtOAc/hexane) afforded alkyne 310 (0.28 g, 52%, 1:1.03 mixture of rotamers A:B) as an orange 
oil; νmax / cm
-1: 2213 (m), 1620 (s), 1490 (m), 1449 (m), 1421 (s), 1274 (m), 756 (s), 730 (s), 689 
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(s); 1H NMR (CDCl3, 400 MHz): δ 7.56 – 7.51 (m, 2H, 2 × C3-H, A), 7.49 – 7.45 (m, 2H, 2 × C3-
H, B), 7.45 – 7.21 (m, 16H, C1-H, C15-H, 2 × C2-H, 2 × C13-H and 2 × C14-H, A+B), 4.98 (s, 
2H, C11-H2, A), 4.80 (s, 2H, C11-H2, B), 3.46 (d, J = 6.9 Hz, 2H, C8-H2, A), 3.27 (d, J = 7.0 Hz, 
2H, C8-H2, B), 1.11 – 0.90 (m, 2H, C9-H, A+B), 0.59 – 0.43 (m, 4H, 2 × C10-HaHb, A+B), 0.31 – 
0.15 (m, 4H, 2 × C10-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 155.0, 154.9 (C7, A+B), 136.8, 
136.8 (C12, A+B), 132.5, 132.4, 130.2, 130.1, 128.9, 128.7, 128.7, 128.6, 128.1, 127.9, 127.6, 
127.5 (C1, C2, C3, C13, C14 and C15, A+B), 120.7, 120.6 (C4, A+B), 90.5, 90.3 (C5, A+B), 82.0, 
82.0 (C6, A+B), 52.7 (C8, A), 52.6 (C11, A), 48.3 (C8, B), 47.4 (C11, B), 10.3, 9.3 (C9, A+B), 4.0, 





General procedure G: N-Benzylcyclopropanamine (0.66 g, 4.50 mmol) and acid 314 (1.00 g, 
4.50 mmol, prepared according to the literature procedure180) were employed and the residue was 
purified by flash column chromatography (20% EtOAc/pentane) to afford the title compound 315 
(1.41 g, 89%, 1:0.15 mixture of rotamers A:B) as a yellow oil; νmax / cm
-1: 1644 (s), 1494 (m), 1444 
(m), 1403 (s), 1373 (m), 756 (s); 1H NMR (DMSO-d6, 500 MHz, major rotamer A only): δ 7.64 – 
7.08 (m, 14H, C1-H, C8-H, C9-H, C10-H, C11-H, C20-H, 2 × C2-H, 2 × C3-H, 2 × C18-H and 2 
× C19-H), 4.72 (br. s, 2H, C16-H2), 2.70 (tt, J = 7.2, 3.9 Hz, 1H, C14-H), 0.50 (br. s, 2H, 2 × C15-
HaHb), 0.41 – 0.33 (m, 2H, 2 × C15-HaHb); 
13C NMR (DMSO-d6, 126 MHz, major rotamer A 
only): 171.1 (C13), 141.0 (C12), 138.1 (C17), 132.0 (C8), 131.4 (C3), 129.0, 128.9, 128.7, 128.6, 
128.3, 127.5, 126.8, 126.6, 121.9, 118.8 (C1, C2, C4, C7, C9, C10, C11, C18, C19 and C20), 92.0 
(C6), 87.3 (C5), 49.3 (C16), 30.7 (C14), 8.4 (C15); HRMS: (ESI+) calculated for C25H22NO: 
352.1696, found [M+H]+: 352.1683. High temperature NMR (100 °C, DMSO-d6) resulted in 
partial coalescence of the signals for rotamers A and B. However, the low signal intensity of the 
resulting 13C spectre did not allow a full characterisation. 
 




General procedure G: N-Benzylcyclopropanamine (0.26 g, 1.80 mmol) and acid 320 (0.39 g, 
1.80 mmol, prepared according to the literature procedure280) were employed and the residue was 
purified by flash column chromatography (50% EtOAc/hexane) to afford the title compound 323 
(0.17 g, 27%) as a colourless oil; νmax / cm
-1: 2896 (m), 2229 (m), 1663 (s), 1490 (m), 1404 (m), 
1148 (s), 1016 (s), 987 (s), 757 (s), 691 (s); 1H NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.45 – 7.20 
(m, 10H, 2 × C2-H, 2 × C3-H, 2 × C12-H, 2 × C13-H, C1-H and C14-H), 4.71 (br. s, 2H, C10-
H2), 4.18 – 4.10 (m, 2H, 2 × C8-HaHb), 4.08 – 3.99 (m, 2H, 2 × C8-HaHb), 2.87 (s, 1H, C15-H), 
0.85 – 0.68 (m, 4H, 2 × C16-H2); 
13C NMR (DMSO-d6, 126 MHz, 110 °C): δ 166.0 (C9), 137.6 
(C11), 131.0, 128.9, 128.1, 127.7, 126.4, 126.3 (C1, C2, C3, C12, C13 and C14), 120.2 (C4), 98.9, 
85.7, 84.5 (C5, C6 and C7), 64.5 (C8), 49.8 (C10), 29.9 (C15), 7.1 (C16); HRMS: (ESI+) calculated 





General procedure I: Amide 323 (34.7 mg, 0.10 mmol) was employed. Flash column 
chromatography (40% EtOAc/hexane) afforded the title compound 324 (9.9 mg, 26%) as a yellow 
oil; νmax / cm
-1: 1710 (s), 1683 (s), 1443 (m), 1242 (s), 1177 (s), 1031 (m), 997 (m), 730 (m), 699 
(s); 1H NMR (CDCl3, 400 MHz): δ 7.40 – 7.23 (m, 8H, C1-H, C19-H, 2 × C2-H, 2 × C17-H and 
2 × C18-H), 7.16 – 7.11 (m, 2H, 2 × C3-H), 4.99 (d, J = 15.0 Hz, 1H, C15-HaHb), 4.35 – 4.28 (m, 
2H, C9-H and C12-H or C13-H), 4.22 (d, J = 15.0 Hz, 1H, C15-HaHb), 4.08 (ddd, J = 7.0, 7.0, 4.2 
Hz, 1H, C12-H or C13-H), 3.97 (ddd, J = 7.4, 6.6, 4.2 Hz, 1H, C12-H or C13-H), 2.91 – 2.84 (m, 
1H, C12-H or C13-H), 2.80 – 2.71 (m, 1H, C7-HaHb), 2.47 – 2.36 (m, 2H, C7-HaHb and C8-HaHb), 
1.91 – 1.78 (m, 1H, C8-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 196.5 (C6), 170.3 (C14), 149.0 
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(C10), 139.2 (C5), 135.3 (C16), 132.9 (C4), 129.8 (C3), 129.2, 128.3, 128.2, 128.1, 127.6 (C1, 
C2, C17, C18 and C19), 102.7 (C11), 67.0, 66.4 (C12 and C13), 54.7 (C9), 44.3 (C15), 35.9 (C7), 
28.4 (C8); HRMS: (ESI+) calculated for C23H21NNaO4: 398.1363, found [M+Na]
+: 398.1345. 
 
Ethyl 2,2-difluoro-4-phenylbut-3-ynoate (321) 
 
To a solution of ethyl 2-oxo-4-phenylbut-3-ynoate 318 (1.00 g, 4.95 mmol, prepared according to 
the literature procedure280) in DCM (10 mL), DAST (1.63 mL, 12.36 mmol) was added dropwise 
at 0 °C, the reaction mixture was warmed up to r.t. and stirred for 90 min. The crude reaction was 
poured into crushed ice and stirred for 2 h. The resulting suspension was extracted with DCM (3 
× 20 mL) and the organic extracts were combined, dried over MgSO4 and concentrated in vacuo. 
The residue was purified by flash column chromatography (10% Et2O/pentane) to afford the title 
compound 321 (0.91 g, 82%) as a colourless oil; 1H NMR (CDCl3, 400 MHz): δ 7.56 – 7.34 (m, 
5H, 2 × C2-H, 2 × C3-H and C1-H), 4.40 (q, J = 7.1 Hz, 2H, C9-H2), 1.39 (t, J = 7.1 Hz, 3H, C10-
H3); 
13C NMR (CDCl3, 101 MHz): δ 161.6 (C8, t, J = 34.1 Hz), 132.4 (C4, t, J = 2.4 Hz), 130.5, 
128.5, 119.3 (C1, C2 and C3), 104.9 (C7, t, J = 241.1 Hz), 89.6 (C5, t, J = 6.3 Hz), 78.3 (C6, t, J 
= 37.7 Hz), 63.8 (C9), 13.9 (C10). The spectroscopic properties of this compound were consistent 
with the data available in the literature.281 
  




To a solution of ester 321 (0.91, 4.06 mmol) in MeOH (8 mL) was added 4.0 M aq. NaOH (5.5 
mL) and the reaction was stirred at r.t. for 16 h. The reaction mixture was concentrated in vacuo, 
diluted with water (20 mL) and extracted with Et2O (20 mL). The aqueous portion was adjusted 
to pH 2 by addition of 6.0 M aq. HCl and then extracted with Et2O (3 × 20 mL). The organic 
extracts were combined, dried over MgSO4 and concentrated in vacuo to afford the title compound 
322 (0.56 g, 70%) as a colourless solid which was used in next step without further purification. 
Acid 322 was dissolved in DCM (6 mL), treated with oxalyl chloride (0.24 mL, 2.85 mmol), a 
drop of DMF and stirred at r.t. for 1 h. DCM and an excess of oxalyl chloride were removed in 
vacuo and the corresponding acyl chloride was dissolved in DCM (2 mL). The solution was added 
dropwise to N-benzylcyclopropanamine (0.44 g, 2.99 mmol) and TEA (0.79 mL, 0.58 mmol) in 
DCM (4 mL) at 0 °C, the reaction was warmed to r.t. and stirred for 18 h. Sat. aq. NaHCO3 (20 
mL) and DCM (10 mL) were added, the layers were separated and the aqueous portion was further 
extracted with DCM (2 × 15 mL). The organic extracts were combined, washed with 1.0 M aq. 
HCl (20 mL), dried over MgSO4 and concentrated in vacuo. The residue was purified by flash 
column chromatography (10% EtOAc/hexane) to afford the title compound 325 (0.45 g, 49%) as 
a pale yellow oil; νmax / cm
-1: 2237 (m), 1682 (s), 1409 (m), 1138 (s), 1078 (s), 757 (s), 690 (m); 
1H NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.57 – 7.50 (m, 3H, 3 × Ar-H), 7.49 – 7.43 (m, 2H, 2 
× Ar-H), 7.36 – 7.31 (m, 2H, 2 × Ar-H), 7.29 – 7.24 (m, 3H, 3 × Ar-H), 4.70 (s, 2H, C9-H2), 2.92 
(br. s, 1H, C14-H), 0.95 – 0.82 (m, 4H, 2 × C10-H2); 
13C NMR (DMSO-d6, 126 MHz, 110 °C): δ 
137.5 (C10), 132.5, 131.4, 129.4, 128.9, 127.6, 127.5, 127.4 (C1, C2, C3, C4, C11, C12 and C13), 
107.32 (C7, t, J = 242.0 Hz), 91.14 (C5, t, J = 6.6 Hz), 79.83 (C6, t, J = 37.6 Hz), 31.1 (C14), 8.5 
(C15); signal corresponding to C8 was not observed due to its weak intensity; 19F NMR (CDCl3, 
376 MHz, 25 °C, 2:1 mixture of rotamers A:B): δ -84.3 (A), -84.5 (B); HRMS: (ESI+) calculated 
for C20H18F2NO: 326.1351, found [M+H]
+: 326.1349. 
  




General procedure I: Amide 325 (32.5 mg, 0.10 mmol) was employed. Flash column 
chromatography (40% EtOAc/hexane) afforded the title compound 326 (3.5 mg, 10%) as a pale 
brown oil; νmax / cm
-1: 1731 (s), 1693 (s), 1445 (m), 1241 (s), 1172 (s), 1071 (s), 732 (s), 698 (s); 
1H NMR (CDCl3, 400 MHz) δ 7.46 – 7.19 (m, 10H, C1-H, C17-H, 2 × C2-H, 2 × C3-H, 2 × C15-
H and 2 × C16-H), 5.12 (d, J = 15.0 Hz, 1H, C13-HaHb), 4.34 (dt, J = 11.7, 3.9 Hz, 1H, C9-H), 
4.25 (d, J = 15.0 Hz, 1H, C13-HaHb), 2.90 – 2.80 (m, 1H, C7-HaHb), 2.58 – 2.42 (m, 2H, C8-HaHb 
and C7-HaHb), 1.96 – 1.83 (m, 1H, C8-HaHb); 
13C{1H,19F} NMR (CDCl3, 101 MHz): δ 195.4 (C6), 
162.8 (C12), 141.4 (C10), 140.5 (C5), 134.3 (C14), 130.8, 129.8, 129.5, 129.4, 128.7, 128.2, 128.1 
(C1, C2, C3, C4 ,C15, C16 and C17), 111.2 (C11), 53.8 (C9), 44.8 (C13), 35.7 (C7), 28.0 (C8); 
19F NMR (CDCl3, 376 MHz) δ -89.9 (dd, J = 302.3, 3.4 Hz), -117.7 (d, J = 302.3 Hz); HRMS: 





This compound was prepared according to the literature procedure.182 Urea 327 (1.00 g, 3.75 
mmol, prepared according to the literature procedure53) and tetrabutylammonium hydrogensulfate 
(0.32 g, 0.94 mmol) were dissolved in toluene (38 mL). The flask was purged with argon using a 
balloon and outlet needle. Then, 50% w/v KOH aqueous solution (17 mL) was added and the 
reaction was heated to 60 °C for 10 min. Trichloroethylene (1.00 mL, 11.25 mmol) was added 
dropwise over 5 min and the mixture was stirred at 60 °C for 2 h. The reaction was cooled to r.t. 
and then water (50 mL) was added. The solution was extracted with Et2O (3 × 50 mL) and the 
organic extracts were combined, washed with brine (50 mL), dried over MgSO4 and concentrated 
in vacuo. The residue was purified by recrystallization (DCM/Et2O, 2 crops) to afford the title 
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compound 328 (0.93 g, 69%) as a colourless solid; m.p. 130-131 °C (DCM/Et2O); νmax / cm
-1: 
3675 (w), 2989 (m), 1666 (s), 1492 (m), 1393 (s), 1256 (s), 1066 (s), 805 (m), 805 (m); 1H NMR 
(CDCl3, 400 MHz): δ 7.38 – 7.21 (m, 7H, 2 × C5-H, 2 × C12-H, 2 × C13-H and C14-H), 7.19 – 
7.12 (m, 1H, C6-H), 7.06 – 6.99 (m, 2H, 2 × C4-H), 6.25 (s, 1H, C1-H), 4.55 (s, 2H, C10-H2), 
1.81 (tt, J = 7.0, 3.9 Hz, 1H, C8-H), 0.94 – 0.85 (m, 2H, 2 × C9-HaHb), 0.55 – 0.47 (m, 2H, 2 × 
C9-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 157.3 (C7), 140.7 (C3), 137.4 (C11), 133.8 (C2), 129.2, 
129.0, 128.6, 127.7 (C5, C12, C13 and C14), 126.4 (C6), 125.2 (C4), 113.3 (C1), 53.3 (C10), 31.1 
(C8), 10.4 (C9); HRMS: (ESI+) calculated for C19H19






This compound was prepared according to the modified literature procedure.182 To a solution of 
(E)-1-benzyl-1-cyclopropyl-3-(1,2-dichlorovinyl)-3-phenylurea 328 in dry Et2O (8 mL), LiHMDS 
(0.66 mL, 1.00 mmol, 1.5 M in THF) was added dropwise at 0 °C. The reaction was stirred for 2 
h at 0 °C and then warmed to r.t. to allow the formation of chloroynamide 329. 
In a second flask, dry toluene (2.5 mL) was added to zinc(II) chloride (0.17 g, 1.25 mmol, dried 
by fusing on Bunsen burner prior to use). Phenylmagnesium bromide (2.49 mL, 2.49 mmol, 1.0 
M in THF) was added dropwise to the resulting suspension at r.t and the mixture stirred for 5 
minutes. To this was added dry TMEDA (1.25 mL, 8.30 mmol) dropwise at r.t. and the solution 
stirred for 5 minutes to allow the formation of diphenylzinc. 
To the previously prepared solution of chloroynamide 329, CuCN•2LiCl (10 L, 0.01 mmol, 1.0 
M in THF) was added at r.t., followed by the previously prepared diphenylzinc solution. The 
reaction was stirred for 30 minutes at r.t. and then sat. aq. NH4Cl (30 mL) was added. The solution 
was extracted with Et2O (3 × 20 mL) and the organic extracts were combined, dried over MgSO4 
and concentrated in vacuo. The residue was purified by flash column chromatography (10% 
EtOAc/petrol) to afford the title compound 330 (0.23 g, 77%) as a pale yellow oil; νmax / cm
-1: 
2240 (m), 1645 (s), 1494 (m), 1389 (s), 1249 (m), 753 (m), 691 (m); 1H NMR (CDCl3, 400 MHz): 
Chapter 8 – Experimental 
221 
δ 7.43 – 7.24 (m, 14H, 2 × C2-H, 2 × C3-H, 2 × C8-H, 2 × C9-H, 2 × C16-H, 2 × C17-H, C1-H 
and C18-H), 7.20 – 7.14 (m, 1H, C10-H), 4.71 (s, 2H, C14-H2), 2.70 (tt, J = 6.7, 4.2 Hz, 1H, C12-
H), 0.88 – 0.78 (m, 4H, 2 × C13-H2); 
13C NMR (CDCl3, 101 MHz): δ 158.5 (C11), 141.0 (C7), 
137.4 (C15), 130.8, 129.1, 128.8, 128.5, 128.3, 127.6, 127.5 (C1, C2, C3, C9, C16, C17 and C18), 
125.2 (C10), 123.6 (C4), 121.9 (C8), 83.9 (C6), 71.8 (C5), 53.0 (C14), 31.5 (C12), 9.8 (C13); 





An oven dried reaction tube, fitted with a magnetic stirrer, was charged with ynamide substrate 
330 (36.6 mg, 0.10 mmol), [Rh(cod)2]OTf (4.7 mg, 0.01 mmol) and PPh3 (5.2 mg, 0.02 mmol). 
The tube was fitted with a rubber septum and purged with argon. Anhydrous PhCN (1.0 mL) was 
added and the reaction was sparged with CO for ca. 10 seconds. The tube was heated to 120 °C, 
under a CO atmosphere (1 balloon) and stirred for 72 h. The mixture was cooled to r.t. and 
concentrated in vacuo. The residue was purified by flash column chromatography (20% 
EtOAc/hexane) to afford the title compound 332 (8.5 mg, 22%) as an orange oil; νmax / cm
-1: 2923 
(w), 1699 (s), 1636 (s), 1596 (s), 1494 (s), 1414 (s), 1220 (s), 750 (s); 1H NMR (CDCl3, 400 MHz): 
δ 8.00 – 7.97 (m, 2H, 2 × C3-H), 7.60 – 7.55 (m, 1H, C1-H), 7.49 – 7.44 (m, 2H, 2 × C2-H), 7.36 
– 7.34 (m, 4H, 4 × Ar-H), 7.32 – 7.27 (m, 1H, Ar-H), 7.21 – 7.15 (m, 2H, 2 × Ar-H), 7.08 – 7.01 
(m, 3H, 2 × Ar-H and C18-H), 5.16 (s, 2H, C6-H2), 4.50 (s, 2H, C14-H2), 1.61 (tt, J = 6.7, 3.8 Hz, 
1H, C12-H), 1.02 – 0.96 (m, 2H, 2 × C13-HaHb), 0.44 – 0.38 (m, 2H, 2 × C13-HaHb); 
13C NMR 
(CDCl3, 101 MHz): δ 195.5 (C5), 160.4 (C11), 145.6 (C7), 138.1 (C15), 135.5 (C4), 133.6 (C1), 
129.0, 128.9, 128.8, 128.5, 128.1, 127.4, 125.3 (C2, C3, C8, C9, C10, C16 and C17), 125.1 (C18), 
59.0 (C6), 53.1 (C14), 31.3 (C12), 10.9 (C13); HRMS: (ESI+) calculated for C25H25N2O2: 
385.1911, found [M+H]+: 385.1914. 
The structure of product 332 was confirmed by HMBC analysis (as indicated on the compound 
structure). 
 
3-Phenylprop-2-yn-1-yl benzyl(cyclopropyl)carbamate (339) 
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This compound was prepared according to the modified literature procedure.282 To a solution of 
triphosgene (1.48 g, 5.00 mmol) in dry ether (20 mL), activated charcoal (0.05 g) was added and 
stirred for 1 h at room temperature. The solution was cooled to 0 °C and 3-phenyl-2-propyn-1-ol 
(1.23 mL, 10.00 mmol) was added dropwise. The reaction was stirred for 12 h and filtered through 
a pad of celite. The crude was concentrated in vacuo and dry DCM (20 mL) was added. The 
reaction was cooled to 0 °C and N-benzylcyclopropanamine (1.47 g, 10.00 mmol) was added, 
followed by triethylamine (2.09 mL, 15 mmol). The reaction was warmed to r.t. and stirred for 16 
h. 1.0 M aq. HCl (20 mL) was added, the layers were separated and the organic portion was further 
washed with sat. aq. NaHCO3 (20 mL), dried over MgSO4 and concentrated in vacuo. The residue 
was purified by flash column chromatography (10% EtOAc/hexane) to afford the title compound 
339 (1.95 g, 64%) as a pale yellow oil; νmax / cm
-1: 3030 (w), 1702 (s), 1405 (s), 1268 (s), 1227 
(s), 1121 (s), 1060 (s), 755 (s), 690 (s); 1H NMR (CDCl3, 400 MHz): δ 7.48 – 7.43 (m, 2H, 2 × 
C3-H), 7.35 – 7.23 (m, 8H, C1-H, C15-H, 2 × C2-H, 2 × C13-H and 2 × C14-H), 4.99 (s, 2H, C7-
H2), 4.52 (s, 2H, C11-H2), 2.54 (br. s, 1H, C9-H), 0.81 – 0.68 (m, 4H, 2 × C10-H2); 
13C NMR 
(CDCl3, 126 MHz): δ 157.3 (br. s, C8), 138.2 (C12), 132.0 (C3), 128.7, 128.6, 128.4, 127.8, 127.4 
(C1, C2, C13, C14 and C15), 122.6 (C4), 86.2 (C5), 84.0 (C6), 53.9 (C7), 51.8 (C11), 29.3 (br. s, 








2,2-Dimethylbut-3-enoic acid 344b was prepared according to a literature procedure.283 1-Chloro-
3-methyl-2-butene 342 was added dropwise to a stirred suspension of magnesium (4.65 g, 191.24 
mmol) in dry THF (60 mL) at room temperature. Once an exotherm was observed, the reaction 
mixture was cooled to 0 °C and the rest of 1-chloro-3-methyl-2-butene (10.78 mL in total, 95.62 
mmol) was added dropwise. The reaction was warmed to r.t., stirred for 2 h and the reaction 
mixture was cannulated into dry ice (approx. 200 g). After stirring for 3 h at r.t., 1.0 M HCl (100 
mL) was added and the solution was extracted with Et2O (3 × 50 mL). The combined organic layer 
was dried over MgSO4 and concentrated in vacuo to afford the acid 344b (7.69 g, 70%, 15:1 
mixture of regioisomers) as a pale yellow oil which was used in the next step without further 
purification; 1H NMR (CDCl3, 400 MHz): δ 6.05 (dd, J = 17.4, 10.6 Hz, 1H, C2-H), 5.15 (dd, J = 
17.4, 0.8 Hz, 1H, C1-Htrans), 5.11 (dd, J = 10.6, 0.8 Hz, 1H, C1-Hcis), 1.33 (s, 6H, 2 × C3-H3);The 
spectroscopic properties of this compound were consistent with the data available in the 
literature.283 
N-Benzyl-N-cyclopropyl-2,2-dimethylbut-3-enamide 341 was prepared according to general 
procedure G. N-Benzylcyclopropanamine (1.29 g, 8.76 mmol) and acid 344 (1.00 g, 8.76 mmol) 
were employed and the residue was purified by flash column chromatography (10% 
EtOAc/hexane) to afford the title compound 341 (1.13 g, 53%) as a colourless oil; νmax / cm
-1: 
2975 (w), 1630 (s), 1545 (m), 1388 (s), 995 (m), 913 (m), 698 (m); 1H NMR (CDCl3, 400 MHz): 
δ 7.34 – 7.13 (m, 5H, 2 × C13-H, 2 × C14-H and C15-H), 6.10 (dd, J = 17.6, 10.6 Hz, 1H, C5-H), 
5.09 (d, J = 17.6 Hz, 1H, C4-Htrans), 5.05 (d, J = 10.6 Hz, 1H, C4-Hcis), 4.58 (s, 2H, C11-H2), 2.69 
(br. s, 1H, C9-H), 1.37 (s, 6H, 2 × C7-H3), 0.73 – 0.58 (m, 4H, 2 × C10-H2); 
13C NMR (CDCl3, 
126 MHz): δ 178.5 (C8), 143.9 (C5), 138.5 (br., C12), 128.6, 127.1, 126.9 (C13, C14 and C15), 
112.2 (C4), 51.4 (br., C11), 46.0 (C6), 30.8 (br., C9), 26.9 (C7), 8.7 (br., C10); HRMS: (ESI+) 









An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate 341 (24.3 mg, 0.10 mmol), [Rh(cod)Cl]2 (2.5 mg, 0.005 mmol) and PPh3 (5.2 mg, 0.02 
mmol). The tube was fitted with a rubber septum and purged with argon. Anhydrous PhCN (1.0 
mL) was added and the reaction was sparged with CO for approx. 10 seconds. The tube was heated 
to 130 °C, under a CO atmosphere (1 balloon) and stirred for 72 h. The mixture was cooled to r.t. 
and concentrated in vacuo. An in situ yield (80%) was obtained by using 1,4-dinitrobenzene as an 
internal standard for 1H NMR spectroscopy. The residue was purified by flash column 
chromatography (50% EtOAc/hexane) to afford 345 (19.7 mg, 73%) as a pale yellow oil; νmax / 
cm-1: 2952 (m), 1688 (s), 1405 (m), 1267 (m), 1177 (w), 753 (w), 703 (m); 1H NMR (CDCl3, 400 
MHz): δ 7.34 – 7.23 (m, 3H, 2 × C7-H and C8-H), 7.22 – 7.17 (m, 2H, 2 × C6-H), 4.92 (d, J = 
15.0 Hz, 1H, C4-HaHb), 4.05 (d, J = 15.0 Hz, 1H, C4-HaHb), 3.26 – 3.15 (m, 1H, C9-H), 2.54 – 
2.46 (m, 1H, C11-HaHb), 2.43 – 2.36 (m, 1H, C13-HaHb), 2.31 – 2.16 (m, 3H, C10-HaHb, C11-
HaHb, C13-HaHb), 1.85 – 1.74 (m, 1H, C14-H), 1.60 – 1.47 (m, 1H, C10-HaHb), 1.18 (s, 3H, C1-
H3), 0.97 (s, 3H, C1'-H3); 
13C NMR (CDCl3, 101 MHz): δ 207.9 (C12), 180.5 (C3), 136.9 (C5), 
128.9, 128.0 (C6 and C7), 127.8 (C8), 56.5 (C9), 50.8 (C14), 44.4 (C4), 42.7 (C2), 39.8 (C13), 
39.3 (C11), 28.4 (C10), 23.0 (C1), 17.0 (C1'); HRMS: (ESI+) calculated for C17H22NO2: 272.1645, 
found [M+H]+: 272.1651. 
The relative stereochemistry of this compound was corroborated by nOe experiments (as indicated 
on the compound structure). A strong nOe was observed between C14-H and C1-H3. A strong nOe 
was observed between C9-H and C1'-H3. No significant nOe was observed between C9-H and 
C14-H. 
General procedure J: Amide 341 (24.3 mg, 0.10 mmol) was employed. Flash column 
chromatography (50% EtOAc/hexane) afforded the title compound (R,S)-345 (17.2 mg, 63%) as 
a yellow oil. The enantiopurity of this compound was determined by chiral SFC against a racemic 
standard. The absolute stereochemistry in (R,S)-345 was assigned by analogy with (S)-380c. 
[𝛼]D
24.2 = -14.4 (c = 0.50, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IB column (25 cm), CO2:MeOH 94:6, 2 mL/min, 140 bars, 
40 °C). Retention times: 10.8 minutes (minor), 12.1 minutes (major), e.r. = 89:11. 




General procedure G: N-Benzylcyclopropanamine (1.00 g, 6.79 mmol) and but-3-enoic acid 
(0.58 g, 6.79 mmol) were employed and the residue was purified by flash column chromatography 
(20% EtOAc/hexane) to afford the title compound 346 (0.21 g, 14%) as a colourless oil; 0.71 g of 
title compound containing ~10% of unidentified impurity was also isolated; νmax / cm
-1: 1652 (s), 
1398 (m), 1259 (w), 1031 (w), 916 (w), 701 (m); 1H NMR (CDCl3, 400 MHz): δ 7.33 – 7.20 (m, 
5H, 2 × C9-H, 2 × C10-H and C11-H), 6.05 (ddt, J = 17.1, 10.5, 6.7 Hz, 1H, C2-H), 5.20 – 5.12 
(m, 2H, C1-H2), 4.60 (s, 2H, C7-H2), 3.41 (d, J = 6.7, 2H, C3-H2), 2.61 – 2.53 (m, 1H, C5-H), 0.89 
– 0.76 (m, 4H, 2 × C6-H2); 
13C NMR (CDCl3, 126 MHz): δ 174.0 (C4), 138.5 (C8), 132.2 (C2), 
128.6, 128.0 (C9 and C10), 127.2 (C11), 117.8 (C1), 49.9 (C7), 39.6 (C3), 30.2 (C5), 9.4 (C6); 





Aminocyclopropane 349 was prepared by Curley. General procedure G: 
N-Benzylcyclopropanamine (1.00 g, 6.80 mmol) and 2-methylbut-3-enoic acid (0.68 g, 6.80 
mmol, prepared according to the literature procedure284) were employed and the residue was 
purified by flash column chromatography (20% EtOAc/hexane) to afford the title compound 349 
(0.61 g, 39%) as a colourless oil; νmax / cm
-1: 1651 (s), 1634 (s), 1395 (s), 1454 (m), 1249 (m), 
1030 (m); 1H NMR (CDCl3, 400 MHz): δ 7.34 – 7.14 (m, 5H, 2 × C10-H, 2 × C11-H and C12-H), 
5.91 (ddd, J = 17.1, 10.2, 8.0 Hz, 1H, C2-H), 5.17 – 5.00 (m, 2H, C1-H2), 4.69 (d, J = 14.6 Hz, 
2H, C8-HaHb), 4.50 (d, J = 14.6 Hz, 2H, C8-HaHb), 4.03 – 3.90 (m, 1H, C3-H), 2.62 – 2.52 (m, 
1H, C6-H), 1.26 (d, J = 6.8 Hz, 3H, C4-H3), 0.91 – 0.70 (m, 4H, 2 × C7-H2); 
13C NMR (CDCl3, 
101 MHz): 177.2 (C5), 139.0 (C9), 138.5 (C2), 128.5, 127.8, 127.1 (C10, C11 and C12), 115.5 
(C1), 49.9 (C8), 41.7 (C3), 29.8 (C6), 18.2 (C4), 9.9 (C7), 9.1 (C7'); HRMS: (ESI+) calculated for 
C15H20NO: 230.1539, found [M+H]
+: 230.1539. 




Cyclohexanone 352 was prepared by Curley. An oven dried reaction tube, fitted with a magnetic 
stirrer, was charged with aminocyclopropane 349 (22.9 mg, 0.10 mmol), [Rh(cod)Cl]2 (2.5 mg, 
0.005 mmol), dimethyl fumarate (14.4 mg, 0.1 mmol) and PPh3 (5.2 mg, 0.02 mmol). The tube 
was fitted with a rubber septum and purged with argon. Anhydrous PhCN (1.0 mL) was added and 
the reaction was sparged with CO for approx. 10 seconds. The tube was heated to 130 °C, under a 
CO atmosphere (1 balloon) and stirred for 72 h. The mixture was cooled to r.t. and concentrated 
in vacuo. An in situ yield (20%) was obtained by using 1,4-dinitrobenzene as an internal standard 
for 1H NMR spectroscopy. The residue was purified by flash column chromatography (70% 
EtOAc/hexane) to afford 345 (5.9 mg, 23%) as a pale yellow oil; νmax / cm
-1: 1688 (s), 1406 (s), 
1454 (m), 1375 (m), 1302 (m), 1194 (m); 1H NMR (CDCl3, 400 MHz): δ 7.35 – 7.19 (m, 5H, 2 × 
C3-H, 2 × C2-H and C1-H), 4.90 – 4.80 (d, J = 14.9 Hz, 1H, C5-HaHb), 4.22 – 4.13 (d, J = 14.9 
Hz, 1H, C5-HaHb), 3.28 – 3.17 (m, 1H, C9-H), 2.69 – 2.63 (m, 1H, C11-HaHb), 2.59 – 2.51 (m, 
1H, C13-HaHb), 2.34 – 2.16 (m, 4H, C11-HaHb, C13-HaHb, C14-HaHb and C7-H), 1.69 (dddd, J = 
14.0, 11.5, 9.9, 3.8 Hz, 1H, C10-H), 1.60 – 1.52 (m, 1H, C14-HaHb) 1.24 (d, J = 6.9 Hz, 3H, C8-
H3); 
13C NMR (CDCl3, 101 MHz): δ 207.3 (C12), 177.7 (C6), 136.9 (C4), 128.9, 128.0, 127.7 (C1, 
C2 and C3), 59.0 (C9), 48.4 (C10), 44.6 (C5), 43.2 (C11), 42.9 (C7), 39.2 (C13), 28.2 (C14), 13.0 
(C8). The spectroscopic properties of this compound were consistent with the data available in the 
literature.285 The relative stereochemistry of this compound was corroborated by nOe experiments 
(as indicated on the compound structure). A strong nOe was observed between C10-H and C8-H3. 
No nOe was observed between C9-H and C8-H3 or C9-H and C10-H. 
  




General procedure G: (1S*,2S*)-N-Benzyl-2-methylcyclopropan-1-amine (0.43 g, 2.66 mmol, 
prepared according to the literature procedure48) and 2,2-dimethyl-4-phenylbut-3-ynoic acid (0.50 
g, 2.66 mmol) were employed and the residue was purified by flash column chromatography (5% 
EtOAc/hexane) to afford the title compound 357a (0.69 g, 79%) as a colourless solid; m.p.  
75-76 °C (DCM/hexane); νmax / cm
-1: 2988 (m), 1651 (s), 1492 (m), 1454 (m), 1394 (s), 1169 (m), 
1077 (m), 756 (s), 692 (s); 1H NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.34 – 7.19 (m, 10H, 2 × 
C2-H, 2 × C3-H, 2 × C12-H, 2 × C13-H, C1-H and C14-H), 4.81 (s, 2H, C10-H2), 2.63 (br. s, 1H, 
C15-H), 1.59 (s, 6H, 2 × C8-H3), 1.11 – 1.02 (m, 1H, C17-H), 0.93 (d, J = 6.1 Hz, 3H, C18-H3), 
0.91 – 0.85 (m, 1H, C16-HaHb), 0.51 – 0.46 (m, 1H, C16-HaHb); 
13C NMR (DMSO-d6, 126 MHz, 
110 °C): δ 172.8 (C9), 137.8 (C11), 130.5, 127.8, 127.7, 127.6, 126.3, 126.1 (C1, C2, C3, C12, 
C13 and C14), 122.2 (C4), 92.7 (C6), 82.8 (C5), 50.1 (C10), 37.9 (C15), 37.2 (C7), 28.1 (C8), 
27.9 (C8'), 16.5 (C18), 15.1 (C17), 14.8 (C16); HRMS: (ESI+) calculated for C23H25NO: 332.2009, 
found [M+H]+: 332.2000. 
 
Data for enantioenriched (S,S)-357a (prepared from (R)-propylene oxide110): 
[𝛼]D
23.5 = +19.8 (c = 0.33, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IB column (25 cm), CO2:i-PrOH 98:2, 2 mL/min, 100 bars, 
40 °C). Retention times: 27.0 minutes (major), e.r. > 99:1. 
  





An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate 357a (27.5 mg, 0.10 mmol), [Rh(cod)Cl]2 (2.5 mg, 0.005 mmol) and P(C6F5)3 (10.6 mg, 
0.02 mmol). The tube was fitted with a rubber septum and purged with argon. Anhydrous PhCN 
(1.0 mL) was added and the reaction was sparged with CO for ca. 10 seconds. The tube was heated 
to 150 °C, under a CO atmosphere (1 balloon) and stirred for 72 h. The mixture was cooled to r.t. 
and concentrated in vacuo. The residue was purified by flash column chromatography (10-25% 
EtOAc/hexane) to afford 358a (30.3 mg, 84%) as a colourless oil, the product was isolated as a 
single diastereomer (>15:1 d.r.); νmax / cm
-1: 1697 (s), 1673 (s), 1410 (s), 1295 (m), 1239 (m), 919 
(m), 730 (s), 700 (s); 1H NMR (CDCl3, 400 MHz): δ 7.41 – 7.27 (m, 6H, 2 × C2-H, 2 × C18-H, 
C1-H and C19-H), 7.22 – 7.17 (m, 2H, 2 × C17-H), 7.08 – 7.00 (m, 2H, 2 × C3-H), 5.17 (d, J = 
15.6 Hz, 1H, C15-HaHb), 4.50 (d, J = 15.6 Hz, 1H, C15-HaHb), 4.11 (d, J = 9.9 Hz, 1H, C10-H), 
2.59 (dd, J = 17.1, 3.6 Hz, 1H, C7-HaHb), 2.40 – 2.27 (m, 1H, C8-H), 2.21 (dd, J = 17.1, 13.1 Hz, 
1H, C7-HaHb), 1.34 (s, 3H, C13-H3), 1.24 (d, J = 6.3 Hz, 3H, C9-H3), 0.88 (s, 3H, C13'-H3); 
13C 
NMR (CDCl3, 101 MHz): δ 197.0 (C6), 179.4 (C14), 162.3 (C11), 136.6, 136.3 (C5 and C16), 
134.0 (C4), 130.0 (C3), 129.0, 128.1, 128.1, 127.7, 127.4 (C1, C2, C17, C18 and C19), 63.1 (C10), 
46.6 (C15), 45.8 (C7), 45.5 (C12), 38.1 (C8), 26.5 (C13), 22.7 (C13'), 20.8 (C9); HRMS: (ESI+) 
calculated for C20H26NO2: 360.1958, found [M+H]
+: 360.1949. 
The relative stereochemistry of this compound was corroborated by nOe experiments (as indicated 
on the compound structure). A strong nOe was observed between C10-H and C9-H3. No significant 
nOe was observed between C10-H and C8-H. 
Data for enantioenriched (S,R)-358a (obtained from enantioenriched amide (S,S)-357a): 
[𝛼]D
23.4 = +61.4 (c = 0.15, CHCl3). 
Chiral SFC: (DAICEL CHIRALPAK-IB column (25 cm), CO2:MeOH 88:12, 2 mL/min, 140 bars, 
40 °C). Retention times: 13.7 minutes (minor), 17.3 minutes (major), e.r. > 99:1. 




General procedure G: (1S*,2S*)-N,2-dibenzylcyclopropan-1-amine (0.25 g, 1.05 mmol, 
prepared according to the literature procedure48) and acid 295 (0.20 g, 1.05 mmol) were employed 
and the residue was purified by flash column chromatography (5% EtOAc/hexane) to afford the 
title compound 357b (0.25 g, 59%) as a pale yellow oil; νmax / cm
-1: 2986 (m), 1644 (s), 1495 (m), 
1454 (m), 1394 (s), 1167 (m), 1029 (m), 756 (s), 728 (s), 691 (s); 1H NMR (DMSO-d6, 500 MHz, 
110 °C): δ 7.33 – 7.11 (m, 13H, 2 × C2-H, 2 × C3-H, 2 × C12-H, 2 × C13-H, 2 × C21-H, C1-H, 
C14-H and C22-H), 7.07 – 7.04 (m, 2H, 2 × C20-H), 4.85 (d, J = 16.0 Hz, 1H, C10-HaHb), 4.74 
(d, J = 16.0 Hz, 1H, C10-HaHb), 2.85 (br. s, 1H, C15-H), 2.75 (dd, J = 14.5, 5.3 Hz, 1H, C18-
HaHb), 2.25 (dd, J = 14.5, 8.1 Hz, 1H, C18-HaHb), 1.59 (s, 3H, C8-H3), 1.59 (s, 3H, C8’-H3), 1.41 
– 1.33 (m, 1H, C17-H), 0.97 – 0.89 (m, 1H, C16-HaHb), 0.71 – 0.65 (m, 1H, C16-HaHb); 
13C NMR 
(DMSO-d6, 126 MHz, 110 °C): δ 172.8 (C9), 139.7 (C19), 137.8 (C11), 130.5, 127.8, 127.8, 127.7, 
127.6, 127.5, 126.2, 126.1, 125.3 (C1, C2, C3, C12, C13, C14, C20, C21 and C22), 122.1 (C4), 
92.7 (C6), 82.9 (C5), 50.0 (C10), 37.2 (C7), 36.8 (C18), 36.7 (C15), 28.1 (C8), 28.0 (C8’), 21.0 






An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate 357b (40.8 mg, 0.10 mmol), [Rh(cod)Cl]2 (2.5 mg, 0.005 mmol) and P(C6F5)3 (10.6 mg, 
0.02 mmol). The tube was fitted with a rubber septum and purged with argon. Anhydrous PhCN 
(1.0 mL) was added and the reaction was sparged with CO for ca. 10 seconds. The tube was heated 
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to 150 °C, under a CO atmosphere (1 balloon) and stirred for 72 h. The mixture was cooled to r.t. 
and concentrated in vacuo. The residue was purified by flash column chromatography (10-25% 
EtOAc/hexane) to afford 358b (29.4 mg, 67%) as a pale yellow oil, the product was isolated as a 
single diastereomer (>15:1 d.r.); νmax / cm
-1: 1698 (s), 1672 (s), 1495 (m), 1409 (m), 1243 (m), 911 
(m), 728 (s), 699 (s); 1H NMR (CDCl3, 400 MHz): δ 7.44 – 7.14 (m, 11H, 2 × C2-H, 2 × C11-H, 
2 × C12-H, 2 × C22-H, C1-H, C13-H and C23-H), 7.05 – 6.97 (m, 2H, 2 × C21-H), 6.87 – 6.80 
(m, 2H, 2 × C3-H), 5.05 (d, J = 16.0 Hz, 1H, C19-HaHb), 4.83 (d, J = 16.0 Hz, 1H, C19-HaHb), 
4.32 (d, J = 9.8 Hz, 1H, C14-H), 3.50 (dd, J = 12.7, 3.1 Hz, 1H, 1H, C9-HaHb), 2.50 – 2.25 (m, 
3H, C8-H, C7-HaHb, C9-HaHb), 2.10 – 1.98 (m, 1H, C7-HaHb), 1.37 (s, 3H, C17-H3), 0.91 (s, 3H, 
C17'-H3); 
13C NMR (CDCl3, 101 MHz): δ 196.7 (C6), 179.8 (C18), 162.1 (C15), 137.6 (C20), 
136.9 (C5), 136.6 (C10), 133.9 (C4), 130.0, 129.2, 129.1, 128.8, 128.2, 128.1, 127.8, 127.2, 126.8 
(C1, C2, C3, C11, C12, C13, C21, C22 and C23), 62.7 (C14), 47.6 (C19), 45.4 (C16), 44.5 (C8), 
41.8 (C7), 40.1 (C9), 26.6 (C17), 22.9 (C17'); HRMS: (ESI+) calculated for C30H30NO2: 436.2271, 




General procedure G: (1S*,2R*)-N-Benzyl-2-methylcyclopropan-1-amine (0.30 g, 1.86 mmol, 
prepared according to the literature procedure48) and acid 295 (0.35 g, 1.86 mmol) were employed 
and the residue was purified by flash column chromatography (5% EtOAc/hexane) to afford the 
title compound 357c (0.31 g, 51%) as a colourless solid; m.p. 53-54 °C (DCM/hexane);  
νmax / cm
-1: 2986 (m), 2258 (w), 1647 (s), 1395 (s), 1233 (m), 1162 (m), 755 (s), 691 (s); 1H NMR 
(DMSO-d6, 500 MHz, 110 °C): δ 7.31 – 7.11 (m, 10H, 2 × C2-H, 2 × C3-H, 2 × C12-H, 2 × C13-
H, C1-H and C14-H), 5.45 (d, J = 16.2 Hz, 1H, C10-HaHb), 4.42 (d, J = 16.2 Hz, 1H, C10-HaHb), 
2.74 (br. s, 1H, C15-H), 1.56 (s, 6H, 2 × C8-H3), 1.07 – 0.93 (m, 4H, C17-H and C18-H3), 0.73 – 
0.64 (m, 1H, C16-HaHb), 0.39 (s, 1H, C16-HaHb); 
13C NMR (DMSO-d6, 126 MHz, 110 °C): δ 
173.8 (C9), 137.6 (C11), 130.5, 127.8, 127.8, 127.6, 126.5, 126.2 (C1, C2, C3, C12, C13 and C14), 
122.1 (C4), 92.6 (C6), 82.9 (C5), 51.2 (C10), 37.4 (C7), 34.5 (C15), 28.3 (C8), 28.0 (C8'), 13.4 
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An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate 357c (33.1 mg, 0.10 mmol), [Rh(cod)Cl]2 (2.5 mg, 0.005 mmol) and P(4-OMeC6H4)3 
(7.0 mg, 0.02 mmol). The tube was fitted with a rubber septum and purged with argon. Anhydrous 
PhCN (1.0 mL) was added and the reaction was sparged with CO for ca. 10 seconds. The tube was 
heated to 150 °C, under a CO atmosphere (1 balloon) and stirred for 72 h. The mixture was cooled 
to r.t. and concentrated in vacuo. The residue was purified by flash column chromatography (10-
25% EtOAc/hexane) to afford 359c (18.0 mg, 50%) as a colourless oil, the product was isolated 
as a single diastereomer (>15:1 d.r.); νmax / cm
-1: 2931 (m), 1677 (s), 1401 (m), 1208 (m), 910 (m), 
729 (s), 699 (s); 1H NMR (CDCl3, 400 MHz): δ 7.35 – 7.19 (m, 8H, 2 × C2-H, 2 × C17-H, 2 × 
C18-H, C1-H and C19-H), 6.98 – 6.91 (m, 2H, 2 × C3-H), 5.07 (d, J = 15.0 Hz, 1H, C15-HaHb), 
4.21 (dd, J = 11.5, 4.3 Hz, 1H, C10-H), 3.99 (d, J = 15.0 Hz, 1H, C15-HaHb), 2.41 (ddd, J = 11.6, 
4.3, 4.3 Hz, 1H, C9-HaHb), 2.36 – 2.25 (m, 1H, C7-H), 1.58 (ddd, J = 13.3, 11.6, 11.5 Hz, 1H, C9-
HaHb), 1.27 (s, 3H, C13-H3), 1.17 (d, J = 6.8 Hz, 3H, C8-H3), 0.73 (s, 3H, C13’'-H3); 
13C NMR 
(CDCl3, 126 MHz): δ 199.2 (C6), 177.6 (C14), 161.6 (C11), 136.0 (C16), 135.7 (C5), 134.3 (C4), 
130.0 (br., C3), 129.1, 128.1, 128.0, 128.0 (C1, C2, C17, C18 and C19), 55.5 (C10), 46.0 (C12), 
44.0 (C15), 40.3 (C7), 36.7 (C9), 26.1 (C13), 21.8 (C13'), 16.3 (C8); HRMS: (ESI+) calculated for 
C24H26NO2: 360.1958, found [M+H]
+: 360.1960. 
The relative stereochemistry of this compound was corroborated by nOe experiments (as indicated 
on the compound structure). A strong nOe was observed between C10-H and C7-H. 
  




General procedure G: (1S*,2R*)-N-Benzyl-2-butylcyclopropan-1-amine (0.40 g, 1.97 mmol, 
prepared according to the literature procedure53) and acid 295 (0.37 g, 1.97 mmol) were employed 
and the residue was purified by flash column chromatography (10% EtOAc/hexane) to afford the 
title compound 357d (0.43 g, 58%) as a colourless oil; νmax / cm
-1: 2928 (m), 1650 (s), 1454 (m), 
1394 (s), 1232 (m), 1162 (m), 1030 (m), 755 (s), 690 (s); 1H NMR (DMSO-d6, 500 MHz, 110 °C): 
δ 7.33 – 7.19 (m, 8H, 2 × C2-H, 2 × C12-H, 2 × C13-H, C1-H, C14-H), 7.16 – 7.11 (m, 2H, 2 × 
C3-H), 5.48 (d, J = 16.3 Hz, 1H, C10-HaHb), 4.44 (d, J = 16.3 Hz, 1H, C10-HaHb), 2.78 (br. s, 1H, 
C15-H), 1.57 (s, 3H, C8-H3), 1.56 (s, 3H, C8'-H3), 1.52 – 1.42 (m, 1H, C18-HaHb), 1.39 – 1.24 
(m, 4H, C19-H2 and C20-H2), 1.06 – 0.91 (m, 2H, C18-HaHb and C17-H), 0.85 (t, J = 7.2 Hz, 3H, 
C21-H3), 0.71 – 0.63 (m, 1H, C16-HaHb), 0.46 – 0.39 (m, 1H, C16-HaHb); 
13C NMR (DMSO-d6, 
126 MHz, 110 °C): δ 173.6 (C9), 137.6 (C11), 130.5 (C3), 127.8, 127.7, 127.6, 126.4, 126.2 (C1, 
C2, C12, C13 and C14), 122.1 (C4), 92.5 (C6), 82.8 (C5), 51.1 (C10), 37.3 (C7 ), 34.5 (C15), 30.7 
(C19), 28.2, 28.0 (C8 and C8'), 26.3 (C18), 21.4 (C20), 19.2 (C17), 13.1 (C21), 11.0 (C16); 




dione (359d) and (R)-1-benzyl-4-((E)-benzylidene)-5-((E)-hex-1-en-1-yl)-3,3-dimethyl-
pyrrolidin-2-one (365) 
 
An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate 357d (37.4 mg, 0.10 mmol), [Rh(cod)Cl]2 (2.5 mg, 0.005 mmol) and P(4-OMeC6H4)3 
(7.0 mg, 0.02 mmol). The tube was fitted with a rubber septum and purged with argon. Anhydrous 
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PhCN (1.0 mL) was added and the reaction was sparged with CO for ca. 10 seconds. The tube was 
heated to 150 °C, under a CO atmosphere (1 balloon) and stirred for 72 h. The mixture was cooled 
to r.t. and concentrated in vacuo. The residue was purified by flash column chromatography (20% 
EtOAc/hexane) to afford 357d (19.1 mg, 48%, isolated as a single diastereomer, >15:1 d.r.) and 
365 (2.2 mg, 6%) as colourless oils. 
Data for 359d: νmax / cm
-1: 2957 (m), 2930 (m), 2863 (m), 1698 (s), 1672 (s), 1418 (s), 1360 (m), 
1310 (m), 1238 (m), 734 (s), 701 (s); 1H NMR (CDCl3, 400 MHz): δ 7.41 – 7.27 (m, 8H, 2 × C2-
H, 2 × C20-H, 2 × C21-H, C1-H and C22-H), 7.03 – 6.98 (m, 2H, 2 × C3-H), 5.15 (d, J = 14.9 Hz, 
1H, C18-HaHb), 4.23 (dd, J = 11.6, 4.3 Hz, 1H, C13-H), 4.08 (d, J = 14.9 Hz, 1H, C18-HaHb), 2.50 
(ddd, J = 11.6, 4.3, 4.3 Hz, 1H, C12-HaHb), 2.29 – 2.20 (m, 1H, C7-H), 1.96 – 1.87 (m, 1H, C8-
HaHb), 1.60 (ddd, J = 13.4, 11.6, 11.6 Hz, 1H, C12-HaHb), 1.55 – 1.47 (m, 1H, C8-HaHb), 1.36 – 
1.23 (m, 7H, C16-H3, C9-H2 and C10-H2), 0.91 (t, J = 7.0 Hz, 3H, C11-H3), 0.81 (s, 3H, C16'-
H3); 
13C NMR (CDCl3, 126 MHz): δ 199.0 (C6), 177.6 (C17), 161.2 (C14), 136.1 (C19), 134.5 
(C5), 130.0 (br., C3), 129.1, 128.1, 128.1, 128.1, 128.0, 128.0 (C1, C2, C4, C20, C21 and C22), 
55.7 (C13), 45.9 (C15), 45.0 (C7), 44.1 (C18), 33.7 (C12), 30.1 (C8), 28.9 (C9), 26.1 (C16), 22.9 
(C10), 21.9 (C16'), 14.1 (C11); HRMS: (ESI+) calculated for C27H31NNaO2: 424.2247, found 
[M+Na]+: 424.2240. The relative stereochemistry of this compound was corroborated by nOe 
experiments (as indicated on the compound structure). A strong nOe was observed between C7-H 
and C13-H. No significant nOe was observed between C8-H2 and C13-H. 
Data for 365 (characteristic signals only): 1H NMR (CDCl3, 400 MHz): δ 6.45 (d, J = 2.2 Hz, 1H, 
C1-H), 5.44 (dt, J = 15.3, 6.9 Hz, 1H, C4-H), 5.11 (d, J = 15.0 Hz, 1H, C5-HaHb), 5.00 (ddt, J = 






General procedure G: (1R*,5S*,6r)-N-benzylbicyclo[3.1.0]hexan-6-amine (0.30 g, 1.60 mmol, 
prepared according to the literature procedure53) and acid 295 (0.30 g, 1.60 mmol) were employed 
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and the residue was purified by flash column chromatography (10% EtOAc/hexane) to afford the 
title compound 357e (0.40 g, 70%) as a colourless oil; νmax / cm
-1: 2934 (m), 1643 (s), 1492 (m), 
1393 (s), 1356 (m), 1165 (m), 755 (s), 691 (s); 1H NMR (DMSO-d6, 500 MHz, 110 °C): δ 7.32 – 
7.17 (m, 10H, 2 × C2-H, 2 × C3-H, 2 × C12-H, 2 × C13-H, C1-H and C14-H), 4.76 (s, 2H, C10-
H2), 2.70 (br. s, 1H, C15-H), 1.67 – 1.54 (m, 12H, 2 × C17-H2, 2 × C8-H3, C18-H2), 1.49 – 1.39 
(m, 1H, C16-H), 0.95 – 0.82 (m, 1H, C16-H); 13C NMR (DMSO-d6, 126 MHz, 110 °C): δ 172.6 
(C9), 137.9 (C11), 130.4, 127.8, 127.6, 127.5, 126.3, 126.0 (C1, C2, C3, C12, C13 and C14), 122.2 
(C4), 92.8 (C6), 82.9 (C5), 49.8 (C10), 37.7 (C15), 37.3 (C7), 28.0 (C8), 26.6, 26.2 (C17 and C18), 






An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate 357e (35.8 mg, 0.10 mmol), [Rh(cod)Cl]2 (2.5 mg, 0.005 mmol) and P(4-OMeC6H4)3 
(7.0 mg, 0.02 mmol). The tube was fitted with a rubber septum and purged with argon. Anhydrous 
PhCN (1.0 mL) was added and the reaction was sparged with CO for ca. 10 seconds. The tube was 
heated to 150 °C, under a CO atmosphere (1 balloon) and stirred for 72 h. The mixture was cooled 
to r.t. and concentrated in vacuo. The residue was purified by flash column chromatography (10-
25% EtOAc/hexane) to afford 368 (15.3 mg, 38%) as a pale yellow oil, the product was isolated 
as a single diastereomer (>15:1 d.r.); νmax / cm
-1: 3406 (br. m), 2969 (m), 2932 (m), 1695 (s), 1680 
(s), 1416 (m), 1074 (m), 910 (m), 731 (s), 700 (s); 1H NMR (CDCl3, 400 MHz): δ 7.43 – 7.27 (m, 
6H, 2 × C2-H, 2 × C20-H, C1-H and C21-H), 7.21 – 7.16 (m, 2H, 2 × C19-H), 7.14 – 7.09 (m, 2H, 
2 × C3-H), 5.16 (d, J = 16.0 Hz, 1H, C17-HaHb), 4.31 (d, J = 16.0 Hz, 1H, C17-HaHb), 4.20 (d, J 
= 9.6 Hz, 1H, C12-H), 3.42 (s, 1H, C7-OH), 2.61 – 2.54 (m, 1H, C11-H), 2.30 – 2.17 (m, 1H, C10-
HaHb), 2.01 – 1.82 (m, 3H, C10-HaHb, C8-HaHb, C9-HaHb), 1.76 – 1.59 (m, 2H, C8-HaHb, C9-
HaHb), 1.45 (s, 3H, C15-H3), 0.80 (s, 3H, C15'-H3); 
13C NMR (CDCl3, 126 MHz): δ 198.6 (C6), 
177.9 (C16), 161.6 (C13), 136.0, 133.8, 133.3 (C4, C5 and C18), 130.3, 129.1, 128.5, 128.1, 127.7, 
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127.1 (C1, C2, C3, C19, C20 and C21), 82.7 (C7), 58.1 (C12), 52.3 (C11), 46.1 (C14), 44.6 (C17), 
37.2 (C8), 29.8 (C10), 26.6 (C15), 21.7, 21.7 (C9 and C15'); HRMS: (ESI+) calculated for 
C26H28NO3: 402.2064, found [M+H]
+: 402.2052. 
The relative stereochemistry of this compound was corroborated by nOe experiment (as indicated 
on the compound structure). An nOe was observed between C11-H and C10-HaHb. An nOe was 




General procedure G: (1S*,2S*)-N-Benzyl-2-methylcyclopropan-1-amine (0.71 g, 4.38 mmol, 
prepared according to the literature procedure48) and acid 344b (0.50 g, 4.38 mmol) were employed 
and the residue was purified by flash column chromatography (10% EtOAc/hexane) to afford the 
title compound 369 (0.61 g, 54%) as a pale yellow oil; νmax / cm
-1: 2974 (w), 1644 (s), 1630 (s), 
1388 (m), 1173 (m), 912 (m), 998 (s); 1H NMR (CDCl3, 400 MHz): δ 7.34 – 7.12 (m, 5H, 2 × C8-
H, 2 × C9-H and C10-H), 6.09 (dd, J = 17.6, 10.7 Hz, 1H, C2-H), 5.13 – 5.01 (m, 2H, C1-H2), 
4.59 (d, J = 15.9 Hz, 1H, C6-HaHb), 4.53 (d, J = 15.9 Hz, 1H, C6-HaHb), 2.29 (br. s, 1H, C11-H), 
1.36 (s, 6H, 2 × C4-H3), 1.00 – 0.87 (m, 4H, C13-H and C14-H3), 0.73 (br. s, 1H, C12-HaHb), 0.45 
– 0.38 (m, 1H, C12-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 178.2 (C5), 144.0 (C2), 138.2 (br., 
C7), 128.6, 127.1, 127.1 (C8, C9 and C10), 112.4 (C1), 51.6 (br., C6), 45.9 (C3), 38.2 (br., C11), 
26.9 (C4), 26.9 (C4'), 17.4 (C14), 16.3 (br., C12), 16.2 (C13); HRMS: (ESI+) calculated for 
C17H24NO: 258.1852, found [M+H]
+: 258.1844. 
  




An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate 369 (25.7 mg, 0.10 mmol), [Rh(cod)Cl]2 (2.5 mg, 0.005 mmol) and P(C6F5)3 (10.6 mg, 
0.02 mmol). The tube was fitted with a rubber septum and purged with argon. Anhydrous PhCN 
(1.0 mL) was added and the reaction was sparged with CO for ca. 10 seconds. The tube was heated 
to 150 °C, under a CO atmosphere (1 balloon) and stirred for 72 h. The mixture was cooled to r.t. 
and concentrated in vacuo. The residue was purified by flash column chromatography (60-70% 
EtOAc/hexane) to afford 370 (19.4 mg, 68%) as a pale yellow oil, the product was isolated as a 
single diastereomer (>15:1 d.r.); νmax / cm
-1: 2961 (m), 1687 (s), 1399 (m), 1315 (m), 1260 (m), 
1137 (m), 733 (m), 701 (m); 1H NMR (CDCl3, 400 MHz): δ 7.34 – 7.20 (m, 3H, 2 × C14-H and 
C15-H), 7.15 – 7.09 (m, 2H, 2 × C13-H), 4.85 (d, J = 16.0 Hz, 1H, C11-HaHb), 4.51 (d, J = 16.0 
Hz, 1H, C11-HaHb), 3.13 (dd, J = 9.6, 9.6 Hz, 1H, C6-H), 2.49 – 2.22 (m, 3H, C1-H2 and C3-
HaHb), 2.08 – 1.87 (m, 3H, C3-HaHb, C4-H and C7-H), 1.21 (s, 3H, C9-H3), 1.06 – 1.02 (m, 6H, 
C5-H3 and C9'-H3); 
13C NMR (CDCl3, 126 MHz): δ 207.7 (C2), 181.7 (C10), 137.3 (C12), 128.8 
(C14), 127.3 (C13), 126.9 (C15), 63.6 (C6), 50.3 (C7), 49.1 (C3), 45.9 (C11), 42.2 (C8), 39.3 (C1), 
37.0 (C4), 23.2 (C9), 21.1 (C9'), 17.6 (C5); HRMS: (ESI+) calculated for C18H23NNaO2: 308.1621, 
found [M+Na]+: 308.1616. The relative stereochemistry of this compound was corroborated by 
nOe experiments (as indicated on the compound structure) and assigned in analogy with 345. No 
nOe was observed between C6-H and C7-H or between C6-H and C4-H. An nOe was observed 
between C6-H and C5-H3. 
  




General procedure G: (1S*,2R*)-N-Benzyl-2-butylcyclopropan-1-amine (0.40 g, 1.97 mmol, 
prepared according to the literature procedure53) and acid 344 (0.22 g, 1.97 mmol) were employed 
and the residue was purified by flash column chromatography (10% EtOAc/hexane) to afford the 
title compound 371 (0.12 g, 20%) as a colourless oil; νmax / cm
-1: 2958 (m), 2928 (m), 1647 (s), 
1631 (s), 1467 (m), 1454 (m), 1389 (s), 713 (m), 696 (m); 1H NMR (CDCl3, 400 MHz): δ 7.34 – 
7.28 (m, 2H, 2 × C9-H), 7.27 – 7.21 (m, 1H, C10-H), 7.15 (d, J = 6.9 Hz, 2H, 2 × C8-H), 6.09 (dd, 
J = 17.6, 10.7 Hz, 1H, C2-H), 5.14 – 5.08 (m, 2H, C6-HaHb and C1-Htrans), 5.05 (d, J = 10.7 Hz, 
1H, C1-Hcis), 4.07 (d, J = 16.2 Hz, 1H, C6-HaHb), 2.69 (br. s, 1H, C11-H), 1.64 – 1.52 (m, 1H, 
C14-HaHb), 1.43 – 1.26 (m, 10H, 2 × C4-H3, C15-H2, C16-H2), 1.08 – 0.95 (m, 1H, C13-H), 0.93 
– 0.77 (m, 4H, C14-HaHb and C17-H3), 0.70 – 0.57 (m, 1H, C12-HaHb), 0.19 (br. s, 1H, C12-
HaHb); 
13C NMR (CDCl3, 126 MHz): δ 178.9 (C5), 144.1 (C2), 138.2 (C7), 128.6 (C9), 127.1 
(C10), 127.0 (C8), 112.5 (C1), 52.2 (br., C6), 46.1 (C3), 35.0 (C11), 31.9 (C15), 27.8 (C14), 27.4 
(C4), 26.4 (C4'), 22.8 (C16), 20.4 (C13), 14.3 (C17), 11.9 (br., C12); HRMS: (ESI+) calculated 
for C20H30NO: 300.2322, found [M+H]
+: 300.2321. 
 
(3aS*,7aR*)-1-Benzyl-6-butyl-3,3-dimethylhexahydro-2H-indole-2,5(3H)-dione (372) and 
(3aS*,7R*,7aR*)-1-benzyl-7-butyl-3,3-dimethylhexahydro-2H-indole-2,5(3H)-dione (373) 
 
An oven dried reaction tube, fitted with a magnetic stirrer, was charged with aminocyclopropane 
substrate 371 (29.9 mg, 0.10 mmol), [Rh(cod)Cl]2 (2.5 mg, 0.005 mmol) and P(4-OMeC6H4)3 (7.0 
mg, 0.02 mmol). The tube was fitted with a rubber septum and purged with argon. Anhydrous 
PhCN (1.0 mL) was added and the reaction was sparged with CO for ca. 10 seconds. The tube was 
heated to 150 °C, under a CO atmosphere (1 balloon) and stirred for 72 h. The mixture was cooled 
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to r.t. and concentrated in vacuo. The residue was purified by flash column chromatography (10-
25% EtOAc/hexane) to afford an unseparable mixture of 372 and 373 (10.8 mg, 33%, 6:1 r.r.) as 
a pale yellow oil. 
NMR data for 372 (3:1 mixture of major A and minor B diastereomers, characteristic signals 
only): 1H NMR (CDCl3, 400 MHz): δ 5.08 (d, J = 14.7 Hz, 1H, C4-HaHb, B), 4.94 (d, J = 15.0 Hz, 
1H, C4-HaHb, A), 4.04 (d, J = 15.0 Hz, 1H, C4-HaHb, A), 3.78 (d, J = 14.7 Hz, 1H, C4-HaHb, B), 
3.27 (ddd, J = 11.6, 10.2, 3.5 Hz, 1H, C2-H, A), 3.20 (ddd, J = 11.9, 10.3, 4.2 Hz, 1H, C2-H, B); 
13C NMR (CDCl3, 101 MHz): δ 209.1 (C1, A), 180.6 (C3, A), 56.6 (C2, A); HRMS: (ESI
+) 
calculated for C21H30NO2: 328.2271, found [M+H]
+: 328.2275. 
NMR data for 373 (>15:1 d.r., characteristic signals only): 1H NMR (CDCl3, 400 MHz): δ 4.95 
(d, J = 14.8 Hz, 1H, C2-HaHb), 3.99 (d, J = 14.8 Hz, 1H, C2-HaHb), 3.34 (dd, J = 10.8, 3.8 Hz, 1H, 
C1-H). 
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General procedure N: N-(Cyclopropylmethyl)benzamide 380a (26.3 mg, 0.15 mmol, prepared 
according to the literature procedure108), [Rh(cod)2]OTf (5.3 mg, 0.01 mmol, 7.5 mol%), P(3,4,5-
F3C6H2)3 (9.5 mg, 0.02 mmol, 15 mol%) and benzoic acid (3.7 mg, 0.03 mmol, 20 mol%) were 
employed and the reaction was stirred for 24 h at 110 °C. The crude mixture was purified by silica 
gel column chromatography (40% EtOAc/hexane) to yield the title compound 381a (21.7 mg, 
71%) as a yellow solid; 1H NMR (400 MHz, CDCl3): δ 7.78 (d, J = 7.0 Hz, 2H, 2 × C8-H), 7.44 
(m, 1H, C10-H), 7.38 – 7.34 (m, 2H, 2 × C9-H), 4.24 (dddd, J = 12.5, 8.0, 5.5, 1.0 Hz, 1H, C5-H), 
2.73 (m, 1H, C4-H2), 2.41 (ddd, J = 20.0, 10.0, 1.0 Hz, 1H, C2-H2), 2.20 (m, 1H, C2-H2), 2.06 (m, 
1H, C3-H2), 1.87 (m, 1H, C3-H2), 1.62 (m, 1H, C4-H2); 
13C NMR (CDCl3, 101 MHz,): δ 215.2 
(C1), 167.7 (C6), 133.7 (C7), 131.8 (C10), 128.6 (C9), 127.1 (C8), 58.6 (C5), 34.9 (C2), 30.3 (C4), 
18.1 (C3). The spectroscopic properties of this compound were consistent with the data available 
in the literature.286 This compound was also obtained by Dr. McCreanor during the preliminary 




General procedure M: Cyclopropylmethylamine (0.21 g, 3.00 mmol), benzaldehyde (0.38 g, 3.60 
mmol) and acetic anhydride (0.31 g, 3.60 mmol) were employed and the reaction was stirred at r.t. 
for 16 h. Flash column chromatography (40% EtOAc/hexane) afforded the title compound 398 
(0.49 g, 80%, 1:1 mixture of rotamers A:B) as a pale yellow oil; νmax / cm
-1: 3003 (m), 2926 (m), 
1639 (s), 1420 (s), 1357 (m), 1249 (s), 1020 (m); 1H NMR (CDCl3, 400 MHz): 7.38-7.13 (m, 10H, 
2 × C8-H, 2 × C9-H, C10-H, A+B), 4.72 (s, 2H, C6-H2, A), 4.64 (s, 2H, C6-H2, B), 3.28 (d, J = 
7.0 Hz, 2H, C3-H2, A), 3.09 (d, J = 6.6 Hz, 2H, C3-H2, B), 2.20 (s, 3H, C5-H3, A), 2.11 (s, 3H, C5-
H3, B), 1.02-0.83 (m, 2H, C2-H, A+B), 0.56-0.49 (m, 2H, C1-H2, A), 0.48-0.40 (m, 2H, C1-H2, B), 
0.20-0.10 (m, 4H, C1-H2, A+B); 
13C NMR (CDCl3, 101 MHz): δ 171.1 (C4, B), 170.5 (C4, A), 
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137.7 (C7, A), 137.0 (C7, B), 128.8, 128.5, 127.8, 127.4, 127.1, 126.2 (C7, C8 and C9, A+B), 52.0 
(C3, B), 51.8 (C6, B), 49.8 (C3, A), 47.9 (C6, A), 21.8 (C5, B), 21.7 (C5, A), 10.0, 9.6 (C2, A+B), 





General procedure N: Compound 36 (30.5 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 mmol, 
7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the reaction 
was stirred for 18 h at 110 °C. The crude mixture was purified by silica gel column chromatography 
(40% EtOAc/hexane) to yield the title compound 37 (34.0 mg, 98%) as a colourless solid; m.p. 
124-125 °C; νmax / cm
-1: 2964 (m), 1742 (s), 1636 (s), 1429 (s), 1363 (s), 1251 (s), 1153 (s); 1H 
NMR (CDCl3, 400 MHz): δ 7.40-7.26 (m, 5H, 2 × C10-H, 2 × C11-H, C12-H), 4.57 (s, 2H, C8-
H2), 3.53 (t, J = 9.8 Hz, 1H, C4-H), 2.48 (ddd, J = 18.4, 11.9, 9.2 Hz, 1H, C1-HaHb), 2.26-1.94 (m, 
4H, C1-HaHb, C2-HaHb, 2 × C3-H2), 2.11 (s, 3H, C7-H3), 1.68-1.53 (m, 1H, C2-HaHb); 
13C NMR 
(CDCl3, 101 MHz): δ 213.4 (C5), 170.1 (C6), 136.6 (C9), 128.9 (C11), 127.8 (C12), 126.6 (C10), 
64.4 (C4), 53.7 (C8), 35.8 (C1), 27.0 (C3), 21.6 (C7), 19.1 (C2); HRMS: (ESI+) calculated for 





General procedure B: Amide 400 (1.00 g, 8.84 mmol) was employed. The title compound 401 
(0.640 g, 73 %) was isolated as a colourless oil and used in the next step without purification;  
νmax / cm
-1: 2946 (m), 2926 (m), 1656 (m), 1626 (m), 1455 (m); 1H NMR (CDCl3, 400 MHz): δ 
2.71-2.55 (m, 2H, C5-H2), 1.06 (s, 3H, C1-H3), 1.04 (s, 3H, C1-H3), 0.69 (dddd, J = 8.5, 7.6, 6.9, 
5.3 Hz, 1H, C4-H), 0.40 (dd, J = 8.5, 4.3 Hz, 1H, C3-H), -0.01 (app. t, J = 4.8 Hz, 1H, C3-H); 13C 
NMR (CDCl3, 101 MHz): δ 42.0 (C5), 27.1 (C1), 24.9 (C4), 19.8 (C3), 18.8 (C2); HRMS: (ESI
+) 
calculated for C6H14N: 100.1121, found [M+H]
+: 100.1118 
 




General procedure D: Amine (0.30 g, 3.02 mmol) and benzoyl chloride (0.51 g, 3.62 mmol) were 
employed and the reaction was stirred at r.t. for 16 h. Flash column chromatography (20% 
EtOAc/hexane) afforded the title compound 402 (0.369 g, 60%) as a colourless solid; m.p. 58-59 
°C; νmax / cm
-1: 3310 (m), 2944 (m), 1635 (s), 1539 (s), 1310 (m), 1593 (m); 1H NMR (CDCl3, 400 
MHz): 7.79-7.75 (m, 2H, 2 × C7-H), 7.53-7.41 (m, 3H, C9-H, and 2 × C8-H), 6.10 (br. s, 1H, N4-
H), 3.55-3.35 (m, 2H, C3-H2), 1.15 (s, 3H, C10-H3), 1.09 (s, 3H, C10-H3), 0.90-0.82 (m, 1H, C2-
H), 0.58-0.50 (m, 1H, C1-H), 0.23-0.14 (m, 1H, C1-H); 13C NMR (CDCl3, 101 MHz): δ 167.3 
(C5), 134.9 (C6), 131.3 (C9), 128.5 (C8), 126.8 (C7), 41.2 (C3), 27.2 (C10), 23.7 (C2), 20.0 (C1), 




N-(4,4-Dimethyl-2-oxocyclopentyl)benzamide (403) and N-(4-Methylpent-3-en-1-
yl)benzamide (404) 
 
General procedure N: (S)-N-((2,2-Dimethylcyclopropyl)methyl)benzamide (30.49 mg, 0.15 
mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 mmol, 7.5 mol%), P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 
15 mol%) and benzoic acid (3.7 mg, 0.030 mmol, 20 mol%) were employed and the reaction was 
stirred at 120 °C for 24 h. Flash column chromatography (2-20% EtOAc/hexane) afforded 
compounds 403 (1.6 mg, 5%) and 404 (8.2 mg, a mixture with starting material and other by-
products) as colourless oils. Alkene 404 could not be readily separated from the starting material 
and other alkene isomers, the structure of the alkene products was determined by analysis of the 
1H NMR spectrum of the reaction mixture and corroborated by HMBC, HSQC and COSY data. 
 
Data for compound 403: 1H NMR (CDCl3, 400 MHz): δ 7.81-7.76 (2H, m, 2 × C3-H), 7.54-7.48 
(2H, m, C1-H), 7.47-7.41 (2H, m, 2 × C2-H), 6.50 (br. s, 1H, N6-H), 4.53 (ddd, J = 12.3, 8.5, 5.7 
Hz, 1H, C7-H), 2.55 (ddd, J = 12.3, 8.5, 2.2 Hz, 1H, C8-H), 2.39-2.31 (m, 1H, C11-H), 2.22 (d, J 
= 19.0 Hz, 1H, C11-H), 1.71 (app. t, J = 12.3 Hz, 1H, C8-H); 13C NMR (CDCl3, 101 MHz): δ 
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215.1 (C12), 171.8 (C5), 31.8 (C1), 128.6 (C3), 127.0 (C2), 57.5 (C7), 50.4 (C11), 43.8 (C12), 
32.5 (C8), 30.3 (C9), 31.9 (C10), 28.8 (C9); HRMS: (ESI+) calculated for C14H17NNaO2: 
254.1151, found [M+Na]+: 254.1155. 
 
Data for compound 404: 1H NMR (CDCl3, 400 MHz, characteristic signals only): δ 6.16 (br. s, 
1H, N18-H), 5.16 (dddd, J = 7.3, 5.9, 2.9, 1.5 Hz, 1H, C21-H), 2.37-2.28 (m, 2H, C20-H2), 1.73 
(s, 3H, C23-H3), 1.65 (s, 3H, C23-H3); 
13C NMR (CDCl3, 101 MHz, characteristic signals only): 
δ 167.4 (C17), 134.9 (C22), 131.4 (C13), 128.8 (C14), 126.9 (C15), 120.7 (C21), 39.8 (C19), 28.1 
(C20), 25.8 (C23), 17.9 (C23). 
 
Ethyl 2,2-diphenylcyclopropane-1-carboxylate (407) 
 
To a solution of Rh2(OAc)4 (36.78 mg, 0.003 eq) and 1,1-diphenylethylene (5.00 g, 27.74 mmol) 
in anhydrous Et2O (70 mL) was added a solution of ethyl diazoacetate (4.75 g, 41.61 mmol) in 
Et2O (12 mL) dropwise by syringe pump over 8 h. The reaction mixture was diluted with petrol 
(50 mL), filtered through a pad of silica and concentrated in vacuo. The crude mixture was purified 
by silica gel column chromatography (5% EtOAc/hexane) to yield the title compound 407 (5.99 
g, 81%) as a yellow oil; 1H NMR (CDCl3, 400 MHz): δ 7.36–7.18 (m, 10H, 2 ×C10-H, 4 × C9-H 
and 4 × C8-H), 3.91 (m, 2H, C2-H2), 2.54 (dd, J = 8.2, 5.9 Hz, 1H, C5-H2), 2.17 (dd, J = 5.9, 4.8 
Hz, 1H, C4-H), 1.59 (dd, J = 8.2, 4.8 Hz, 1H, C5-H2), 1.01 (t, J = 7.1 Hz, 3H, C1-H3); 
13C NMR 
(CDCl3, 101 MHz): δ 170.73 (C3), 144.99 (C7), 140.38 (C7), 129.88 (C9), 128.55 (C9), 128.38 
(C8), 127.69 (C8), 127.06 (C10), 126.61 (C10), 60.53 (C2), 39.91 (C6), 29.16 (C4), 20.21 (C5), 
14.12 (C1). The spectroscopic properties of this compound were consistent with the data available 
in the literature.17 
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2,2-Diphenylcyclopropane-1-carboxylic acid (30) 
 
Ester 407 (5.00 g, 18.77 mmol) was dissolved in a mixture of 1,4-dioxane and water (1:1, 80 mL), 
then potassium hydroxide pellets (5.26 g, 93.87 mmol) were added and the reaction mixture was 
stirred at 80 °C for 4h. The reaction mixture was concentrated in vacuo, diluted with water (100 
mL) and extracted with Et2O (50 mL). The aqueous portion was adjusted to pH 2 by addition of 
2.0 M aq. HCl and then extracted with Et2O (3 × 50 mL). The organic extracts were combined, 
washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo to afford the title 
compound 408 (4.48 g, 99%) as a colourless solid; 1H NMR (CDCl3, 400 MHz): δ 10.9 (br. s, 1H, 
O1-H), 7.19-7.38 (m, 10H, 2 ×C9-H, 4 × C8-H and 4 × C7-H), 2.52 (dd, J = 8.0, 5.8 Hz, 1H, C4-
H2), 2.15 (dd, J = 5.8, 4.9 Hz, 1H, C3-H), 1.70 (dd, J = 8.0, 4.9 Hz, 1H, C4-H2); 
13C NMR (CDCl3, 
101 MHz): δ 176.9 (C2), 144.5 (C6), 139.7 (C6), 129.5 (C8), 128.5 (C8), 128.3 (C7), 127.5 (C7), 
127.0 (C9), 126.6 (C9), 41.0 (C5), 28.5 (C3), 20.7 (C4). The spectroscopic properties of this 




General procedure L: Acid 408 (2.00 g, 8.39 mmol) and oxalyl chloride (1.48 mL, 16.78 mmol) 
were employed. The title compound 409 (1.95 g, 98%) was isolated as a colourless solid; 1H NMR 
(CDCl3, 400 MHz): 7.40-7.12 (m, 10H, 2 ×C9-H, 4 × C8-H and 4 × C7-H), 5.36 (br. s, 2H, N1-
H2), 2.35 (dd, J = 8.3, 6.0 Hz, 1H, C4-H2), 2.12 (dd, J = 6.0, 5.0 Hz, 1H, C3-H), 1.64 (dd, J = 8.3, 
5.0 Hz, 1H, C4-H2); 
13C NMR (CDCl3, 101 MHz): δ 171.5 (C2), 145.1, 139.8, 129.8, 128.5, 127.3, 
127.1, 126.5 (C6, C7, C8 and C9), 39.20 (C5), 30.620 (C3), 20.20 (C4). The spectroscopic 
properties of this compound were consistent with the data available in the literature.19 
  




General procedure K: Amide 409 (1.00 g, 4.21 mmol) and LiAlH4 (0.26 g, 6.85 mmol) were 
employed. The title compound 410 (0.76 g, 81 %) was isolated as a yellow oil and used in the next 
step without purification; νmax / cm
-1: 3056 (m), 3023 (m), 1598 (m), 1494 (s), 1445 (s), 1308 (m), 
1028 (m); 1H NMR (CDCl3, 400 MHz): δ 7.39-7.14 (m, 10H, 2 ×C9-H, 4 × C8-H and 4 × C7-H), 
2.63 (dd, J = 13.1, 7.0 Hz, 1H, C2-H2), 2.40 (dd, J = 13.1, 7.0 Hz, 1H, C2-H2), 1.86 (dtd, J = 8.8, 
7.0, 5.9 Hz, 1H, C3-H), 1.35 (dd, J = 5.9, 4.9 Hz, 1H, C4-H2), 1.28 (br. s, 2H, N1-H2), 1.25 (dd, J 
= 8.8, 4.9 Hz, 1H, C4-H2); 
13C NMR (CDCl3, 101 MHz): δ 146.7 (C6), 141.4 (C6), 130.1 (C8), 
128.3 (C8), 128.2 (C7), 127.9 (C7), 126.4 (C9), 125.8 (C9), 43.5 (C2), 34.4 (C5), 29.1 (C3), 18.9 





General procedure D: Amine 410 (0.76 g, 3.40 mmol) and benzoyl chloride (0.47 mL, 4.08 
mmol) were employed. The crude mixture was purified by silica gel column chromatography (20-
40% EtOAc/hexane) to yield the title compound 406 (0.92 g, 83%) as a colourless solid; m.p. 102-
103 °C; νmax / cm
-1: 3312 (m), 3059 (m), 3025 (m), 1634 (s), 1538 (s), 1491 (s), 1294 (m), 1035 
(m); 1H NMR (CDCl3, 400 MHz): δ 7.73-7.68 (m, 2H, 2 ×C12-H), 7.56-7.14(m, 13H, 2 ×C9-H, 4 
× C8-H, 4 × C7-H, 2 × C13-H and C14-H), 6.05(br. s, 1H, N1-H), 3.35 (dd, J = 7.1, 5.8 Hz, 2H, 
C2-H2), 2.12 (dtd, J = 8.8, 7.1, 5.8 Hz, 1H, C3-H), 1.50 (m, 1H, C4-H2), 1.32 (dd, J = 8.8, 5.0 Hz, 
1H, C4-H2); 
13C NMR (CDCl3, 101 MHz): δ 167.2 (C10), 146.0 (C6), 141.0 (C6), 134.6 (C11), 
131.4, 130.1, 128.7, 128.6, 128.3, 127.8, 126.9, 126.8, 126.1(C7, C8, C9, C12, C13 and C14), 41.1 









General procedure N: Amide 406 (49.1 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 mmol, 
7.5 mol%), P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) and benzoic acid (3.70 mg, 0.030 
mmol, 20 mol%) were employed and the reaction was stirred at 160 °C for 24 h. Flash column 
chromatography (20-40% EtOAc/hexane) afforded compound 412 (33.2 mg, 68%) as a colourless 
solid; 1H NMR (CDCl3, 400 MHz): δ 7.70 (d, J = 6.9 Hz, 2H, 2 × C7-H), 7.52-7.10 (m, 13 H, Ar-
H), 6.11 (t, J = 7.5 Hz, 1H, C2-H), 6.10 (br. s, 1H, N5-H), 3.56 (app. q, J = 6.8 Hz, 2H, C4-H2), 
2.46 (app. q, J = 7.1 Hz, 2H, C3-H2); 
13C NMR (CDCl3, 101 MHz): δ 167.5 (C6), 144.3(C1), 
142.2, 139.7, 134.3, 131.2, 129.6, 128.4, 128.3, 128.1, 127.4, 127.3, 126.8 (Ar-C), 125.6 (C2), 
39.9 (C4), 30.0 (C3). The spectroscopic properties of this compound were consistent with the data 




General procedure L: (1R*,2S*)-2-Benzylcyclopropane-1-carboxylic acid (1.65 g, 9.36 mmol, 
prepared according to the literature procedure48) and oxalyl chloride (1.65 mL, 18.73 mmol) were 
employed. The title compound 415 (1.64 g, 99%) was isolated as a colourless solid; m.p. 114-115 
°C (DCM/hexane); νmax / cm
-1: 3333 (br. m), 3166 (br. m), 1651 (s), 1620 (s), 1454 (s), 1428 (s); 
1H NMR (CDCl3, 400 MHz): δ 7.32-7.18 (m, 5H, C1-H, 2 × C2-H and 2 × C3-H), 5.50 (br. s, 1H, 
N10-H2), 5.27 (br. s, 1H, N10-H2), 2.71 (dd, J = 14.6, 6.8 Hz, 1H, C5-H2), 2.65 (dd, J = 14.6, 6.9 
Hz, 1H, C5-H2), 1.76-1.65 (m, 1H, C6-H), 1.32-1.22 (m, 2H, C7-HaHb and C8-H), 0.83-0.76 (m, 
1H, C7-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 175.5 (C9), 140.2 (C4), 128.4, 128.3 (C2 and C3), 
126.2 (C1), 38.4 (C5), 22.1 (C8), 21.4 (C6), 14.7 (C7); HRMS: (ESI+) calculated for C11H14NO: 
176.1070, found [M+H]+: 176.1071. 
 




General procedure K: Amide 415 (1.50 g, 8.56 mmol) and was employed. The title compound 
416 (1.00 g, 73 %) was isolated as a pale yellow oil and used in the next step without purification; 
νmax / cm
-1: 3026 (m), 2997 (m), 2912 (m), 2849 (m), 1574 (s), 1495 (s), 1453 (s); 1H NMR (CDCl3, 
400 MHz): δ 7.32-7.16 (m, 5H, C1-H, 2 × C2-H and 2 × C3-H), 2.64-2.50 (m, 4H, C5-H2 and C9-
H2), 0.89-0.77 (m, 2H, C6-H and C8-H), 0.41 (ddd, J = 15.7, 8.0, 4.9 Hz, 2H, C7-H2); 
13C NMR 
(CDCl3, 101 MHz): δ 142.0 (C4), 128.3, 128.3 (C2 and C3), 125.9 (C1), 46.5 (C9), 39.6 (C5), 22.4 






General procedure M: Amine 416 (1.99 g, 12.34 mmol), benzaldehyde (1.38 g, 12.96 mmol) and 
acetic anhydride (1.40 mL, 14.81 mmol) were employed and the reaction was stirred at r.t. for 18 
h. Flash column chromatography (30% EtOAc/pentane) afforded the title compound 413 (2.49 g, 
69%, 1:1.3 mixture of rotamers A:B) as a colourless oil; νmax / cm
-1: 3026 (br. m), 2998 (br. m), 
2917 (br. m), 1641 (s), 1419 (s), 1246 (s), 1028 (s); 1H NMR (CDCl3, 400 MHz): δ 7.37 – 7.04 
(m, 20H, 2 × C1-H, 2 × C2-H, C3-H, 2 × C14-H, 2 × C15-H, C16-H, A+B), 4.66 (d, J = 15.1 Hz, 
1H, C12-H2, A), 4.46 (d, J = 15.1 Hz, 1H, C12-H2, A), 4.35 (d, J = 17.2 Hz, 1H, C12-H2, B), 4.29 
(d, J = 17.2 Hz, 1H, C12-H2, B), 3.51 (dd, J = 14.0, 5.5 Hz, 1H, C5-H2, B), 3.25 (dd, J = 15.1, 5.4 
Hz, 1H, C5-H2, A), 3.08 – 2.92 (m, 2H, C5-H2, A+B), 2.65 (dd, J = 14.4, 5.8 Hz, 1H, C9-H2, B), 
2.56 – 2.48 (m, 2H, C9-H2, A), 2.38 – 2.30 (m, 1H, C9-H2, B), 2.17 (s, 3H, C11-H3, A), 2.04 (s, 
3H, C11-H3, B), 0.96 – 0.76 (m, 4H, C6-H and C8-H, A+B), 0.53 – 0.35 (m, 4H, C7-H, A+B); 
13C 
NMR (CDCl3, 101 MHz): δ 171.0 (C10, B), 170.3 (C10, A), 141.9 (C4, A), 141.1 (C4, B), 137.7 
(C13, A), 136.9 (C13, B), 128.8, 128.5, 128.4, 128.4, 128.3, 128.2, 127.8, 127.4, 127.1, 126.2, 
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126.1, 125.9 (C1, C2, C3, C14, C15 and C16, A+B), 51.3 (C12, B), 51.3 (C5, A), 48.8 (C5, B), 
47.7 (C12, A), 39.5 (C9, B), 39.2 (C9, A), 21.7 (C11, B), 21.7 (C11, A), 19.7 (C6, A), 19.4 (C6, B), 
17.5 (C8, A), 17.0 (C8, B), 10.7 (C7, A+B); HRMS: (ESI+) calculated for C20H24NO: 294.1852, 




General procedure N: Compound 413 (44.0 mg, 0.15 mmol), [Rh(cod)2]BARF (13.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 24 h at 120 °C. The crude mixture was purified by silica gel column 
chromatography (1% MeOH/DCM) to yield the title compound 417b (25.1 mg, 52%, 1:2.2 
mixture of diastereomers A:B) as a light brown oil; νmax / cm
-1: 2922 (br. w), 1747 (s), 1643 (s), 
1453 (s), 1432 (s), 740 (m); 1H NMR (CDCl3, 400 MHz): δ 7.43 – 7.01 (m, 20H, 2 × C8-H, 2 × 
C9-H, C10-H, 2 × C15-H, 2 × C16-H, C17-H, A+B), 4.61 – 4.47 (m, 4H, C13-H2, A+B), 3.55 – 
3.44 (m, 2H, C4-H, A+B), 2.82 – 2.67 (m, 3H, C3-H2, B and C2-H, A), 2.56 – 2.52 (m, 2H, C3-
H2, A), 2.35 – 1.96 (m, 5H, C1-H2, A+B and C2-H, B), 2.12 (s, 3H, C7-H3, B), 2.11 (s, 3H, C7-H3, 
A); 13C NMR (CDCl3, 101 MHz): δ 213.0 (C5, A), 212.0 (C5, B), 170.1 (C11, B), 170.0 (C11, A), 
140.0 (C7, B), 139.7 (C7, A), 136.4 (C14, B), 136.3 (C14, A), 129.0, 128.9, 128.8, 128.6, 128.4, 
128.4, 127.9, 127.8, 126.8, 126.6, 126.2, 126.2 (C8, C9, C10, C15, C16 and C17, A+B), 65.2 (C4, 
B), 62.1 (C4, A), 54.1 (C13, A), 53.8 (C13, B), 42.6 (C3, B), 42.5 (C3, A), 41.7 (C1, B), 41.5 (C1, 
A), 35.0 (C2, B), 34.3 (C2, A), 33.1 (C6, B), 32.5 (C6, A), 21.6 (C12, B), 21.5 (C12, A); HRMS: 
(ESI+) calculated for C21H24NO2: 322.1802, found [M+H]
+: 322.1812. 
  




The title compound was prepared following a literature procedure.287 A flame-dried flask was 
charged with a stirring bar and Mg turnings (0.73 g, 30 mmol, 4.00 eq), heated with a heatgun 
under high vacuum and then the turnings were suspended in 50 ml of dry THF. 
Bromocyclopropane (3.59 mL, 45 mmol, 4.50 eq) was added dropwise at 0 °C, the reaction was 
warmed to r.t. and stirred for ~1 h until complete consumption of Mg turnings. The resulting 
solution was added dropwise to the solution of benzonitrile (1.10 mL, 10 mmol, 1.00 eq) in dry 
THF (10 mL) at 0 °C over a period of 10 minutes under nitrogen atmosphere. The reaction was 
stirred at 0 °C for 5 h, then 30 mL of MeOH was added dropwise and NaBH4 (0.80 g, 20.9 mmol, 
2.10 eq) was added batchwise. The mixture was warmed to r.t. and stirred for 18 h. The solution was 
concentrated in vacuo the and then water (5 mL/mmol) and chloroform (5 mL/mmol) were added. 
The resulting solution was adjusted to pH 2 by addition of aq. 2 M HCl and phases were separated. 
The aqueous layer was extracted with chloroform (3 × 5 mL/mmol), then adjusted to pH 9 by 
addition of aq. 10% NaOH and again extracted with chloroform (3 × 5 mL/mmol). The organic 
extracts were combined, washed with brine (5 mL/mmol), dried over MgSO4 and concentrated in 
vacuo to afford the title compound 423 as a pale yellow oil (1.47 g, 99%) which was used in the 
following step without further purification; νmax / cm
-1: 3077 (m), 3001 (m), 1602 (m), 1492 (m), 
1452 (m) 1046 (m), 1017 (s); 1H NMR (CDCl3, 400 MHz): δ 7.42-7.39 (m, 2H, 2 × C6-H), 7.37-
7.31 (m, 2H, 2 × C7-H), 7.28-7.23 (m, 1H, C8-H), 3.21 (d, J = 8.6 Hz, 1H, C3-H), 1.66 (br. s, 2H, 
N4-H2), 1.15-1.05 (m, 1H, C2-H), 0.64-0.56 (m, 1H, C1-HaHb), 0.52-0.43 (m, 1H, C1-HaHb), 0.37-
0.24 (m, 2H, C1-H2); 
13C NMR (CDCl3, 101 MHz): δ 145.4 (C5), 128.4 (C7), 127.0 (C6), 126.5 









General procedure D: Amine 423 (0.73 g, 5.00 mmol) and benzoyl chloride (0.70 mL, 6.00 
mmol) were employed and the reaction was stirred at r.t. for 16 h. The residue was purified by 
recrystallization (EtOAc/hexane) to afford the title compound 421a (0.65 g, 56%) as a crystalline 
colourless solid; m.p. 107-108 °C; νmax / cm
-1: 3338 (m), 3074 (m), 2999 (m), 1630 (s), 1521 (s), 
1490 (s), 1317 (m), 1018 (m); 1H NMR (CDCl3, 400 MHz): δ 7.84-7.77 (m, 2H, 2 × C9-H), 7.54-
7.24 (m, 8H, 2 × C5-H, 4 × C6-H, 2 × C7-H), 6.50 (d, J = 7.9 Hz, 1H, N5-H), 4.66 (app. t, J = 8.3 
Hz, 1H, C3-H), 1.32-1.21 (m, 1H, C2-H), 0.71-0.52 (m, 3H, C1-HaHb and 2 × C1-H2), 0.50-0.42 
(m, 1H, C1-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 168.5 (C8), 142.0 (C4), 131.5 (C10), 128.6, 
128.5, 127.3, 127.3, 126.9, 126.7 (10 × Ar-CH), 57.5 (C3), 16.8 (C2), 4.1 (C1), 3.7 (C1); HRMS: 
(ESI+) calculated for C17H17NNaO: 274.1202, found [M+Na]
+: 274.1202. 
 
tert-Butyl [cyclopropyl(tosyl)methyl]carbamate (424) 
 
The title compound was prepared following a literature procedure.288 To a stirring solution of tert-
butyl carbamate (0.70 g, 5.98 mmol) and sodium p-toluenesulfinate (1.18 g, 6.62 mmol) in 
H2O/MeOH (2:1 v/v, 30 mL) cyclopropanecarboxaldehyde (0.50 mL, 3.97 mmol) and formic acid 
(0.89 mL, 23.50 mmol) were added at room temperature. The mixture was stirred for 48 h. The 
resulting off-white precipitate was filtered off, triturated with copious amounts of 10% DCM in 
petroleum spirit and dried under high vacuum to afford pure α-amido sulfone (3.94 g, 78%) as a 
colourless solid. 1H NMR (CDCl3, 400 MHz): δ 7.82 (d, J = 8.0 Hz, 2H, 2 × C5-H), 7.35 (d, J = 
8.0 Hz, 2H, 2 × C6-H), 5.17 (d, J = 11.5 Hz, 1H, N12-H), 4.34 (app. t, J = 10.0 Hz, 1H, C3-H), 
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2.42 (s, 3H, C8-H3), 1.39-1.32 (m, 1H, C2-H), 1.25 (s, 9H, 3 × C11-H3), 0.83-0.74 (m, 1H, C1-
HaHb–C1-HaHb), 0.70-0.61 (m, 1H, C1-HaHb–C1-HaHb), 0.61-0.53 (m, 1H, C1-HaHb–C1-HaHb), 
0.45-0.37 (m, 1H, C1-HaHb–C1-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 153.8 (C9), 145.0 (C7), 
134.5 (C4), 129.6 (C6), 129.2 (C5), 80.5 (C3), 74.3 (C10), 27.7 (C11), 21.3 (C8), 9.0 (C2), 4.2 
(C1), 2.0 (C1); The spectroscopic properties of this compound were consistent with the data 
available in the literature.289 
 
tert-Butyl (1-cyclopropylallyl)carbamate (425) 
 
The title compound was prepared following an adapted literature procedure.288 To a stirring 
solution of 424 (3.90 g, 12.00 mmol) in dry THF, vinylmagnesium bromide (28 mL, 1.0 M in 
THF, 28.00 mmol) was added dropwise over 10 min at -78 °C. The reaction mixture was warmed 
to r.t. and stirred for 2 h. The reaction was quenched with sat. aq. NH4Cl (2 mL/mmol) at 0 °C and 
warmed to r.t. The solution was extracted with Et2O (3 × 75 mL) and the organic extracts were 
combined, washed with brine (100 mL), dried over MgSO4 and concentrated in vacuo. The residue 
was purified by flash column chromatography (20% EtOAc/hexane) to afford the title compound 
425 (1.47 g, 62%) as a colourless oil; 1H NMR (CDCl3, 400 MHz): δ 5.80 (ddd, J = 17.0, 10.5, 5.0 
Hz, 1H, C4-H), 5.21-5.06 (m, 2H, C5-H2), 4.61 (app. br. s, 1H, C3-H), 3.58 (br. s, 1H, N6-H), 1.43 
(s, 9H, 3 × C9-H3), 0.85 (dtt, J = 8.1, 8.1, 5.0 Hz, 1H, C2-H), 0.53-0.45 (m, 2H, C1-H2), 0.41-0.33 
(m, 1H, C1-HaHb), 0.27-0.22 (m, 1H, C1-HaHb); 
13C NMR (CDCl3, 101 MHz,): δ 155.3 (C7), 
137.9 (C4), 114.4 (C5), 79.2 (C8), 56.3 (C3), 28.4 (C9), 15.6 (C2), 2.7 (C1); The spectroscopic 
properties of this compound were consistent with the data available in the literature.289 
  




To a stirring solution of Boc-protected amine 400 (0.40 g, 2.03 mmol) in DCM (10 mL), TFA 
(1.50 mL, 20.30 mmol) was added and the solvent was removed in vacuo. The residue was 
dissolved in dry DCM, then TEA (1.41 mL, 10.15 mmol) and benzoyl chloride (0.70 mL, 6.09 
mmol) were added dropwise at 0°C under nitrogen. The reaction was warmed to r.t. and stirred for 
16 h. The reaction mixture was concentrated in vacuo and then distilled water and DCM were 
added. The aqueous portion was further extracted with DCM (2 × 5 mL/mmol) and the organic 
extracts were combined washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo. 
The residue was purified by flash column chromatography (16% EtOAc/hexane) to afford the title 
compound 401 (193 mg, 47%) as a colourless solid; m.p. 96-97 °C; νmax / cm
-1: 3278 (m), 3080 
(m), 3006 (m), 1624 (s), 1545 (s), 1335 (m), 1292 (m); 1H NMR (CDCl3, 400 MHz): δ 7.82-7.78 
(m, 2H, 2 × C9-H), 7.54-7.41 (m, 3H, C11-H and 2 × C10-H), 6.20 (br. s, 1H, N6-H), 5.93 (ddd, 
J = 17.2, 10.5, 5.1 Hz, 1H, C4-H), 5.30 (dd, J = 17.2, 1.5 Hz, 1H, C5-H2, trans), 5.17 (dd, J = 10.5, 
1.5 Hz, 1H, C5-H2, cis), 4.18-4.10 (m, 1H, C3-H), 1.05-0.95 (m, 1H, C2-H), 0.65-0.43 (m, 3H, 3 × 
C1-H2), 0.41-0.34 (m, 1H, C1-H2); 
13C NMR (CDCl3, 101 MHz): δ 166.7 (C7), 137.3 (C4), 134.7 
(C8), 131.5 (C11), 128.6 (C10), 126.9 (C9), 115.1 (C5), 55.6 (C3), 15.5 (C2), 3.1 (C1), 3.0 (C1); 





General procedure D: Cyclopropylmethylamine (0.42 g, 3.00 mmol) and 2-chlorobenzoyl 
chloride (0.91 mL, 3.60 mmol) were employed and the reaction was stirred at r.t. for 16 h. Flash 
column chromatography (30-40% EtOAc/hexane) afforded the title compound 432a (1.26 g, 95%) 
as a colourless solid; m.p. 82-83 °C; νmax / cm
-1: 3277 (m), 3080 (m), 1637 (s), 1530 (s) 1433 (s), 
1302 (s), 1265 (s), 1156 (m); 1H NMR (CDCl3, 400 MHz): δ 7.57-7.52 (m, 1H, C7-H), 7.37-7.31 
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(m, 3H, C8-H, C9-H, C10-H), 6.23 (br. s, 1H, N4-H), 3.23 (dd, J = 7.2, 5.4 Hz, 2H, C3-H2), 1.04-
0.91 (m, 1H, C2-H), 0.50-0.42 (m, 2H, C1-H2), 0.22-0.15 (m, 2H, C1-H2); 
13C NMR (CDCl3, 101 
MHz,): δ 166.4 (C5), 135.4 (C11), 131.1 (C9), 130.6 (C6), 130.2, 130.1 (C7 and C10), 127.0 (C8), 
44.9 (C3), 10.8 (C2), 3.5 (C1); HRMS: (ESI+) calculated for C11H13ClNO: 210.0680, found 
[M+H]+: 210.0684. 




To a solution of cyclopropylmethylamine (1.78 g, 25.00 mmol), EDCI (4.46 g, 28.75 mmol) and 
DMAP (0.31 g, 2.50 mmol) in DCM (0.5 M) at 0 °C was added 2-bromophenylacetic acid (5.91 
g, 27.50 mmol). The reaction was warmed to r.t., stirred for 18 h and then concentrated in vacuo. 
1.0 M aq. NaOH (5 mL/mmol) was added and the solution was extracted with EtOAc (3 × 3 
mL/mmol). The organic extracts were combined, washed with 1.0 M aq. HCl (5 mL/mmol) and 
brine (5 mL/mmol), dried over Na2SO4 and concentrated in vacuo. The residue was purified by 
recrystallisation (EtOAc/hexane) to afford the title compound 433 (5.68 g, 85%) as a colourless 
solid; m.p. 107-108 °C (EtOAc/hexane); νmax / cm
-1: 3298 (s), 3077 (m), 3010 (m), 2917 (m), 1641 
(s), 1549 (s), 1240 (s), 1026 (s); 1H NMR (CDCl3, 400 MHz): δ 7.58 (dd, J = 7.9, 1.3 Hz, 1H, C11-
H), 7.38 – 7.26 (m, 2H, C8-H and C9-H), 7.15 (td, J = 7.9, 1.9 Hz, 1H, C10-H), 5.63 (br. s, 1H, 
N4-H), 3.69 (s, 2H, C6-H2), 3.09 (dd, J = 7.1, 5.5 Hz, 2H, C3-H2), 0.95 – 0.83 (m, 1H, C2-H), 
0.49 – 0.39 (m, 2H, C1-HaHb), 0.17 – 0.10 (m, 2H, C1-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 
169.4 (C5), 135.0 (C7), 133.1 (C11), 131.7 (C8-H or C9-H), 129.0 (C10), 127.9 (C8-H or C9-H), 
124.9 (C12), 44.4 (C3), 44.0 (C6), 10.6 (C2), 3.2 (C1); HRMS: (ESI+) calculated for 
C12H15
79BrNO: 268.0332, found [M+H]+: 268.0330. 
  




To a solution of 2-bromophenylacetic acid (0.70 g, 3.26 mmol) in DCM (1 mL), stirring under a 
nitrogen atmosphere at room temperature, oxalyl chloride (0.34 mL, 3.91 mmol) and a drop of 
N,N-dimethylformamide were added. The reaction was stirred until gas effervescence stopped. 
DCM and an excess of oxalyl chloride were removed in vacuo and the resulting acyl chloride was 
adder dropwise to a mixture of N-benzyl-1-cyclopropylmethanamine (0.53 g, 3.26 mmol, prepared 
according to the literature procedure290) and TEA (0.54 mL, 3.91 mmol) at 0 °C. The mixture was 
warmed to r.t. and stirred for 18 h. The mixture was diluted with water (30 mL) and extracted with 
DCM (3 × 20 mL). The organic extracts were combined, washed with brine (50 mL), dried over 
MgSO4 and concentrated in vacuo. The residue was purified by flash column chromatography 
(20% EtOAc/petrol) to afford the title compound 434 (0.87 g, 74%, 1.04:1 mixture of rotamers 
A:B) as a colourless oil; νmax / cm
-1: 3063 (w), 3003 (w), 1642 (s), 1440 (s), 1427 (s), 1026 (s); 1H 
NMR (CDCl3, 400 MHz): δ 7.57 (dd, J = 8.0, 1.3 Hz, 1H, C10-H, A), 7.54 (dd, J = 8.0, 1.3 Hz, 
1H, C10-H, B), 7.39 – 7.21 (m, 14H, C7-H, C8-H, C10-H, C16-H, 2 × C14-H and 2 × C15-H, 
A+B), 7.16 – 7.08 (m, 2H, C9-H, A+B), 4.78 (s, 2H, C12-H2, A), 4.69 (s, 2H, C12-H2, B), 3.94 (s, 
2H, C5-H2, A), 3.82 (s, 2H, C5-H2, B), 3.35 (d, J = 7.0 Hz, 2H, C3-H2, A), 3.15 (d, J = 6.6 Hz, 1H, 
C3-H2, B), 1.08 – 0.87 (m, 2H, C2-H, A+B), 0.58 – 0.50 (m, 2H, C1-HaHb, A), 0.50 – 0.42 (m, 2H, 
C1-HaHb, B), 0.25 – 0.12 (m, 4H, C1-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 170.4 (C4, A), 
169.9 (C4, B), 137.7, 136.9, 135.5, 135.4, 132.7, 132.7, 131.1, 130.9, 128.8, 128.5, 128.5, 128.0, 
127.6, 127.5, 127.5, 127.2, 126.4, 125.1, 124.8, 124.7 (C6, C7, C8, C9, C10, C11, C13, C14, C15 
and C16, A+B), 51.4 (C3, B), 51.3 (C12, B), 50.2 (C3, A), 48.3 (C12, A), 41.0 (C5, B), 40.9 (C5, 
A), 10.0 (C2, A), 9.5 (C2, B), 3.9 (C1, A), 3.6 (C1, B); HRMS: (ESI+) calculated for C19H21
79BrNO: 
358.0801, found [M+H]+: 358.0810. 
  




General procedure M: Cyclopropylmethylamine (0.23 mL, 2.60 mmol), 2-bromobenzaldehyde 
(0.51 g, 2.73 mmol) and acetic anhydride (0.26 g, 2.50 mmol) were employed and the reaction was 
stirred at r.t. for 16 h. Flash column chromatography (20-30% EtOAc/hexane) afforded the title 
compound 435 (0.48 g, 65%, 1:1.25 mixture of rotamers A:B) as a colourless oil; νmax / cm
-1: 3003 
(m), 2929 (m), 1651 (s), 1440 (s), 1421 (s), 1252 (m), 1024 (m); 1H NMR (CDCl3, 400 MHz): δ 
7.57 (dd, J = 7.8, 1.2 Hz, 1H, C9-H, A), 7.52 (dd, J = 7.9, 1.2 Hz, 1H, C9-H, B), 7.35-7.06 (m, 6H, 
C10-H, C11-H and C12-H, A+B), 4.81 (s, 2H, C6-H2, B), 4.65 (s, 2H, C6-H2, A), 3.31 (d, J = 7.0 
Hz, 2H, C3-H2, A), 3.16 (d, J = 6.7 Hz, 2H, C3-H2, B), 2.24 (s, 3H, C5-H3, B), 2.06 (s, 3H, C5-H3, 
A), 1.02-0.87 (m, 2H, C2-H, A+B), 0.57-0.42 (m, 4H, C1-HaHb, A+B), 0.23-0.14 (m, 4H, C1-
HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 171.3 (C4, B), 170.7 (C4, A), 136.6 (C7, A), 135.9 
(C7, B), 133.0 (C9, A), 132.7 (C9, B), 128.9, 128.5, 128.5, 127.8, 127.5, 126.9 (C10, C11 and C12, 
A+B), 123.2, 122.5 (C8, A+B), 52.9 (C3, B), 52.4 (C6, A), 50.3 (C3, A), 48.5 (C6, B), 21.6 (C5, 
A+B), 10.2, 9.6 (C2, A+B), 3.7 (C1, B), 3.6 (C1, A); HRMS: (ESI+) calculated for C13H17
79BrNO: 




General procedure N: Compound 435 (42.3 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 24 h at 140 °C. The crude mixture was purified by silica gel column 
chromatography (30% EtOAc/hexane) to yield the title compound 436 (38.3 mg, 82%) as a brown 
oil; νmax / cm
-1: 2964 (m), 2880 (m), 1745 (s), 1647 (s), 1425 (s), 1253 (s), 1025 (s); 1H NMR 
(CDCl3, 400 MHz,): δ 7.61 (d, J = 7.7 Hz, 1H, C11-H), 7.56 (d, J = 7.9 Hz, 1H, C14-H), 7.38 (dd, 
J = 7.7, 7.5 Hz, 1H, C12-H), 7.21-7.15 (m, 1H, C13-H), 4.67 (d, J = 17.8 Hz, 1H, C8-HaHb), 4.49 
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(d, J = 17.8 Hz, 1H, C8-HaHb), 3.52 (t, J = 9.7 Hz, 1H, C4-H), 2.52 (ddd, J = 18.5, 11.9, 9.3 Hz, 
1H, C1-HaHb), 2.29-2.08 (m, 4H, C1-HaHb, C2-HaHb, 2 × C3-H2), 2.06 (s, 3H, C7-H3), 1.73-1.57 
(m, 1H, C2-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 213.1 (C5), 170.4 (C6), 135.4 (C9), 132.9 
(C14), 129.2 (C13), 128.0, 128.0 (C11 and C12), 122.5 (C10), 64.6 (C4), 53.9 (C8), 35.9 (C1), 
26.9 (C3), 21.4 (C7), 19.1 (C2); HRMS: (ESI+) calculated for C14H17





An oven-dried Schlenk flask, fitted with a magnetic stirrer, was charged with PdCl2(PPh3)2 (4.2 mg, 
6 mol%) and Cs2CO3 (65.2 mg, 2.00 eq). The flask was fitted with a rubber septum, evacuated and 
backfilled with nitrogen three times. Then, a solution of cyclopentanone 436 (31.0 mg, 0.10 mmol) 
in dry and degassed toluene (0.10 M) was added via syringe. The flask was sealed and the reaction 
mixture was heated at 110 °C for 18 h. The mixture was cooled to r.t. and concentrated in vacuo. 
The residue was purified by flash column chromatography (40% EtOAc/pentane) to afford the title 
compound 40 (18.5 mg, 81%) as a colourless solid; m.p. 177-178 °C (DCM/hexane); νmax / cm
-1: 
2960 (m), 2924 (m), 2860 (m), 1746 (s), 1645 (s), 1410 (s), 1355 (m), 1147 (s); 1H NMR (CDCl3, 
400 MHz): δ 7.34-7.24 (m, 3H, C8-H, C9-H and C10-H), 7.16-7.09 (m, 1H, C7-H), 4.94 (d, J = 
13.5 Hz, 1H, C12-HaHb), 4.82 (d, J = 13.5 Hz, 1H, C12-HaHb), 2.94-2.78 (m, 2H, C1-H2 and C2-
H2), 2.55-2.46 (m, 1H, C1-H2), 2.43-2.33 (m, 1H, C3-H2), 2.23-2.08 (m, 2H, C2-H2 and C3-H2), 
2.15 (s, 3H, C14-H3); 
13C NMR (CDCl3, 101 MHz): δ 215.0 (C5), 168.6 (C13), 142.3 (C6), 135.7 
(C11), 128.5, 128.2, 122.8 (C8, C9, C10), 121.4 (C7), 75.9 (C4), 53.8 (C12), 36.4 (C1), 35.6 (C2), 
22.5 (C14), 19.0 (C3); HRMS: (ESI+) calculated for C14H16NO2: 230.1176, found [M+H]
+: 
230.1179. The structure of 437 was determined unambiguously by X-ray crystallography. 
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Crystal image of 437 generated in Olex2, ellipsoids at 50% probability; Crystal data for 437: 
C14H15NO2, MW = 229.27, orthorhombic, space group Pnma, a = 16.1606(16) Å, b = 6.8731(7) 
Å, c = 9.9963(9) Å, V = 1110.32(19) Å3, α = 90.00°, β = 90.00°, γ = 90.00°, Z = 4, Dc = 1.372 
g/cm3, Mo-Kα radiation, λ = 0.71073 Å, μ = 0.092 mm-1, T = 100 K; colourless plate, crystal size 
0.564 × 0.306 × 0.17 mm3, Bruker Apex II diffractometer, 7747 reflections were collected, 1109 
were unique, Rint = 0.0868; refinement on F
2 gave R1 = 0.0914 and wR2 = 0.2225, GOF = 1.214 




Phenylacetaldehyde (0.70 mL, 6.05 mmol, 1.05 eq) was added dropwise to the solution of 
cyclopropylmethylamine (0.5 mL, 5.77 mmol, 1.00 eq) in MeOH (0.5 M) at -78 °C and the reaction 
was stirred for 3 min. NaBH4 (0.44 g, 2.00 eq) was added portionwise, the solution was warmed to 
0 °C and stirred for 2 h.  
Note: It is important to reduce the imine promptly, otherwise it self-polymerises in less than 10 
min. 
The reaction mixture was concentrated in vacuo and then sat. aq. NaHCO3 (10 mL/mmol) was 
added. The solution was extracted with DCM (3 × 5 mL/mmol) and then the organic extracts were 
combined, washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo to afford the 
secondary amine intermediate.  
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To a stirring solution of secondary cyclopropylmethylamine (1.00 g, 5.71 mmol, 1.00 eq) in dry 
DCM (5 mL), TEA (0.95 mL, 1.20 eq) and acetic anhydride (0.65 mL, 1.20 eq) were added at 0 
°C under nitrogen. The solution was warmed to r.t. and stirred for 16 h. Sat. aq. NaHCO3 (50 mL) 
was added and the aqueous layer was extracted with DCM (3 × 20 mL). The combined organic 
extracts were washed with brine (70 mL), dried over MgSO4 and concentrated in vacuo. The 
residue was purified by flash column chromatography (20-40% EtOAc/hexane) to afford the title 
compound 439 (0.77 g, 58% over two steps, 1:1 mixture of rotamers A:B) as a colorless oil; νmax / 
cm-1: 3002 (w), 2930 (br. w), 1639 (s), 1453 (s), 1421 (s) ,1020 (m); 1H NMR (CDCl3, 400 MHz): 
δ 7.37-7.12 (m, 10H, 2 × C7-H, 2 × C8-H and C9-H, A+B), 3.65-3.54 (m, 4H, C4-H2, A+B), 3.29 
(d, J = 6.9 Hz, 2H, C3-H2, A), 3.06 (d, J = 6.6 Hz, 2H, C3-H2, B), 2.93-2.82 (m, 4H, C5-H2, A+B), 
2.12 (s, 3H, C11-H3, A), 1.96 (s, 3H, C11-H3, B), 1.07-0.97 (m, 1H, C2-H, A), 0.96-0.85 (m, 1H, 
C2-H, B), 0.62-0.49 (m, 4H, 2 × C1-HaHb, A+B), 0.29-0.24 (m, 2H, 2 × C1-HaHb, A), 0.23-0.17 
(m, 2H, 2 × C1-HaHb, B); 
13C NMR (CDCl3, 101 MHz): δ 170.4 (C10, A), 170.0 (C10, B), 139.5 
(C6, A), 138.3 (C6, B), 128.8, 128.8 (C8, A+B), 128.7, 128.4 (C7, A+B), 126.70, 126.2 (C9, A+B), 
53.7 (C3, B), 50.3 (C4, A), 49.5 (C3, A), 48.1 (C4, B), 35.3, 34.1 (C5, A+B), 21.9 (C11, A), 21.3 
(C11, B), 10.5 (C2, B), 9.8 (C2, A), 3.8 (C1, A+B); HRMS: (ESI+) calculated for C14H20NO: 




General procedure N: Compound 439 (32.6 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 18 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (40% EtOAc/hexane) to yield the title compound 440 (29.1 mg, 79%) as a yellow 
oil; νmax / cm
-1: 2959 (m), 2912 (br. m), 1744 (s), 1632 (s), 1430 (s), 1153 (m), 1102 (m); 1H NMR 
(CDCl3, 400 MHz): δ 7.34-7.15 (m, 5H, 2 × C11-H, 2 × C12-H and C13-H), 3.61-3.46 (m, 2H, 
C8-H2), 3.40 (t, J = 9.6 Hz, 1H, C4-H), 2.96-2.80 (m, 2H, C9-H2), 2.55 (ddd, J = 18.2, 11.8, 9.3 
Hz, 1H, C1-H), 2.35-2.06 (m, 4H, 2 × C3-H2, C1-H and C2-H), 1.84 (s, 3H, C7-H3), 1.79-1.62 (m, 
1H, C2-H); 13C NMR (CDCl3, 101 MHz): δ 213.5 (C5), 169.4 (C6), 138.0 (C10), 128.8, 128.8 
(C11 and C12), 126.8 (C13), 64.9 (C4), 52.9 (C8), 36.0 (C9), 35.8 (C1), 27.2 (C3), 21.0 (C7), 19.4 
(C2); HRMS: (ESI+) calculated for C15H20NO2: 246.1489, found [M+H]
+: 246.1491. 




Compound 433 (0.50 g, 1.86 mmol) was dissolved in dry THF (10 mL) and the reaction vessel 
was cooled to 0 °C. Borane-THF complex solution (1 M in THF, 9.30 mmol, 5.00 eq) was added 
dropwise. The solution was warmed to room temperature and then heated to reflux for 20 h. The 
reaction was allowed to cool to room temperature, 40 mL of 2.0 M aq. HCl was added and the 
solution was heated to 85 °C for 1 h. The solution was washed with Et2O (2 × 20 mL) and adjusted 
to pH 10 with 2.0 M aq. NaOH. The aqueous portion was diluted with water (50 mL) and extracted 
with Et2O (3 × 20 mL). The organic extracts were combined, dried over MgSO4 and concentrated 
in vacuo. The resulting secondary amine (0.23 g, 0.90 mmol) was acylated according to the 
general procedure D with acetic anhydride (0.10 mL, 1.09 mmol) and the residue was purified 
by flash column chromatography (15-20% EtOAc/petrol) to afford the title compound 441 (254 
mg, 46% over two steps, 1:1.04 mixture of rotamers A:B) as a colourless oil; νmax / cm
-1: 3003 (w), 
2932 (w), 1642 (s), 1472 (m), 1420 (s), 1023 (m); 1H NMR (CDCl3, 400 MHz): δ 7.56 (dd, J = 
8.0, 1.3 Hz, 1H, C10-H, A), 7.52 (dd, J = 8.0, 1.3 Hz, 1H, C10-H, B), 7.32-7.17 (m, 4H, C7-H and 
C8-H, A+B), 7.15-7.05 (m, 2H, C9-H, A+B), 3.65 – 3.57 (m, 4H, C4-H2, A+B), 3.30 (d, J = 6.9 
Hz, 2H, C3-H2, B), 3.07 (d, J = 6.6 Hz, C3-H2, 2H, A), 3.05 – 2.99 (m, 4H, C5-H2, A+B), 2.12 (s, 
3H, C13-H3, A), 2.03 (s, 3H, C13-H3, B), 1.08 – 0.99 (m, 1H, C2-H, A), 0.96 – 0.88 (m, 1H, C2-
H, B), 0.59 – 0.49 (m, 4H, C1-HaHb, A+B), 0.31 – 0.25 (m, 2H, C1-HaHb, A), 0.25 – 0.20 (m, 2H, 
C1-HaHb, B); 
13C NMR (CDCl3, 101 MHz): δ 170.5, 170.2 (C12, A+B), 138.8, 137.6 (C6, A+B), 
133.0 (C10, A), 132.7 (C10, B), 131.3, 131.0, 128.6, 128.0 (C7 and C8, A+B), 127.9, 127.6 (C9, 
A+B), 124.4, 124.3 (C11, A+B), 53.6 (C3, A), 49.6 (C3, B), 48.3, 46.2 (C4, A+B), 35.6, 34.2 (C5, 
A+B), 21.8 (C13, A), 21.4 (C13, B), 10.4 (C2, B), 9.8 (C2, A), 3.7, 3.7 (C1, A+B); HRMS: (ESI+) 
calculated for C14H19
79BrNO: 296.0645, found [M+H]+: 296.0638. 
  




General procedure N: Compound 441 (44.4 mg, 0.150 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 24 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (20-40% EtOAc/petrol) to yield the title compound 442 (43.1 mg, 88%) as a 
yellow oil; νmax / cm
-1: 2964 (w), 1745 (s), 1635 (s), 1472 (m), 1431 (s), 1154 (m), 1024 (m); 1H 
NMR (400 MHz, CDCl3): δ 7.56 (dd, J = 7.9.0, 1.5 Hz, 1H, C12-H), 7.35-7.27 (m, 2H, C14-H and 
C15-H), 7.13 (td, J = 7.9, 1.8 Hz, 1H, C13-H), 3.65 – 3.44 (m, 3H, C4-H and C8-H2), 3.07 – 3.00 
(m, 2H, C9-H2), 2.58 (ddd, J = 18.3, 11.9, 9.4 Hz, 1H, C1-HaHb), 2.37 – 2.11 (m, 4H, C1-HaHb, 
C2-HaHb, 2 × C3-H2), 1.94 (s, 3H, C7-H3), 1.82 – 1.66 (m, 1H, C2-HaHb); 
13C NMR (CDCl3, 101 
MHz): δ 213.5 (C5), 169.5 (C6), 137.2 (C10), 133.0 (C15), 131.4 (C14), 128.7, 127.9 (C12 and 
C13), 124.3 (C11), 64.9 (C4), 50.7 (C8), 36.5 (C1), 35.9 (C9), 27.2 (C3), 21.0 (C7), 19.4 (C2); 
HRMS: (ESI+) calculated for C15H19





An oven-dried Schlenk flask, fitted with a magnetic stirrer, was charged with PdCl2(PPh3)2 (4.2 mg, 
6 mol%) and Cs2CO3 (65.2 mg, 0.20 mmol, 2.00 eq). The flask was fitted with a rubber septum, 
evacuated and backfilled with nitrogen three times. Then, a solution of cyclopentanone 442 (32.4 
mg, 0.10 mmol) in dry and degassed toluene (0.10 M) was added via syringe. The flask was sealed 
and the reaction mixture was heated at 110 °C for 18 h. The mixture was cooled to r.t. and 
concentrated in vacuo. The residue was purified by flash column chromatography (40% 
EtOAc/petrol) to afford the title compound 443 (23.1 mg, 95%) as a colourless solid; m.p. 151-
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152 °C (DCM/hexane); νmax / cm
-1: 2954 (w), 1740 (s), 1633 (s), 1416 (s), 1149 (m); 1H NMR 
(CDCl3, 400 MHz): δ 7.23 – 7.14 (m, 3H, C8-H, C9-H and C10-H), 7.00 – 6.95 (m, 1H, C7-H), 
3.74 (ddd, J = 12.2, 7.3, 4.0 Hz, 1H, C13-HaHb), 3.60 (ddd, J = 12.0, 7.8, 3.8 Hz, 1H, C13-HaHb), 
3.04 (ddt, J = 15.9, 7.8, 4.0 Hz, 1H, C12-HaHb), 2.99 – 2.93 (m, 1H, C2-HaHb), 2.94 – 2.82 (m, 
1H, C12-HaHb), 2.68 – 2.59 (m, 1H, C1-HaHb), 2.50 – 2.41 (m, 1H, C2-HaHb), 2.32 – 2.16 (m, 2H, 
C3-HaHb and C1-HaHb), 2.15 (s, 3H, C15-H3), 2.03 – 1.92 (m, 1H, C3-HaHb); 
13C NMR (CDCl3, 
101 MHz): δ 214.7 (C12), 169.0 (C14), 138.1 (C6), 135.0 (C11), 128.3, 127.1, 127.0 (C8, C9, 
C10), 125.5 (C7), 68.1 (C4), 44.3 (C13), 39.2 (C1), 36.7 (C2), 30.4 (C12), 22.6 (C15), 18.7 (C3); 





To a solution of (1R*,2S*)-2-benzylcyclopropane-1-carboxylic acid 444 (1.20 g, 6.81 mmol, 
prepared according to the literature procedure48) in DCM (1 mL), stirring under a nitrogen 
atmosphere at room temperature, oxalyl chloride (0.88 mL, 10.21 mmol) was added. The reaction 
was stirred until gas effervescence stopped. DCM and an excess of oxalyl chloride were removed 
in vacuo and the resulting acyl chloride was adder dropwise to a mixture of 2-bromobenzylamine 
hydrochloride (1.59 g, 7.15 mmol) and TEA (2.08 mL, 14.98 mmol) at 0 °C. The mixture was 
warmed to r.t. and stirred for 18 h. The mixture was diluted with water (50 mL) and extracted with 
DCM (3 × 40 mL). The organic extracts were combined, washed with brine (50 mL), dried over 
MgSO4 and concentrated in vacuo. The residue was purified by recrystallization (DCM/hexane) 
to afford the title compound 445 (1.57 g, 67%) as a colourless solid; m.p. 138-139 °C 
(DCM/hexane); νmax / cm
-1: 3282 (br. m), 2920 (br. w), 1643 (s), 1543 (s), 1440 (s), 1239 (s), 1028 
(s); 1H NMR (CDCl3, 400 MHz): δ 7.55 (dd, J = 8.0, 1.3 Hz, 1H, C16-H), 7.36 – 7.11 (m, 8H, C1-
H, C13-H, C14-H, C15-H, 2 × C2-H and 2 × C3-H), 6.01 (br. m, 1H, N4-H), 4.51 (d, J = 6.0 Hz, 
2H, C11-H2), 2.68 (d, J = 3.4 Hz, 1H, C5-H2), 2.66 (d, J = 3.4 Hz, 1H, C5-H2), 1.75 – 1.66 (m, 
1H, C6-H), 1.30 – 1.21 (m, 2H, C7-HaHb and C8-H), 0.75 (ddd, J = 7.2, 6.3, 3.6 Hz, 1H, C7-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 172.7 (C9), 140.3 (C4), 137.5 (C12), 132.7 (C16), 130.3, 129.1, 
128.4, 128.3, 127.7, 126.1 (C1, C2, C3, C13, C14 and C15), 123.7 (C17), 44.0 (C11), 38.4 (C5), 
22.2 (C6), 21.7 (C8), 14.3 (C7); HRMS: (ESI+) calculated for C18H19
79BrNO: 344.0645, found 
[M+H]+: 344.0649. 




Compound 445 (1.00 g, 2.90 mmol) was dissolved in dry THF (10 mL) and the reaction vessel 
was cooled to 0 °C. Borane-THF complex solution (1 M in THF, 14.52 mmol, 5.00 eq) was added 
dropwise. The solution was warmed to room temperature and then heated to reflux for 24 h. The 
reaction was allowed to cool to room temperature, 50 mL of 2.0 M aq. HCl was added and the 
solution was heated to 85 °C for 1 h. The solution was washed with Et2O (2 × 20 mL) and adjusted 
to pH 10 with 2.0 M aq. NaOH. The aqueous portion was diluted with water (50 mL) and extracted 
with Et2O (3 × 30 mL). The organic extracts were combined, dried over MgSO4 and concentrated 
in vacuo. The resulting secondary amine was acylated according to the general procedure D with 
acetic anhydride (0.33 mL, 3.48 mmol) and the residue was purified by flash column 
chromatography (4.5/4.5/1 DCM/hexane/acetone) to afford the title compound 446 (0.48 g, 44% 
over two steps, 1.55:1 mixture of rotamers A:B) as a colourless oil; νmax / cm
-1: 2997 (w), 2918 (br. 
w), 1647 (s), 1439 (s), 1420 (s), 1248 (m), 1025 (s); 1H NMR (CDCl3, 400 MHz): δ 7.56 (dd, J = 
8.0, 1.2 Hz, 1H, C17-H, A), 7.52 (dd, J = 8.0, 1.2 Hz, 1H, C17-H, B), 7.32 – 7.04 (m, 16H, C8-H, 
C14-H, C15-H, C16-H, 2 × C6-H and 2 × C7-H, A+B), 4.75 (d, J = 16.1 Hz, 1H, C12-H2, B), 4.68 
(d, J = 16.1 Hz, 1H, C12-H2, B), 4.41 (s, 2H, C12-H2, A), 3.48 (dd, J = 14.0, 5.6 Hz, 1H, C4-H2, 
A), 3.29 (dd, J = 15.2, 5.9 Hz, 1H, C4-H2, B), 3.12 (dd, J = 14.0, 7.5 Hz, 1H, C4-H2, A), 3.05 (dd, 
J = 15.2, 7.0 Hz, 1H, C4-H2, B), 2.64 – 2.35 (m, 4H, C9-H2, A+B), 2.21 (s, 3H, C11-H3, B), 1.97 
(s, 3H, C11-H3, A), 1.01 – 0.79 (m, 4H, C2-H and C3-H, A+B), 0.52 – 0.37 (m, 4H, C1-H, A+B); 
13C NMR (CDCl3, 101 MHz): δ 171.3 (C10, A), 170.6 (C10, B), 141.7 (C5, A), 141.1 (C5, B), 
136.6 (C13, B), 135.9 (C13, A), 133.1 (C17, A), 132.7 (C17, B), 128.9, 128.7, 128.6, 128.4, 128.3, 
128.3, 127.8, 127.6, 127.0, 126.2, 125.9 (C8, C14, C15, C16, C7 and C6, A+B), 123.3 (C18, B), 
122.5 (C18, A), 52.2 (C4, B), 52.2 (C12, A), 49.4 (C4, A), 48.4 (C12, B), 39.4 (C9, A), 39.1 (C9, 
B), 21.6 (C11, B), 21.6 (C11, A), 19.5 (C2, B), 19.2 (C2, A), 17.7 (C3, B), 17.1 (C3, A), 10.8 (C1, 
A), 10.7 (C1, B); HRMS: (ESI+) calculated for C20H23








To a solution of but-3-en-1-yl 4-methylbenzenesulfonate (3.39 g, 15.00 mmol, prepared according 
to the literature procedure48) and K2CO3 (2.07 g, 15.00 mmol) in MeCN (3 mL) in a sealed tube 
was added a solution of cyclopropylmethylamine (1.07 g, 15.00 mmol) in MeCN (15 mL). The 
tube was sealed and the reaction was heated to 90 °C for 18 h. The reaction mixture was cooled to 
r.t. and then the solution was concentrated in vacuo. Water (50 mL) was added and the solution 
was extracted with DCM (3 × 30 mL). The organic extracts were combined, washed with brine 
(40 mL), dried over MgSO4 and concentrated in vacuo to yield the secondary amine intermediate.  
To a stirring solution of secondary amine in dry DCM (5 mL), TEA (5.98 mL, 3.00 eq) and acetic 
anhydride (4.05 mL, 3.00 eq) were added at 0 °C under nitrogen. The solution was warmed to r.t. 
and stirred for 16 h. Sat. aq. NaHCO3 (30 mL) was added and the aqueous layer was extracted 
with DCM (3 × 20 mL). The combined organic extracts were washed with brine (20 mL), dried 
over MgSO4 and concentrated in vacuo. The crude mixture was purified by silica gel column 
chromatography (20-40% EtOAc/hexane) to yield the title compound 449 (1.39 g, 55% over two 
steps, 1:1 mixture of rotamers A:B) as a yellow oil; νmax / cm
-1: 2978 (m), 2930 (m), 1636 (s), 1422 
(s), 1019 (m), 996 (m); 1H NMR (CDCl3, 400 MHz): δ 5.79 (ddt, J = 17.1, 10.2, 6.9 Hz, 2H, C8-
H, A+B), 5.17-4.99 (m, 4H, C9-H2, A+B), 3.49 (t, J = 7.5 Hz, 2H, C6-H2, A), 3.43 (t, J = 7.7 Hz, 
2H, C6-H2, B), 3.28 (d, J = 6.9 Hz, 2H, C3-H2, A), 3.18 (d, J = 6.5 Hz, 2H, C3-H2, B), 2.40-2.30 
(m, 4H, C7-H2, A+B), 2.13 (s, 3H, C5-H3, A), 2.12(s, 3H, C5-H3, B), 1.07-0.89 (m, 2H, C2-H, 
A+B), 0.64-0.58 (m, 2H, 2 × C1-HaHb, B), 0.55-0.48 (m, 2H, 2 × C1-HaHb, A), 0.28-0.21 (m, 4H, 
2 × C1-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 170.3, 170.0 (C4, A+B), 135.7, 134.4 (C8, 
A+B), 117.4, 116.3 (C9, A+B), 53.3 (C3, B), 49.5 (C3, A), 48.1 (C6, B), 45.4 (C6, A), 33.2, 32.2 
(C7, A+B), 21.8, 21.6 (C5, A+B), 10.5, 9.8 (C2, A+B), 3.8 (C1, B), 3.7 (C1, A); HRMS: (ESI+) 
calculated for C10H18NO: 168.1383, found [M+H]
+: 168.1385. 
  




A flame-dried flask was charged with alkene 449 (0.70 g, 4.19 mmol) and 1-phenylprop-2-en-1-
one (1.66 g, 12.56 mmol, prepared according to the literature procedure291). Dry DCM (0.1 M) 
and Hoveyda-Grubbs Catalyst™ 2nd Generation (40 mg, 1.5 mol%) were added and the solution 
was stirred at r.t. for 18 h. A few drops of DMSO were added, the crude was concentrated in vacuo 
and the residue was purified by silica gel column chromatography (20-50% EtOAc/petrol) to yield 
the title compound 90a (0.28 g, 25%, 1:1.83 mixture of rotamers A:B) as a brown oil; νmax / cm
-1: 
3004 (w), 292 (br. w), 1669 (s), 1691 (s), 1448 (m), 1262 (m); 1H NMR (CDCl3, 400 MHz): δ 7.94 
– 7.90 (m, 4H, 2 × C12-H, A+B), 7.60 – 7.44 (m, 6H, C14-H and 2 × C13-H, A+B), 7.04 – 6.90 
(m, 4H, C8-H and C9-H, A+B), 3.62 – 3.53 (m, 4H, C6-H2, A+B), 3.29 (d, J = 6.9 Hz, 2H, C3-H2, 
A), 3.18 (d, J = 6.6 Hz, 2H, C3-H2, B), 2.67 – 2.58 (m, 4H, C7-H2, A+B), 2.13 (s, 3H, C5-H3, A), 
2.12 (s, 3H, C5-H3, B), 1.04 – 0.88 (m, 2H, C2-H, A+B), 0.64 – 0.58 (m, 2H, 2 × C1-HaHb, B), 
0.55 – 0.50 (m, 2H, 2 × C1-HaHb, A), 0.29 – 0.21 (m, 4H, 2 × C1-HaHb, A+B); 
13C NMR (CDCl3, 
101 MHz): δ 190.7 (C10, B), 190.0 (C10, A), 170.3 (C4, B), 170.3 (C4, A), 146.0 (C8, B), 144.1 
(C8, A), 137.7 (C11, B), 137.5 (C11, A), 133.0 (C14, A), 132.7 (C14, B), 128.7, 128.6, 128.6, 
128.5(C12 and C13, A+B), 127.9 (C9, A), 127.4 (C9, B), 53.8 (C3, B), 49.7 (C3, A), 47.3 (C6, A), 
45.1 (C6, B), 32.4 (C7, A), 31.2 (C7, B), 21.8 (C5, B), 21.6 (C5, A), 10.6 (C2, B), 9.8 (C2, A), 3.9 








General procedure N: Compound 450a (40.7 mg, 0.150 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%), and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) and Mg(OTf)2 (4.8 mg, 
0.015 mmol, 10 mol%) were employed and the reaction was stirred for 24 h at 110 °C. The crude 
mixture was purified by silica gel column chromatography (40% EtOAc/ n-pentane) to yield the 
title compound 451a (29.0 mg, 65%, 1:1.5 mixture of diastereomers A:B) as a brown oil; νmax / cm
-
1: 2965 (w), 1740 (s), 1683 (s), 1631 (s), 1448 (s), 1415 (s), 1216 (s); 1H NMR (CDCl3, 400 MHz): 
δ 8.00 – 7.86 (m, 4H, 2 × C14-H, A+B), 7.59 – 7.39 (m, 6H, 2 × C15-H and C16-H, A+B), 3.69 – 
3.44 (m, 4H, C8-H2, A+B), 3.12 (dd, J = 16.6, 5.9 Hz, 1H, C11-HaHb, B), 2.98 (dd, J = 16.6, 8.4 
Hz, 1H, C11-HaHb, B), 3.04 – 2.47 (m, 3H, C6-H, A+B and C11-H2, A), 2.41 – 2.03 (m, 10H, C1-
H2, C2-HaHb, C3-HaHb and C7-HaHb, A+B), 2.02 (s, 3H, C10-H3, B), 1.97 (s, 3H, C10-H3, A), 1.96 
– 1.45 (m, 6H, C2-HaHb, C3-HaHb and C7-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 216.8, 
216.1 (C5, A+B), 198.8, 197.4 (C12, A+B), 168.2, 168.1 (C9, A+B), 136.8, 136.2 (C13, A+B), 
133.5, 133.2 (C16, A+B), 128.8, 128.6 (C14, A+B), 128.0, 127.9 (C15, A+B), 72.1, 71.1 (C4, 
A+B), 47.3, 47.1 (C8, A+B), 42.4, 42.3 (C6, A+B), 38.6, 37.5 (C11, A+B), 37.0, 36.2 (C7, A+B), 
35.6, 31.0 (C3, A+B), 30.4, 29.9 (C1, A+B), 22.7, 22.1(C10, A+B), 19.2, 18.9 (C2, A+B); HRMS: 
(ESI+) calculated for C18H21NNaO3: 322.1414, found [M+H]
+: 322.1424. 
 
Methyl (E)-5-(N-(cyclopropylmethyl)acetamido)pent-2-enoate (450b) 
 
A flame-dried flask was charged with alkene 449 (0.30 g, 1.79 mmol) and methyl acrylate (0.46 
g, 5.38 mmol). Dry DCM (6 mL) and Hoveyda-Grubbs Catalyst™ 2nd Generation (0.05 g, 5 mol%) 
were added and the solution was stirred at r.t. for 18 h. A few drops of DMSO were added, the 
crude was concentrated in vacuo and the residue was purified by silica gel column chromatography 
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(20-50% EtOAc/petrol) to yield the title compound 450b (0.30 g, 73%, 1:1.79 mixture of rotamers 
A:B) as a brown oil; νmax / cm
-1: 3002 (w), 2951 (w), 1720 (s), 1634 (s) 1423 (s), 1273 (s), 1200 
(s), 1174 (s), 1021 (s); 1H NMR (CDCl3, 400 MHz): δ δ 6.92 (dt, J = 15.6, 7.2 Hz, 1H, C8-H, B), 
6.89 (dt, J = 15.7, 7.3 Hz, C8-H, 1H, A), 5.89 (dt, J = 15.7, 1.4 Hz, 1H, C9-H, A), 5.85 (dt, J = 
15.6, 1.5 Hz, C9-H, 1H, B), 3.73 (s, 3H, C11-H3, A), 3.71 (s, 3H, C11-H3, B), 3.53 – 3.46 (m, 4H, 
C6-H2, A+B), 3.25 (d, J = 6.9 Hz, 2H, C3-H2, A), 3.15 (d, J = 6.5 Hz, 2H, C3-H2, B), 2.52 – 2.47 
(m, 4H, C7-H2, A+B), 2.10 (s, 3H, C5-H3, B), 2.10 (s, 3H, C5-H3, B), 1.01 – 0.86 (m, 2H, C2-H, 
A+B), 0.62 – 0.56 (m, 2H, 2 × C1-HaHb, B), 0.53 – 0.48 (m, 2H, 2 × C1-HaHb, A), 0.25 – 0.19 (m, 
4H, 2 × C1-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 170.2 (C4, B), 170.2 (C4, A), 166.8 (C10, 
B), 166.4 (C10, A), 146.0 (C8, B), 144.3 (C8, A), 123.4 (C9, A), 122.5 (C9, B), 53.8 (C3, B), 51.6 
(C11, A), 51.5 (C11, B), 49.6 (C3, A), 47.1 (C6, A), 45.0 (C6, B), 31.8 (C7, A), 30.7 (C7, B), 21.8 
(C5, B), 21.6 (C5, A), 10.5 (C2, B), 9.8 (C2, A), 3.8 (C1, B), 3.8 (C1, A); HRMS: (ESI+) calculated 
for C12H19NNaO3: 248.1257, found [M+Na]
+: 248.1263. 
 
Methyl 2-(1-acetyl-6-oxo-1-azaspiro[4.4]nonan-4-yl)acetate (451b) 
 
General procedure N: Compound 450b (33.8 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%), and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) and Mg(OTf)2 (4.8 mg, 
0.015 mmol, 10 mol%) were employed and the reaction was stirred for 24 h at 110 °C. The crude 
mixture was purified by silica gel column chromatography (40% EtOAc/ n-pentane) to yield the 
title compound 451b (20.0 mg, 53%, 1:3.6 mixture of diastereomers A:B) as a brown oil; νmax / 
cm-1: 2954 (w), 1736 (s), 1627 (s), 1418 (s), 1203 (s), 1168 (s), 1145 (s); 1H NMR (CDCl3, 400 
MHz): δ 3.65 (s, 3H, C13-H3, B), 3.63 (s, 3H, C13-H3, A), 3.62 – 3.31 (m, 4H, C8-H2, A+B), 2.81 
(dt, J = 18.7, 10.6 Hz, 1H, C1-HaHb, B), 2.70 – 2.47 (m, 4H, C1-HaHb and C11-HaHb, A; C6-H, 
A+B), 2.42 (dd, J = 15.8, 6.0 Hz, 1H, C11-HaHb, B), 2.35 (dd, J = 15.7, 9.2 Hz, 1H, C11-HaHb, B), 
2.32 – 2.04 (m, 9H, C11-HaHb, A; C1-HaHb, C2-HaHb, C3-H2, A+B), 2.00 (s, 3H, C10-H3, A), 1.96 
(s, 3H, C10-H3, B), 1.92 – 1.49 (m, 6H, C2-HaHb and C7-H2, A+B); 
13C NMR (CDCl3, 101 MHz): 
δ 216.6 (C5, B), 215.6 (C5, A), 172.8 (C12, A), 171.6 (C12, B), 168.2 (C10, A), 167.9 (C10, B), 
71.8 (C4, A), 70.9 (C4, B), 51.8 (C13, B), 51.7 (C13, A), 47.1 (C8, B), 46.9 (C8, A), 43.5 (C6, A), 
Chapter 8 – Experimental 
266 
42.8 (C6, B), 37.0 (C1, A), 36.2 (C1, B), 35.3 (C3, A), 34.1 (C11, A), 33.1 (C11, B), 30.7 (C7, A), 
30.4 (C7, B), 29.7 (C3, B), 22.7 (C10, A), 22.1 (C10, B), 18.9 (C2, B), 18.8 (C2, A); HRMS: (ESI+) 
calculated for C13H20NO4: 254.1387, found [M+H]
+: 254.1388. 
 
But-3-yn-1-yl 4-methylbenzenesulfonate (453') 
 
To a solution of 3-butyn-1-ol (3.00 g, 42.80 mmol) and Et3N (5.97 mL, 42.80 mmol) in DCM (40 
mL) was added tosyl chloride (7.42 g, 38.91 mmol) and the reaction was stirred for 18 h at r.t. 
Water (80 mL) was added and the solution was extracted with DCM (3 × 40 mL). The organic 
extracts were combined, dried over MgSO4 and concentrated in vacuo to provide the title 
compound 453' (8.35 g, 87%) as a colourless oil; 1H NMR (CDCl3, 400 MHz): δ 7.84-7.80 (m, 
2H, 2 × C6-H), 7.39-7.35 (m, 2H, 2 × C7-H), 4.11 (t, 2H, J = 7.0 Hz, C4-H2), 2.57 (td, J = 7.0, 2.5 
Hz, 2H, C3-H2), 2.47 (s, 3H, C9-H3), 1.98 (t, J = 2.5 Hz, 1H, C1-H); 
13C NMR (CDCl3, 101 MHz): 
δ 145.0 (C8), 132.8 (C5), 129.9 (C7), 128.0 (C6), 78.3 (C2), 70.7 (C1), 67.4 (C4), 21.6 (C9), 19.4 





To a sealed tube containing 453' (2.24 g, 10.00 mmol) in MeCN (15 mL) was added a 
cyclopropylmethylamine (3.47 mL, 40.00 mmol). The tube was sealed and the reaction was heated 
to 90 °C for 18 h. The reaction mixture was cooled to r.t., trifluoroacetic acid (1.15 mL, 15.00 
mmol) was added and then the solution was concentrated in vacuo. The residue was dissolved in 
DCM (50 mL) and washed with sat. aq. NaHCO3 (100 mL). The aqueous portion was extracted 
with DCM (3 × 30 mL). The organic extracts were combined, washed with brine (40 mL), dried 
over MgSO4 and concentrated in vacuo to yield the secondary amine intermediate.  
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To a stirring solution of secondary amine in dry DCM (30 mL), TEA (11.15 mL, 80.00 mmol) and 
acetic anhydride (3.77 mL, 40.00 mmol) were added at 0 °C under nitrogen. The solution was 
warmed to r.t. and stirred for 16 h. Sat. aq. NaHCO3 (30 mL) was added and the aqueous layer was 
extracted with DCM (3 × 20 mL). The combined organic extracts were washed with brine (20 
mL), dried over MgSO4 and concentrated in vacuo. The crude mixture was purified by silica gel 
column chromatography (20-40% EtOAc/pentane) to yield the title compound 453 (0.75 mg, 46% 
over two steps, 1:1.4 mixture of rotamers A:B) as a pale yellow oil; νmax / cm
-1: 3296 (m), 3237 
(m), 3003 (m), 1634 (s), 1421 (s), 1250 (m), 1011 (m); 1H NMR (CDCl3, 400 MHz): δ 3.57 (t, J = 
7.1 Hz, 4H, C6-H2, A+B), 3.30-3.24 (m, 4H, C3-H2, A+B), 2.52-2.44 (m, 4H, C7-H2, A+B), 2.16 
(s, 3H, C5-H3, A), 2.11 (s, 3H, C5-H3, B), 2.03 (t, J = 3.2 Hz, 1H, C9-H, A), 1.95 (t, J = 2.7 Hz, 
1H, C9-H, B), 1.03-0.88 (m, 2H, C2-H, A+B), 0.63-0.56 (m, 2H, 2 × C1-HaHb, B), 0.54-0.48 (m, 
2H, 2 × C1-HaHb, A), 0.29-0.20 (m, 4H, 2 × C1-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 
170.3, 170.3 (C4, A+B), 82.2, 80.5 (C8, A+B), 70.7 (C9, A), 69.4 (C9, B), 54.0 (C3, B), 49.3 (C3, 
A), 46.9 (C6, A), 45.1 (C6, B), 21.7(C5, A+B), 18.8 (C7, A), 17.6 (C7, B), 10.5 (C2, B), 9.7 (C2, 






To a solution of 453 (1.00 g, 6.05 mmol) in dry THF (1 M) was added n-BuLi (3.47 mL, 5.55 
mmol, 1.6 M in hexanes) dropwise over 5 minutes at 0 °C and the reaction was stirred at this 
temperature for 30 min. Then, benzaldehyde (0.51 mL, 5.04 mmol) was added dropwise over 5 
minutes and the reaction mixture was warmed to r.t. and stirred for 2 h. Sat. aq. NH4Cl (100 mL) 
was added and the solution was extracted with EtOAc (3 × 50 mL). The organic extracts were 
combined, washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo. The residue 
was purified by flash column chromatography (20-40% EtOAc/petrol) to afford the title compound 
454 (580 mg, 42%, 1:1.5 mixture of rotamers A:B) as an orange oil; νmax / cm
-1: 3335 (br. m), 1618 
(s), 1450 (s), 1421 (s), 1131 (m), 1261 (s), 1011 (s); 1H NMR (CDCl3, 400 MHz): δ 7.53-7.48 (m, 
4H, 2 × C13-H, A+B), 7.41-7.29 (m, 6H, 2 × C12-H and C14-H, A+B), 5.45 (br. s, 1H, C10-H, 
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A), 5.43 (s, 1H, C10-H, B), 3.58 (t, J = 7.3 Hz, 2H, C6-H2, B), 3.57 (t, J = 7.8 Hz, 2H, C6-H2, A), 
3.27 (d, J = 6.9 Hz, 2H, C3-H2, A), 3.19 (d, J = 6.6 Hz, 2H, C3-H2, B), 2.59-2.54 (m, 4H, C7-H2, 
A+B), 2.12 (s, 3H, C5-H3, A), 2.09 (s, 3H, C5-H3, B), 1.03-0.84 (m, 2H, C2-H, A+B), 0.61-0.53 
(m, 2H, C1-HaHb, B), 0.54-0.46 (m, 2H, C1-HaHb, A), 0.26-0.16 (m, 4H, 2 × C1-HaHb, A+B); 
13C 
NMR (CDCl3, 101 MHz): δ 170.7 (C4, A), 170.6 (C4, B), 141.3 (C11, B), 141.0 (C11, A), 128.6 
(C13, A), 128.5 (C13, B), 128.2 (C14, A), 128.1 (C14, B), 126.5 (C12, B), 126.5 (C12, A), 84.6 
(C8, B), 82.9 (C8, A), 82.7 (C9, A), 81.6 (C9, B), 64.5 (C10, A+B), 53.8 (C3, B), 49.4 (C3, A), 46.9 
(C6, A), 45.0 (C6, B), 21.7 (C5, A+B), 19.2 (C7, A), 18.0 (C7, B), 10.4 (C2, B), 9.7 (C2, A), 3.7 





To a stirring solution of 454 (0.20 g, 0.47 mmol) in DCM (10 mL), a spatula of celite and 
pyridinium dichromate (0.42 g, 1.11 mmol, 1.50 eq) were added and the mixture was stirred at r.t. 
for 2 h. The reaction was filtered through a pad of celite, a filtrate was evaporated to dryness in 
vacuo and purified by flash column chromatography (40% EtOAc/petrol) to afford the title 
compound 455 (156 mg, 78%, 1:2.94 mixture of rotamers A:B) as a yellow oil; νmax / cm
-1: 3004 
(br. w), 2235 (m), 1637 (s), 1597 (m), 1449 (m), 1419 (m), 1262 (S); 1H NMR (CDCl3, 400 MHz): 
δ 8.14 – 8.07 (m, 4H, 2 × C12-H, A+B), 7.64 – 7.57 (m, 2H, C14-H, A+B), 7.52 – 7.44 (m, 4H, 2 
× C13-H, A+B), 3.74 – 3.66 (m, 4H, C6-H2, A+B), 3.33 (d, J = 6.9 Hz, 2H, C3-H2, A), 3.28 (d, J 
= 6.6 Hz, 2H, C3-H2, B), 2.83 (t, J = 7.1 Hz, 2H, C7-H2, B), 2.80 (t, J = 7.2 Hz, 2H, C7-H2, A), 
2.19 (s, 3H, C5-H3, A), 2.14 (s, 3H, C5-H3, B), 1.03 – 0.85 (m, 2H, C2-H, A+B), 0.66 – 0.57 (m, 
2H, C1-HaHb, B), 0.56 – 0.51 (m, 2H, C1-HaHb, A), 0.30 – 0.23 (m, 4H, 2 × C1-HaHb, A+B); 
13C 
NMR (CDCl3, 101 MHz): δ 178.0 (C10, B), 177.7 (C10, A), 170.5 (C4, B), 170.3 (C4, A), 136.7 
(C11, B), 136.4 (C11, A), 134.3 (C14, A), 134.0 (C14, B), 129.6, 129.5, 128.6, 128.5 (C12 and 
C13, A+B), 93.7 (C8, B), 91.4 (C8, A), 81.1 (C9, A), 80.4 (C9, B), 54.2 (C3, B), 49.5 (C3, A), 46.4 
(C6, A), 44.6 (C6, B), 21.7 (C5, B), 21.7 (C5, A), 19.7 (C7, A), 18.4 (C7, B), 10.5 (C2, B), 9.8 (C2, 








To a stirring solution of cyclopropylmethylamine (7.00 mL, 80.00 mmol) in dry acetonitrile (40 
mL) was added ethyl bromoacetate (2.21 mL, 20.00 mmol) at 0 °C under nitrogen. The solution 
was warmed to r.t. and stirred for 1 h. The reaction mixture was concentrated in vacuo and the 
residue was dissolved in DCM (40 mL). 3.0 M aq. NaOH solution (15 mL) was added and the 
aqueous portion was extracted with DCM (3 × 30 mL). The organic extracts were combined, dried 
over MgSO4 and concentrated in vacuo until the concentration was reduced to ca. 2 mL/mmol.  
To the resulting solution of secondary amine in DCM, TEA (5.58 mL, 40.00 mmol) and acetic 
anhydride (3.77 mL, 40.00 mmol) were added at 0 °C under nitrogen. The solution was warmed 
to r.t. and stirred for 16 h. Water (50 mL) was added and the aqueous layer was extracted with 
DCM (3 × 20 mL). The combined organic extracts were washed with brine (30 mL), dried over 
MgSO4 and concentrated in vacuo. The crude mixture was purified by silica gel column 
chromatography (20-50% EtOAc/petrol) to yield the title compound 457 (3.94 g, quantitative over 
2 steps, 1:2.4 mixture of rotamers A:B) as a colourless oil; νmax / cm
-1: 2984 (br. m), 1745 (s), 1646 
(s), 1425 (s), 1258 (m), 1190 (s), 1023 (s); 1H NMR (CDCl3, 400 MHz): δ 4.25-4.10 (m, 8H, C6-
H2 and C8-H2, A+B), 3.31 (d, J = 7.0 Hz, 2H, C3-H2, A), 3.26 (d, J = 6.7 Hz, 2H, C3-H2, B), 2.17 
(s, 3H, C5-H3, B), 2.06 (s, 3H, C5-H3, A), 1.31-1.24 (m, 6H, C9-H3, A+B), 0.98-0.84 (m, 2H, C2-
H, A+B), 0.62-0.54 (m, 2H, C1-HaHb, B), 0.52-0.45 (m, 2H, C1-HaHb, A), 0.21-0.16 (m, 4H, 2 × 
C1-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 170.9 (C4, A), 170.7 (C4, B), 169.5 (C7, B), 
169.4 (C7, A), 61.5 (C8, A), 61.0 (C8, B), 53.9 (C3, B), 50.8 (C3, A), 50.2 (C6, A), 46.9 (C6, B), 
21.6 (C5, A), 21.3 (C5, B), 14.2 (C9, A+B), 9.9 (C2, B), 9.2 (C2, A), 3.6 (C1, B), 3.5 (C1, A); 
HRMS: (ESI+) calculated for C10H18NO3: 200.1281, found [M+H]
+: 200.1282. 
  




To a suspension of N,O-dimethylhydroxylamine hydrochloride (1.96 g, 20.01 mmol) in 40 mL of 
dry DCM, Me2AlCl (1 M in hexanes, 20 mL) was added at 0 °C. The mixture was warmed to r.t. 
and stirred for 1 h. Then, a solution of ester 457 in 10 mL of dry DCM was added dropwise and 
the reaction was stirred at r.t. for 16 h. The solution was cooled to 0 °C, sat. aq. NaHCO3 (50 mL) 
was added dropwise and the crude was filtered through Celite®. The filtrate was extracted with 
DCM (3 × 50 mL). The organic extracts were combined, washed with brine (50 mL), dried over 
MgSO4 and concentrated in vacuo to afford the title compound 458 (1.49 g, 83%, 3:1 mixture of 
rotamers A:B) as a colourless oil which was used without further purification; νmax / cm
-1: 3496 
(br. w), 3001 (br. m), 2940 (br. m), 1641 (s), 1423 (s), 1388 (s), 988 (s); 1H NMR (CDCl3, 400 
MHz): δ 4.36 (s, 2H, C6-H2, A), 4.29 (s, 2H, C6-H2, B), 3.74 (s, 2H, C9-H2, A), 3.71 (s, 2H, C9-
H2, B), 3.30 – 3.24 (m, 4H, C3-H2, A+B), 3.19 (s, 2H, C8-H2, B), 3.15 (s, 2H, C8-H2, A), 2.15 (s, 
2H, C5-H2, A), 2.01 (s, 2H, C5-H2, B), 0.97 – 0.84 (m, 2H, C2-H, A+B), 0.58 – 0.52 (m, 2H, 2 × 
C1-HaHb, A), 0.49 – 0.43 (m, 2H, 2 × C1-HaHb, B), 0.19 – 0.13 (m, 4H, 2 × C1-HaHb, A+B); 
13C 
NMR (CDCl3, 101 MHz): δ 171.4 (C4, B), 171.0 (C4, A), 169.7 (br. s, C7, A+B), 61.5 (C9, B), 
61.3 (C9, A), 53.9 (C3, A), 50.7 (C3, B), 48.9 (C6, B), 45.7 (C6, A), 32.6 (C8, B), 32.3 (C8, A), 
21.6 (C5, B), 21.4 (C5, A), 9.9 (C2, A), 9.3 (C2, B), 3.6 (C1, A), 3.5 (C1, B); HRMS: (ESI+) 





Vinylmagnesium bromide (13.8 mL, 1.0 M in THF, 3.0 eq) was added dropwise to a solution of 
Weinreb amide 458 (984 mg, 4.59 mmol) in dry THF (25 mL) at -78 °C. The reaction was stirred 
at this temperature for 2.5 h (monitored by TLC, 8:2 EtOAc:petrol) and then poured into an ice-
cold sat. aq. NH4Cl. The mixture was extracted with Et2O (3 × 20 mL). The organic extracts were 
combined, washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo. The crude 
Chapter 8 – Experimental 
271 
mixture was purified by silica gel column chromatography (50% EtOAc/petrol) to yield the title 
compound 459a (66 mg, 8%, 1:3.7 mixture of rotamers A:B) as a colourless oil; νmax / cm
-1: 3457 
(br. w), 3003 (br. w), 2926 (br. w), 1697 (s), 1643 (s), 1427 (s), 988 (m); 1H NMR (CDCl3, 400 
MHz): δ 6.51 – 6.27 (m, 4H, C9-H2,cis and C8-H, A+B), 5.92 (dd, J = 10.4, 1.2 Hz, 1H, C9-H2,trans, 
A), 5.84 (dd, J = 10.3, 1.4 Hz, 1H, C9-H2,trans, B), 4.47 (s, 2H, C6-H2, B), 4.38 (s, 2H, C6-H2, A), 
3.27 (d, J = 7.0 Hz, 2H, C3-H2, A), 3.22 (d, J = 6.7 Hz, 2H, C3-H2, B), 2.17 (s, 3H, C5-H3, B), 1.95 
(s, 3H, C5-H3, A), 0.95 – 0.79 (m, 2H, C2-H, A+B), 0.59 – 0.42 (m, 4H, 2 × C1-HaHb, A+B), 0.17 
– 0.10 (m, 4H, 2 × C1-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 195.0 (C7, B), 194.6 (C7, A), 
171.0 (C4, A), 170.6 (C4, B), 133.8 (C8, B), 133.1 (C8, A), 129.9 (C9, A), 129.0 (C9, B), 55.8 (C6, 
A), 53.9 (C3, B), 52.6 (C6, B), 50.9 (C3, A), 21.5 (C5, A), 21.3 (C5, B), 9.9 (C2, B), 9.3 (C2, A), 





1-Propenylmagnesium bromide (5.6 mL, 0.5 M in THF, 2.0 eq) was added dropwise to a solution 
of Weinreb amide 458 (300 mg, 1.4 mmol) in dry THF (2 mL) at -78 °C. The reaction was stirred 
at this temperature for 2.5 h (monitored by TLC, 8:2 EtOAc:petrol) and then poured into an ice-
cold sat. aq. NH4Cl. The mixture was extracted with Et2O (3 × 20 mL). The organic extracts were 
combined, washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo. The crude 
mixture was purified by silica gel column chromatography (30-50% EtOAc/petrol) to yield the 
title compound 459b (57 mg, 21%, 1:2.9 mixture of rotamers A:B) as a yellow oil; νmax / cm
-1: 
3003 (br. w), 2934 (br. w), 1684 (s), 1634 (s), 1428 (s), 1207 (s); 1H NMR (CDCl3, 400 MHz): δ 
6.91 – 6.75 (m, 2H, C9-H, A+B), 6.09 (dq, J = 15.8, 1.7 Hz, C8-H, A), 6.03 (dq, J = 15.8, 1.7 Hz, 
1H, C8-H, B), 4.28 (s, 2H, C6-H2, B), 4.18 (s, 2H, C6-H2, A), 3.13 (d, J = 7.0 Hz, 2H, C3-H2, A), 
3.08 (d, J = 6.7 Hz, 2H, C3-H2, B), 2.03 (s, 3H, C5-H3, B), 1.81 (s, 3H, C5-H3, A), 1.81 – 1.79 (dd, 
J = 7.0, 1.7 Hz, 3H, C10-H3, A), 1.76 (dd, J = 6.9, 1.7 Hz, 3H, C10-H3, B), 0.74 (m, 2H, C2-H, 
A+B), 0.43 – 0.37 (m, 2H, 2 × C1-HaHb, B), 0.34 – 0.28 (m, 2H, 2 × C1-HaHb, A), 0.03 – -0.03 (m, 
4H, 2 × C1-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 194.5 (C7, B), 194.0 (C7, A), 171.1 (C4, 
A), 170.6 (C4, B), 144.8 (C9, A), 143.6 (C9, B), 129.0 (C8, B), 128.2 (C8, A), 56.0 (C6, A), 53.8 
(C3, B), 52.6 (C6, B), 50.9 (C3, A), 21.5 (C5, A), 21.3 (C5, B), 18.5 (C10, B), 18.4 (C10, A), 9.9 
(C2, B), 9.3 (C2, A), 3.6 (C1, B), 3.5 (C1, A); HRMS: (ESI+) calculated for C11H17NNaO2: 
218.1151, found [M+Na]+: 218.1162. 




Styrylmagnesium bromide (5.6 mL, 0.55 M in THF, 2.0 eq, freshly prepared from β-
bromostyrene27) was added dropwise to a solution of Weinreb amide 458 (300 mg, 1.4 mmol) in 
dry THF (2 mL) at -78 °C. The reaction was stirred at this temperature for 2.5 h (monitored by 
TLC, 8:2 EtOAc:petrol) and then poured into an ice-cold sat. aq. NH4Cl. The mixture was 
extracted with Et2O (3 × 20 mL). The organic extracts were combined, washed with brine (50 mL), 
dried over MgSO4 and concentrated in vacuo. The crude mixture was purified by silica gel column 
chromatography (20-40% EtOAc/petrol) to yield the title compound 459c (53 mg, 22%, 1:3.0 
mixture of rotamers A:B) as a yellow oil; νmax / cm
-1: 3003 (w), 2925 (w), 1639 (s), 1612 (s), 1449 
(m), 1426 (m), 1188 (m); 1H NMR (CDCl3, 400 MHz): δ 7.70 (d, J = 16.1 Hz, 1H, C9-H, A), 7.64 
(d, J = 16.2 Hz, 1H, C9-H, B), 7.58 – 7.51 (m, 4H, 2 × C11, A+B), 7.43 – 7.36 (m, 6H, C13 and 2 
× C12, A+B), 6.84 (d, J = 16.1 Hz, 1H, C8-H, A), 6.78 (d, J = 16.2 Hz, 1H, C8-H, B), 4.54 (s, 2H, 
C6-H2, B), 4.43 (s, 2H, C6-H2, A), 3.33 (d, J = 6.9 Hz, 2H, C3-H2, A), 3.27 (d, J = 6.7 Hz, 2H, C3-
H2, B), 2.20 (s, 3H, C5-H3, B), 2.01 (s, 3H, C5-H3, A), 0.96 – 0.85 (m, 2H, C2-H, A+B), 0.60 – 
0.53 (m, 2H, 2 × C1-HaHb, B), 0.51 – 0.45 (m, 2H, 2 × C1-HaHb, A), 0.20 – 0.15 (m, 4H, 2 × C1-
HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 194.8 (C7, B), 194.4 (C7, A), 171.1 (C4, A), 170.7 
(C4, B), 144.4 (C9, A), 143.4 (C9, B), 134.3 (C10, B), 133.9 (C10, A), 131.16 (C13, A), 130.7 
(C13, B), 129.1 (C12, A), 128.9 (C12, B), 128.5 (C11, A), 128.4 (C11, B), 123.2 (C8, B), 121.8 
(C8, A), 56.8 (C6, A), 53.9 (C3, B), 53.4 (C6, B), 51.0 (C3, A), 21.6 (C5, A), 21.3 (C5, B), 10.0 
(C2, B), 9.4 (C2, A), 3.7 (C1, B), 3.6 (C1, A); HRMS: (ESI+) calculated for C16H20NO2: 258.1489, 
found [M+H]+: 258.1493. 
  




General procedure P: Acetanilide (1.88 g, 13.91 mmol) was employed. Flash column 
chromatography (10-20% EtOAc/petrol) afforded the title compound 462a (2.40 g, 91%) as a pale 
pink solid; m.p. 44-45 °C (EtOAc/hexane); νmax / cm
-1: 3005 (br. w), 1654 (s), 1595 (s), 1496 (s), 
1396 (s), 1290 (s); 1H NMR (CDCl3, 400 MHz): δ 7.45 – 7.31 (m, 3H, C9-H and 2 × C8-H), 7.24 
– 7.19 (m, 2H, 2 × C7-H), 3.57 (d, J = 7.2 Hz, 2H, C3-H2), 1.83 (s, 3H, C5-H3), 1.01 – 0.87 (m, 
1H, C2-H), 0.45 – 0.38 (m, 2H, C1-HaHb), 0.14 – 0.08 (m, 2H, C1-HaHb); 
13C NMR (CDCl3, 101 
MHz): δ 170.2 (C4), 143.3 (C6), 129.5 (C8), 128.4 (C7), 127.8 (C9), 53.2 (C3), 22.8 (C5), 9.9 





General procedure N: Compound 462a (28.4 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 24 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (30% EtOAc/petrol) to yield the title compound 463a (27.7 mg, 85%) as an off-
white solid; m.p. 77-78 °C (DCM/hexane); νmax / cm
-1: 2965 (br. w), 1746 (s), 1652 (s), 1595 (s), 
1493 (s), 1399 (s), 1328 (s), 1257 (s); 1H NMR (CDCl3, 400 MHz): δ 7.42 – 7.30 (m, 3H, C11-H 
and 2 × C10-H), 7.26 – 7.22 (m, 2H, 2 × C9-H), 4.20 – 4.12 (m, 1H, C4-H), 2.42 – 2.01 (m, 5H, 
C2-HaHb, C3-H2 and C1-H2), 1.82 (s, 3H, C7-H3), 1.78 – 1.64 (m, 1H, C2-HaHb); 
13C NMR 
(CDCl3, 101 MHz): δ 213.4 (C5), 170.0 (C6), 142.6 (C8), 129.8 (C10), 128.5 (C9), 128.3 (C11), 
66.3 (C4), 35.9, 26.7 (C1 and C3), 22.5 (C7), 18.9 (C2); HRMS: (ESI+) calculated for 








General procedure P: N-(3,5-Dimethylphenyl)acetamide (1.25 g, 7.66 mmol, prepared according 
to the literature procedure293 from 3,5-dimethylaniline) was employed. Flash column 
chromatography (15-20% EtOAc/petrol) afforded the title compound 462b (1.29 g, 78% over two 
steps) as a pale yellow oil; νmax / cm
-1: 3004 (br. w), 2919 (br. w), 1657 (s), 1595 (s), 1378 (s), 
1305 (s); 1H NMR (CDCl3, 400 MHz): δ 6.96 (s, 1H, C9-H), 6.82 (br. s, 2H, 2 × C7-H), 3.53 (d, 
J = 7.1 Hz, 2H, C3-H2), 2.39 – 2.26 (m, 6H, 2 × C10-H3), 1.83 (s, 3H, C5-H3), 1.02 – 0.87 (m, 1H, 
C2-H), 0.45 – 0.37 (m, 2H, C1-HaHb), 0.16 – 0.11 (m, 2H, C1-HaHb); 
13C NMR (CDCl3, 101 
MHz): δ 170.2 (C4), 143.2 (C6), 139.1 (C8), 129.3 (C9), 125.9 (C7), 53.2 (C3), 22.7 (C5), 21.2 





General procedure N: Compound 462b (32.6 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 24 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (30% EtOAc/petrol) to yield the title compound 463b (26.9 mg, 73%) as a pale 
yellow oil; νmax / cm
-1: 2964 (br. w), 2919 (w), 1747 (s), 1657 (s), 1596 (s), 1398 (s), 1327 (s); 1H 
NMR (CDCl3, 400 MHz): δ 6.97 (br. s, 1H, C11-H), 6.86 (br. s, 2H, 2 × C9-H), 4.05 (t, J = 10.0 
Hz, 1H, C4-H), 2.41 (ddd, J = 18.5, 11.8, 9.2 Hz, 1H, C1-HaHb), 2.32 (s, 6H, 2 × C12-H3), 2.30 – 
2.19 (m, 3H, C1-HaHb and C3-H2), 2.14 – 2.04 (m, 1H, C2-HaHb), 1.84 (s, 3H, C7-H3), 1.78 – 1.63 
(m, 1H, C2-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 213.5 (C5), 169.9 (C6), 142.7 (C8), 139.6 
(C10), 129.8 (C11), 125.8 (C9), 66.5 (C4), 35.9 (C1), 26.8 (C3), 22.4 (C7), 21.1 (C12), 19.0 (C2); 
HRMS: (ESI+) calculated for C15H20NO2: 246.1489, found [M+H]
+: 246.1498. 





General procedure P: N-(Benzo[d][1,3]dioxol-5-yl)acetamide (1.00 g, 5.58 mmol, prepared 
according to the literature procedure294 from 3,4-(methylenedioxy)aniline) was employed. Flash 
column chromatography (40% EtOAc/petrol) afforded the title compound 462c (1.06 g, 79% over 
two steps) as a pale brown solid; m.p. 71-72 °C (DCM/hexane); νmax / cm
-1: 2908 (br. w), 1655 
(s), 1485 (s), 1214 (s), 1034 (s); 1H NMR (CDCl3, 400 MHz): δ 6.82 – 6.78 (m, 1H, C7-H), 6.70 
– 6.66 (m, 2H, C8-H and C12-H), 6.02 (s, 2H, C10-H2), 3.51 (d, J = 7.2 Hz, 2H, C3-H2), 1.85 (s, 
3H, C5-H3), 0.99 – 0.88 (m, 1H, C2-H), 0.46 – 0.38 (m, 2H, C1-HaHb), 0.16 – 0.10 (m, 2H, C1-
HaHb); 
13C NMR (CDCl3, 101 MHz): δ 170.5 (C4), 148.2 (C11), 147.0 (C9), 137.1 (C6), 121.8 
(C12), 109.2 (C8), 108.4 (C7), 101.7 (C10), 53.3 (C3), 22.6 (C5), 9.9 (C2), 3.7 (C1); HRMS: 





General procedure N: Compound 462c (35.0 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 18 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (30-40% EtOAc/hexane) to yield the title compound 463c (21.3 mg, 54%) as a 
pale yellow oil; νmax / cm
-1: 2965 (br. w), 2906 (br. w), 1745 (s), 1655 (s), 1484 (s), 1215 (s), 1034 
(s); 1H NMR (CDCl3, 400 MHz): δ 6.78 (dd, J = 7.9, 0.6 Hz, 1H, C9-H), 6.74 – 6.69 (m, 2H, C10-
H and C14-H), 6.00 (s, 2H, C12-H2), 4.23 (t, J = 9.6 Hz, 1H, C4-H), 2.39 – 2.01 (m, 5H, C1-H2, 
C3-H2, C2-HaHb), 1.86 (s, 3H, C7-H3), 1.81 – 1.66 (m, 1H, C2-HaHb); 
13C NMR (CDCl3, 101 
MHz): δ 213.5 (C5), 170.4 (C6), 148.3, 147.4 (C11 and C13), 136.2 (C8), 122.1 (C9), 109.4 (C10), 
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108.5 (C14), 101.8 (C12), 66.1 (C4), 35.8 (C1), 26.6 (C3), 22.4 (C7), 18.9 (C2); HRMS: (ESI+) 





The secondary amine intermediate was prepared according to the general procedure O from 2-
bromonaphthalene (0.62 g, 3.00 mmol) and cyclopropylmethylamine (0.39 mL, 4.50 mmol). Flash 
column chromatography (2% EtOAc/petrol) afforded the secondary amine (0.51 g, 86%) as a pale 
yellow oil which was acylated according to the general procedure D using acetic anhydride (0.29 
mL, 3.10 mmol). Flash column chromatography (20% EtOAc/petrol) afforded the title compound 
462d (0.61 g, 98%) as a colourless oil; νmax / cm
-1: 3003 (br. w), 1653 (s), 1627 (s), 1597 (m), 1397 
(s), 1286 (s); 1H NMR (CDCl3, 400 MHz): δ 7.92 – 7.82 (m, 3H, Ar-CH), 7.70 (d, J = 2.1 Hz, 1H, 
Ar-CH), 7.57 – 7.51 (m, 2H, Ar-CH), 7.33 (dd, J = 8.6, 2.1 Hz, 1H, Ar-CH), 3.67 (d, J = 7.2 Hz, 
2H, C3-H2), 1.88 (s, 3H, C5-H3), 1.05 – 0.94 (m, 1H, C2-H), 0.46 – 0.39 (m, 2H, C1-HaHb), 0.16 
– 0.09 (m, 2H, C1-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 170.3 (C4), 140.7 (C6), 133.6 (C8), 
132.4, 129.5, 127.9, 127.8, 126.9, 126.8, 126.6, 126.4 (C7, C9, C10, C11, C12, C13, C14 and 
C15), 53.4 (C3), 22.9 (C5), 10.0 (C2), 3.7 (C1); HRMS: (ESI+) calculated for C16H17NNaO: 




General procedure N: Compound 462d (35.9 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 24 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (30% EtOAc/petrol) to yield the title compound 463d (26.1 mg, 65%) as a pale 
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brown oil; νmax / cm
-1: 2965 (br. w), 1747 (s), 1658 (s), 1629 (s), 1401 (m), 1326 (m); 1H NMR 
(CDCl3, 400 MHz): δ 7.91 – 7.82 (m, 3H, Ar-CH), 7.75 (d, J = 2.1 Hz, 1H, C17-H), 7.57 – 7.51 
(m, 2H, Ar-CH), 7.36 (dd, J = 8.6, 2.1 Hz, 1H, C9-H), 4.34 – 4.24 (m, 1H, C4-H), 2.44 – 2.18 (m, 
4H, C1-H2 and C3-H2), 2.14 – 2.03 (m, 1H, C2-HaHb), 1.88 (s, 3H, C7-H3), 1.82 – 1.68 (m, 1H, 
C2-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 213.5 (C5), 170.2 (C6), 139.9 (C8), 133.6, 132.6 (C11 
and C16), 129.9, 128.0, 127.7 (C10, C12 and C15), 127.1 (C17), 126.9, 126.9 (C13 and C14), 
126.4 (C9), 66.4 (C4), 35.9 (C1), 26.8 (C3), 22.7 (C7), 19.0 (C2); HRMS: (ESI+) calculated for 





Amide 469 (2.00 g, 10.57 mmol, prepared according to the literature procedure294 from 3,5-
dimethylaniline) was reduced according to the general procedure K. The resulting secondary 
amine was protected according to the general procedure D with pivaloyl chloride (1.56 mL, 12.68 
mmol) and the residue was purified by flash column chromatography (10% EtOAc/petrol) to 
afford the title compound 468 (2.18 g, 80% over two steps) as a pale yellow oil; νmax / cm
-1: 2997 
(br. w), 2958 (br. w), 2919 (br. w), 1636 (s), 1593 (s), 1480 (m), 1185 (s); 1H NMR (CDCl3, 400 
MHz): δ 6.95 – 6.93 (br. m, 1H, C10-H), 6.85 – 6.84 (br. m, 2H, 2 × C8-H), 3.46 (d, J = 7.1 Hz, 
2H, C3-H2), 2.36 – 2.26 (m, 6H, 2 × C11-H3), 1.03 (s, 9H, 2 × C6-H3), 1.01 – 0.94 (m, 1H, C2-
H), 0.43 – 0.36 (m, 2H, C1-HaHb), 0.12 – 0.06 (m, 2H, C1-HaHb);
13C NMR (CDCl3, 101 MHz): δ 
177.5 (C4), 143.6 (C7), 138.3 (C9), 129.1 (C10), 127.6 (C8), 56.9 (C3), 41.1 (C5), 29.6 (C6), 21.2 








Acetamide 471 (2.00 g, 12.58 mmol, prepared according to the literature procedure295 from aniline) 
was alkylated according to the general procedure P. Trifluoroacetyl group was removed under 
these reaction conditions. The resulting secondary amine (0.55 g, 3.74 mmol) was protected 
according to the general procedure D with trifluoroacetic anhydride (0.55 mL, 3.92 mmol) and 
the residue was purified by flash column chromatography (0-5% diethyl ether/petrol) to afford the 
title compound 470 (0.41 g, 13% over two steps) as a yellow oil; νmax / cm
-1: 3084 (br. w), 3010 
(br. w), 1691 (s), 1495 (m), 1194 (s), 1144 (s); 1H NMR (CDCl3, 400 MHz): δ 7.46 – 7.39 (m, 3H, 
C9-H, 2 × C8-H), 7.30 – 7.25 (m, 2H, 2 × C7-H), 3.63 (d, J = 7.3 Hz, 2H, C3-H2), 1.06 – 0.94 (m, 
1H, C2-H), 0.55 – 0.44 (m, 2H, C1-HaHb), 0.22 – 0.14 (m, 2H, C1-HaHb);
13C NMR (126 MHz, 
CDCl3): δ 156.71 (q, J = 35.3 Hz, C4), 139.2 (C6), 129.2 (C8), 129.0 (C7), 128.7 (C9), 116.48 (q, 
J = 288.5 Hz, C5), 56.1 (C3), 9.1 (C2), 3.7 (C1); 19F NMR (CDCl3, 376 MHz): -67.1(C5-F3); 





General procedure P: N-(3,5-Dimethoxyphenyl)acetamide (1.50 g, 7.68 mmol, prepared 
according to the literature procedure296 from 3,5-dimethoxyaniline) was employed. Flash column 
chromatography (20-30% EtOAc/pentane) afforded the title compound 474a (1.59 g, 83% over 
two steps) as a pale yellow oil; νmax / cm
-1: 3003 (br. w), 2937 (br. w), 1656 (s), 1589 (s), 1205 (s), 
1152 (s), 1061 (m); 1H NMR (CDCl3, 400 MHz): δ 6.44 (t, J = 2.3 Hz, 1H, C9-H), 6.37 (d, J = 2.3 
Hz, 2H, 2 × C7-H), 3.79 (s, 6H, 2 × C10-H3), 3.54 (d, J = 7.1 Hz, 2H, C3-H2), 1.89 (s, 3H, C5-
H3), 1.04 – 0.92 (m, 1H, C2-H), 0.47 – 0.40 (m, 2H, 2 × C1-HaHb), 0.18 – 0.12 (m, 2H, 2 × C1-
HaHb); 
13C NMR (CDCl3, 101 MHz): δ 170.1 (C4), 161.2 (C8), 145.1 (C6), 106.7 (C7), 99.6 (C9), 
55.5 (C10), 53.1 (C3), 22.6 (C5), 10.0 (C2), 3.7 (C1); HRMS: (ESI+) calculated for C14H20NO3: 
250.1438, found [M+H]+: 250.1444. 




General procedure N: Compound 474a (37.4 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 24 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (10% EtOAc/pentane) to yield the title compound 61a (34.2 mg, 88%) as a 
colourless solid; m.p. 183-184 °C (DCM/hexane); νmax / cm
-1: 2967 (m), 2928 (br. m), 1696 (s), 
1609 (s), 1583 (s), 1425 (s), 1379 (s), 1301 (s), 1287 (s), 1111 (s); 1H NMR (CDCl3, 400 MHz): δ 
7.69 (s, 1H, C8-H), 6.35 (s, 1H, C10-H), 3.85 (s, 3H, C14-H3 or C15-H3), 3.84 (s, 3H, C14-H3 or 
C15-H3), 3.06 – 2.99 (m, 2H, C3-H2), 2.90 – 2.83 (m, 2H, C1-H2), 2.53 (s, 3H, C13-H3), 2.51 – 
2.44 (m, 3H, C2-H2); 
13C NMR (CDCl3, 126 MHz,): δ 169.5 (C12), 158.6, 152.6 (C7 and C9), 
142.1 (C11), 138.2 (C4), 126.0 (C5), 111.2 (C6), 95.2 (C10), 94.4 (C8), 55.8, 55.5 (C14 and C15), 
30.1 (C3), 28.0 (C2), 25.5 (C1), 25.2 (C13); HRMS: (ESI+) calculated for C15H18NO3: 260.1281, 




General procedure P: 3-(3,5-Dimethoxyphenyl)-1,1-dimethylurea (0.30 g, 1.34 mmol, prepared 
according to the literature procedure297 from 3,5-dimethoxyaniline) was employed. Flash column 
chromatography (10-30% EtOAc/petrol) afforded the title compound 474b (0.22 g, 64% over two 
steps) as a pale brown oil; νmax / cm
-1: 2936 (br. m), 1648 (m), 1592 (s), 1376 (m), 1206 (s), 1153 
(m), 1063 (m); 1H NMR (CDCl3, 400 MHz): δ 6.24 – 6.19 (m, 3H, C9-H and 2 × C7-H), 3.76 (s, 
6H, 2 × C10-H3), 3.48 (d, J = 6.8 Hz, 2H, C3-H2), 2.72 (s, 6H, 2 × C5-H3), 1.18 – 1.06 (m, 1H, 
C2-H), 0.45 – 0.37 (m, 2H, 2 × C1-HaHb), 0.19 – 0.13 (m, 2H, 2 × C1-HaHb); 
13C NMR (CDCl3, 
101 MHz): δ 161.4 (C4), 161.2 (C8), 147.9 (C6), 102.8 (C7), 95.9 (C9), 56.3 (C3), 55.4 (C10), 
37.9 (C5), 10.8 (C2), 3.7 (C1); HRMS: (ESI+) calculated for C15H22N2NaO3: 301.1523, found 
[M+Na]+: 301.1526. 




General procedure N: Compound 474b (41.8 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 24 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (20% EtOAc/petrol) to yield the title compound 476b (32.3 mg, 75%) as a brown 
oil; νmax / cm
-1: 2940 (br. m), 1684 (s), 1611 (s), 1453 (s), 1388 (s), 1152 (s); 1H NMR (CDCl3, 
400 MHz): δ 6.59 (d, J = 2.0 Hz, 1H, C7-H), 6.25 (d, J = 2.0 Hz, 1H, C9-H), 3.86 (s, 3H, C13-
H3), 3.82 (s, 3H, C13'-H3), 3.04 (s, 6H, 2 × C12-H3), 2.90 – 2.82 (m, 4H, 2 × C2-H2), 2.50 – 2.42 
(m, 2H, C1-H2); 
13C NMR (CDCl3, 101 MHz): δ 157.4 (C6 or C8), 155.3 (C11), 153.2(C6 or C8), 
141.5 (C10), 140.8 (C3), 121.7 (C4), 110.8 (C5), 93.0, 90.4 (C7 and C9), 55.8 (C13), 55.5 (C13'), 
38.2 (C12), 28.3 (C1), 26.6 (C2), 25.7 (C2); HRMS: (ESI+) calculated for C16H21N2O3: 289.1547, 




To a solution of (3,5-dimethoxyphenyl)acetic acid (0.75 g, 3.82 mmol) in DCM (1 mL), stirring 
under a nitrogen atmosphere at room temperature, oxalyl chloride (0.40 mL, 4.59 mmol) and a 
drop of N,N-dimethylformamide were added. The reaction was stirred until gas effervescence 
stopped. DCM and an excess of oxalyl chloride were removed in vacuo and the resulting acyl 
chloride was adder dropwise to a mixture of cyclopropylmethylamine (0.40 mL, 4.59 mmol) and 
TEA (0.64 mL, 4.59 mmol) at 0 °C. The mixture was warmed to r.t. and stirred for 18 h. The 
mixture was diluted with water (30 mL) and extracted with DCM (3 × 20 mL). The organic extracts 
were combined, washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo. The 
residue was purified by recrystallisation (Et2O/DCM/hexane, 2 crops) to afford the title compound 
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477a (0.66 g, 69%) as a colourless solid; m.p. 93-94 °C (Et2O/DCM/hexane); νmax / cm
-1: 3295 
(br. s), 3008 (br. w), 2960 (br. w), 1640 (s), 1596 (s), 1548 (m), 1205 (s), 1151 (s); 1H NMR 
(CDCl3, 400 MHz): δ 6.42 – 6.37 (m, 3H, C11-H and 2 ×C8-H), 5.60 (br. s, 1H, N4-H), 3.78 (s, 
3H, C10-H3), 3.49 (s, 2H, C6-H2), 3.07 (dd, J = 6.3, 6.3 Hz, 1H, C3-H), 0.92 – 0.81 (m, 1H, C2-
H), 0.47 – 0.39 (m, 2H, 2 × C1-HaHb), 0.15 – 0.09 (m, 2H, 2 ×C1-HaHb); 
13C NMR (CDCl3, 101 
MHz): δ 170.5 (C5), 161.2 (C9), 137.2 (C7), 107.4 (C8), 99.3 (C11), 55.4, 55.3 (C10), 44.3 (C3), 






General procedure N: Compound 477a (37.4 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 18 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (40-50% EtOAc/hexane) to yield the title compound 479 (20.1 mg, 48%) as a 
pale yellow oil; νmax / cm
-1: 3285 (br. w), 2962 (br. w), 1747 (s), 1647 (s), 1595 (s), 1460 (s), 1204 
(s), 1150 (s); 1H NMR (CDCl3, 400 MHz): δ 6.43 – 6.41 (m, 2H, 2 × C10-H), 6.37 (t, J = 2.3 Hz, 
1H, C12-H), 5.92 (br. d, J = 6.0 Hz, 1H, N6-H), 4.08 (dddd, J = 12.4, 7.9, 6.2, 1.2 Hz, 1H, C4-H), 
3.78 (s, 6H, 2 × C13-H3), 3.53 (s, 2H, C8-H2), 2.62 – 2.52 (m, 1H, C3-HaHb), 2.42 – 2.32 (m, 1H, 
C2-HaHb), 2.22 – 2.09 (m, 1H, C2-HaHb), 2.08 – 1.98 (m, 1H, C1-HaHb), 1.83 (tddd, J = 13.0, 10.9, 
9.0, 6.2 Hz, 1H, C1-HaHb), 1.63 – 1.49 (m, 1H, C3-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 214.8 
(C5), 171.0 (C7), 161.2 (C11), 136.6 (C9), 107.3 (C10), 99.4 (C12), 58.1 (C4), 55.4 (C13), 43.7 
(C8), 34.9 (C2), 29.8 (C3), 18.1 (C1); HRMS: (ESI+) calculated for C15H20NO4: 278.1387, found 
[M+H]+: 278.1387. 
  




General procedure M: Cyclopropylmethylamine (1.00 g, 14.06 mmol), 3,5-
dimethoxybenzaldehyde (2.45 g, 14.76 mmol) and acetic anhydride (1.72 g, 16.87 mmol) were 
employed and the reaction was stirred at r.t. for 16 h. Flash column chromatography (40-50% 
EtOAc/petrol) afforded the title compound 477b (2.52 g, 68%, 1:1.11 mixture of rotamers A:B) as 
a pale yellow oil; νmax / cm
-1: 3001 (w), 2938 (br. w), 1641 (s), 1595 (s), 1420 (s), 1203 (s), 1153 
(s); 1H NMR (CDCl3, 400 MHz): δ 6.39 – 6.29 (m, 6H, C10-H and 2 × C8-H, A+B), 4.66 (s, 2H, 
C6-H2, A), 4.57 (s, 2H, C6-H2, B), 3.77 (s, 6H, 2 × C11-H3, B), 3.76 (s, 6H, 2 × C11-H3, A), 3.29 
(d, J = 7.0 Hz, 2H, C3-H2, B), 3.10 (d, J = 6.6 Hz, 2H, C3-H2, B), 2.20 (s, 3H, C5-H3, A), 2.11 (s, 
3H, C5-H3, B), 1.03 – 0.86 (m, 2H, C2-H, A+B), 0.58 – 0.51 (m, 2H, C1-HaHb, A), 0.49 – 0.43 (m, 
2H, C1-HaHb, B), 0.22 – 0.13 (m, 4H, C1-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 171.1 (C4, 
B), 170.4 (C4, A), 161.3 (C9, B), 160.9 (C9, A), 140.2 (C7, A), 139.8 (C7, B), 105.9 (C8, A), 104.2 
(C8, B), 99.0 (C10, B), 98.9 (C10, A), 55.4 (C11, B), 55.3 (C11, A), 51.9 (C3, A), 51.9 (C6, B), 
50.0 (C3, B), 48.0 (C6, A), 21.8 (C5, B), 21.7 (C5, A), 10.0 (C2, A), 9.6 (C2, B), 3.7 (C1, A), 3.6 





General procedure N: Compound 477b (39.5 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 24 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (20% EtOAc/petrol) to yield the title compound 478b (38.5 mg, 94%) as a brown 
oil; νmax / cm
-1: 2957 (br. w), 2939 (br. w), 1652 (m), 1604 (s), 1574 (s), 1199 (s), 1156 (s), 1070 
(s); 1H NMR (DMSO-d6, 500 MHz, 100 °C, all signals are very broad at r.t., heating to 100 °C 
caused the formation of trace amounts of isoquinoline 480: δ 6.49 (s, 1H, C9-H), 6.45 (s, 1H, C11-
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H), 4.63 (s, 2H, C7-H2), 3.76 (s, 3H, C14-H3), 3.75 (s, 3H, C14'-H3), 2.80 (dt, J = 14.0, 7.4 Hz, 
4H, 2 × C2-H2), 2.09 (s, 3H, C6-H3), 1.94 (p, J = 7.4 Hz, 2H, C1-H2); 
13C NMR (CDCl3, 101 MHz, 
some signals were elucidated by HMBC correlation): δ 169.3 (C5), 159.6 (C12), 156.1 (C10), 
134.9 (C4), 129.4 (C8), 126.1 (C3), 114.5 (C13), 102.7 (C9), 97.3 (C11), 55.4 (C14 and C14', 
broad), 47.0 (C7), 34.0 (C2), 32.1 (C2), 29.7 (C1), 23.7 (C6); HRMS: (ESI+) calculated for 





This compound was prepared using an adapted literature procedure.298 The solvent of the crude 
catalytic reaction mixture containing 478b (~0.15 mmol, not purified, obtained according to 
General procedure C) was taken off in vacuo. The residue was dissolved in 2 mL of 1,4-dioxane, 
2 ml of deionized water and 2 mL of conc. aq. HCl. The reaction was heated to reflux for 2 h and 
then concentrated in vacuo, Water (5 mL) and EtOAc (5 mL) were added, the layers were basified 
with K2CO3, separated and the aqueous portion was further extracted with EtOAc (2 × 5 mL). The 
organic extracts were combined, dried over MgSO4 and concentrated in vacuo. The residue was 
purified by flash column chromatography (1-5% MeOH/DCM) to afford the title compound 480 
(22.4 mg, 65%) as a brown oil; νmax / cm
-1: 2926 (br. m), 1626 (m), 1576 (s), 1453 (m), 1206 (m), 
1158 (s), 1049 (m); 1H NMR (CDCl3, 400 MHz): δ 8.84 (s, 1H, C6-H), 6.77 (d, J = 2.3 Hz, 1H, 
C10-H), 6.58 (d, J = 2.3 Hz, 1H, C12-H), 3.91 (s, 3H, C13-H3), 3.89 (s, 3H, C13’-H3), 3.47 (ddd, 
J = 7.8, 7.0, 1.1 Hz, 2H, C3-H2), 3.10 (t, J = 7.8 Hz, 2H, C1-H2), 2.16 (dt, J = 15.0, 7.8 Hz, 2H, 
C2-H2); 
13C NMR (CDCl3, 101 MHz): δ 158.0 (C9), 157.0 (C11), 156.2 (C4), 148.8 (C6), 129.7 
(C5), 129.4 (C8), 123.5 (C7), 101.8 (C12), 97.2 (C10), 55.5 (C13), 55.4 (C13'), 33.6 (C1), 32.8 









General procedure M: Cyclopropylmethylamine (1.22 mL, 14.06 mmol), piperonal (2.22 g, 
14.76 mmol) and acetic anhydride (1.59 mL, 16.87 mmol) were employed and the reaction was 
stirred at r.t. for 18 h. Flash column chromatography (10-40% EtOAc/petrol) afforded the title 
compound 481 (3.05 g, 88%, 1:1.13 mixture of rotamers A:B) as a colourless oil; νmax / cm
-1: 3002 
(br. m), 2899 (br. m), 1638 (s), 1489 (s), 1440 (s), 1422 (s), 1238 (s), 1036 (s); 1H NMR (CDCl3, 
400 MHz): δ 6.79 – 6.59 (m, 6H, C8-H, C11-H and C12-H, A+B), 5.94 (s, 2H, C13-H2, A), 5.91 
(s, 2H, C13-H2, B), 4.61 (s, 2H, C6-H2, B), 4.53 (s, 2H, C6-H2, A), 3.25 (d, J = 6.9 Hz, 2H, C3-H2, 
A), 3.08 (d, J = 6.6 Hz, 2H, C3-H2, B), 2.18 (s, 3H, C5-H3, B), 2.11 (s, 3H, C5-H3, A), 1.01 – 0.83 
(m, 2H, C2-H, A+B), 0.58 – 0.49 (m, 2H, C1-HaHb, B), 0.49 – 0.41 (m, 2H, C1-HaHb, A), 0.20 – 
0.11 (m, 4H, C1-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 170.9 (C4, A), 170.4 (C4, B), 148.2, 
147.9, 147.0, 146.7 (C9 and C10, A+B), 131.7 (C7, B), 130.9 (C7, A), 121.1, 119.4, 108.5, 108.4, 
108.0, 106.7 (C8, C11 and C12, A+B), 101.2 (C13, A), 100.9 (C13, B), 51.7 (C3, B), 51.6 (C6, A), 
49.6 (C3, A), 47.7 (C6, B), 21.8 (C5, A), 21.7 (C5, B), 10.0 (C2, B), 9.6 (C2, A), 3.8 (C1, B), 3.6 





General procedure N: Compound 481 (37.1 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 18 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (30-50% EtOAc/petrol) to yield the title compound 483 (31.4 mg, 76%) as a pale 
brown oil; νmax / cm
-1: 2966 (br. m), 2883 (br. m), 1743 (s), 1637 (s), 1490 (s), 1437 (s), 1248 (s), 
1236 (s), 1034 (s); 1H NMR (CDCl3, 400 MHz): δ 6.81 – 6.73 (m, 3H, C10-H, C13-H and C14-
H), 5.96 (s, 2H, C15-H2), 4.47 (s, 2H, C8-H2), 3.54 – 3.46 (m, 1H, C4-H), 2.49 (ddd, J = 18.4, 
12.0, 9.2 Hz, 1H, C1-HaHb), 2.26 – 1.93 (m, 4H, C1-HaHb, C2-HaHb, C3-H2), 2.12 (s, 3H, C7-H3), 
1.70 – 1.56 (m, 1H, C2-HaHb); 
13C NMR (101 MHz, CDCl3) δ 213.4 (C5), 169.9 (C6), 148.2, 
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147.2 (C11 and C12), 130.3 (C9), 120.0 (C14), 108.5 (C10), 107.2 (C13), 101.2 (C15), 64.2 (C4), 
53.6 (C8), 35.8 (C1), 27.0 (C3), 21.6 (C7), 19.2 (C2); HRMS: (ESI+) calculated for C15H18NO4: 




General procedure D: Cyclopropylmethylamine (1.00 g, 14.06 mmol) and phenylacetyl chloride 
(2.23 mL, 16.87 mmol) were employed and the reaction was stirred at r.t. for 16 h. The residue 
was purified by recrystallisation (EtOAc/hexane) to afford the title compound 484 (2.07 g, 78%) 
as a colourless solid; m.p. 85-86 °C (DCM/hexane); 1H NMR (CDCl3, 400 MHz): δ 7.39-7.25 (m, 
5H, C10-H, 2 × C9-H and 2 × C8-H), 5.45 (br. s, 1H, N4-H), 3.58 (s, 2H, C6-H2), 3.08 (dd, J = 
7.1, 5.7 Hz, 2H, C3-H2), 0.92-0.80 (m, 1H, C2-H), 0.48-0.39 (m, 2H, C1-HaHb), 0.12 (dt, J = 5.7, 
4.6 Hz, 2H, C1-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 170.8 (C5), 135.1 (C7), 129.4 (C8), 129.0 
(C9), 127.3 (C10), 44.3 (C3), 43.9 (C6), 10.6 (C2), 3.2 (C1). The spectroscopic properties of this 




General procedure N: Compound 484 (28.4 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%), and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 18 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (40% EtOAc/ n-pentane) to yield the title compound 485 (21.7 mg, 67%) as an 
off-white solid; m.p. 113-114 °C; νmax / cm
-1: 3257 (br. m), 3067 (m), 2968 (m), 1745 (s), 1640 
(s), 1558 (s); 1H NMR (CDCl3, 400 MHz): δ 7.38-7.32 (m, 2H, 2 × C10-H), 7.31-7.25 (m, 3H, 2 
× C11-H and C12-H), 5.86 (br. s, 1H, N6-H), 4.07 (dddd, J = 12.4, 7.8, 6.2, 1.2 Hz, 1H, C4-H), 
3.59 (s, 2H, C8-H2), 2.59 (dddd, J = 15.4, 8.1, 5.1, 1.7 Hz, 1H, C3-HaHb), 2.37 (ddd, J = 19.2, 9.2, 
1.7 Hz, 1H, C1-HaHb), 2.14 (ddd, J = 19.2, 10.8, 9.2 Hz, 1H, C1-HaHb), 2.08-1.96 (m, 1H, C2-
HaHb), 1.90-1.77 (m, 1H, C2-HaHb), 1.54 (m, 1H, C3-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 214.9 
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(C5), 171.3 (C7), 134.5 (C9), 129.4 (C11), 129.0 (C10), 127.4 (C12), 58.1 (C4), 43.4 (C8), 34.9 






To a solution of 3-chloropropiophenone (3.00 g) and TEA (7.40 mL) in dry DCM (45 mL),  
cyclopropylmethylamine (1.41 mL) was added dropwise at 0 °C. The solution was warmed to r.t. 
and stirred for 6 h. Water (75 mL) was added and the organic layer was washed with water (2 × 
50 mL) and brine (50 mL). The organic layer was dried over MgSO4 and concentrated in vacuo to 
afford the secondary amine intermediate. The resulting secondary amine was protected according 
to the general procedure D with acetic anhydride (2.00 mL) and the residue was purified by flash 
column chromatography (20-50% EtOAc/petrol) to afford the title compound 490 (2.43 g, 56% 
over two steps, 1:2.7 mixture of rotamers A:B) as a pale yellow oil; νmax / cm
-1: 3003 (br. w), 1635 
(s), 1448 (s), 1423 (s), 11210 (s); 1H NMR (CDCl3, 400 MHz): δ 8.01-7.93 (m, 4H, 2 × C10-H, 
A+B), 7.63-7.42 (m, 6H, 2 × C11-H and C12-H, A+B), 3.87-3.82 (m, 2H, C6-H2, A), 3.79 (t, J = 
7.0 Hz, 2H, C6-H2, B), 3.35 (t, J = 7.0 Hz, 2H, C7-H2, B), 3.33-3.25 (m, 4H, C3-H2 and C7-H2, 
A), 3.25 (d, J = 6.6 Hz, 2H, C3-H2, B), 2.16 (s, 3H, C5-H3, A), 2.11 (s, 3H, C5-H3, B), 1.07-0.90 
(m, 2H, C2-H, A+B), 0.62-0.55 (m, 2H, 2 × C1-HaHb, B), 0.55-0.47 (m, 2H, 2 × C1-HaHb, A), 
0.30-0.23 (m, 4H, 2 × C1-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 199.3 (C8, B), 197.8 (C8, 
A), 170.5 (C4, B), 170.3 (C4, A), 136.7 (C9, B), 136.4 (C9, A), 133.6 (C12, A), 133.2 (C12, B), 
128.8 (C11, A), 128.6 (C11, B), 128.1 (C10, B), 127.9 (C10, A), 54.3 (C3, B), 49.6 (C3, A), 43.6 
(C6, A), 42.7 (C6, B), 37.7 (C7, A), 37.3 (C7, B), 21.8 (C5, B), 21.6 (C5, A), 10.6 (C2, B), 9.8 (C2, 
A), 3.8 (C1, A), 3.7 (C1, B); HRMS: (ESI+) calculated for C15H19NNaO2: 268.1308, found 
[M+Na]+: 268.1320. 
  




General procedure N: Compound 490 (36.8 mg, 0.150 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%), and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 18 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (1-5% MeOH/DCM) to yield the title compound 491 (30.1 mg, 73%, 2.1:1 
mixture of diastereomers A:B) as a brown oil; νmax / cm
-1: 3355 (br. m), 2961 (br. m), 1678 (m), 
1616 (s), 1597 (s), 1448 (s), 1229 (s); 1H NMR (CDCl3, 400 MHz): δ 8.07 – 8.03 (m, 1H, 2 × C12-
H, A), 7.95 – 7.89 (m, 2H, 2 × C12-H, B), 7.65 – 7.39 (m, 6H, 2 × C13-H and C14-H, A+B), 4.17 
(dd, J = 8.1, 4.8 Hz, 1H, C4-H, A), 4.08 (dd, J = 7.6, 4.9 Hz, 1H, C4-H, B), 4.07 – 4.01 (m, 1H, 
C9-H, A), 4.00 – 3.83 (m, 5H, C9-H, B and C8-H2, A+B), 2.39 – 2.28 (m, 2H, C3-HaHb, A+B), 
2.04 (s, 3H, C7-H3, B), 2.00 (s, 3H, C7-H3, A), 1.99 – 1.74 (m, 8H, C1-H2 and C2-H2, A+B), 1.72 
– 1.62 (m, 2H, C3-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 201.3 (C10, B), 200.1 (C10, A), 
169.9 (C6, B), 169.3 (C6, A), 136.7 (C11, A), 135.9 (C11, B), 134.2 (C14, B), 134.1 (C14, A), 
128.9 (C13, B), 128.6 (C12, B), 128.5 (C13, A), 128.2 (C12, A), 90.3 (C5, B), 89.0 (C5, A), 69.9 
(C4, B), 69.8 (C4, A), 51.3 (C9, A), 50.7 (C8, A), 49.9 (C9, B), 48.8 (C8, B), 37.8 (C1, B), 37.7 
(C1, A), 33.2 (C3, B), 31.5 (C3, A), 24.0 (C2, B), 23.9 (C2, A), 22.3 (C7, A), 21.9 (C7, B); HRMS: 





To a solution of N-(cyclopropylmethyl)-2-nitroaniline (2.00 g, 10.40 mmol, prepared according to 
the literature procedure300) in acetic anhydride (10.40 mL) and 5 drops of conc. H2SO4 were added 
at r.t. and the reaction mixture was heated to 50 °C for 2 h and then to 80 °C for 45 min. Then 
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MeOH (6.90 mL) was added at 0 °C and the solution was stirred for 20 min. Neat K2CO3 was 
added to the reaction mixture until the effervescence was no longer observed. Water (50 mL) was 
added and the solution was extracted with DCM (3 × 30 mL). The organic extracts were combined, 
washed with brine (40 mL), dried over MgSO4 and concentrated in vacuo. The residue was purified 
by silica gel column chromatography (50% EtOAc/hexane) to yield the title compound 493 (1.80 
g, 74%, 9:1 mixture of isomers A:B) as a bright yellow oil; νmax / cm
-1: 1664 (s), 1601 (m), 1525 
(s), 1379 (m), 1348 (s), 1286 (m), 785 (m); 1H NMR (CDCl3, 400 MHz, main isomer only): δ 7.98 
(dd, J = 8.2, 1.6 Hz, 1H, C8-H), 7.68 (ddd, J = 7.8, 7.6, 1.6 Hz, 1H, C10-H), 7.55 (ddd, J = 8.2, 
7.6, 1.4 Hz, 1H, C9-H), 7.42 (dd, J = 7.8, 1.4 Hz, 1H, C11-H), 3.66 (dd, J = 14.1, 7.2 Hz, 1H, C3-
HaHb), 3.34 (dd, J = 14.1, 7.2 Hz, 1H, C3-HaHb), 1.84 (s, 3H, C5-H3), 0.88 – 0.74 (m, 1H, C2-H), 
0.42 – 0.32 (m, 2H, C1-HaHb), 0.06 – -0.05 (m, 2H, C1-HaHb); 
13C NMR (CDCl3, 101 MHz, main 
isomer only): δ 170.1 (C4), 147.7 (C7), 136.5 (C6), 134.1 (C10), 132.4 (C11), 129.6 (C9), 125.6 
(C8), 53.5 (C3), 22.8 (C5), 9.6 (C2), 4.0 (C1), 3.6 (C1’); HRMS: (ESI+) calculated for 





General procedure N: Compound 493 (35.1 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 24 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (5% acetone/DCM) to yield the title compound 494 (35.7 mg, 91%, 1:2.7 mixture 
of atropisomers A:B) as a yellow oil; νmax / cm
-1: 1747 (m), 1667 (s), 1527 (s), 1399 (m), 1354 (m), 
1325 (m), 1303 (m); 1H NMR (CDCl3, 500 MHz): δ 7.95 (dd, J = 8.1, 1.6 Hz, 1H, C10-H, A), 7.91 
(dd, J = 8.1, 1.5 Hz, 1H, C10-H, B), 7.75 – 7.49 (m, 6H, C11-H, C12-H and C13-H, A+B), 5.18 
(dd, J = 13.2, 8.1 Hz, 1H, C4-H, A), 3.48 (dd, J = 11.3, 8.9 Hz, 1H, C4-H, B), 2.62 – 2.50 (m, 4H, 
C1-HaHb and C3-HaHb, A+B), 2.37 – 2.09 (m, 5H, C1-HaHb and C3-HaHb, A+B; C2-HaHb, A), 2.04 
– 1.93 (m, 1H, C2-HaHb, B), 1.92 (s, 3H, C7-H3, A), 1.81 (s, 3H, C7-H3, B), 1.73 – 1.59 (m, 4H, 
C2-HaHb, B), 1.45 – 1.33 (m, 1H, C2-HaHb, A); 
13C NMR (CDCl3, 126 MHz): δ 213.7 (C5, B), 
213.1 (C5, A), 170.8 (C6, A), 169.4 (C6, B), 137.0 (C9, B), 134.6, 134.3, 133.6, 133.1, 132.3 (C9, 
A; C11 and C13, A+B), 130.2 (C12, A), 129.8 (C12, B), 125.4 (C10, A), 125.0 (C10, B), 68.8 (C4, 
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B), 64.1 (C4, A), 35.8 (C1, B), 35.4 (C1, A), 26.6 (C3, B), 26.0 (C3, A), 22.6 (C7, A), 22.4 (C7, B), 
19.4 (C2, B), 18.3 (C2, A); HRMS: (ESI+) calculated for C13H15N2O4: 263.1026, found [M+H]
+: 
263.1029. High temperature NMR (DMSO-d6, 100 °C) did not result in coalescence of the signals 




Compound 494 (50.0 mg, 0.19 mmol) was dissolved in MeOH (5 mL) and Pd on carbon (10 mg, 
10% w/w) was added. The reaction tube was sealed, sparged with H2 for 1 min and stirred under 
an atmosphere of H2 for 8 h. The solution was filtered through Celite
® (rinsing with MeOH) and 
concentrated in vacuo. The residue was purified by silica gel column chromatography (5% 
acetone/DCM) to yield the title compound 495 (22.8 mg, 55%) as a pale brown oil; νmax / cm
-1: 
3340 (m), 2956 (m), 1631 (s), 1502 (s), 1388 (s), 1314 (s), 730 (s); 1H NMR (CDCl3, 500 MHz, 
50 °C): δ 7.13 – 6.96 (m, 3H, C9-H, C10-H and N14-H), 6.67 (ddd, J = 7.6, 7.7, 1.4 Hz, 1H, C11-
H), 6.58 (dd, J = 7.7, 1.5 Hz, 1H, C12-H), 5.31 (br. s, 1H, C5-H), 3.87 (ddd, J = 7.0, 5.0, 2.4 Hz, 
1H, C1-H), 2.22 (s, 3H, C7-H3), 1.97 – 1.87 (m, 2H, C2-HaHb and C4-HaHb), 1.80 – 1.69 (m, 1H, 
C3-HaHb), 1.65 – 1.51 (m, 2H, C2-HaHb, C3-HaHb), 1.35 – 1.24 (m, 1H, C4-HaHb); 
13C NMR 
(CDCl3, 126 MHz): δ 169.5 (C6), 126.3, 125.6 (C9 and C10), 117.0 (C11), 114.3 (C12), 56.5 (C1), 
33.5 (C2), 27.3 (C4), 22.9 (C7), 21.7 (C3); signals corresponding to C5, C8 and C13 were not 
observed due to their weak intensity; HRMS: (ESI+) calculated for C13H17N2O: 217.1335, found 
[M+H]+: 217.1337. The relative stereochemistry of this compound was corroborated by nOe 
experiments (as indicated on the compound structure). A strong nOe was observed between C1-H 
and C5-H. 
  




General procedure M: Cyclopropylmethylamine (1.22 mL, 14.06 mmol), 2-nitrobenzaldehyde 
(2.22 g, 14.76 mmol) and acetic anhydride (1.59 mL, 16.87 mmol) were employed and the reaction 
was stirred at r.t. for 18 h. Flash column chromatography (20-50% EtOAc/pentane) afforded the 
title compound 496 (2.78 g, 80%, 1:1.07 mixture of rotamers A:B) as a dark yellow oil; νmax / cm
-
1: 1643 (s), 1521 (s), 1421 (m), 1339 (s), 1253 (m), 857 (m), 789 (m), 726 (s); 1H NMR (CDCl3, 
400 MHz): δ 8.15 (dd, J = 8.1, 1.3 Hz, 1H, C9-H, A), 8.00 (dd, J = 8.2, 1.3 Hz, 1H, C9-H, B), 7.66 
(td, J = 7.6, 1.3 Hz, 1H, C11-H, A), 7.55 (td, J = 7.6, 1.3 Hz, 1H, C11-H, B), 7.48 (t, J = 8.1 Hz, 
1H, C10-H, A), 7.41 – 7.35 (m, 2H, C10-H, B and C12-H, A), 7.33 – 7.29 (m, 1H, C12-H, B), 5.03 
(s, 4H, C6-H2, A+B), 3.31 (d, J = 7.0 Hz, 2H, C3-H2, A), 3.21 (d, J = 6.7 Hz, 2H, C3-H2, B), 2.26 
(s, 3H, C5-H3, B), 2.05 (s, 3H, C5-H3, A), 1.01 – 0.84 (m, 2H, C2-H, A+B), 0.55 – 0.41 (m, 4H, 2 
× C1-HaHb, A+B), 0.21 – 0.10 (m, 4H, 2 × C1-HaHb, A+B); 
13C NMR (CDCl3, 101 MHz): δ 171.6 
(C4, A), 171.1 (C4, B), 148.5 (C8, A), 147.9 (C8, B), 134.3 (C11, A), 133.6 (C7, B), 133.6 (C7, A), 
133.5 (C11, B), 128.6 (C12, B), 128.5 (C10, A), 127.8, 127.6 (C12, A and C10, B), 125.8 (C9, A), 
125.0 (C9, B), 54.0 (C3, B), 50.7 (C3, A), 50.0 (C6, A), 46.5 (C6, B), 21.7 (C5, A+B), 10.4 (C2, 
B), 9.7 (C2, A), 3.9 (C1, B), 3.8 (C1, A); HRMS: (ESI+) calculated for C13H17N2O3: 249.1234, 




General procedure N: Compound 496 (37.2 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%) and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 18 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (30-50% EtOAc/petrol) to yield the title compound 497 (31.1 mg, 75%) as a pale 
brown solid; m.p. 106-107 °C (DCM/hexane); νmax / cm
-1: 2968 (br. w), 1744 (m), 1645 (s), 1523 
(s), 1424 (m), 1338 (s), 1258 (m), 729 (m); 1H NMR (CDCl3, 400 MHz): δ 8.14 (dd, J = 8.2, 1.3 
Hz, 1H, C11-H), 8.09 (dd, J = 7.9, 1.3 Hz, 1H, C14-H), 7.78 – 7.71 (m, 1H, C13-H), 7.53 – 7.47 
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(m, 1H, C12-H), 5.08 (d, J = 18.9 Hz, 1H, C8-HaHb), 4.80 (d, J = 18.9 Hz, 1H, C8-HaHb), 3.37 (t, 
J = 9.6 Hz, 1H, C4-H), 2.57 (ddd, J = 18.5, 11.9, 9.3 Hz, 1H, C1-HaHb), 2.30 – 2.06 (m, 4H, C1-
HaHb, C2-HaHb, C3-H2), 2.02 (s, 3H, C7-H3), 1.72 – 1.57 (m, 1H, C2-HaHb); 
13C NMR (101 MHz, 
CDCl3) δ 213.0 (C5), 170.5 (C6), 147.7 (C10), 134.8 (C13), 132.9 (C9), 128.8, 128.6 (C12 and 
C14), 125.7 (C11), 65.0 (C4), 51.4 (C8), 36.1 (C1), 27.0 (C3), 21.4 (C7), 19.4 (C2); HRMS: (ESI+) 





General procedure N: Compound 449 (25.1 mg, 0.15 mmol), [Rh(cod)2]OTf (5.3 mg, 0.011 
mmol, 7.5 mol%), and P(3,4,5-F3C6H2)3 (9.5 mg, 0.023 mmol, 15 mol%) were employed and the 
reaction was stirred for 18 h at 110 °C. The crude mixture was purified by silica gel column 
chromatography (30-50% EtOAc/pentane) to yield the title compound 505a (18.2 mg, 62%) as a 
brown oil; νmax / cm
-1: 2967 (br. w), 2921 (br. w), 1744 (s), 1631 (s), 1431 (s), 1154 (m), 1001 (m); 
1H NMR (CDCl3, 400 MHz): δ 5.73 (ddt, J = 17.1, 10.2, 6.9 Hz, 1H, C10-H), 5.11 – 5.02 (m, 2H, 
C11-H2), 3.35 – 3.26 (m, 3H, C4-H and C8-H2), 2.48 (ddd, J = 18.3, 11.8, 9.4 Hz, 1H, C1-HaHb), 
2.33-2.25 (m, 2H, C9-H2), 2.25 – 2.04 (m, 4H, C1-HaHb, C2-HaHb and C3-H2), 2.01 (s, 3H, C7-
H3), 1.69 – 1.59 (m, 1H, C2-HaHb); 
13C NMR (CDCl3, 101 MHz): δ 213.4 (C5), 169.3 (C6), 134.1 
(C01), 117.8 (C11), 64.7 (C4), 50.7 (C8), 35.8 (C1), 33.9 (C9), 27.3 (C3), 21.4 (C7), 19.4 (C2); 
HRMS: (ESI+) calculated for C11H18NO2: 196.1336, found [M+H]
+: 196.1332. 
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General procedure O: 2-Bromopyridine (0.20 mL, 2.00 mmol) and cyclobutylamine (0.20 mL, 
2.40 mmol) were employed. Flash column chromatography (9% EtOAc/hexane) afforded the title 
compound 524 (0.15 g, 49 %) as a yellow solid; 1H NMR (CDCl3, 400 MHz): δ 8.06 (dt, J = 4.8, 
1.4 Hz, 1H, C1-H), 7.42 (m, 1H, C3-H), 6.56 (ddd, J = 7.2, 5.1, 1.0 Hz, 1H, C2-H), 6.31 (d, J = 
8.4 Hz, 1H, C4-H), 4.68 (br. s, 1H, N6-H), 4.12 (h, J = 7.5 Hz, 1H, C7-H), 2.51-2.36 (m, 2H, C9-
H2), 1.90-1.74 (m, 4H, 2 × C8-H2); 
13C NMR (101 MHz, CDCl3): δ 158.0 (C5), 148.3 (C1), 137.8 
(C3), 113.0 (C2), 106.5 (C4), 47.5 (C7), 31.5 (C8), 15.4 (C9). The spectroscopic properties of this 




General procedure O: Iodobenzene (0.36 mL, 3.20 mmol) and cyclobutylamine (0.33 mL, 3.84 
mmol) were employed. Flash column chromatography (2% EtOAc/hexane) afforded the title 
compound 525 (0.38 g, 81 %) as a yellow oil; 1H NMR (400 MHz, CDCl3): δ 7.21 (ddd, J = 8.7, 
7.3, 1.6 Hz, 2H, 2 × C2-H), 6.75-6.67 (m, 1H, C1-H), 6.59 (dt, J = 8.7, 1.3 Hz, 2H, 2 × C3-H), 
3.98-3.89 (m, 1H, C6-H), 3.82 (br. s, 1H, N5-H), 2.43-2.24 (m, 2H, C8-H2), 1.84-1.62 (m, 4H, 2 
× C7-H2); 
13C NMR (101 MHz, CDCl3): δ 147.2 (C4), 129.3 (C2), 117.40 (C1), 113.06 (C3), 49.04 
(C6), 31.28 (C7), 15.30 (C8). The spectroscopic properties of this compound were consistent with 
the data available in the literature.301 
  




General procedure N: N-Cyclobutylaniline (14.72 mg, 0.10 mmol), [Rh(cod)Cl]2 (3.70 mg, 0.008 
mmol, 7.5 mol%), PPh3 (3.93 mg, 0.015 mmol, 15 mol%) were employed and the reaction was 
stirred at 180 °C for 24 h. No benzoic acid was used. Flash column chromatography (20% 
EtOAc/hexane) afforded compound 527 (21.3 mg, 75%) as a colourless oil; νmax / cm
-1: 2987 (m), 
2947 (m), 1652 (s), 1594 (m), 1495 (s), 1395 (m), 1346 (s), 1280 (m).1H NMR (400 MHz, CDCl3): 
δ 7.28-6.95 (m, 9H, Ar-H), 5.23 (app. p, J = 8.7 Hz, 1H, C2-H), 2.33-2.30 (m, 2H, 2 × C3-HaHb), 
1.96-1.83 (m, 2H, 2 × C3-HaHb), 1.75-1.63 (m, 1H, C4-HaHb), 1.62-1.49 (m, 1H, C4-HaHb); 
13C 
NMR (101 MHz, CDCl3): δ 167.6 (C6), 138.5 (C1), 137.2, 129.8, 129.3, 129.2, 128.6, 128.3, 
127.9, 126.0 (Ar-C), 50.7 (C2), 28.8 (C4), 15.3 (C5); HRMS: (ESI+) calculated for C17H17ClNO: 





General procedure O: 2-Bromo-3-methylpyridine (0.90 mL, 8.00 mmol) and cyclobutylamine 
(0.82 mL, 9.60 mmol) were employed. Flash column chromatography (9% EtOAc/hexane) 
afforded the title compound 529 (1.02 g, 79 %) as a crystalline colourless solid; m.p. 77-78 °C; 
νmax / cm
-1: 2969 (m), 2938 (m), 1598 (s). 1582 (s), 1494 (s), 1467 (s), 1413 (m), 1340 (m), 1253 
(m); 1H NMR (CDCl3, 400 MHz): δ 8.00 (dd, J = 5.2, 1.8 Hz, 1H, C1-H), 7.19 (ddq, J = 7.1, 1.8, 
0.9 Hz, 1H, C3-H), 6.50 (dd, J = 7.1, 5.2 Hz, 1H, C2-H), 4.63-4.52 (m, 1H, C7-H), 4.24 (br. s, 1H, 
N6-H), 2.52-2.44 (m, 2H, 2 × C8-H2), 2.07 (s, 3H, C10-H3), 1.92-1.71 (m, 4H, 2 × C8-H2 and C9-
H2); 
13C NMR (101 MHz, CDCl3): δ 156.0 (C5), 145.5 (C1), 136.8 (C3), 116.2 (C4), 112.5 (C2), 
46.7 (C7), 32.2 (C8), 17.0 (C10), 15.1 (C9); HRMS: (ESI+) calculated for C10H15N2: 163.1230, 
found [M+H]+: 163.1229. 
 
 




General procedure N: Amine 529 (19.0 mg, 0.10 mmol), [Rh(cod)2]OTf (3.5 mg, 0.0075 mmol, 
7.5 mol%) and PPh3 (3.9 mg, 0.015 mmol, 15 mol%) were employed and the reaction was stirred 
at 160 °C for 24 h. No benzoic acid was used. Preparative thin layer chromatography (10% 
MeOH/DCM) afforded title compound 530 (1.1 mg, 6%) as a colourless oil; νmax / cm
-1: 3419 (m), 
3402 (m), 2917 (m), 1695 (s), 1645 (s), 1590 (s), 1524 (s), 1413 (s), 1113 (m); 1H NMR (400 MHz, 
CDCl3): δ 8.16-8.12 (dd, J = 5.0, 1.8 Hz, 1H, C12-H), 7.91 (t, J = 3.2 Hz, 1H, C5-H), 7.35 (dd, J 
= 7.3, 1.8, 1H, C10-H), 6.72 (dd, J = 7.3, 5.0 Hz, 1H, C11-H), 6.69 (br. s, 1H, N6-H), 2.73-2.68 
(m, 2H, C3-H2), 2.48-2.45 (m, 2H, C2-H2), 2.26 (s, 3H, C9-H3); 
13C NMR (101 MHz, CDCl3): δ 
204.9 (C1), 152.7 (C7), 145.3 (C12), 138.1 (C4), 137.6 (C10), 133.6 (C5), 118.4 (C8), 115.5 (C11), 





Amine 529 (0.50 g, 3.08 mmol) and acetaldehyde (0.35 mL, 6.16 mmol) in dry 1,2-dichloroethane 
(5 mL) were stirred at r.t. for 15 min. Sodium triacetoxyborohydride (1.63 g, 7.70 mmol) was 
added and the reaction was stirred at r.t. for 4 h. The reaction mixture was quenched with 2.0 M 
aq. HCl and adjusted to neutral pH by the addition of sat. aq. NaHCO3. The solution was extracted 
with DCM (3 × 15 mL) and then the organic extracts were combined, washed with brine (30 mL), 
dried over MgSO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography (20% EtOAc/hexane) to afford the title compound 534 (0.56 g, 95%) as a bright 
yellow oil; νmax / cm
-1: 2969 (s), 2936 (m), 2869 (m), 1586 (m), 1449 (s), 1422 (s), 1337 (m), 1256 
(m), 1105 (s); 1H NMR (400 MHz, CDCl3): δ 8.16 (dd, J = 5.2, 1.9 Hz, 1H, C1-H), 7.39 (ddq, J = 
6.7, 1.9, 1.0 Hz, 1H, C3-H), 6.84-6.79 (m, 1H, C2-H), 4.06 (tt, J = 8.8, 6.8 Hz, 1H, C8-H), 3.15 
(q, J = 7.1 Hz, 2H, C6-H2), 2.26 (s, 3H, C11-H3), 2.19-2.08 (m, 2H, C9-H2), 1.91-1.77 (m, 2H, 
C9-H2), 1.70-1.60 (m, 2H, C10-H2), 0.89 (t, J = 7.1 Hz, 3H, C7-H3); 
13C NMR (101 MHz, CDCl3): 
δ 160.6 (C5), 145.3 (C1), 138.9 (C3), 127.4 (C4), 117.8 (C2), 54.9 (C8), 42.6 (C6), 28.9 (C9), 18.7 
(C11), 15.0 (C10), 12.3 (C7); HRMS: (ESI+) calculated for C12H19N2: 191.1543, found [M+H]
+: 
191.1549. 
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Dimethyl 2-methylenemalonate (539) 
 
The title compound was prepared following a literature procedure.302 TFA (7.70 mL, 100 mmol) 
was added dropwise to a stirred solution of diisopropylamine (10.10 g, 100 mmol) in Et2O (100 
mL) at 0 °C. The reaction mixture was stirred at 0 °C for 10 min and then filtered to obtain the 
white precipitate. The filter cake was washed with Et2O and dried under high vacuum to obtain 
diisopropylamine 2,2,2-trifluoroacetate as colourless crystals (20.73 g, 96%).  
Dimethyl malonate (10.00 mL, 87.50 mmol), diisopropylamine 2,2,2-trifluoroacetate (18.83 g, 
87.50 mmol), paraformaldehyde (5.26 g, 175 mmol) and trifluoroacetic acid (0.67 mL, 8.75 mmol) 
in dry THF (130 mL) were heated to reflux and stirred for 2 h. Paraformaldehyde (5.26 g, 175 
mmol) was added and the reflux was restarted for 5 h. The reaction was cooled to room temperature 
and THF was removed under reduced pressure (50 mbar at 40°C). The crude mixture was dissolved 
in diethyl ether (50 mL) and filtered through a paper filter. The organic layer was washed with 2.0 
M HCl (2 × 20 mL). The aqueous layers were combined and extracted with diethyl ether (25 mL). 
The organic layers were combined, dried over MgSO4, filtered and concentrated under reduced 
pressure. The crude oil was purified by distillation. Compound 539 (9.22 g, 73%) was collected as 
a colourless oil between 45 °C at 1.5 mbar and 50 °C at 1 mbar. Due to an unstable nature, the 
product was stored under nitrogen in a glovebox freezer. 1H NMR (CDCl3, 400 MHz): 6.58 (s, 2H, 
C1-H2), 3.83 (s, 6H, 2 × C2-H3); 
13C NMR (101 MHz, CDCl3): δ 167.0 (C3), 135.3 (C1), 134.5 
(C4), 52.70 (C2). The spectroscopic properties of this compound were consistent with the data 




The title compound was prepared following a literature procedure.240 To a stirred solution of 
pyrrolidine-2,5-dione (1.00 g, 10.10 mmol) in vinyl acetate (25 mL), Na2PdCl4 (59.0 mg, 0.20 
mmol) was added. The reaction was heated to reflux and stirred for 72h. The residue was purified 
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by flash column chromatography (20-40% EtOAc/hexane) to provide 540 (0.96 g, 76%) as a 
yellow solid; m.p. 48-49 °C (DCM/hexane); 1H NMR (CDCl3, 400 MHz): δ 6.50 (dd, J = 16.4, 
9.9 Hz, 1H, C3-H), 5.88 (d, J = 16.4 Hz, 1H, C4-H2), 4.87 (d, J = 9.9 Hz, 1H, C4-H2), 2.57 (s, 4H, 
2 × C2-H2); 
13C NMR (101 MHz, CDCl3): δ 175.4 (C1), 124.3 (C3), 106.6 (C4), 27.8 (C2). The 
spectroscopic properties of this compound were consistent with the data available in the 
literature.240 
 
Dimethyl 2-(2,5-dioxopyrrolidin-1-yl)cyclobutane-1,1-dicarboxylate (538) 
 
The title compound was prepared following a literature procedure.240 To a stirred solution of iron 
trichloride (0.13 g, 0.80 mmol) in dry DCM (5 mL), 1-vinylpyrrolidine-2,5-dione 540 (0.50 g, 4.00 
mmol) and dimethyl 2-methylenemalonate 539 (1.15 g, 8.00 mmol) in dry dichloromethane (10 
mL) were added dropwise at 0 °C under nitrogen. The reaction was warmed to r.t. and stirred for 
18 h. The reaction mixture was diluted with dichloromethane, filtered through a pad of silica and 
concentrated in vacuo. The residue was purified by flash column chromatography (4-50% 
EtOAc/hexane) to provide cyclobutane 538 (0.95 g, 88%) as a colourless oil; 1H NMR (CDCl3, 
400 MHz): δ 5.32-5.23 (m, 1H, C2-H), 3.71 (s, 3H, C5-H3), 3.67 (s, 3H, C5-H3), 3.14-3.01 (m, 
1H, C6-H2), 2.95-2.85 (m, 1H, C6-H2), 2.74-2.56 (m, 4H, 2 × C8-H2), 2.24-2.09 (m, 2H, C1-H2); 
13C NMR (101 MHz, CDCl3): δ 177.2 (C7), 170.5 (C4), 168.6 (C4), 57.8 (C3), 53.1 (C5), 52.9 
(C5), 48.2 (C2), 28.0 (C8), 24.8 (C6), 20.7 (C1). The spectroscopic properties of this compound 
were consistent with the data available in the literature.240 
 
Dimethyl (E)-2-(3-(2,5-dioxopyrrolidin-1-yl)allyl)malonate (542) 
 
General procedure N: In a modification to the general procedure, no benzoic acid was used and 
the reaction was run under an atmosphere of argon. Cyclobutane 538 (40.4 mg, 0.15 mmol), 
[Rh(cod)2]OTf (5.27 mg, 0.011 mmol, 7.5 mol%) and PPh3 (5.90 mg, 0.023 mmol, 15 mol%) were 
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employed and the reaction was stirred at 180 °C for 24 h. Flash column chromatography (40% 
EtOAc/hexane) afforded compound 542 (13.2 mg, 33%) as a colourless oil; νmax / cm
-1: 2956 (m), 
2924 (m), 2853 (m), 1730 (s), 1701 (s), 1436 (m), 1385 (s), 1201 (s), 1152 (s), 1101 (m); 1H NMR 
(CDCl3, 400 MHz): δ 6.62-6.52 (m, 1H, C7-H and d, J = 14.6 Hz, 1H, C6-H), 3.74 (s, 6H, 2 × 
C11-H3), 3.47 (t, J = 7.5 Hz, 1H, C9-H), 2.73-2.68 (m, 2H, C8-H2), 2.71 (s, 4H, 2 × C1-H2); 
13C 
NMR (101 MHz, CDCl3): δ 175.2 (C2), 169.0(C10), 120.7 (C6), 119.2 (C7), 52.7 (C11), 51.7 
(C9), 30.5 (C8), 27.8 (C1); HRMS: (ESI+) calculated for C12H15NNaO6: 292.0792, found 
[M+Na]+: 292.0793. 
 
Dimethyl 2-(4-methoxyphenyl)cyclobutane-1,1-dicarboxylate (549) 
 
The title compound was prepared following a modified literature procedure.242 In the glovebox, a 
flame-dried flask was charged with previously fused and dried on the oil pump for 18 h ZnBr2 
(1.32 g, 5.90 mmol), fitted with a rubber septum, removed from the glovebox and placed under an 
atmosphere or Ar. Dry DCM (20 mL) was added and the flask was cooled to -130 °C in a 
pentane/liquid N2 bath. A solution of dimethyl 2,2-methylidene malonate (1.70 g, 11.8 mmol) in 
dry DCM (10 mL) and a solution of 1-methoxy-4-vinylbenzene (0.78 mL, 5.90 mmol) in dry DCM 
(10 mL) were prepared and cooled to -130 °C in a pentane/liquid N2 bath. Dimethyl 2,2-
methylidene malonate solution followed by 1-methoxy-4-vinylbenzene solution were added to the 
flask containing ZnBr2 via syringe over a period of 5 min at -130 °C. The reaction was warmed to 
-78 °C in an isopropanol/dry ice bath and stirred for 3 h. A solution of pyridine (2 ml) in wet DCM 
(15 mL) pre-cooled to -78 °C was added to the reaction via syringe. The reaction was warmed to 
room temperature, washed with saturated aq. Na2EDTA (2 x 60 mL), dried over Mg2SO and 
concentrated in vacuo. The residue was purified by flash column chromatography (4% 
EtOAc/hexane) to afford the title compound 549 (1.00 g, 61%) as a colourless solid; 1H NMR (400 
MHz, CDCl3): δ 7.21 (d, J = 8.8 Hz, 2H, 2 × C4-H), 6.82 (d, J = 8.8 Hz, 2H, 2 × C3-H), 4.31 (t, J 
= 9.5 Hz, 1H, C6-H), 3.78 (s, 3H, C10-H3), 3.77 (s, 3H, C11-H3), 3.28 (s, 3H, C1-H3), 2.71 – 2.65 
(m, 1H, C8-H2 ), 2.62-2.51 (m, 1H, C8-H2), 2.28-2.19 (m, 1H, C7-H2), 2.18-2.11 (m, 1H, C7-H2); 
13C NMR (101 MHz, CDCl3): δ 172.1 (C10), 169.8 (C10), 158.6 (C2), 131.3 (C5), 128.7 (C4), 
113.4 (C3), 59.8 (C9), 55.2 (C1), 52.4 (C11), 51.8 (C11), 44.7 (C6), 25.5 (C8), 21.0 (C7); The 
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spectroscopic properties of this compound were consistent with the data available in the 
literature.242 
 
2-(4-Methoxyphenyl)cyclobutane-1,1-dicarboxylic acid (551) 
 
Dicarboxylate 549 (3.23 g, 11.60 mmol) was dissolved in a mixture of 1,4-dioxane and water (1:1, 
200 mL), then potassium hydroxide pellets (6.50 g, 116 mmol) were added and the reaction 
mixture was stirred at 80 °C for 16 h. The reaction mixture was concentrated in vacuo, diluted 
with water (100 mL) and extracted with Et2O (50 mL). The aqueous portion was adjusted to pH 2 
by addition of 2.0 M aq. HCl and then extracted with Et2O (3 × 50 mL). The organic extracts were 
combined, washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo to afford pure 
title compound 551 (2.75 g, 95%) as a colourless solid; m.p. 118-119 °C; νmax / cm
-1: 2953 (m), 
1729 (s), 1708 (s), 1611 (m), 1513 (s), 1245 (s), 1175 (s), 1033 (s); 1H NMR (400 MHz, MeOD): 
δ 7.27 (d, J = 8.7 Hz, 2H, 2 × C6-H), 6.85 (d, J = 8.7 Hz, 2H, 2 × C7-H), 4.88 (br. s, 2H, O11-H), 
4.28 (t, J = 9.3 Hz, 1H, C2-H), 3.78 (s, 3H, C9-H3), 2.67-2.51 (m, 2H, C1-H2 and C4-H2), 2.36-
2.11 (m, 2H, C1-H2 and C4-H2); 
13C NMR (101 MHz, MeOD): δ 174.17 (C10), 171.69 (C10), 
158.61 (C8), 131.65 (C5), 128.43 (C6), 112.91 (C7), 59.68 (C3), 54.19 (C9), 44.57 (C2), 25.32 
(C4), 20.51 (C1); HRMS: (ESI-) calculated for C13H13O5: 249.0768, found [M-H]
-: 249.0770. 
 
tert-Butyl (2-(4-methoxyphenyl)cyclobutyl)carbamate (552) 
 
Dicarboxylic acid 551 (1.75 g, 7.00 mmol) was dissolved in DMF (50 mL) and heated to reflux 
for 3 hours before being co-evaporated with toluene to dryness in vacuo. The crude was taken up 
in EtOAc (50 mL). The solution was washed with water (3 × 20 mL) and brine (30 mL), dried 
over MgSO4 and concentrated in vacuo to afford the crude decarboxylated product 552. To a 
solution of carboxylic acid and Et3N (0.98 mL, 7.00 mmol) in anhydrous t-BuOH (60 mL) was 
added diphenylphosphoryl azide (1.66 mL, 7.70 mmol) dropwise. The reaction was heated to 80 
°C and stirred for 24 h before cooling to r.t. The reaction mixture was concentrated in vacuo and 
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the residue was dissolved in Et2O (50 mL). Water (50 mL) was added and the aqueous portion was 
further extracted with Et2O (3 × 30 mL). The organic extracts were combined, washed with sat. 
aq. NaHCO3 (50 mL) and brine (50 mL), dried over MgSO4 and concentrated in vacuo. The residue 
was purified by flash column chromatography (1-7% EtOAc/hexane) to afford the title compound 
553 (0.70 g, 36%, single diastereomer) as a colourless solid; m.p. 102-103 °C (Et2O); νmax / cm
-1: 
3361 (m), 2975 (m), 2931 (m), 2857 (m), 1710 (s), 1513 (s), 1456 (m), 1366 (s), 1247 (s), 1173 
(s), 1041 (s); 1H NMR (400 MHz, CDCl3): δ 7.17 (d, J = 8.6 Hz, 2H, 2 × C7-H), 6.87-6.82 (m, 
2H, 2 × C8-H), 4.83 (br. s, 1H, N5-H), 4.21-4.07 (m, 1H, C3-H), 3.78 (s, 3H, C10-H3), 3.27-3.12 
(m, 1H, C2-H), 2.36-2.25 (m, 1H, C4-HaHb), 2.15-2.05 (m, 1H, C1-HaHb), 1.85-1.60 (m, 2H, C1-
HaHb and C4-HaHb), 1.42 (br. s, 9H, 3 × C12-H3); 
13C NMR (101 MHz, CDCl3): δ 158.1 (C9), 
154.7 (C11), 134.8 (C6), 127.5 (C7), 113.7 (C8), 79.2 (C12), 55.3 (C10), 51.8 (C3), 48.8 (C2), 
28.4 (C13), 28.0 (C4), 22.53(C1); HRMS: (ESI+) calculated for C16H23NNaO3: 300.1570, found 
[M+Na]+: 300.1578. The relative stereochemistry of this compound was corroborated by nOe 




To a solution of protected amine 553 (0.10 g, 0.36 mmol) in DCM (5 mL) was added TFA (0.28 
mL, 3.60 mmol) and the reaction mixture was stirred at r.t. for 10 min. The solvent was removed 
in vacuo and the residue was redissolved in DCM (10 mL) and washed with sat. aq. NaHCO3 (10 
mL/mmol). The aqueous portion was further extracted with DCM (2 × 5 mL) and the organic 
extracts were combined, washed with brine (10 mL), dried over MgSO4 and concentrated in vacuo 
until the concentration was reduced to approx. 15 mL/mmol. The solution was cooled to 0 °C and 
Et3N (0.47 mmol, 50 µL) and benzoyl chloride (0.59 mmol, 35 µL) were added. The reaction was 
warmed to r.t. and stirred for 8 h under nitrogen. Water (5 mL) was added to the reaction mixture 
and the solution was extracted with DCM (3 × 5 mL). The organic extracts were combined, washed 
with brine (10 mL), dried over MgSO4 and concentrated in vacuo. The residue was purified by 
flash column chromatography (20-50% EtOAc/hexane) to afford the title compound 544 (47.0 mg, 
47%) as a colourless solid; m.p. 142-143 °C; νmax / cm
-1: 3304 (m), 2978 (m), 2947 (m), 1635 (s), 
1534 (s), 1513 (s), 1294 (m), 1249 (s); 1H NMR (400 MHz, CDCl3): δ 7.76 (d, J = 7.2 Hz, 2H, 2 
× C13-H), 7.51-7.40 (m, 3H, C15-H and 2 × C14-H), 7.22 (d, J = 8.5 Hz, 2H, 2 × C7-H), 6.85 (d, 
J = 8.5 Hz, 2H, 2 × C8-H), 6.32 (br. d, J = 7.8 Hz, 1H, N5-H), 4.73 (app. p, J = 8.7 Hz, 1H, C3-
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H), 3.78 (s, 3H, C9-H3), 3.43-3.38 (m, 1H, C2-H), 2.45 (m, 1H, C4-HaHb), 2.23 (app. q, J = 9.2 
Hz, 1H, C1-HaHb), 1.92 (app. p, J = 9.8 Hz, 1H, C4-HaHb), 1.85-1.73 (m, 1H, C1-HaHb); 
13C NMR 
(101 MHz, CDCl3): δ 166.5 (C11), 157.9 (C9), 134.5, 134.4 (C6 and C12), 131.4 (C15), 128.5 
(C14), 127.5 (C7), 126.9 (C13), 113.9 (C8), 55.3 (C10), 50.8 (C3), 48.7 (C2), 28.0 (C4), 23.1 (C1); 





The title compound was prepared following a slightly modified literature procedure.303 A mixture 
of titanium (IV) ethoxide (22.4 mL, 107.0 mmol) and cyclobutanone (5.37 mL, 71.0 mmol) in dry 
tetrahydrofuran (120 mL) was stirred for 10 minutes. tert-Butanesulfinamide (7.17 g, 59.0 mmol) 
was added and the reaction mixture was stirred at room temperature for 18 hours. The reaction 
mixture was poured over stirring brine (130 ml), Celite® was added and the slurry was diluted with 
EtOAc (200 ml). The slurry was filtered, washed with EtOAc (3 × 50 ml) and the filtrate was 
charged into a separatory funnel and the organic layer was separated. The organic layer was 
washed with brine, dried over MgSO4 and concentrated in vacuo. The residue was purified by flash 
column chromatography (10% EtOAc/petrol) to afford the title compound 568 (7.53 g, 60%) as a 
colorless oil; νmax / cm
-1: 2959 (m), 1661 (s), 1362 (m), 1116 (s), 1078 (s); 1H NMR (CDCl3, 400 
MHz): δ 3.51 – 3.39 (m, 1H, C2-H2), 3.28 – 3.16 (m, 1H, C2-H2), 3.14 – 2.97 (m, 2H, C2-H2), 
2.10 – 2.00 (m, 2H, C1-H2), 1.20 (s, 9H, 3 × C5-H3); 
13C NMR (CDCl3,101 MHz): δ 186.8 (C3), 
56.7 (C4), 40.5 (C2), 39.9 (C2), 22.2 (C5), 15.0 (C1). The spectroscopic properties of this 




A solution of 568 (3.00 g, 17.31 mmol) in dry THF was quickly added to vinylmagnesium bromide 
(1 M in THF, 86.6 mL, 5.0 eq) in one batch at -78 °C and the reaction mixture was stirred at room 
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temperature for 18 hours. The reaction was cooled to -78 °C and sat. aq. NH4Cl (50 mL) was 
added. The solution was extracted with Et2O (3 × 75 mL) and the organic extracts were combined, 
washed with brine (100 mL), dried over MgSO4 and concentrated in vacuo. The residue was 
purified by flash column chromatography (30% EtOAc/petrol) to afford the title compound 569 
(2.08 g, 41%) as a colorless oil; νmax / cm
-1: 3206 (br. w), 2982 (m), 2950 (m), 1363 (m), 1150 (m), 
1051 (s), 914 (m); 1H NMR (CDCl3, 400 MHz): δ 6.02 (dd, J = 17.3, 10.5 Hz, 1H, C4-H), 5.30 
(dd, J = 17.3, 0.8 Hz, 1H, C5-H2, trans), 5.19 (dd, J = 10.5, 0.8 Hz, 1H, C5-H2, cis), 3.37 (br. s, 1H, 
N6-H), 2.33 – 2.16 (m, 4H, 2 × C2-H2), 1.91 – 1.80 (m, 1H, C1-H2), 1.73 (dp, J = 10.9, 8.6 Hz, 
1H, C1-H2), 1.20 (s, 9H, 3 × C8-H3); 
13C NMR (CDCl3,101 MHz): δ 141.8 (C4), 113.4 (C5), 60.8 
(C3), 55.5 (C7), 34.5 (C2), 33.7 (C2), 22.5 (C8), 14.0 (C1); HRMS: (ESI+) calculated for 





To a solution of 569 (2.78 g, 13.81 mmol) in dry Et2O (15 mL), MeOH (5.59 mL, 138.08 mmol) 
and then HCl (2 M in Et2O, 7.1 mL) were added via syringe at 0 °C. The reaction mixture was 
warmed to r.t., stirred for 1 h and then the precipitated was separated by filtration, washed with 
Et2O:hexane = 1:2 (3 × 15 mL) and dried under the high vacuum to afford amine hydrochloride 
570 (1.85 g, >99%). To a suspension of amine salt 570 (1.85 g, 13.85 mmol) in dry toluene (20 
mL) over 3 Å molecular sieves, Et3N (2.03 mL, 14.54 mmol) was added at r.t. and the reaction 
mixture was stirred for 1 h. Benzaldehyde (1.47 mL, 14.54 mmol) was added at r.t. and the reaction 
was stirred for further 16 h at r.t. The resulting mixture was filtered, rinsed with toluene and 
concentrated in vacuo. The residue was dissolved in MeOH (20 mL), cooled to 0 °C and NaBH4 
(0.63 g, 16.61 mmol) was added portionwise. The solution was warmed to r.t. and stirred for 6 h. 
The reaction mixture was concentrated in vacuo and then sat. aq. NaHCO3 (30 mL) was added. 
The solution was extracted with DCM (3 × 30 mL) and then the organic extracts were combined, 
washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo to afford the secondary 
amine intermediate. The obtained amine was dissolved in DCM (15 mL), Et3N (2.31 mL, 16.61 
mmol) and acetic anhydride (1.57 mL, 16.61 mmol) were added at 0 °C under nitrogen. The 
solution was warmed to r.t. and stirred for 16 h. Sat. aq. NaHCO3 (40 mL) was added and the 
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aqueous layer was extracted with DCM (3 × 30 mL). The combined organic extracts were washed 
with brine (50 mL), dried over MgSO4 and concentrated in vacuo. Flash column chromatography 
(20% EtOAc/petrol) afforded the title compound 571 (2.76 g, 87%, 1.12:1 mixture of rotamers 
A:B) as a pale yellow oil; νmax / cm
-1: 2986 (w), 2946 (w), 1645 (s), 1398 (s), 1349 (m), 708 (m); 
1H NMR (CDCl3, 400 MHz): δ 7.42 – 7.18 (m, 10H, 2 × C10-H, 2 × C11-H and C12-H, A+B), 
6.22 (dd, J = 17.1, 10.7 Hz, 1H, C4-H, B), 6.17 (dd, J = 17.1, 10.5 Hz, 1H, C4-H, A), 5.20 – 5.04 
(m, 4H, C5-H2, A+B), 4.47 (br. s, 2H, C8-H2, A), 4.34 (s, 2H, C8-H2, B), 2.54 – 2.09 (m, 8H, 2 × 
C2-H2, A+B), 2.02 (s, 3H, C7-H3, A), 1.95 (s, 3H, C7-H3, B), 1.89 – 1.57 (m, 4H, C1-H2, A+B); 
13C NMR (CDCl3,101 MHz): δ 172.5, 171.0 (C3, A+B), 139.8, 139.3, 138.8, 138.8 (C4 and C9, 
A+B), 129.0, 128.6, 127.3, 126.7 (2 signals), 125.8 (C10, C11 and C12, A+B), 112.2, 111.6 (C5, 
A+B), 64.4, 63.8 (C3, A+B), 49.3, 48.4 (C8, A+B), 34.6, 32.7 (C2, A+B), 23.4, 23.1 (C7, A+B), 






The title compound was prepared following a literature procedure.304 To a solution of 
bromocyclopropane (2.54 mL, 31.7 mmol) in diethyl ether (50 mL) at -78 °C. under nitrogen was 
added, dropwise, tert-butyllithium (18.2 mL of a 1.7 M solution in pentane, 31 mmol). Diethyl 
ether (30 mL) was added and the mixture was stirred for 1 hour at -78 °C. A solution of 
cyclopentanone (2.74 mL, 34 mmol) in diethyl ether (40 mL) was then added dropwise. The 
reaction was stirred for 4 hours at -78 °C. and was then allowed to warm to room temperature over 
16 hours. Water (40 mL) was added, the solution was extracted with Et2O (3 × 25 mL) and the 
organic extracts were combined, dried over MgSO4 and concentrated in vacuo. The residue was 
purified by flash column chromatography (100% DCM) to afford the title compound 572 (2.45 g, 
61%) as a colorless oil; νmax / cm
-1: 3422 (br. m), 2959 (m), 2926 (m), 1455 (m), 1391 (m), 1051 
(s), 1023 (s); 1H NMR (CDCl3, 400 MHz): δ 1.86 – 1.74 (m, 2H, C5-H2), 1.67 – 1.48 (m, 6H, C5-
H2 and 2 × C4-H2), 1.14 (br. s, 1H, O6-H), 1.09 (tt, J = 8.4, 5.5 Hz, 1H, C2-H), 0.45 – 0.39 (m, 
2H, 2 × C1-HaHb), 0.33 – 0.28 (m, 2H, 2 × C1-HaHb); 
13C NMR (CDCl3,101 MHz): δ 82.3 (C3), 
38.6 (C4), 23.9 (C5), 20.1 (C2), 1.5 (C1). The spectroscopic properties of this compound were 
consistent with the data available in the literature.304  




The amine intermediate was prepared following a slightly literature procedure.305 To a solution of 
sodium azide (1.12 g, 17.12 mmol) in toluene (8 mL) under nitrogen at room temperature was 
added trifluoroacetic acid (1.31 mL, 17.12 mmol). The mixture was cooled to 0° C and a solution 
of 1-cyclopropylcyclopentan-1-ol 572 (1.08 g, 8.56 mmol) in toluene (2 ml) was added dropwise. 
The mixture was stirred for 4 hours at 0 °C and allowed to warm to room temperature. 
Concentrated ammonium hydroxide solution (8 mL) was then added and the toluene layer was 
separated, washed with water (2 × 5 mL) and dried over MgSO4. The resulting solution was added 
dropwise to a solution of LiAlH4 (2 M in THF, 8.56 mL) in tetrahydrofuran (8 ml) at 0 °C under 
nitrogen. The mixture was stirred at room temperature for 16 h and then heated to 50 °C for 1 h. 
The reaction mixture was cooled to 0 °C, water (0.68 ml) was added dropwise, followed by 2.0 M 
aq. NaOH solution (1.28 ml) and water (2.05 ml). The mixture was stirred for 15 minutes, filtered 
and evaporated under reduced pressure to a volume of approx. 20 mL. The solution was washed 
with sat. aq. NaHCO3 (20 ml) and dried over MgSO4. Half of the resulting solution (approx. 8.56 
mmol of amine 574) was used in the next step without further purification. The amine 574 was 
converted to an amide 575 according to the General Procedure D using benzoyl chloride (0.75 
mL, 6.42 mmol) and the residue was purified by flash column chromatography (5-10% 
EtOAc/hexane) to afford the title compound 575 (230.3 mg, approx. 23% over three steps) as a 
colourless solid; m.p. 106-107 °C (DCM/hexane); νmax / cm
-1: 3356 (m), 2954 (m), 1634 (s), 1532 
(s), 1490 (m), 1309 (m), 1295 (m), 709 (m), 691 (m); 1H NMR (CDCl3, 400 MHz): δ 7.75 – 7.70 
(m, 2H, 2 × C9-H), 7.51 – 7.38 (m, 3H, 2 × C10-H and C11-H), 5.97 (br. s, 1H, N6-H), 2.16 – 
2.07 (m, 2H, 2 × C4-HaHb), 1.86 – 1.73 (m, 2H, 2 × C5-HaHb), 1.71 – 1.52 (m, 5H, 2 × C4-HaHb, 
2 × C5-HaHb and C2-H), 0.52 – 0.44 (m, 2H, 2 × C1-HaHb), 0.38 – 0.32 (m, 2H, 2 × C1-HaHb); 
13C NMR (CDCl3,101 MHz): δ 167.1 (C7), 136.2 (C8), 131.2 (C11), 128.6 (C10), 126.9 (C9), 65.3 
(C3), 35.6 (C4 and C7), 24.3 (C5 and C6), 18.8 (C2), 2.0 (C1); HRMS: (ESI+) calculated for 
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